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Summary 
Periodontitis is a ubiquitous infectious disease severely affecting 10% of the 
population. There are many areas of our knowledge regarding this disease that are 
incomplete. In particular, the microbial, inflammatory and immunological aetiology 
and pathogenesis of this disease remain the subject of many current investigations. 
Substantial literature exists on the humoral immune response against micro-organisms 
present within periodontal pockets and tissues. However, the literature is complex 
and it is difficult to elucidate due to the large number of putative periodontal 
pathogens, the large array of immunogenic antigens present on the surface of these 
micro-organisms and the potential cross reactive nature of them. In addition, there is 
enormous variation in both individual immune responses and the timing of a serum 
sample collection with respect to treatment stage and disease course. Identification of 
the immunodominant antigen or antigens involved in the disease process of 
periodontitis would be extremely informative, as it would pin point the important 
pathogens relevant to periodontal disease and identify the specific bacterial antigens 
of importance. In addition, it may furnish us with new approaches to diagnosis, aid 
the selection of potential vaccine candidates and suggest new therapeutic possibilities. 
This thesis reports on investigations carried out to identify the important antigens 
inducing a humoral immune response in periodontal disease. A number of different 
techniques were used. The first study examined the systemic immune response, 
specifically the effects of treatment on the immune response of patients with chronic 
periodontitis against a panel of periodontal pathogens and a large panel of antigen 
preparations from these bacteria. The results of the study indicated that there was no 
difference in antibody titre following treatment against any of the putative periodontal 
antigenic targets tested. These results conflict with many published reports, however, 
differences in factors such as length of treatment and antigen preparation often make 
the comparison of different studies futile. 
XXIII 
An investigation to examine the phenomenon of cross-reactivity between antibodies 
induced against putative periodontal pathogens was the second part of this overall 
project. The results suggested a high proportion of cross-reactivity between the 4 
periodontal pathogens P. gingivalis, A. actinomycetemcomitans, P. intermedia and B. 
forsythus. Results indicating such a high cross-reactivity between these micro- 
organisms prove that the issue of cross-reactivity is an important one that should be 
considered when carrying out any immunological and microbiological investigations 
in this field. 
Following the above investigations of the systemic immune response the remainder of 
this thesis is a report of three studies examining the local immune response in 
periodontal disease. The study reported in chapter 4 was an attempt to produce human 
monoclonal antibodies from immortalised antibody-bearing cells. These were isolated 
from the granulation tissue of diseased sites and the peripheral blood of patients with 
chronic periodontal disease. The aim of this study was to produce monoclonal 
antibodies against periodontal pathogens to be able to examine the antigenic target of 
the antibodies produced in more detail and to assess which bacteria induced humoral 
responses. Sequencing of the antigen binding domain of a monoclonal antibody 
produced in this way could indicate which antigen on the surface of a micro-organism 
is immunogenic and the target of the immune response in a particular disease. The 
results were disappointing in terms of monoclonal antibody production, however, 
antibodies specific for putative periodontal pathogens were initially produced which 
were indicative that the technique has potential for this type of study. 
An alternative approach was, therefore, undertaken to investigate the local immune 
response in periodontal disease. Chapter 5 describes the study that was carried out to 
examine the target of antibody-bearing cells isolated from granulation tissue removed 
from patients with chronic periodontal disease. This was investigated utilising 
Enzyme Linked Immunospot (ELISPOT), a technique which detects antibody- 
secreting cells directly. The results of the study indicate that there are antibody- 
bearing cells in diseased periodontal lesions specific to the pathogens tested, and there 
is no significant difference in the number of antibody-bearing cells detected against 
the 4 micro-organisms. 
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The final study set out to detect and enumerate antibody-bearing cells in tissue 
samples and this was accomplished by the development of an innovative and unique 
technique. The technique used was an immunohistochemical technique developed for 
this project. The results of this experiment were in agreement with those of the 
ELISPOT technique, that there was no significant difference in the number of cells 
detected against the antigenic targets tested. When the number of cells detected 
against the antigenic targets were compared in the granulation and gingival tissues 
sections there were significantly more cells detected against P. gingivalis, A. 
aetinomycetemcomitans and P. intermedia in the granulation tissue sections. When 
the numbers of cells were expressed as percentages of the total number of infiltrating 
plasma cells, however, this difference was not seen. To have the ability to express the 
numbers of cells specific for a particular antigen as a percentage of the total infiltrate, 
and in particular the total plasma cell infiltrate, could have major effects in the 
determination of the importance of a particular micro-organism and antigenic target 
and in the overall magnitude of a specific response. 
The future identification of the target of the humoral immune response in periodontal 
disease could have wide-ranging effects, not only in the progression of research and 
knowledge but also in terms of diagnostics and therapeutics. Numerous reports have 
suggested that elevations in humoral immune responses to micro-organisms are 
associated with disease severity (Genco et al., 1980b; Mouton et al., 1981; Tolo and 
Brandtzaeg, 1982; Listgarten et al., 1981; Ebersole et al., 1982b). Thus the discovery 
of the target of the humoral immune response is of utmost importance in diagnosis of 
disease activity and the possibilities of enhancing or modifying the humoral immune 
response to achieve treatment outcome benefits. 
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Chapter 1. General Introduction 
1.1 Biological Structure of the Periodontium 
1.1.1 Introduction 
A definition of the periodontium is "the tissues investing and supporting the teeth" 
(Hassell, 1993). This includes the alveolar bone, root cementum, periodontal 
ligament, and the gingivae. Together these form a functional unit (Lindhe and 
Karring, 1997), which can be reversibly or irreversibly disrupted by the inflammatory 
mechanisms of disease. Periodontal disease is a general term for the inflammatory 
reactions affecting the periodontium. From the above description, it can be seen that 
there are a number of different tissue types from a number of different development 
origins making up the periodontium, thus disease affecting any one of these tissues is 
strictly speaking a disease of the periodontium (Kinane and Davies, 1990). In the 
context of this thesis the term periodontal disease will be restricted to denote 
gingivitis and periodontitis, as classified in section 1.2. 
1.1.2 The gingiva 
The gingiva is the part of the oral mucosa that covers the alveolar processes of the 
jaws and the cervical portions of the teeth. Anatomically, it is divided into three 
distinct areas; the marginal, attached and interdental areas. The tissues collectively 
termed the gingiva are said to belong to the oral mucous membrane and the 
periodontium (Schroeder and Listgarten, 1997). Clinically, the gingiva is regarded as 
a combination of epithelial and connective tissues. These make up the mucosa that is 
around the teeth of the complete deciduous or permanent dentition and is attached to 
both teeth and alveolar processes (Schroeder and Listgarten, 1997). 
The gingiva is normally pink in colour, has a scalloped outline, a firm texture, 
stippling, and is demarcated apically from the oral mucosa by the mucogingival line. 
The colour of the gingivae may vary due to various amounts of melanin pigmentation. 
The mucogingival line normally resides approximately 3-5mm apical to the level of 
the alveolar crest. Attached keratinsed gingiva extends coronally from the 
mucogingival line and is firmly bound to the underlying periosteum by collagen 
fibres. The corono-apical width of the attached gingiva can vary significantly from 
tooth to tooth. The free gingival margin, which is normally about 1.5mm in the 
corono-apical dimension, surrounds but is not attached to each tooth. In health the 
gingiva completely fills the embrasure space between the teeth, and this part is termed 
the papilla (Wennström, 1988). 
The gingival sulcus consists of the tooth surface on one side and sulcular epithelium 
of the free gingiva on the other. It is a shallow crevice, and in fully developed teeth is 
lined coronally with sulcular epithelium, the non keratinised extension of the oral 
epithelium. The bottom of the sulcus is formed by the coronal surface of the 
junctional epithelium. 
The attached gingiva is continuous with the free gingiva and its apical extension leads 
to the mucogingival junction. At this point it is continuous with the relatively loose 
and movable alveolar mucosa. The attached gingiva is tightly attached to the 
underlying alveolar bone and demonstrates comparative immobility relative to the 
underlying tissue. The width of the attached gingiva differs among different teeth 
(Bowers, 1963). 
The interdental gingiva occupies the interproximal space beneath the area of tooth 
contact. The interdental gingiva can be pyramidal in shape i. e. one papilla's tip is 
immediately beneath the contact point, or have a `col' shape i. e. a valley-like 
depression that connects a facial and a lingual papilla and conforms to the shape of the 
interproximal contact (Cohen, 1959). 
The marginal gingiva is comprised of three areas of epithelium; the oral epithelium 
which faces the oral cavity, the sulcular epithelium which faces the tooth without any 
contact with the tooth surface and the junctional epithelium which is in contact with 
the tooth surface. The principal cell type of the gingival and oral epithelium is the 
keratinocyte, which constitutes more than 90% of the gingival epithelium. Other cell 
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types present include Langerhans cells (DiFranco et at., 1985), Merkel cells (Ness 
Morton and Dale, 1987) and melanocytes (Schroeder, 1969a). Keratinisation is a 
process that involves a sequence of biochemical and morphologic events that occur in 
the cell during its migration from the basal layers towards the surface (Schroeder, 
1969b). The gingival epithelium is able to express three types of surface 
differentiation; keratinisation, where the surface cells form scales of keratin and lose 
their nuclei, parakeratinisation, where the cells of the superficial layers retain their 
nuclei but there is no granular layer present, and non-keratinisation where the cells 
preserve their nuclei but all signs of keratinisation are absent. 
1.1.3 The oral epithelium 
The crest and the outer surface of the marginal gingiva and the surface of the attached 
gingiva are covered by the oral epithelium. This epithelium is made up of cells that 
are stratified squamous type, and exhibit keratinisation or parakeratinisation or both. 
The epithelium is bound to connective tissue by a basal lamina (Stem, 1965). In 
health the border between the oral epithelium and the connective tissue is 
characterised by deep epithelial ridges or rete pegs which are separated from each 
other by connective tissue papillae. 
1.1.4 The sulcular epithelium 
The sulcular epithelium lines the gingival sulcus and is a thin, non-keratinised 
stratified squamous epithelium displaying rete pegs. 
1.1.5 The junctional epithelium 
The junctional epithelium is also known as the dento-gingival epithelium. It is 
characterised by a collar-like band of stratified squamous epithelium and can range in 
length from 0.25 to 1.35mm. The junctional epithelium is attached to the tooth 
surface by a basal lamina (Listgarten, 1966). Unlike the oral and sulcular epithelium, 
the junctional epithelium lacks rete pegs (Lindhe and Karring, 1997). 
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The lamina propria consists of supra-alveolar fibre apparatus, blood and lymphatic 
vessels and nerves (Schroeder and Listgarten, 1997). The fibre apparatus is a dense 
network of fibre bundles which make up 55-60% of the connective tissue volume. 
The fibres are densely populated by fibroblasts and consist of collagen type I and III 
(Narayanan and Page, 1976). Mast cells are regularly found in this area and 
lymphocytes, monocytes and macrophages can also be evident. The supra-alveolar 
fibre apparatus plays an important role in attaching the gingiva to the teeth and bone, 
and also provides a dense framework that gives the rigidity and biochemical resistance 
to the gingiva (Schroeder and Listgarten, 1997). As well as providing this important 
rigid framework, the fibre apparatus also protects the cellular defences that are located 
at the dento-gingival interface (Schroeder, 1986). 
The gingival lamina propria or connective tissue, is highly vascularised. Branches of 
the main arteries supplying the blood to the maxilla and the mandible reach the 
gingiva from 3 sites; the interdental septa, the periodontal ligament and the oral 
mucosa (Castelli, 1963, Saunders and Röckert, 1967). The blood vessels of the 
gingiva are arterioles, capillaries and small veins. The nutritional supply for the 
gingival epithelium is provided by thin capillaries that terminate immediately below 
the basement membrane. The lymphatic drainage of the periodontal tissues involves 
the lymphatics of the connective tissue papillae. The lymph progresses into the 
collecting network of the larger lymph vessels and is drained into the regional lymph 
nodes of the head and the neck, before entering the blood circulation. Lymphatics just 
below the junctional epithelium extend into the periodontal ligament and accompany 
the blood vessels. High endothelial venules are not present when the gingiva is 
healthy, however, even in the early stages of experimental gingivitis, high endothelial 
venules are seen. It is considered their presence may be induced by mediators of 
inflammation. The reason for their presence is not confirmed, however, it may 
indicate a process of selective homing and migration of lymphocytes to the gingiva on 
infection (Wynne et al., 1988). 
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1.1.6 Clinical features of the healthy gingiva 
In `normal' appearance the gingiva is pink in colour, firm in consistency and the 
gingival margin has a clear scalloped outline. It does not bleed when gently probed 
and fills the entire space between adjacent teeth (Ainamo and Löe, 1966; Wennström, 
1988). Characteristically in health, the depth of the gingival sulcus is minimal at the 
microscopic level, with the alveolar bone located 1mm apical to the cementoenamel 
junction (Eliasson et al., 1986). The oral surface is covered by oral epithelium that is 
keratinised and fused with the junctional epithelium. The junctional epithelium is 
weakly attached to the tooth surface by hemidesmosomes. The oral and junctional 
epithelia are supported by the collagenous structures of the underlying connective 
tissue. Directly below the junctional epithelium is a microvascular plexus containing 
numerous venules (Egelberg, 1967). 
1.1.7 Clinical features of the diseased periodontium 
The discussion of the pathogenesis and histopathology of gingivitis and periodontitis 
can be found in section 1.7 of this thesis. As discussed there, the inflammatory and 
immune reactions that results from the hosts response to the plaque microflora and its 
products are visible both histopathologically and clinically in the affected 
periodontium. 
Periodontal disease is broadly classified into two distinct entities; gingivitis and 
periodontitis. Gingivitis refers to the pathological changes which are confined to the 
gingivae. Clinically this disease entity is characterised by a change in colour from 
pink to red of the gingivae, as well as a change in texture and appearance of the 
gingivae as it swells. The gingivae becomes more prone to bleeding on gentle probing 
and gingival sensitivity may be experienced, however, this disease is largely reversible 
(Löe et al., 1965). Periodontitis, affects the deeper attachment apparatus including the 
alveolar bone, periodontal ligament and the cementum, resulting in loss of periodontal 
support, and is largely irreversible. It is frequently associated with the presence of 
periodontal pockets, bleeding on probing, and bone loss is a pathognomonic feature. 
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1.2 The Classifications of Periodontal Disease 
1.2.1 Normal gingiva 
A normal healthy gingiva is characterised as described in 1.1.6. In histological terms 
a normal gingivae is free from inflammation and accumulation of inflammatory cells 
is not significant. As described by Kinane and Lindhe (1997), two different types of 
`healthy' gingivae can be described. The `pristine' gingiva has all the characteristics 
described above including little or no inflammatory infiltrate. This condition can only 
be achieved in humans by several weeks of experimental conditions requiring 
supervised and meticulous daily plaque control. The second type is the `clinically 
healthy' gingiva, which again has the features as described above, but histologically 
an inflammatory infiltrate is seen. This picture of health is clinically seen in everyday 
situations. 
1.2.2 Gingival diseases 
The following classifications of periodontal diseases and conditions is based on the 
recent classification system developed at the 1999 International Workshop for the 
Classification of Periodontal Diseases and Conditions. 
To define all the various clinical entities that effect the gingiva as `gingivitis' is 
considered too restrictive and confusing. The term `gingival diseases' has, therefore, 
been chosen as it provides a more comprehensive and encompassing definition of all 
the different entities that effect the gingiva. The following characteristics are common 
to all gingival diseases: (i) the clinical signs are confined to the gingiva; (ii) bacteria is 
present and its role is in either initiation or exacerbation of the severity of the lesion; 
(iii) there are clinical signs of inflammation and these include enlarged gingival 
contours due to oedema or fibrosis (Mühlemann and Son, 1971; Poison and Goodson, 
1985) colour transition from pink to a red and/or bluish-red hue (Mühlemann and Son, 
1971; Polson and Goodson, 1985), elevated sulcular temperature (Haffajee et al., 
1992; Wolff et al., 1997), bleeding on probing (Mühlemann and Son, 1971; Löe et al., 
1965, Greenstein et al., 1981; Engelberger et al., 1983) and increased gingival exudate 
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(Löe and Holm-Pedersen, 1965, Egelberg 1966, Oliver et al., 1969; Rüdin et al., 
1970); (iv) the clinical signs are not associated with attachment loss, and are therefore, 
reversible when the aetiologies are removed. 
Gingival diseases that are dependent on the presence of dental plaque for their 
initiation fall into two categories; plaque-induced gingivitis that is associated with 
local factors, and plaque-induced gingivitis that is affected by local factors and 
modified by specific systemic factors found in the host. 
1.2.2.1 Plaque-induced gingivitis associated with local factors 
Plaque-induced gingivitis is the result of bacterial presence. The aetiology of plaque 
bacteria was convincingly demonstrated by classical studies of experimental gingivitis 
in humans (Löe et al., 1965; Theilade et al., 1986). These studies have shown that in 
healthy individuals, gingivitis can develop when plaque bacteria accumulate, 
particularly at the gingival margin, and can be reversed by removing the plaque. 
Plaque-induced gingivitis has been shown to be prevalent at all ages in dentate 
populations (U. S. Public Health Service, 1965; U. S. Public Health Service, 1972; 
Stamm, 1986; U. S. Public Health Service, 1987; Bhat, 1991). This disease is 
considered to be the most common form of periodontal disease (Page, 1985). 
Clinically this disease is an inflammation of the gingiva. The normal `healthy' firm, 
regular contour of the gingiva appears swollen. In light skinned people the normal 
pink colour may appear red or blue-red (Mühlemann and Son, 1971; Polson and 
Goodson, 1985), however, in dark skinned individuals, this may not be so obvious. 
Within 10-20 days clinical signs of inflammation can be detected in most individuals, 
although this varies between individuals markedly depending on whether an 
individual is resistant or prone to the disease (Van der Weijden et al., 1994). 
The clinical changes in the early stages of gingivitis are usually subtle, although the 
intensity of the symptoms will vary amongst individuals as well as between sites 
within a dentition (Mariotti, 1999). Histologically the symptoms of gingivitis are 
quite marked. Many capillary beds are opened as alterations in the vascular network 
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occur. The tissues begin to take on the characteristic swollen appearance as exudative 
fluid, proteins and inflammatory cells move into the connective tissues subjacent to 
the junctional epithelium. The cellular infiltrate is comprised of mainly lymphocytes, 
macrophages and polymorphonuclear leukocytes (PMN). The lymphocytes and 
macrophages adhere to the collagen matrix and remain there, whereas the PMN tend 
to migrate into the gingival sulcus (Kinane and Lindhe, 1997). Other changes include 
proliferation of basal and junctional epithelium, which leads to apical and lateral cell 
migration. A marked reduction in the amount of collagen and fibroblasts occurs 
(Kinane and Lindhe, 1997). As previously mentioned, this disease is reversible, and 
radiographic analysis and examination of individuals with plaque-induced gingivitis 
do not reveal loss of supporting tissues (Mariotti, 1999). 
1.2.2.2 Plaque-induced gingivitis associated with local factors and modified by 
specific systemic factors 
It has been shown that gingival disease can be associated with many different factors. 
Endocrinotropic gingival diseases 
Studies undertaken in the eighteenth century revealed that an exaggerated gingival 
response can be seen during pregnancy (Eiselt, 1840; Pinard, 1877). Since these early 
reports, many others have followed indicating that sex hormones such as androgens, 
oestrogens and progestins can have an effect on the periodontal tissues. These types 
of gingival diseases are mainly seen in females at the time of distinct hormonal events, 
such as menstruation (menstrual-cycle-associated gingivitis) (Hugoson, 1971) and 
pregnancy (pregnancy-associated gingivitis) (Hugoson, 1971; Lbe and Silness, 1963; 
Löe, 1965; Arafat, 1974). They can also be seen in both sexes during puberty 
(puberty-associated gingivitis) (Mariotti, 1994). It should be noted that although the 
sex hormones can modulate the tissues during this disease, plaque micro-organisms 
must also be present to produce the gingival response. 
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Drug influenced gingival diseases 
Drug-induced gingival enlargement has a number of characteristics and there is a wide 
variation in inter-patient and intra-patient patterns (Hassell and Hefti, 1991; Seymour 
et al., 1996). It is more often found on the anterior gingiva (Hassell and Hefti, 1991; 
Seymour et al., 1996) and there is a higher prevalence of this disease in children 
(Esterberg and White, 1945; Rateitschak-Plüss et al., 1983; Hefti et al., 1994). Its 
onset is usually within 3 months (Hassell and Hefti, 1991; Hassell, 1981; Seymour, 
1991; Seymour and Jacobs, 1992) and enlargement is first observed at the interdental 
papilla (Hassell and Hefti, 1991). A change in gingival contour is seen which leads to 
modification of its size, and there is a change in colour of the gingiva and an increased 
gingival exudate. Clinically bleeding on probing is seen and it is found in the gingiva 
with or without bone loss, but it is not associated with attachment loss (Hassell and 
Hefti, 1991; Seymour et al., 1996). In this disease, as with all of the gingival diseases, 
there is a pronounced inflammatory infiltrate in response to the dental plaque present. 
Removal of the bacterial aetiologies can limit the severity of the lesion (Mariotti, 
1999). 
This disease is associated with anticonvulsants (e. g. phenytoin), immunosuppressants 
(e. g. cyclosporin A) and calcium channel blockers (e. g. nifedipine, verapamil, 
diltiazem, sodium valproate) (Hassell and Hefti, 1991; Seymour et al., 1996). 
Oral-contraceptive associated gingivitis 
Use of oral contraceptive agents has been linked to the development of gingival 
overgrowth. Several reports have shown the development of this disease in patients 
that had previously healthy gingivae (Kaufman, 1969; Lynn, 1969; Sperber, 1969). 
The reports indicate that the disease is reversed when the patients discontinue the 
contraceptive, or the dose is reduced. However, it has been shown that this disease is 
developed in the presence of very little plaque. 
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1.2.2 3 Gingival diseases associated with systemic diseases 
Diabetes mellitus-associated gingivitis 
A number of studies have been carried out investigating a possible link between 
diabetes and diseases of the periodontium (Bacic et al., 1988; Campbell, 1972). It has 
also been reported that diabetes mellitus-associated gingivitis seems to be a common 
feature of children with poorly controlled type I diabetes. The characteristics 
associated with this type of gingivitis are very similar to those of plaque-induced 
gingivitis, however, the control of the diabetes is much more important that control of 
plaque levels (Cianciola et al., 1982; Gusberti et al., 1983; Ervasti et al., 1985). 
Haematologic gingival diseases 
One example of these diseases is leukaemia-associated gingivitis. Most of the studies 
on this disease type have noted an association between the acute forms of leukaemia 
(Lynch and Ship, 1967). The characteristics of the disease are inflammation of the 
gingivae which give it a swollen, glazed appearance and the tissues appear spongy and 
purple (Dreizen et al., 1984). 
Although most of the cases of gingival diseases seen are plaque-induced, non-plaque 
associated types of gingivitis do exist. These can be related to bacterial, viral or even 
fungal infections. They will not be discussed in this thesis. 
1.2.3 Periodontitis 
Periodontitis is distinguished from gingivitis by the inflammation which extends to 
the periodontal structures, leading to a loss of connective tissue attachment of the 
teeth (Ranney, 1991). It has been recognised that there are different forms of 
periodontitis, and classifications of the different types is based on the classification 
system developed at the 1999 International Workshop for the Classification of 
Periodontal Diseases and Conditions. 
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1.2.3.1 Chronic periodontitis 
Until the World Workshop on classification in 1999, this form of periodontitis was 
referred to as adult periodontitis. It was characterised as a form of periodontitis that 
has an onset after the age of 35. The point of contention over the name for this form 
of periodontitis comes from the fact that although the prevalence, extent and severity 
of the disease increase with age, it is very difficult to determine at what age exactly 
the onset of the disease will occur. Although the disease is seen most commonly in 
the adult population, it can also be found in children and adolescents. Therefore, for 
this reason it has been renamed chronic periodontitis. 
Before periodontitis can occur there has to be a pre-existing gingivitis, and hence 
bacterial flora in association with the tissues. However, not all cases of gingivitis 
progress to periodontitis (Anerud et al., 1979; Listgarten et al., 1985). Periodontitis in 
contrast to gingivitis is seen in a much smaller subset of the population. Results from 
studies suggest that relatively few subjects in each age group suffer from advanced 
periodontal destruction, and that site predilection may be evident in the individuals 
affected (Jenkins and Kinane, 1989; Löe et al., 1965; Papapanou et al., 1988). 
Clinically, periodontitis is described by a number of features including clinical 
attachment loss, alveolar bone loss, periodontal pocketing and gingival inflammation 
(Flemmig, 1999). In addition to these features, enlargement and recession of the 
gingiva, bleeding on probing and increased mobility, drifting and tooth exfoliation 
may occur (Page and Schroeder, 1976). 
The recent World Workshop on classification (1999) decided that chronic 
periodontitis can be further characterised by the extent and severity of the disease and 
can be designated either localised chronic periodontitis or generalised chronic 
periodontitis. A guide has been given that disease can be termed localised if <30% of 
the sites are affected and generalised if >30% of the sites are affected. 
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1.2.3.2 Aggressive periodontitis 
This form of periodontitis was previously referred to as early onset periodontitis. Like 
adult periodontitis, there has been controversy over the name early onset periodontitis, 
as the disease is not confined to individuals under the chosen age of 35, which is used 
for diagnosis. It has therefore, been decided that diagnosis of the disease should not 
be based on the age at the which the patient presents his or her symptoms, but by 
clinical, radiographic, historical and laboratory findings, as this is a more reliable 
method (World Workshop Consensus Report, 1999). 
Aggressive periodontal disease is identified by common features which include: (i) 
that apart from periodontal disease the patients are fit and healthy; (ii) rapid 
attachment loss and bone destruction must be present; and (iii) that there is familial 
aggregation. The 1999 World Workshop also decided that the disease, sometimes but 
not always, has other characteristics and have therefore, published a list of secondary 
features that may be useful in diagnosis. These include: (i) that the amount of 
microbial deposits seen are inconsistent with the severity of the tissue destruction; (ii) 
that there are elevated proportions of Actinobacillus actin omycetemcoin itans (A. 
Actinonryceterncomitans), and in some populations Porphyromonas gingivalis (P. 
gingivalis); (iii) there are phagocyte abnormalities; (iv) there may be a hyper- 
responsive macrophage phenotype evident, including elevated levels of prostaglandin 
E2 (PGE2) and interleukin-1(3 (IL-lß); and (v) that the progression of attachment and 
bone loss may be self arresting (World Workshop Consensus Report, 1999). 
There are two forms of aggressive periodontal disease; localised aggressive 
periodontitis and generalised aggressive periodontitis. Both of these are classified by 
the common features listed above, however, the disease entities may be subdivided by 
the following features. Localised aggressive periodontitis may have: (i) a 
circumpubertal onset; (ii) a robust serum antibody response to infecting micro- 
organisms; and (iii) the disease may be localised to a first molar/incisor. There should 
also be interproximal attachment loss on at least two permanent teeth, one of which is 
a first molar, and involving no more than two teeth, other than first molars and 
incisors. 
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Generalised aggressive periodontitis may be diagnosed by the following 
characteristics: (i) usually the individuals presenting with this form of the disease are 
under 35 years of age. However, as already discussed, age is a disputable factor to use 
for diagnostic purposes, because classification will change the diagnosis as the patient 
grows older. The time that a patient presents with the disease does not necessarily 
mean that it is the age of onset, and therefore, may be older than 35; (ii) that 
individuals with this form of the disease have a poor serum antibody response to 
infecting agents; (iii) the destruction of attachment and alveolar bone is episodic; and 
(iv) there is a generalised interproximal attachment loss affecting at least 3 permanent 
teeth, other than first molars and incisors. 
1.3 The Microbiology of Periodontal Disease 
1.3.1 Introduction 
Although there are various environmental factors and host predispositions associated 
with the onset of periodontal disease, it is accepted that this disease is associated with 
microbial plaque, that is micro-organisms colonising tooth surfaces (Socransky and 
Haffajee, 1993). 
The oral cavity is made up of a number of distinct habitats, all of which experience 
different ecological conditions. These different ecological niches all support different 
populations of bacteria, and have a microbial community distinctive to themselves 
(Marsh, 1989). This microbial colonisation of the oral cavity originates from birth 
and it is thought that the colonising bacteria are acquired from the mother. Evidence 
for this theory comes from studies on scrotype tracing, bacteriocin patterns and more 
recently by restriction endonuclease mapping (Berkowitz and Jordan, 1975; Kulkarni 
et al., 1989). 
There are several ways of detecting and sampling oral micro-organisms. The most 
commonly used sampling techniques in the detection of bacterial species in 
periodontal samples are dental curettes and paper points (Baehni and Guggenheim, 
1996). Quantification of oral micro-organisms can be difficult. One of the main 
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methods used in characterisation of the oral microbiota is that of in vitro culturing 
methods, and hence, culturing observations (Baehni and Guggenheim, 1996). When 
using this approach, the sample is plated out on to non-selective agar, and the 
`predominant cultivable flora' detected and identified. Although an effective method, 
this approach can be technique-sensitive and very difficult to carry out. In addition it 
has been estimated that less than 50% of the total flora from subgingival samples can 
be cultivated (Loesche et ei., 1992b). Other molecular biology techniques have been 
developed over recent years including immunoassay and DNA probe methods. 
Three different types of DNA probe method have been developed; whole-genomic 
probes, cloned probes and synthetic oligonucleotide probes (Dewhirst and Paster, 
1991). The basis for this method is that DNA segments or sequences of nucleotides of 
16S rRNA unique to each bacteria are isolated. DNA probes prepared from a 
representative strain of the target micro-organism will hybridise to these sequences, 
hence, the detection of these bacteria is due to the binding of the DNA probe to the 
complementary strands of nucleic acids in these unique regions (Baehni and 
Guggenheim, 1996). 
Immunological methods have also been developed to detect different bacteria species 
(Tanner et al., 1991). Immunoassays include immunoprecipitation, 
immunofluorescence, immunohistochemistry, flow cytometry and Enzyme Linked 
Immunosorbent Assay (ELISA). Most of these methods do not identify the bacteria 
directly. In general polyclonal or monoclonal antibodies against species-specific 
surface antigens can be used to identify target bacteria (Baehni and Guggenheim, 
1996). 
Research by taxonomists has identified 300-400 bacterial species as being present in 
the human oral cavity (Moore and Moore, 1994). Some species are recognised as 
being transient, however, most are permanent residents (Darveau et al., 1997). These 
have fully adapted themselves to living in the environment offered to them by both the 
tooth surface and the surrounding conditions of the oral cavity and gingival epithelium 
(Darveau et al., 1997). Most of the time a dynamic equilibrium exists between the 
plaque bacteria and the host. Even in health, there are large numbers of micro- 
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organisms present in the oral cavity. The bacteria have adapted themselves to be able 
to survive in the environment, and the hosts immune system, both innate and adaptive 
arms, normally limit the growth of these micro-organisms. As mentioned, in health 
these micro-organisms challenge the host to maintain an effective defence. Under 
select conditions that may involve acquisition of certain species, combinations of 
species or less than optimal host defence, these bacteria can cause destructive 
inflammation (Darveau et al., 1997). 
If a tooth is freshly cleaned, a bacterial coating occurs rapidly on its surface (Marsh 
and Bradshaw, 1995). Within the first few hours, on the tooth surface a pellicle forms 
that consists of proteins and glycoproteins, that are found in saliva and gingival 
crevicular fluid (GCF) (Marsh and Bradshaw, 1995). Numerous studies have 
indicated the role of the pellicle in providing specific receptors for bacterial 
attachment (Duan et al., 1994; Gibbons et al., 1991; Hsu et al., 1994; Scannapieco, 
1994; Scannapieco et al., 1989; Scannapieco et al., 1995). The bacterial attachment is 
enhanced by the formation of the pellicle in both initial bacterial colonisation, and 
also additional bacterial attachment (Skopek and Liljemark, 1994). The term co- 
aggregation (Whittaker et al., 1996), is used to describe the phenomenon of two 
genetically different bacteria recognising and binding to one another. This is the 
mechanism by which the formation of dental plaque biofilm occurs (Whittaker et al., 
1996), and is based on specific interactions of a proteinaceous adhesion produced by 
one bacterium and a respective carbohydrate or protein receptor found on the surface 
of another bacterium (Darveau et al., 1997). Streptococcus species and 
Fusobacterium are thought to play a major role in the supragingival biofilm formation 
(Whittaker et al., 1996). 
Once the bacterial biofilm has been established, bacterial growth will occur. 
Characteristically, biofiims contain areas of high and low bacterial biomass interlaced 
with aqueous channels of different size (Costerton et al., 1995). The biofilm is 
designed to give each bacterial species its optimal environment for growth and gaining 
nutrients. There are two different types of dental plaque biofilms, each of which is 
composed of distinctly different species; supragingival plaque, which forms above the 
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gingival margin and subgingival plaque which forms below the margin (Darveau et 
al., 1997). 
Supragingival plaque resides above the gingival margin and is, therefore, found in the 
open space of the oral cavity. Due to its location it experiences constant disruption 
due to mastication and salivary flow, which restricts its net accumulation (Sissons et 
al., 1995). Supragingival plaque is also exposed to the innate immune mechanisms 
found in the saliva of the host. Saliva firstly, flows around the oral cavity creating a 
`washing' characteristic. It also contains numerous host defence components 
including secretary IgA, lactoferrin, lysosyme, and peroxidases (Shenkels et al., 
1995). Plaque accumulation occurs in the absence of oral hygiene. 
Subgingival plaque resides in a more protected location and the space available for 
this bacterial growth is limited in periodontally healthy individuals (Darveau et (1l., 
1997). More space can be made however, by reduction of the epithelial cell 
attachment levels and by an increase in pocket depth, related to this and the gingival 
swelling. GCF is not always advantageous to the host. Although it contains the 
innate and adaptive components of the host defence (Cimasoni, 1983), it also contains 
nutrients for the biofilm. In terms of the studies carried out in this thesis, subgingival 
plaque plays a more pivotal role in periodontal disease and the immune response that 
is induced. The following discussion highlights the species of importance in this 
disease, the characteristics they possess that make them harmful and their role in the 
disease progression. The problem with a discussion of this type when considering 
periodontal disease, is that unlike most other diseases, where the presence of some 
bacterial species can indicate disease, prevalence does not always correlate with 
periodontal disease. It is known that dental plaque is a complex permanent 
community and that the presence of large numbers of an indigenous species alone is 
not enough to lead to periodontal disease. The balance of the species probably plays a 
role, as well as the characteristics of the teeth, the gingival crevice and the host itself 
(Liljemark and Bloomquist, 1996). 
The bacteria resident in plaque could be advantageous to the host as well as making 
the host susceptible to disease. Firstly, it has been suggested that exposure to normal 
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microbial flora (commensal flora) may protect against colonisation by more 
pathogenic strains of the same species. Many indigenous microbes are thought to be 
closely related to their more virulent relatives and often possess common antigens 
(Liljemark and Bloomquist, 1996). Antibodies induced in an individual against a 
common antigen may provide a rapid immune response against a more pathogenic 
strain should the situation arise. 
Evidence for the accepted dogma, that most periodontal diseases are caused by 
bacteria in dental plaque (Socransky and Haffajee, 1990; Socransky and Haffajee, 
1991; Socransky and Haffajec, 1992), is strong and comes from several sources 
including: (i) Studies that show a correlation between most forms of gingivitis and 
periodontitis, and accumulated dental plaque; (ii) evidence suggesting that elimination 
of plaque micro-organisms leads to clinical improvement; and (iii) in vivo and in vitro 
reports indicating that different plaque micro-organisms have been shown to have 
virulent properties (Zambon, 1996). 
The last 3 decades have seen the emergence of the concept of microbial specificity in 
the aetiology of periodontal disease (Loesche, 1976; Socransky, 1977). Until 
discussions began as to the relative importance of individual bacterial species within 
the dental plaque, it was believed that periodontal disease resulted from the gross 
accumulation of dental plaque. This theory, known as the non-specific plaque 
hypothesis, suggested that the plaque associated with periodontal disease causes the 
disease when the homogeneous mass accumulates to the point of exceeding the host 
defences. This hypothesis explained previous clinical experiences when investigators 
linked the universal presence of gingival inflammation and periodontal pocket 
formation with the presence of abundant plaque (Tanner, 1988). Loesche (1976) 
suggested that periodontal disease be considered as non-specific because: (i) the lack 
of bacterial invasion. Bacterial invasion has been demonstrated, but it does not 
appear, as yet, to be part of an acute phase of disease progression; (ii) their apparent 
non-specific nature; (iii) their chronicity; and (iv) their universality. This non- 
specific hypothesis was also supported by Löe et al. (1965), who demonstrated that 
cessation of oral hygiene is associated with the concominant development of 
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gingivitis, and that resumption of oral hygiene eliminated the accumulated plaque 
mass and resolved the marginal gingivitis. 
This non-specific theory has been disregarded because the 300-400 bacterial species in 
the oral cavity show different characteristics and therefore, must play different roles 
(Dahlen, 1993). The non-specific hypothesis is contrasted by that of the specific 
plaque hypothesis. This states that the dental plaque micro-organisms isolated from 
periodontitis lesions are qualitatively different from those isolated from healthy sites 
(Loesche, 1976). Further evidence from cross-sectional and longitudinal studies of 
the predominant cultivable microflora, indicated that although periodontal diseases are 
polymicrobial infections, only a small number of species are associated with human 
periodontal disease (Moore et al., 1983; Theilade, 1986; van Winkelhoff et al., 1988a; 
Haffajee & Socransky, 1994). 
The concept of bacterial specificity in periodontal disease has been further supported 
by clinical observations, by therapeutic effect of control of these bacteria, and by 
experimental models of periodontitis in both gnotobiotic and conventionally 
maintained animals. However, the continued finding of increased numbers of a range 
of species in periodontitis patients, the presence of suspected agents in inactive sites, 
the failure of "specific" antibiotics to stop disease progression, and the absence of 
these agents in some active sites indicates that the specific plaque hypothesis may be 
invalid (Tanner, 1988). 
Therefore, while it is accepted that gingival inflammation can be associated with the 
build up of non-specific dental plaque micro-organisms, periodontitis may be 
associated with a much smaller number of bacterial species. The actual identification 
of these important pathogenic species remains elusive, but there are a number of 
bacteria which are considered possible candidates. 
In an attempt to identify periodontal pathogens the approach has been to use the 
criteria known as Koch's postulates. Koch's postulates were originally developed 
when Robert Koch was attempting to identify the aetiology of monoinfections such as 
the importance of Mycobacterium tuberculii in tuberculosis (Zambon, 1996). They 
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are less useful in the quest for the identification of periodontal pathogens for a number 
of reasons, firstly, it is a polymicrobial infection. Further to this, the postulates cannot 
be fulfilled for organisms that cannot be grown in pure culture, that demonstrate a 
long incubation period, that express pathogenicity first after another infectious agent 
has weakened the host immune response and that exhibit a range that is restricted to 
humans or to animal species in which the human disease cannot be reproduced (Slots, 
1999). Therefore, in recent years, Koch's postulates have been extended by 
periodontal research workers, to try and develop a set of postulates especially for the 
study of chronic infectious diseases such as periodontitis. As reported by Socransky 
(1977), the criteria used for identifying bacteria as being important in the aetiology of 
periodontal disease include: (i) compared to low numbers or absence in healthy or 
non-progressing sites there is a high number of the micro-organism in the periodontal 
lesion. The micro-organism is to be identified at numbers above a critical threshold 
prior to initiation of progressive disease, and statistical determination of the micro- 
organism as a risk factor; (ii) clinical improvement in the site should be seen on 
elimination of the micro-organism; (iii) host responses to the micro-organism should 
be seen. Indicators of this are high levels of specific antibody in the serum, saliva or 
GCF and a cell mediated immune response; (iv) clinical disease can be correlated with 
virulence factors; and (v) demonstration of tissue destruction in the presence of the 
micro-organism in appropriate animal models. 
A small number of the 300-400 of species that inhabit the oral cavity have been 
implicated as periodontal pathogens. These species include; Actinobacillus 
actinomycetemcomitans (A. actinomycetemcomitans), Bacteroides forsythus (B. 
forsythus), Canipylobacter rectus (C. rectus), Fusobacterium nucleatum (F. 
nucleatum), Prevotella intermedia (P. intermedia), Prevotella nigrescens (P. 
nigrescens), Porphyromonas gingivalis (P. gingivalis) and treponemes (Zambon, 
1996). 
Longitudinal studies examining the periodontal pathogens in sites undergoing clinical 
attachment loss have provided much of the evidence implicating pathogens in 
periodontal disease. In brief, pocket depth, attachment levels, subgingival 
temperatures, bleeding on probing, suppuration, redness and plaque were all 
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monitored in a group of 67 patients with no prior evidence of destructive periodontal 
disease. In addition to these clinical indices, the levels of 14 subgingival species were 
determined in subgingival plaque samples. These included A. actinomycetemcomitans 
serotypes a and b, B. forsythus, F. nucleatum ss vincentii, Peptostreptoccus micros, P. 
gingivalis, P. intermedia homology groups I and II, Streptococcus interinedius and C. 
rectos, also four beneficial species Capnocytophaga ochracea, Streptococcus Banguis 
I and II and Veillonella parvula. The results of this particular study confirmed the role 
of certain suspected pathogens (Haffajee et al., 1991). However, microbial species 
have been shown not to be evenly distributed from subject to subject or even from site 
to site, and even more so between different periodontal disease entities. A further 
problem connected with the clinical indices is that it is generally impossible to sample 
subgingival plaque bacteria at exactly the same time as clinically detectable 
connective tissue loss occurs. Therefore, speculation arises as to whether the resulting 
micro-organisms are the cause of the connective tissue loss or arrive secondary to it 
(Zambon, 1996). 
Of the putative periodontal pathogens, stronger evidence exists for some more than 
others. The following discussion looks at the micro-organisms considered to be the 
more important species in periodontal disease. It is important to stress that these 
bacterial species are currently considered as putative periodontal pathogens, however, 
whether these pathogens are true aetiologic agents remains elusive. 
1.3.2 Porplryromonas gingivalis 
Members of the Porphyromonas gingivalis species have the characteristics of being 
non-motile, asaccharolytic, Gram negative and obligately anaerobic coccobacilli 
which exhibit smooth, raised colonies. The morphology of the colonies may vary 
from smooth to cauliflower shaped on blood agar plates. The normal habitat of P. 
gingivalis is the oral cavity and most likely the gingival sulcus (Olsen et al., 1999). 
The organism is rarely found in supragingival plaque or outside the oral cavity (van 
Winkelhoff et al., 1988a). 
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These species show excellent properties for evading the host immune responses due to 
the production of enzymes, proteins and end products of their metabolism, which are 
active against a large number of host proteins (Holt et al., 1999). Many strains of P. 
gingivalis possess an external capsule. A strong correlation has been identified 
between the extent of encapsulation and several biological functions that have a 
significant effect on the biological properties of the bacteria (Holt et al., 1999). 
Studies have suggested that there is a decreased tendency of the encapsulated strains 
to be phagocytosed, an important factor for host response evasion (Schifferle et al., 
1993, Sundqvist et al., 1991). P. gingivalis has been shown to differ from other Gram 
negative bacteria, in that it does not have the capacity to directly stimulate the 
production of E-selectin by human endothelial cells, thus, hindering the migration of 
leukocytes into the extravascular compartment (Darveau et al., 1995). Further to this, 
lipopolysaccharide (LPS) of P. gingivalis has also been shown to bind LPS binding 
protein (LBP) very poorly, leading to poor myeloid cell activation (Cunningham et al., 
1996). Both of these strategies by this micro-organism hinder the protective 
characteristics of the innate host response. In addition, the cysteine proteases of P. 
gingivalis appear to be of great physiological importance, and will be discussed later 
in section 1.6.7. 
P. gingivalis is found rarely in health, however is often found in disease, particularly 
in periodontitis (Slots and Listgarten, 1988; van Winklelhoff et al., 1988a; Moore et 
al., 1991). It has also been shown that there is a higher load of P. gingivalis in active 
lesions compared with inactive lesions (Dzink et al., 1988; Walker and Gordon, 
1990). Evidence from studies investigating the effect of therapy on disease, indicate 
that levels of P. gingivalis remain high in sites that have responded poorly to therapy 
(van Winkelhoff et al., 1988b; Choi et al., 1990). High proportions of P. gingivalis 
were found in sites following breakdown of treatment, (Choi et al., 1990) indicating 
that this species may play an important role in the pathogenesis of disease recurrence. 
1.3.3 Actinobacillus actinonryceteincomitans 
Actinobacillus is a member of the family of Pasteurellaecae. This family are a group 
of nonenteric, fermenting Gram negative rods. The term `Actinobacillus' refers to the 
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internal star shaped morphology of its bacterial colonies on solid media, and to the 
short rod or bacillary shape of individual cells. Many of the family are found in 
animals, however, only A. actinoniycetemcomitans is routinely cultured from humans 
(Lally et al., 1996). A. actinomycetenicoinitans has been associated with a number of 
disease entities in man including; infective endocarditis, brain abscesses, 
osteomyelitis, subcutaneous abscesses and several forms of periodontal disease (Block 
et al., 1973; Page and King, 1966; Zambon et al., 1983; Zambon, 1985). 
Most periodontally healthy adults show low or no detectable levels of subgingival A. 
actinoniycetemcoin itans (Alaluusua and Asikainen, 1988; Gmür and Guggenheim, 
1994). There are five known scrotypes of A. actinoinycetemcomitans, a-e, and studies 
have indicated that serotype c seems to be found predominantly in health and that 
serotype b is found more frequently in patients with periodontal disease (Asikainen et 
al., 1991). 
A. actinonrycetemcomitans was first described to be found in increased numbers in 
patients with localised aggressive periodontitis (Slots et al., 1980; Zambon, 1985). 
More recently, studies on localised aggressive periodontitis have shown A. 
actinomycetemcomitans to be higher in numbers in periodontal lesions when 
compared with non-diseased sites (van Winkelhoff et al., 1994), and in active sites 
compared to inactive sites (Haffajee et al., 1984; Mandell, 1984). Although, A. 
actinomycetemcomitans has been linked predominantly with aggressive periodontitis, 
it is still implicated in chronic periodontitis (Gmür and Guggenheim, 1990). 
Further evidence of a pathogenic role for A. actinotnycetemcomitans comes from 
studies investigating the effects of periodontal treatment on the microbiological 
parameters. Studies have reported a correlation between successful treatment and 
suppression of A. actinomycetemcomitans, below detectable levels and unsuccessful 
treatment and a failure to suppress numbers of this micro-organism (Christersson et 
al., 1985; Mandell et al., 1986). Given the virulence of A. actinomycetemcomitans a 
number of authors have suggested that elimination of this micro-organism should be 
the goal of any periodontal therapy. Failure to eliminate this bacteria can lead to 
continued attachment loss or reduced healing (Zambon, 1996). 
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This species produces a number of virulence factors, such as cell surface 
carbohydrates and leukotoxin. Leukotoxin has drawn much interest and may play an 
important role in periodontal disease. It will not be covered here as a more 
comprehensive discussion of the topic can be found in section 1.6.6. 
1.3.4 Prevotella intermedia 
Prevotella intermedia is a black pigmented, short, round-ended anaerobic rod. It is 
thought that P. interinedia has a number of virulence properties also exhibited by P. 
gingivalis. Recently two species of P. intermedia that show identical phenotypic traits 
have been separated into two species; P. intermedia and P. nigrescens (Shah and 
Gharbia, 1992). 
P. intermedia has been associated with many forms of periodontal disease (Slots, 
1982; Loesche et al., 1982; Slots and Listgarten, 1988; Williams et al., 1985). Levels 
of P. intermedia have been shown to be elevated in certain forms of periodontitis 
(Dzink et al., 1983, Moore et al., 1985; Tanner et al., 1979). Both the frequency of 
detection and levels of P. intermedia are increased in active periodontitis lesions 
(Slots et al., 1986; Dzink et al., 1988; Moore et al., 1991), and it has been detected 
attached to epithelial cells in increased numbers at diseased sites (Dzink et al., 1989; 
Dibart et al., 1998). P. intermedia is a likely candidate for a periodontopathic 
organism, however, it does not appear to be as prevalent or pathogenic as P. 
gingivalis. 
1.3.5 Bacteroidesforsythus 
Bacteroides forsythus is a Gram negative, anaerobic, spindle shaped, highly 
pleomorphic rod. The last decade has seen the utilisation of new molecular biology 
techniques, such as detection of bacteria in plaque samples using immunofluorescence 
with polyclonal and monoclonal antibodies (Lai et al., 1987, Gmür, 1988) and DNA 
probes (Moncla et al., 1991). This work has led to suggestions that B. forsythus is a 
putative periodontal pathogen. Until these studies, B. forsythus was rarely reported to 
be one of the more predominant organisms in periodontal lesions. This was probably 
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due to the difficulties that occur when trying to culture B. forsythus. Culture of B. 
forsythus in vitro has many specific requirements (Wyss et al., 1989) and often 
requires 7-14 days for minute colonies to develop. Growth of this organism in vitro 
has been shown to be enhanced by co-cultivation with F. nucleatum, which it has been 
shown to commonly occur in subgingival sites (Socransky et al., 1988). B . 
forsythus 
has a requirement for N-acetylmuramic acid, and inclusion of this in media enhances 
growth of this micro-organism (Wyss et al., 1989). 
B. forsythus has been detected in the supragingival plaque of healthy patients (Gmür 
and Guggenheim, 1994). However, studies have shown B. forsythus to be at higher 
proportions in patients with gingivitis and periodontitis, than healthy subjects (Lai et 
al., 1987; Gmür, 1988; Moncla et al., 1991). Dzink et al. (1988) showed B. forsythus 
to be at increased proportions and with increased frequency in active sites compared 
to quiescent sites of periodontitis patients, and Lai et al. (1987) also showed increased 
numbers of the micro-organism in sites with periodontal breakdown. 
1.3.6 Spirochaetes 
Of the oral spirochaetes, the Treponema genera appears to be regarded as one of the 
more important. There are currently four named human species: T denticola; T. 
vincentii; T. pectinovarum; and T. socranskii. The organism T. denticola has been 
consistently reported to be associated with periodontal disease (Simonson et al., 1988; 
Haapasalo et al., 1992; Zambon, 1996), and is the cultivable spirochaete which 
predominates in most patients with chronic periodontal disease (Moter et al., 1998). 
Spirochaetes are not usually detected in healthy sites, but reach high levels in sites of 
disease. It is thought they average 30-50% of the microscopic counts in subgingival 
plaque samples recovered from periodontal pockets (Listgarten and Hellden, 1978). 
However, it has been difficult to ascertain whether the oral treponemes are present in 
large numbers in subgingival plaque from periodontitis sites and discover whether 
they are aetiologically relevant. Moter and colleagues (1998) recently suggested that 
the environment of the periodontal pocket is a very suitable niche, with its anaerobic 
environment and plentiful supply of host and microbial molecules for enriched growth 
of these species. 
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Spirochaete numbers are generally increased in patients with chronic periodontitis and 
can be found in very high prevalence (60-100%) (Loesche et al., 1985; Savitt and 
Socransky, 1984; Riviere et al., 1992; Riviere et al., 1995). They have also been 
linked with increasing pocket depth, bleeding on probing and bone loss (Omar et al., 
1991; Tanner et al., 1984; Savitt and Socransky, 1984). 
A number of potential virulence factors have been reported for T. denticola and 
following the trend seen for other putative periodontal pathogens, potential significant 
antigens have been suggested. These include: a periplasmic flagella, which provides 
motility (Boehringer et al., 1986); and two proteases (Ohta et al., 1986; Grenier et al., 
1990). The latter could contribute to the pathogenesis of periodontal disease, through 
their activity on other bacteria and host proteins (Grenier, 1996). A 53 kDa porin 
(Olsen et al., 1984; Haapasolo et al., 1992; Egli et al., 1993); some major outer- 
membrane proteins, which appear to function in attachment of the micro-organism to 
various host cells (Weinberg et al., 1990); and cystalysin, which enzymatically 
produces H2S and acts an hemolysin (Chu et al., 1997). Difficulties encountered 
when working with these often uncultivable species, have contributed to minimal data 
detailing the host immune responses to the oral treponemes. 
Further evidence indicating the importance of T. denticola is given in a study by 
Simonson et al. (1992) which shows a decrease in the proportion of T. denticola 
following successful treatment, however, MacFarlane et al. (1988) reported that 
spirochaetes are poor predictors of future disease activity. 
1.3.7 Microbial composition associated with health 
Further studies of the microbial composition of a healthy gingivae could provide 
important information regarding the distribution and numbers of bacteria present 
between health and disease. This could also lead to a clearer picture of micro- 
organisms that colonise and play a more important role in disease progression. 
The nature of periodontal disease makes comparison with healthy gingiva difficult as 
mentioned earlier. Subgingival plaque resides in more protected locations and the 
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space available for bacterial growth is limited in periodontally healthy individuals 
(Darveau et al., 1997). Much of the data regarding health has come from evaluation 
of healthy sites that have been selected as controls in other studies. The type of 
studies that this kind of data is obtained from includes; the starting point of 
experimental gingivitis (Listgarten et al., 1975; Moore et al., 1982; Syed and Loesehe, 
1978; Theilade et al., 1966) and healthy sites in periodontally diseased subjects 
(Moore et at., 1987; Moore and Moore, 1994; Tanner et at., 1979). The literature 
suggests the bacterial load associated with health in young individuals is relatively 
low and the micro-organisms present are predominantly Gram positive, streptococci 
and actinomyces. Approximately 15% of the microbiota isolated seem to be Gram 
negative rod species (Moore et al., 1982; Syed and Loesche, 1978; Tanner et at., 
1996). The situation appears to be a little different in older individuals. It has been 
reported that in healthy individuals, with no signs of previous gingivitis, up to 45% of 
the microbiota isolated from them appeared to be Gram negative bacteria (Newman et 
al., 1978; Slots, 1977). Microbiota isolated from healthy sites of adult patients with 
periodontitis were also identified as being from a similar range of Gram negative 
microflora (Moore and Moore, 1994; Tanner et at., 1979). The results discussed 
above suggest that colonisation of healthy sites with Gram negative bacteria occurs, 
however, it does not appear to result in disease alone. 
1.3.8 Microbial composition associated with gingivitis 
Although it is not the only predisposing factor for disease, colonisation by Gram 
negative bacteria is necessary for the onset and progression of disease. Many studies, 
both cross-sectional and longitudinal, have reported that gingivitis is associated with a 
change in the balance of Gram negative and Gram positive organisms and an 
increased microbial load. The microbial load has been suggested to change from 
approximately 102-103 in health to 104-106 in gingivitis and that there is an increase of 
15-50% of Gram negative organisms isolated from gingivitis versus health (Gmür et 
al., 1989; Lai et al., 1987; Listgarten et al., 1975; Moore et al., 1987; Moore et al., 
1984; Moore et al., 1982; Preus et al., 1995; Riviere et al., 1996; Slots et al., 1978; 
Syed and Loesche, 1978; Tanner et al., 1996; Theilade et al., 1966). 
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1.3.9 Microbial composition associated with periodontitis 
A further increase in microbial load is seen in periodontitis compared to health and 
gingivitis, and the load is reported to be in the range of 105-108 micro-organisms 
(Darveau et al., 1997). A significant proportion of periodontal sites harbour 
periodontal pathogens at a high prevalence, and this prevalence is seen to increase in 
deep periodontal pockets (Wolff et al., 1993). All of the above micro-organisms are 
found at high prevalence in disease sites of patients with periodontal disease. 
1.4 The Host Immune Response 
1.4.1 Introduction 
The immune system can be divided into two broad categories; the innate response and 
the adaptive immune response. Innate immunity is present from birth and does not 
change or adapt in response to a particular antigen. The adaptive or acquired immune 
response is specific and is acquired during the lifetime of an individual. The 
following discussion highlights the role of these two arms of the immune response in 
the onset and progression of periodontal disease. 
1.4.2 The innate immune system 
The innate immune response was first described by the Russian immunologist Elie 
Metchnikoff (1905). Metchnikoff discovered that many micro-organisms could be 
engulfed and digested by phagocytic cells called macrophages. This non-specific 
defence against infection is inborn or innate since its action does not depend upon 
prior exposure to a particular antigen (Janeway and Travers, 1994). 
The innate immune response is important as it is the first line of defence against 
infection. It can be divided into two clear phases. The first phase operates 
immediately, is constantly present and requires no induction. Physical barriers such as 
the skin and mucous membranes represent this component, which infectious agents 
must breach to gain access to the host. The washing action of fluids such as saliva, 
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tears, urine and GCF keeps mucosal surfaces clear of invading organisms. These 
secretions also contain bacteriocidal agents. The intact epithelial barrier of the 
gingival, sulcular and junctional epithelium usually prevents bacterial invasion of the 
periodontal tissues. The epithelial cell wall, secretes proteins and fatty acids which 
are toxic to many microbes. Salivary secretions provide a continuous flushing of the 
oral cavity as well as providing a continuing supply of agglutinins and antibodies. In 
addition, the GCF flushes the gingival sulcus and delivers all the components of the 
serum. Most epithelia of the body are associated with a normal flora of non- 
pathogenic bacteria which compete with pathogenic micro-organisms for nutrients and 
attachment sites on cells. The normal flora can also produce anti-microbial 
substances that prevent colonisation by other bacteria. 
All of these physical and chemical barriers to infection may be considered to be part 
of the innate immune system since they are non-specific and do not become more 
effective after exposure to a particular pathogen. However, barriers can be breached. 
All surfaces of the host can be damaged by cuts, grazes and burns which allow 
pathogens entry, and some bacteria can break down the barriers with enzymes. Thus, 
a second line of defence is necessary. 
Within seconds of a breach in the epithelial barrier, the second phase of the innate 
immune response is initiated. This is induced but still non-specific for the particular 
invading organisms, and does not generate immunological memory. One of the first 
signs of this phase of the immune response is inflammation. An inflammatory 
response can be triggered directly by pathogens, especially bacteria. The term itself is 
purely descriptive and was originally defined by the four Latin words dolor, rubor, 
calor and tumor, meaning pain, redness, heat and swelling. The quality of the host 
inflammatory response is critical to the disease process, although its purpose is 
protection and prevention of bacterial invasion, it can also be detrimental. It may also 
be an ineffective, chronic frustrated response which actually causes much of the tissue 
damage that occurs in periodontal disease. As the inflammatory immune response is 
non-specific and is induced against many different infectious agents all over the body, 
it seems reasonable to assume that it is not defective. Periodontitis patients, are not 
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typically susceptible to infections at other sites and hence it can be assumed that the 
inflammatory immune response that they induce, is effective. 
1.4.3 The inflammatory response 
The effects that occur due to the induction of an inflammatory response result from 
dilation of the local blood vessels. These vessels also become permeable and show 
expression of adhesion molecules which capture passing leukocytes. The reaction is 
accelerated by the first cells to arrive. These cells release molecules or inflammatory 
mediators which recruit more cells and which further enhance the reaction. The 
inflammatory response is mediated by an array of molecules including complement 
components, the contents of mast cell and basophil granules, and molecules secreted 
by macrophages. There is strong evidence that inflammatory mediators play a role in 
periodontal disease. In the periodontium, inflammatory mediators such as cytokines, 
proteinases, thrombin, histamine and prostaglandins are evident. These are produced 
and released from the activated infiltrating cells, plasma cells, resident fibroblasts and 
other connective tissue cells, and from activated complement and other plasma 
proteins (Page, 1991). They are produced in the blood plasma by the complement 
cascade and kinin system. Monocytes from individuals susceptible to or suffering 
from severe periodontitis, produce elevated amounts of mediators (Garrison and 
Nichols, 1989). Mediators are present within the inflamed gingiva and in the GCF of 
diseased sites in high concentrations. Concentrations of inflammatory mediators 
usually decrease following successful periodontal therapy (Offenbacher et al., 1993). 
1.4.4 Complement 
Complement is a collective term for a series of about 20 serum proteins that circulate 
in the body fluids in an inactive form. When the first component of a complement 
cascade is activated, a complex reaction is set in motion. The reaction products of 
each step in the sequence activate the next component in the cascade. A complement 
cascade can occur due to both innate and adaptive immune responses. The final 
products of a complement cascade are known as the membrane attack complex. This 
is a cylindrical assembly of molecules that are inserted into the cell wall of the 
29 
microbe in question. The insertion of this complex, opens up a pore through which 
sodium ions and then water flood into the cell, hence causing death (Janeway and 
Travers, 1994). 
The alternative pathway of the complement cascade can occur in the absence of 
specific antibodies when directly triggered by a microbial surface. In this way the 
same antimicrobial complement actions take place as seen in the classical pathway, 
but without the delay of 5-7 days that it takes to induce a specific antibody response. 
The necessary characteristics of a pathogens cell surface that allow direct triggering of 
the complement cascade are unknown. Endotoxins such as LPS from cell walls of 
Gram negative bacteria have been suggested as a possible trigger (Eley and Cox, 
1998). 
The protein C3 is abundant in the plasma and C3b is constantly produced by 
spontaneous cleavage. Although most of this will be inactivated by hydrolysis, some 
will bind covalently to the surface of host cells and pathogens. Binding of C3b leads 
to the binding of Factor B and the initiation of the cascade. The C3b that binds to the 
surface of host cells will not generally lead to the initiation of further activation steps. 
Cell surface proteins such as decay accelerating factor, membrane co-factor protein 
and the plasma protein factor H, prevent further activation. 
Not only is the membrane attack complex of importance, but in addition the small 
fragments of C5 and C3, called C5a and C3a are peptide mediators of inflammation. 
These fragments play a role early on and mediate local inflammatory responses, 
recruiting leukocytes and protein to the site of infection. They also lead to the 
accumulation of fluid. C3a and C5a are also able to attach to receptor sites on mast 
and inflammatory cells. They bring about the release of histamine and other 
substances from mast cells and prostaglandins from inflammatory cells. These 
complement fragments are chemotactic for PMN. They also aid phagocytosis by 
attaching the antigen to the phagocyte through the C3 receptor on the surface of PMN, 
monocytes and macrophages (Rietschel et al., 1984). Complement activation in the 
gingival crevice could provide the chemotactic stimulus for leukocyte recruitment and 
the release of leukocyte lysosomal enzymes, further increasing epithelial permeability. 
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Complement activation in the tissues itself can lead to increased vascular permeability 
and kinin activity (Nisengard, 1977). Complement studies of GCF from patients with 
periodontal disease suggest that complement is activated by the alternate pathway 
(Schenkein et al., 1976). Although studies have detected the presence of some 
complement factors in both periodontal patients and in subjects taking part in 
experimental gingivitis studies (Pattres et al., 1989), none of these factors appear to 
have any diagnostic value (Eley and Cox, 1998). 
1.4.5 Prostaglandins 
Prostaglandins play an important role in inflammation. PGE2 particularly exhibits a 
broad range of proinflammatory effects and these effects are enhanced by synergism 
with other inflammatory mediators (Williams and Peck, 1977). In vitro studies have 
indicated that prostaglandins have numerous effects in periodontal disease. They 
mediate bone resorption (Klein and Raisz, 1970; Goldhaber, 1971; Goldhaber et al., 
1973; Gomes et al., 1976). In terms of the inflammatory response, the production of 
prostaglandins from gingival tissues increases with inflammation (El Attar, 1976). In 
addition human monocytes have been shown to produce PGE2 when stimulated with 
LPS from various periodontal pathogens (Garrison et al., 1988). Gingival and 
periodontal ligament fibroblasts also secrete PGE2 in response to both IL-lß and in 
culture to media conditioned with LPS (Richards and Rutherford, 1988). 
1.4.6 Cytokines in inflammation 
The term "cytokine" is derived from the Greek word kytos meaning cell and kinesis 
meaning movement. Cytokines are small soluble proteins that make up a large and 
diverse group of molecules. They have a vast range of potent biological functions. 
Cytokines were first discovered in the context of research into the mechanisms of 
pyrogenesis and cellular immunology and the first cytokines to be discovered were IL- 
1 and IL-2. The number of cytokines discovered over the last 20 years now exceeds 
100. Cytokines are referred to as mediators because they are molecules which direct 
and regulate inflammation and wound healing. As a rule, the synthesis of cytokines is 
inducible, although some factors are known to be produced constitutively. 
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Cytokine regulation is achieved through several mechanisms. Control can take place 
at the gene activation level, during secretion and circulation and at the cell receptor 
level (Bendtzen, 1994). Although good control mechanisms exist, cytokine 
production is usually short lived and self limiting (Howells, 1995). In addition, many 
cytokine receptors exist in soluble forms, which may be cleaved from the target cells 
allowing them to bind and neutralise cytokines extracellularly (Bendtzen, 1994). 
Cytokines can be broadly split into two groups, those involved in inflammatory and 
immune reactions, and those involved in tissue growth and repair. The first group can 
be further sub-divided into; the interleukins that transmit information between 
leukocytes, chemokines or chemotactic cytokines that are involved in cell recruitment, 
and interferons which are involved in influencing lymphocyte activity. 
1.4.6.1 Interleukin-1 
In humans, there are two distinct gene products that have been cloned IL-la and IL- 
I P. These molecules are distinct but structurally related (Tatakis, 1993), they have 
similar proinflammatory properties, although IL-I 3 is more potent (Stashenko et al., 
1987). Sources of IL-1 production include macrophages, monocytes, lymphocytes, 
vascular cells, brain cells, skin cells, fibroblasts (Alexander and Damoulis, 1994), 
keratinocytes (Luger et al., 1981), endothelial cells (Miossec et al., 1986) and 
osteoblasts (Hanazawa et al., 1987). IL-I is a multifunctional cytokine and is one of 
the key mediators of the body's response to microbial invasion, inflammation, 
immunologic reactions and tissue injury (Alexander and Damoulis, 1994). 
IL-1 is a major mediator in periodontal disease. It has been found in the GCF of 
patients with the disease (Reinhardt et al., 1993) and also both as a protein (Jandinski 
et al., 1991) and mRNA transcripts (Matsuki et al., 1993) in inflamed gingival tissues. 
Production of IL-I is induced by LPS (Manthey and Vogel, 1994) and other bacterial 
components, including cell surface carbohydrates (Takada et al., 1993) and porins 
(Galdiero et al., 1993). 
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IL-1 is known to stimulate the proliferation of keratinocytes, fibroblasts and 
endothelial cells, and also to enhance fibroblast synthesis of type I pro-collagen, 
collagenase, hyaluronate, fibronectin and PGE2. From these functions it is obvious 
that IL-I is a critical component in the homeostasis of the periodontal tissues (Okada 
and Murakami, 1998). However, when the inflammatory response becomes chronic 
and there is unrestricted production of IL-I, it can become harmful and promote tissue 
damage. 
1.4.6.2 Interleukin-6 
IL-6 is a multifunctional cytokine that regulates immune responses, acute phase 
reactions and haematopoiesis (Hirano, 1991). IL-6 is produced by macrophages, 
fibroblasts, lymphocytes and endothelial cells. The production is induced by IL-1, 
tumour necrosis factor-a (TNF-a) and interferon-y (IFN-y) (Shalaby et al., 1989). 
The biological effects of this cytokine are similar and overlap with the properties of 
other cytokines including IL-I and TNF-a. 
There have been reports of the presence of IL-6 in the periodontal tissues (Kamagata 
et al., 1989; Barthold and Haynes, 1991; Shimizu et al., 1992), often at levels higher 
than those found in healthy controls. IL-6 is thought to be an essential cytokine for 
the terminal differentiation of activated B cells and may play a role in the induction of 
the elevated B-cell response seen in the gingival tissues of patients with chronic 
periodontitis (Fujihashi et al., 1993). 
1.4.6.3 Interleukin-8 
There are 12 members in the human IL-8 family (Skerka et al., 1993). IL-8 falls into 
the category of cytokines known as the chemokines. The chemokines are divided into 
two broad groups, a and P. They are distinguished by minor differences in structure 
and activation of different cell types. IL-8 is an a-chemokine and this group promotes 
the migration of PMN. IL-8 is a chemotactic factor for PMN, inducing them to leave 
the bloodstream and migrate into the surrounding tissues, in this case, the gingival 
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tissues. This process occurs in two stages. Firstly, IL-8 arrests the circulation of the 
cell. Subsequently it directs the migration of the cell along a gradient that increases in 
concentration towards the site of infection. 
IL-8 is produced by monocytes, macrophages, fibroblasts and keratinocytes. The 
production of mature protein and expression of IL-8 mRNA was demonstrated by 
various cell types, including neutrophils, particularly following phagocytosis (Skerka 
et al., 1993). 
Takashiba et al. (1992), reported that human gingival fibroblasts expressed IL-8 
mRNA when stimulated with IL-1(x and IL-1p. In addition, these cells also produced 
biologically detectable IL-8 when stimulated with IL-1(3 or TNF-a. This study also 
showed an increase in chemotactic activity in the conditioned culture medium which 
was in parallel with IL-8 mRNA expression. It is hardly surprising that IL-8 should be 
found in the tissues of the periodontium since PMN are the first cells to arrive at the 
site of inflammation and infection. 
1.4.6.4 Tumour necrosis factor-a 
TNF-a and TNF-ß are proinflammatory cytokines, produced mainly by macrophages 
and lymphocytes respectively (Manogue et al., 1991). TNF-a and TNF-ß show 
considerable sequence homology and bind to the same receptor (Aggarwal et al., 
1985). TNF-a is produced by macrophages in response to the recognition of 
microbial constituents, particularly LPS (Beutler et al., 1985), and the local effects of 
TNF-a are extremely striking. TNF-a primarily initiates the inflammatory response. 
It increases the vascular diameter of the local blood vessels, leading to increased blood 
flow and vascular permeability and local accumulation of serum. TNF-a also has an 
effect on the endothelium, inducing the expression of adhesion molecules that bind to 
the surface of circulating monocytes and PMN. This greatly enhances the rate at 
which these cells migrate across capillary walls into the tissue. TNF has been 
reported to have similar effects to IL-1 and IL-6 (Manogue et al., 1991). 
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Matsuki et a!. (1992), reported that TNF-a mRNA was abundant in macrophages and 
T cells in the gingival tissues of patients with moderate to severe periodontitis. 
1.4.7 Adhesion molecules 
One of the effects of TNF-a is to act on the endothelium to induce the expression of 
adhesion molecules that bind to the surface of circulating monocytes and PMN. This 
binding increases the rate at which these cells migrate from the small blood vessels 
into the tissues, This process is called extravasation. It is now evident that adhesive 
interactions control inflammatory/immune reactions from the initial stages through to 
the end stage "effector" functions of host-response cells (Crawford, 1994). 
Leukocyte adhesion deficiency (LAD), gives evidence of the beneficial role of cell 
adhesion molecules in inflammatory diseases. Patients suffering from this disease 
have an abnormal gene that codes for the family of adhesion molecules called the 
leukocyte integrins. Patients with this abnormal gene have a dramatically increased 
susceptibility to infections and suffer from a very severe form of periodontal disease 
that can lead to premature loss of deciduous and permanent teeth (Crawford, 1994). 
The main classes of adhesion molecules known to have a role in inflammation and 
immunity are the selectins, integrins, members of the immunoglobulin superfamily 
and some mucin-like molecules. All of these groups share similar properties. They 
are all complex proteins that interact via heterophilic binding with one or more 
ligands on other cells or the extracellular matrix. They are all involved in signalling 
events across the cell membrane, are regulated by cytokines and their expression and 
activity is localised at the site of inflammatory lesions. 
1.4.7.1 The selectins 
Selectins are cell surface molecules and all members of this group have a similar core 
structure but they differ in the lectin-like domain in their extracellular portion. 
Lectins are molecules that bind to specific sugar groups, and each selectin binds to a 
cell surface carbohydrate molecule. The selectins have therefore, so been named 
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based on their selective distribution and lectin arninoterminal domain (Bevilaqua, 
1989; Bevilaqua et al., 1991). There are 3 selectins described to date; E-selectin, P- 
selectin and L-selectin. Selectins are particularly important for leukocyte homing to 
specific tissues, and can be expressed on either leukocytes (L-selectin) or on vascular 
endothelium (P- and E-selectins). Selectin expression is induced by C5a, histamine 
and TNF-a and these selectins can be considered as the initial binding molecules. 
They mediate leukocyte rolling on the endothelial cells, thus allowing the leukocyte to 
be exposed to the same soluble factors as the endothelium. They are expressed 
relatively early in the inflammatory process i. e. 3-6 hours after exposure to antigen in 
vitro (R&D Systems, 1994). 
E-selectin was originally described as an activation antigen on endothelial cells in 
inflamed skin (Cotran et al., 1986). It is expressed by endothelial cells at the site of 
PMN infiltration (Munro et al., 1991), and constitutively by large blood vessels (Page 
et al., 1992a). In the periodontal setting it has been shown that E-selectin is expressed 
very early on in the inflammatory process (Moughal, 1992) and is drastically down- 
regulated in the more established lesion (Gemmel et al., 1994). It shows high affinity 
for PMN (Janeway and Travers, 1994) which explains its elevated expression in the 
inflammatory response when PMN numbers are high and decreased expression later 
on in the immune response when PMN numbers have declined (Kinane and Lindhe, 
1997; Lappin et al., 1999). 
P-selectin is only expressed on the cell surface after activation with thrombin, 
histamine or phorbol esters (Larsen et al., 1990; Toothill et al., 1990). P-selectin is 
contained in Wiebel-palade bodies of endothelial cells and a-granules of platelets. It 
is released during clotting, and at times of platelet activation and mediating adhesion 
between leukocytes and platelets (Freemont, 1998). 
L-selectin is the only selectin to be expressed constitutively at the cell surface. It is 
expressed by some lymphocytes, PMN, monocytes and other myeloid cells (Stoolman, 
1989). L selectin has been termed the "homing receptor" and is involved in 
trafficking PMN into inflammatory lesions. 
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E-, P- and L-selectin all have the common ligand the Siayl-Lewisx moiety. This is 
found in the sulphated form as part of the structures of mucin-like vascular addressins: 
CD34; Glycosylated Cellular Adhesion Molecule-1 (GlyCAM-1); and Mucosal 
Addressin Cellular Adhesion Molecule-1 (MadCAM-1) molecules. Each integrin also 
has other ligands (see Table 1.1) (Janeway and Travers, 1994; McMurray, 1996). 
1.4.7.2 The integrins 
The integrins comprise an extensive family of adhesion molecules and consist of a 
large a chain paired non-covalently with a smaller ß chain. There are several 
subfamilies of integrins which are defined by their 1 chain. However, this concept is 
controversial since it is difficult to group integrins by individual a chains associated 
with one ß chain, as one a chain can associate itself with more than one ß chain 
(Crawford and Watanabe, 1994). Despite this, 3 distinct families of integrins have 
arisen based on (3l, (32 and ß3 chains. The ß1 family, are involved in adhesion to 
connective tissue macromolecules such as fibronectin, laminin and collagens. The ß2 
family are involved in cell/cell interactions in inflammation and immunological 
reactions. The ß3 family, are involved in binding to vascular ligands such as 
fibrinogen, van Willebrand factor, thrombospondin and vitronectin (Crawford and 
Watanabe, 1994) and are recognised as playing an important role in inflammation. 
al ß2 (LFA-1) was the first integrin to be characterised and is expressed on all 
leukocytes, with the exception of some macrophages. Ligands of a1ß2 include 
Intercellular Adhesion Molecule I (ICAM-1) (Marlin and Springer, 1987), ICAM-2 
(Diamond et al., 1990) and ICAM-3 (Vaseuax et al., 1992). LFA-1 is thought to be 
the most important adhesion molecule for lymphocyte activation, as antibodies to 
LFA-l inhibit the activation of naive and effector T cells. a2ß2 (Mac-1), is expressed 
by PMN, monocytes and macrophages and a3ß2 (gp150,95) is mainly expressed by 
monocytes and macrophages, and at a lower density on PMN. 
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1.4.7.3 The immunoglobulin superfamily 
The immunoglobulin superfamily has a distinguishing feature from other adhesion 
molecules, they have a domain that is a compact region of the polypeptide chain 
enclosed by a disulphide bond. Members of this family include ICAM-1, ICAM-2, 
ICAM-3, LFA-3, and VCAM-1 (Simmons et al., 1988; Staunton et al., 1989; Osborn 
et al., 1989). 
ICAM-l is expressed on vascular endothelium, thymic epithelial cells, fibroblasts, 
macrophages and germinal centre dendritic cells in lymphoid tissue, epithelial cells in 
the mucosa of tonsils (Dustin et al., 1986) and Langerhans cells (De Panfilis et al., 
1990). ICAM-1 plays an important role in the inflammatory response, by being 
induced on endothelial cells and encouraging the migration of leukocytes into infected 
tissues. 
ICAM-2 binds to LFA-1 but not Mac-1 (Diamond et al., 1990). It is thought to be 
more important in re-circulation of lymphocytes, rather than in extravasation and their 
localisation into sites of infection. The reasoning behind this theory is that ICAM-2 is 
the major ligand for LFA-1 on resting endothelium (Defougerolles et al., 1991) 
ICAM-3 is expressed on unstimulated peripheral blood lymphocytes, monocytes and 
PMN (DeFougerolles and Springer, 1992; Fawcett et al., 1992). ICAM-3 is 
homologous to ICAM 
V-CAM-I is another adhesion molecule that is involved in the extravasation process 
of leukocytes into sites of infected tissue. During inflammation at peripheral sites, 
postcapillary venules express V-CAM-I in response to cytokines such as IL-I and IL- 
8 (Albeda et al., 1994). As the periodontal lesion progresses there is increased 
expression of VCAM-1 and ICAM-1, which favours the migration of leukocytes 
expressing ligands for these molecules i. e. Very Late Antigen-4 (VLA-4/ (X4ß1 
integrin) and LFA-I integrin respectively. VLA-4 is specific for T and B lymphocytes 
and is upregulated on these cells when in contact with activated endothelium 
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(McMurray, 1996), hence the increased proportions of lymphocytes in the more 
established lesion (Kinane and Lindhe, 1997; Lappin et al., 1999). 
Mucosal Addressin Cellular Adhesion Molecule-I (MAdCAM-1) has recently been 
identified on the post-capillary venules of gut mucosa and high endothelial venules of 
lymphoid tissue and dendritic cells. It is considered to be a specific adhesion 
molecule for the mucosal tissue and is an important controlling factor determining 
whether a mucosal or non-mucosal immune reaction occurs due to the cell type it 
recruits (Briskin et al., 1997). MAdCAM-1 has been shown to have strong homology 
with VCAM-1 and ICAM-1 in certain domains and its principle ligand is the a4137 
integrin on T and B lymphocytes which can bind to MAdCAM-1 or VCAM-1, 
probably via the common a4 sub-unit (Leung et al., 1996). L-selectin is also a known 
ligand for MAdCAM-1. The role of MAdCAM-1 in the periodontal disease immune 
response is still not clear. 
The migration of leukocytes from blood vessels into the tissues is called 
extravasation. The whole process can be described in four different steps. The first 
step involves weak adhesion of leukocytes to the vessel wall. Circulating leukocytes 
are seen "rolling" along the area of endothelium which is involved in the 
inflammatory response. These weak adhesions are mediated by the adhesion 
molecules P-selectin and E-selectin which are found on endothelium cells. P-selectin 
is expressed after a few minutes of exposure to TNF-a, and E-selectin after a few 
hours. All selectins bind leukocytes after recognition of specific carbohydrate 
epitopes on their surface; for example the Siayl-Lewisx moiety on specific 
glycoproteins. 
The second step of this migration process involves interactions between the 
immunoglobulin related molecule ICAM-1 and LFA-1 and Mac-1. ICAM-1 is 
induced by TNF-a on the surface of endothelial cells. LFA-1 and Mac-1 are always 
found on the surface of phagocytic cells, however, they do not have a high affinity for 
ICAM-1. IL-8 is a chemotactic factor for PMN inducing them to leave the 
bloodstream and migrate into the surrounding tissue, in this case the gingival tissues. 
IL-8 induces phagocytes to leave the blood vessels by greatly increasing the affinity of 
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LFA-1 and Mac-I for ICAM-1. This causes the phagocytes to bind tightly to 
endothelium, and the rolling to arrest. 
The third step involves the cell actually crossing the endothelial wall. This is due to 
adhesive interactions involving LFA-1 and Mac-1 found on the leukocytes and also 
PECAM or CD31, an immunoglobulin related molecule found both on the leukocyte 
and also at the junctions of the endothelial cells. These interactions allow the 
leukocyte to cross the vascular endothelial cell wall by a process called diapedesis. 
The final step, is the migration of leukocytes through the tissues to the site of 
infection. This occurs along a chemotactic gradient set up by chemotactic factors. 
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Table 1.1 Major Adhesion Molecules 
NAME SYNONYM 
CD number) 
LIGAND(S) RECEPTOR 
EXPRESSION 
SELECTINS 
Initiate leukocyte to endothelium interaction 
L-Selectin LAM-1, Mel-14, 
(CD62L) 
G1yCAM-1, 
MAdCAM-1, (CD34), 
Siayl Lewisx moiety 
T-cell, Monocyte, 
Neutrophil 
E-Selectin ELAM-1, (CD62E) Siayl Lewis' moiety Endothelium 
P-Selectin GMP-140, PADGEM, 
(CD62E) 
PSGL-1, Siayl Lewis' 
moiety 
Platelets, Endothelium 
MUCIN LIKE VASCULAR ADDRESSINS 
Bind to L-selectin to initiate leukocyte-endothelial interactions 
CD34 L-Selectin Endothelium 
Gl CAM-l L-Selectin HEV Endothelium 
MAdCAM-1 
(Immunoglobulin supergene member 
also) 
L-Selectin/a4ß7/CS-1 Mucosal Lymphoid 
Tissue Venules 
INTEGRINS 
Bind cell adhesion molecules and extra cellular matrix strongly 
ß1 (VLA) 
a4(31 VLA-4 (CD49d/29) VCAM-1, Fibronectin, 
Peyer's Patches High 
Endothelial Venules 
T-cell, B-cell 
a5(3l VLA-5 (CD49e/29) Fibronectin T-cell, Endothelium, 
E ithelium, Platelets 
ß2 
aL 2 LFA-1, (CDIIa/18) ICAM-1, ICAM-2 Leukocytes 
amß2 MAC-1, CR3, 
CD1lb/18) 
ICAM-1, C3bi 
Fibronectin 
Monocytes 
Neutro hils 
I7 
a4 p7 LPAM-1 (CD49d/-) MAdCAM-1, V CAM-1 T-cell, B-cell 
IMMUNOGLOBULIN GENE SUPER-FAMILY 
Various roles- Tar et or Integrins 
ICAM-1 (CD54) MAC-1, LFA-1 All cells 
ICAM-2 (CD 102) al 2 Endothelium 
PECAM-1 (CD31) PECAM-1 Endothelium 
VCAM-1 (CD106) a4 1 Endothelium 
LFA-2 (CD2) LFA-3 T-cell 
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1.4.8 Polymorphonuclear leukocytes (PMN) 
PMN are granulocytes and along with basophils, mast cells and eosinphils are short 
lived phagocytes which play an important role in the inflammatory immune response. 
Under normal conditions PMN comprise between 50% and 70% of the circulating 
leukocyte pool in man (Miller et al., 1984). The half-life of the PMN in the peripheral 
circulation is brief, being 6-7 hours (Murphy, 1976). 
The PMN plays a key role in the early stages of an inflammatory response and arrives 
at the site of infection within a few hours. As previously discussed, when functioning 
against an infectious agent, PMN leave the blood vessels and move across tissues 
towards a chemotactic source. Adhesion molecules necessary for the movement of 
PMN from vessels are expressed on endothelial cells and PMN (Rosales and Brown, 
1993). The adhesion of PMN is controlled by upregulation of P-selectin, on 
endothelial cells of post capillary venules by thrombin or histamine (Staunton et al., 
1990). 
PMN respond to many different chemoattractants, including N-formyl peptides, 
complement derived C5a-desarg, Leukotriene B4, IL-8, TNF and platelet activating 
factor (Havarth, 1991). Using time-lapse cinematography or other visual methods for 
following the tracks of cells, it has been shown that PMN can migrate in fairly straight 
paths towards the source of a chemical gradient (Zigmond, 1974; Allan and 
Wilkinson, 1978). Once PMN have been stimulated by chemoattractants they 
undergo morphological changes from their unstimulated spherical morphology. 
Within two or three minutes, the typical locomotor morphology changes to a ruffled 
anterior lamellipodium, tapered cell body, with a tail (Smith et al., 1979; Shields and 
Haston, 1985; Keller et al., 1983). As the cell moves forward, the most active 
movements are seen at its head, and contraction waves may pass down through the 
body of the cell to the tail (Haston and Shields, 1984). There is also evidence that 
some receptors of the PMN may redistribute to the head of moving cells (Wilkinson, 
1990). The mechanism for this is unknown. One theory suggests that a signal from a 
ligand causes actin polymerisation. Thereafter, the newly formed cytoskeleton in the 
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pseudopod sweeps forward not only activating the receptor-ligand complex, but also 
other membrane proteins (Wilkinson, 1990). 
Once at the site of the chemotactic stimulus and prior to attachment of the PMN to the 
invading organism, opsonisation takes place either in the presence or absence of 
complement and antibody. The presence of opsonins, as mediated by PMN membrane 
receptors, dramatically increases the rate of phagocytosis by PMN. Heat stable 
opsonins include all 4 classes of Immunoglobulin G (IgG) (Miller et al., 1984) and the 
heat labile opsonin, attributed to complement cleavage protein C3b (Stosse], 1974). 
The products of C3 activation and IgG bind their respective PMN receptors, CRI and 
CR3 for complement and FcyRII and FcyRIII for IgG. The only drawback of this 
mechanism is when the host is dealing with a capsular organism. Capsular organisms 
are able to evade this opsonisation process, and hence phagocytosis. This is due to the 
masking of the antigenic portion of their cell wall by the capsule which avoids the 
deposition of complement on their surface (Slots and Genco, 1984). 
If antibody or complement are not available then alternative mechanisms of 
opsonisation of the bacteria come into play. Lipopolysaccharide binding protein 
(LBP) is an acute phase reactant which binds LPS, a cell wall component of Gram 
negative bacteria themselves. Opsonisation is achieved in this way, as the binding of 
LBP to LPS on bacteria enables ligation of bacteria to PMN through the CD14 
receptor, thus enhancing phagocytosis (Wright et al., 1989). 
Following opsonisation, phagocytosis can take place. Phagocytosis is the process 
whereby the PMN takes up a particle. Adherence of the phagocytic cell to a pathogen 
triggers a system of contractile actin-myosin filaments inside the phagocyte. This 
enables the cell to "throw its arms" or pseudopodia around the target and enclose it in 
its membrane. The membrane surrounding the pathogen fuses with membranes 
surrounding lysosomes in the phagocytic cell. Lysosomes are small intracellular 
packets of powerful degradative enzymes and toxic molecules, which are emptied 
onto the engulfed pathogen with a destructive effect. 
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Once phagocytosed and engulfed by the PMN, there are two mechanisms for killing 
the target organism; the oxygen dependent and the oxygen independent pathways 
(Van Dyke, 1985). Oxygen dependent killing is activated when the PMN undergoes a 
respiratory burst coincident with phagocytosis. Nicotinamide adenine dinucleotide 
hydrogen phosphate (NADPH), a continuous supply of which is generated from 
glucose via the hexose monosulphate shunt in the phagolysosome membrane, is 
activated and reduces oxygen (02) to superoxide (02) (Weiss et al., 1982). Following 
the generation of hydrogen peroxide (H202) and hydroxyl ions (OH), a second enzyme 
system involving myeloperoxidase becomes activated. Myeloperoxidase is released in 
large quantities, however, on its own has little effect. In combination with H202, 
myeloperoxidase is capable of oxidising halides to reactive toxic compounds like 
HOC13 and chloramines (Weiss, 1989). 
OH is considered the most toxic of all the free radicals. This reaction in vivo is 
limited by the availability of iron. Little free iron is actually available due to its 
binding to transferrin and lactoferrin extracellularly and apoferrin intracellularly 
(Sanchez et al., 1992). In the phagocytic vacuole the pH is reduced and some iron 
may be lost from transferrin. Lactoferrin retains its ability to bind iron at low pH, thus 
protecting the cell and limiting the production of OH (Halliwell and Gutteridge, 
1985). 
Oxygen independent killing is based on the PMN granule network. Antimicrobial 
agents, which are independent of oxygen, are released into the phagolysosome during 
phagocytosis (Thomas et al., 1988). These granule components, include 
bactericidal/permeability-increasing protein, chymotrypsin-like cationic protein and 
defensins (Weiss et al., 1982) and those outlined above. They are strongly 
bactericidal and in most cases kill bacteria (Miyazaki et al., 1997). In addition to 
killing bacteria, the proteolytic enzymes, including elastase and the 
metalloproteinases, have the potential to damage extracellular tissue. 
Many investigators have addressed the issue of whether the presence of PMN in the 
sulcus indicates anything about the pathogenesis of periodontal disease. An 
experimental study was carried out by Löe (1961). This investigated healthy gingival 
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sulci in a group of dogs that were sealed at the margin. The results of the study 
indicated that neutrophils and epithelial cells clustered near the margin and had filled 
the sulci in 12-48 hours. This study demonstrated that the increase in trapped material 
was due to the continuing phenomenon of epithelial desquarnation and migration of 
neutrophils that occurs in normal situations. It is generally accepted that PMN 
migrate into clinically healthy sulci in small numbers. One study which supports this 
theory, was carried out by Yamasaki et al. (1979). This report showed that PMN were 
routinely seen within the intercellular spaces of the junctional epithelium of germ free 
rats, at all levels of attachment. This investigation was carried out on germ free rats 
and therefore, indicted that the presence of PMN in the sulcus cannot be exclusively 
explained on the basis of the presence of micro-organisms. It may represent a 
physiological phenomenon specific to this tissue type. 
There is a statistically significant increase in PMN in the junctional epithelium of 
humans in experimental gingivitis trials after 2-4 days, compared to clinically healthy 
gingiva (Payne et al., 1975). In this study, as gingivitis developed, the number of 
leukocytes also increased, until oral hygiene measures were reinstated. Cell counts 
showed that 95-100% of the cells collected were PMN. Very few leukocytes were 
found in the crevices of healthy gingiva. 
Animals have been used over the last few decades for immunological studies to 
provide evidence for the function and importance of PMN in the periodontal 
environment. Garant (1976) showed that in monoinfected rats, the PMN response to 
micro-organisms resulted in formation of a neutrophil wall or barrier between the 
plaque and host tissue. It has been suggested that this barrier may assist in preventing 
invasion of bacterial products into the tissues. 
Further indications that PMN play a role in the inflammatory immune response, come 
from patients that suffer from periodontal disease, as well as other clinical 
manifestations, particularly deficient PMN function. Neutropenic states have been 
associated with rapidly progressive forms of periodontal disease (Miller et al., 1984). 
In cyclic neutropenia, every 14-21 days, PMN disappear from the circulation and 
reappear after approximately 5 days. In health, PMN comprise 50% to 70% of the 
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circulating leukocyte pool, whereas in cyclic neutropenia they never comprise more 
than 50%. Recurrent ulcerations of the oral cavity are common, particularly on the 
mucosa, the lips and the throat, whenever the number of PMN fall. Radiographs have 
been taken in some cases, these have indicated involvement of the periodontal tissues, 
showing bone loss around the primary and secondary teeth (Miller et al., 1984). 
A high percentage of family members, with a background of localised aggressive 
periodontitis, have been reported to show abnormal chemotaxis (Van Dyke et al., 
1985). When 22 families with localised aggressive periodontitis were analysed, it was 
shown that in 19 of these families, the localised aggressive periodontitis patient and 
their family members all had neutrophil chemotaxis disorders. In all of the 22 
families the chemotactic defect was shown in 50% of the siblings, indicating a 
dominant mode of inheritance. The cause of the defect remains controversial, being 
due to either intrinsic defects in the PMN itself or extrinsic factors in the sera is 
unknown (Agarwal et al., 1996). If the neutrophil chemotactic defect is due to a 
major gene locus, heterogeneity exists as there is a significant number of patients and 
families that show no evidence of the defect (Kinane et al., 1989a; Page and Beck, 
1997) 
1.4.9 The adaptive immune system 
It is unclear how many infectious agents encountered by an individual, are dealt with 
and eliminated by our innate immune system. For the adaptive arm of the immune 
system to be triggered, infection has to elude the innate defence mechanisms and 
exceed the threshold dose of antigen required to initiate the adaptive immune 
response. The adaptive immune response can be divided into two distinct entities; the 
humoral immune response and the cell mediated immune response. Both of these 
arms of the immune system are adaptive, both involve the single most important 
principle in adaptive immunity, which is clonal selection of lymphocytes, and both 
lead to a long lasting protection. The divergent lifestyles of different pathogens lead 
to the requirement of different mechanisms for their recognition and elimination. 
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1.4.10 The humoral immune response 
The antibody was the first product of the specific immune response to be identified. It 
was found in plasma of blood, and at that point body fluids were called humors, so the 
antibody immune response became known as the humoral immune response (Janeway 
and Travers, 1994). B lymphocytes are small lymphocytes that give rise to antibody- 
producing cells. They are called B lymphocytes or cells because they emanate in the 
bursa of Fabricius. This is a central lymphoid organ for B cell development, and 
found only in birds and the bone marrow in mammals. B cells are stimulated by 
antigen to produce and secrete antibodies, however, at the point when antibodies are 
produced, the B cells have differentiated into plasma cells. The regulation of 
immunoglobulin synthesis can be divided into two different processes; the control of 
the maturation of stem cells into B cells, and the regulation of the terminal maturation 
of B cells into immunoglobulin secreting plasma cells, a process which is under the 
control of a complex network of regulatory T cells (Waldmann, 1983). Plasma cells 
differ from B cells, as they have cytoplasm characteristic of an active secretary cell. It 
is dominated by layers of rough endoplasmic reticulum and a prominent golgi 
apparatus. The interaction between an antibody and an antigen comes about solely on 
the basis of specific antigen recognition (Janeway and Travers, 1994). 
Antibodies of all specificity's belong to a family of plasma proteins called 
immunoglobulins (Igs). Five distinct classes of immunoglobulin or isotypes exist; 
IgM, IgD, IgE, IgA and IgG (McGhee and Kiyono, 1999). These different classes of 
immunoglobulin can be distinguished biochemically and functionally. Each antibody 
is a `Y' shaped molecule whose arms form two identical antigen binding sites, that are 
highly variable between one molecule and another. An example can be seen in figure 
1.1. The stem of the `Y' shaped molecule has limited diversity and is known as the 
constant region. The structure of the `Y' shaped molecule has been determined using 
x-ray crystallography. 
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Figure 1.1 Structure of Immunoglobulin IgGI 
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Adapted from the Department of Immunology, University of Glasgow web site. 
Constant regions 
The immunoglobulin molecule is made up of 3 equally sized globular domains and 
these are held together by a hinge region, that is a stretch of polypeptide chain. Each 
arm of the `Y' is formed by the association of a light polypeptide chain of 
approximately 25 kDa, with the amino terminal half of a heavy polypeptide chain of 
approximately 50 kDa. There are 2 types of light chain that exist. These have been 
termed lambda (2) and kappa (K). No functional difference has been found between 
antibodies that possess k chains or x chains, however, the ratio with which they are 
used does vary between species. There are 5 types of heavy chain or isotypes that 
exist as previously mentioned. The distinct functional properties of the 5 isotypes are 
conferred by the carboxy-terminal half of the heavy chain of the molecule. From 
protein sequencing of the heavy and light chains of numerous different antibody 
molecules, it has been revealed that there is substantial sequence variability at the N- 
terminal ends of the chains. These regions of the heavy and light chains have thus 
been named the variable regions. Conversely, the C-terminal ends of both the light 
and heavy chains are considerably similar and have therefore, been termed the 
constant regions. Variable regions of the molecule correspond to the parts of the 
antibody that recognise and are specific for antigens. Antigens are found to bind and 
lie in the cleft formed by the interface of the heavy and light chain variable domains, 
specific for that antigen (Janeway and Travers, 1994). 
Regions of antigens recognised by antibodies are called antigenic determinants or 
epitopes. When an epitope is recognised by a specific antigen binding portion of an 
immunoglobulin an interaction is made. A number of environmental factors can 
disrupt interactions, examples of which are extremes of pH, high salt concentrations 
and detergents. Interactions are held together by non-covalent forces the sum total 
strength of which is called the avidity. Hence, the above mentioned environmental 
factors can disrupt the interaction and decrease the avidity. 
As previously mentioned, differentiation from aB cell into an immunoglobulin 
secreting plasma cell, requires the co-operation of other cell types. The current theory 
indicates the requirement of B cells, T cells and macrophages, implying that aB cell 
requires more than one signal for activation, as well as the essential recognition signal 
of an antigen. The first contact between antigen and the B cell evokes a primary 
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antibody response. This has the characteristically long lag period between stimulus 
and detection of specific antibodies, an exponential increase in antibody before it 
reaches equilibrium after some days, followed by a steady decline (Virella, 1990). In 
the primary antibody response, the first antibody class to be synthesised is usually 
IgM. The activation of these small naive resting B cells is a multistep process. The B 
cell leaves the bone marrow expressing on its surface both IgM and IgD, which are 
receptors specific to that B cell. They also express major histocompatability complex 
(MHC) II molecules and CD45 (Snow and Noelle, 1993). After leaving the bone 
marrow the naive B cells circulate around the body, between the blood and the 
lymphatics, before they either converge with their specific antigen or die. Most 
peripheral B cells have a life span of less that two weeks (Freitas et al., 1986; 
Udhayakumar et al., 1988). 
During the humoral immune response, B cells are activated through the recognition 
and binding of their immunoglobulin receptor with that of an antigen. This activation 
leads to a differentiation process which results in the production of either plasma cells 
or long lived memory cells (Berek, 1992). With some bacterial antigens, for example 
surface polysaccharides, the process of plasma cell differentiation is independent of T 
cell help. The activation of B cells by protein antigens however, induces a more 
complex set of reactions (Berek, 1992). 
For activation to occur, aB cell must interact with aT cell also specific for the 
antigen, as well as with the antigen itself (Vitetta et al., 1989; Noelle and Snow, 
1990). This mechanism may have arisen because the regulation of B cells is not as 
stringent as for T cells. Surface immunoglobulin specificity is generated through 
random gene rearrangements. This makes the existence of B cells expressing surface 
immunoglobulin reactive with self antigens possible. T cells, however, have to 
undergo extensive selection in the thymus, to try and ensure all the self-reactive T 
cells are removed. Therefore, to activate aB cell, an antigen also has to be processed 
and recognised by aT cell. Consequently, the lack of self-reactive T cells can directly 
limit B cell responses to self antigens (Myers, 1991). 
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The B cell receptor, which as previously discussed is the immunoglobulin molecule, 
recognises epitopes on the native antigen and has the same specificity as the antibody 
that is eventually secreted by the cell (Vitetta et al., 1989). However, before most 
antigens can be presented and recognised by T cells, they have to be processed (Allen, 
1987). Protein antigens can be processed by B cells and other antigen presenting 
cells. T and B cells, both with specific receptors for the antigen can collaborate by 
cross-linking of the immunoglobulin and T cell receptor antigen receptor complexes 
(Reth, 1992; Weiss and Littman, 1994). The interaction of T cells with antigen- 
activated B cells and antigen presenting cells initiates a cascade of reactions which 
lead to the maturation of the immune response and development of memory cells 
(Berek, 1992). 
There seem to be two discrete developmental pathways following primary antigenic 
exposure of B cells (Maclennan and Gray, 1986). The first pathway involves a rapid 
clonal expansion and plasma-cell differentiation of the cells in the T-cell rich areas of 
the secondary lymphoid organs. These clonally expanded plasma cells thus, carry out 
the immediate effector function, the clearing of target antigens (McHeyzer-Williams 
and Ahmed, 1999). The second pathway involves extensive clonal expansion within 
the specialised micro environment of the germinal centre (GC). GCs are sites of 
intense B-cell proliferation. A GC reaction is observed only where T helper cells are 
involved (Kroese et al., 1990). 
Therefore, B cells first bind antigen specific to their immunoglobulin receptors, and 
are activated by helper T cells in the T cell areas of lymphoid tissues. This area is 
known as the periarteriolar lymphoid sheath, or PALS (Kelsoe, 1996). At this point B 
cells or centrocytes, as they are known, proliferate in the PALS and then either 
develop locally into foci of antibody secreting plasmacytes, or migrate to adjacent 
lymphoid follicles to initiate the GC reaction (Kelsoe, 1996). The majority of early 
primary antibody is produced by these plasmacytic foci. They are able to secrete 
unmutated IgM or IgG over the following 10-12 days, thus providing an early source 
of circulating antibodies. These cells eventually undergo apoptosis and disappear 
(Jacob et al., 1991 a; Jacob et al., 1991 b; Jacob and Kelsoe, 1992; Smith et al., 1996). 
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Other activated B cells migrate into the primary follicles and form GCs. Primary 
follicles contain resting B cells clustered around a dense network of follicular 
dendritic cells (FDC), a specialised cell type in this area. The activated B cells 
accumulate amongst the FDC which bear antigen-antibody and antigen-complement 
complexes on their surface (Kelsoe, 1996). The activated B cells rapidly proliferate 
and acquire new phenotypic characteristics (Kelsoe, 1996). Over the period of the 
following 14 days, these B cells give rise to a GC developing into at least two regions: 
a dark and a light zone (Maclennan, 1994). 
Hypermutation of the variable region of the immunoglobulin molecules and selection 
of high affinity variants occurs in the GC. This is of key importance to the maturation 
of the immune response in this environment (Berek and Ziegner, 1993). Somatic 
hypermutation affects all the rearranged variable-regions in aB cell, allowing the 
generation of variability (Janeway and Travers, 1994). This is due to a molecular 
mechanism that introduces point mutations into V regions. The recruitment of aB 
cell into the maturation process is dependent on the affinity of its receptor for antigen 
(Berek and Ziegner, 1993). One view is that the initial selection of these cells is based 
upon their continuous ability to bind antigen from the surface of the FDC, as an 
antigen-antibody complex (MacLennan et al., 1990; MacLennan et al., 1992; Liu et 
al., 1992). Efficient affinity selection is only thought to occur when cells that have a 
higher affinity for antigen than the antibody within the FDC immune complex are 
stimulated (MacLennan and Gray, 1986). This makes sense considering the memory 
B cell response is of higher affinity than the primary response (Gray, 1993). 
Following this positive selection in the GC reaction, affinity matured B cells can 
either exit the GC as memory cells or sometimes re-enter the dark zone of the GC for 
a further round of mutation and selection (Berek and Ziegner, 1993) 
It is generally accepted that the cells produced in the GC are memory cells, which then 
migrate into the circulation to be stimulated on a second encounter with the same 
antigen (Hanna et al., 1968; Jacobson and Thorbecke, 1968; Wakefield and 
Thorbecke, 1968a; Wakefield and Thorbecke, 1968b). Studies have shown that cells 
produced from the GC are not likely to be involved in antibody production, since there 
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is no correlation between the production of cells in the GC and serum levels of 
antibody (Buerki et al., 1974). 
At the beginning of the humoral immune response, the predominant antibody isotype 
is IgM (Snow and Noelle, 1993). Later on in the immune response, the B cells are 
able to undergo isotype switching and other immunoglobulin isotypes are seen. This 
phenomenon is important to the humoral immune response, as each different isotype 
possess unique capabilities that improve the effector capabilities of the organism 
against pathogens (Snow and Noelle, 1993). Isotype switching occurs during the GC 
reaction (Kraal et al., 1982; Butcher et al., 1982; Ape] and Berek, 1991). 
Antibodies have different functions, all of which are centred around protecting the 
host from extracellular pathogens and their products. Antibodies have a number of 
ways of providing protection. 
Neutralisation is a process whereby antibody binds to the surface of a pathogen itself, 
or to a toxin or product produced by the pathogen. Intracellular bacteria and viruses 
survive and reproduce inside cells. However, in order to increase in number they need 
to be transferred from cell to cell and to accomplish this, these bacteria and viruses 
bind to cell surface molecules of other host cells. Specific antibodies are able to bind 
to the bacteria or virus particles and neutralise them, preventing cell binding and 
spread. Many bacteria cause devastating effects by secreting molecules called 
bacterial toxins. The toxins bind to a molecule that acts as a receptor, on the surface 
of a host target cell. Antibodies specific for the receptor portion of the toxin, can 
block binding to a host cell and protect it from toxic attack. Although neutralisation 
prevents adherence of pathogens and their products to host cell surfaces, it does not 
remove the pathogens from the host altogether. Furthermore, many pathogens are not 
neutralised by antibodies. They have developed strategies whereby they can avoid this 
defence mechanism. 
Other bacteria and pathogens reproduce and survive extracellularly. These pathogens, 
along with those that cannot be neutralised, need to be removed. Antibodies protect 
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against these by facilitating their uptake into phagocytic cells, such as PMN, by a 
process called opsonisation. There are two ways in which this can occur. 
Opsonisation can occur when an antibody binds to a micro-organism by its Fab 
portion. The Fc portion of the antibody is recognised and bound by a receptor found 
on PMN. The micro-organism then becomes engulfed by the phagocyte as receptors 
for Fc and the Fc regions on the antibodies continue to combine, leading to final 
engulfment and destruction of the micro-organism. The second way in which 
opsonisation can occur is by activation of the complement cascade and binding of 
phagocytes to complement components found on the surface of the micro-organism. 
1.4.10.1 IgM 
The first antibodies to be produced in an immune response are IgM. Antibodies of 
this isotype are produced before B cells have undergone somatic hypermutation and 
affinity maturation, and hence tend to be of low affinity. However, IgM molecules are 
usually found as pentamers with 5 immunoglobulin molecules and 10 antigen binding 
sites. This compensates for the low affinity binding of these antibodies, as it allows 
simultaneous binding of antibody to repetitive sites, which are often found to be 
expressed by bacterial cell wall polysaccharides. This binding to multimeric antigens 
can confer high avidity. 
IgM is a large molecule and the pentamer is formed in association with aJ chain and 
for this reason it does not pass through the placenta. The monomers of IgM are cross- 
linked to each other by disulphide bonds and also to the J chain. Due to the large size 
of the IgM molecule, it is usually confined to the blood, however, IgM can be found in 
tissues at sites of infection that are undergoing an inflammatory response. Elevated 
levels of IgM usually indicate either recent infection or exposure to antigens. 
One of the most important functions of IgM is that it is very potent at activating the 
complement cascade. Activation of these plasma proteins is extremely important, 
especially at the beginning of an infection as it helps recruit and activate phagocytes 
and can directly destroy pathogens (Janeway and Travers, 1994). IgM antibodies are 
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not particularly versatile, are poor toxin-neutralising antibodies and are not efficient in 
the neutralisation of viruses. 
1.4.10.2 IgA 
IgA is the major mucosal immune system isotype made by plasma cells and has a half- 
life of 5.5 days. The primary site of IgA synthesis is at the epithelial surfaces of the 
body and its main role is thought to be to protect epithelial cells from infectious 
agents. IgA achieves this by preventing attachment of bacteria and toxins to epithelial 
cells, and is involved in the neutralisation of harmful toxins. IgA provides the first 
line of defence for these surfaces. IgA is a poor opsonin and does not contain 
receptors for complement, and thus is not a complement-activating or complement- 
fixing immunoglobulin. This is not surprising as IgA is usually found in areas which 
are lacking in accessory cells. 
The lamina propria (connective tissue), that is found beneath the basement membrane 
of many surface epithelia, hosts a large number of IgA secreting plasma cells 
(Heremans, 1974). Active transport or transcytosis of IgA occurs from the lamina 
propria, where it is produced, to the external surface of the epithelium. Secretary IgA, 
or IgA that undergoes transport is predominantly of the polymeric form (Heremans, 
1974). Polymeric IgA is usually found as a dimer with a molecular weight of 400 
kDa. Two IgA molecules are held together by disulphide bonds and are both also 
bound to aJ chain, found also in pentameric IgM. The J chain, produced by plasma 
cells has been implicated as a component for the polymerisation of IgA and IgM 
(Koshland, 1975). 
There are 2 subclasses of IgA; IgAl and IgA2. IgAl and IgA2 are distributed 
differently in the body fluids; 80% or more of serum IgA belongs to the IgAl 
subclass, whereas 50-74% of the IgA found in external secretions is of this subclass 
(Vaerman et al., 1968; Grey et al., 1968; Delacroix et al., 1982). IgA2 is found in a 
higher percentage in external secretions. The reason for this is unknown, but it could 
be due to the preferential transport of IgA2, or that increased numbers of IgA2 
secreting cells are found at secretary surfaces. 
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IgA antibodies are secreted in breast milk and transferred to the gut of new born 
infants. Their specialised defence of mucosal surfaces provide protection of the new 
born until they can provide their own. 
1.4.10.3 IgG 
IgG molecules are small and able to diffuse out of the blood and into the tissues. IgG 
molecules are always monomeric and are the principal isotype in the blood and 
extracellular fluids. 
There are 4 different subclasses of IgG; IgGI, IgG2, IgG3 and IgG4. Except for IgG3 
which has a rapid turnover, the half-life of IgG is the longest of all the isotypes at 
about 23 days. Functional differences can be noted amongst the different isotypes. 
IgG2 subclass is more frequently found to be produced in response to polysaccharide 
antigens, IgGI and IgG3 are involved in defence against protein and viral antigens, 
and IgG4 is mainly associated with responses that can lead to allergic type reactions. 
IgGI, IgG2 and particularly IgG3 play an important role in the activation of the 
classical pathway of the complement cascade. IgGI and IgG3 are the only subclasses 
that are found to bind to macrophages and other phagocytes, and hence play an 
important role in the process of opsonisation. IgG are high affinity antibodies, as they 
are produced by B cells that have undergone affinity maturation and isotype switching 
in the GC reaction. They also have the ability to cause neutralisation of toxins and 
agglutination. 
IgG molecules play an important role in antibody-dependent cell mediated 
cytotoxicity (ADCC). This process involves binding of the Fab portion of the 
antibody with the target cell, and the Fc portion binds with specific receptors found on 
natural killer (NK) cells. The target cell is then killed, not by opsonisation but by 
specific release of harmful molecules produced by NK cells. 
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IgG is the only antibody that is transported across the placenta. It is actively 
transported directly into the bloodstream of the foetus by a specific IgG transport 
protein. The small size and high affinity nature of the IgG molecule makes it an ideal 
isotype for this function. IgG2 is the only isotype of IgG that does not cross the 
placenta (Janeway and Travers, 1994). 
1.4.10.4 IgD 
IgD has a half-life of 2.8 days and is found on the surface of B cells at different stages 
of their maturation. The function of IgD remains elusive. 
1.4.10.5 IgE 
IgE has a half-life of 2 days, which is the shortest of all the immunoglobulins. It is 
also found at the lowest concentration in the serum. IgE cannot cause agglutination or 
neutralisation, and has very specific functions in the immune surveillance of the body. 
IgE antibodies are thought to play an important role in parasitic infections and 
hypersensitivity reactions. IgE antibodies are able to bind directly to mast cells and 
basophils by a receptor. The receptor is found on the surface of these cells and is 
specific for the Fc portion of the IgE molecule. Cross-linking of IgE to an antigen via 
its Fab portion, and a basophil or mast cell via its Fc portion, leads to activation of 
these leukocytes. Activated mast cells and basophils release the contents of their 
granules which include; histamine, heparin and leukotrienes and these can trigger 
hypersensitivity reactions (Benjamini et al., 1996). The Fc receptors found on mast 
cells and basophils, which are designated FcEI receptors, bind the Fc portion of IgE 
with very high affinity. 
Degranulation occurs within seconds of cross-linkage. First the vasoactive amines, 
histamine and serotonin are released which leads to the initiation of an inflammatory 
immune response. There is increased vasodilation and vascular permeability, which 
quickly leads to the accumulation of immune cells and exudative fluids at the site of 
infection. Serotonin and histamine are very short lived, but the inflammatory response 
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is sustained by the subsequent release of other mediators by the mast cells and 
basophils such as leukotrienes and other metabolites of archidonic acid (Janeway and 
Travers, 1994). 
1.4.11 The role of the adaptive humoral immune response in periodontal disease. 
Two distinct humoral effector systems that contribute to the defence in the oral cavity 
have been postulated by Brandtzaeg (1972,1973). Salivary IgA has been suggested to 
be the first line of defence, perhaps playing a role which involves trapping of the 
antigen in a mucin layer with subsequent disposal of the antigen (Brandtzaeg, 1972). 
The second involves the local production of IgG which is protective in nature and 
found in inflamed gingival and periodontal tissues (Brandtzaeg, 1973). These early 
ideas are still postulated in publications on this topic, and are often referred to as the 
local systemic immune responses. The importance of these different fluid types and 
what they actually indicate is still to be confirmed. In addition, it is not fully 
understood whether the local levels, such as that of saliva and GCF, are reflections of 
the serum antibody levels or whether production of the antibodies found in such fluids 
is distinct and unique. 
1.4.12 The local antibody response 
In terms of the local immune response, saliva is known to contribute to maintaining 
oral health, and secretary IgA is found in large quantities in saliva. It has been 
suggested that an individual with high levels of IgA in their saliva, which is directed 
against micro-organisms such as A. actinomycetemcomitans, P. gingivalis and 
Streptococcus mutans, are more likely to be protected against gingivitis (Shenk et al., 
1993). Another study carried out by Sandholm et al. (1987), found elevated levels of 
salivary IgG in patients with chronic and aggressive periodontitis against A. 
actinomycetemcomitans. 
Various studies have reported an increase in antibody levels in the GCF (Reinhardt et 
al., 1989; Wilton et al., 1993) and in the gingival tissues (Smith et al., 1985). Further 
studies have detected specific antibody activity in the GCF of patients with 
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periodontal disease (Ebersole and Cappelli, 1994; Ebersole et al., 1985a; Ebersole et 
al., 1985b; Smith et cal., 1985). Through clinical observation of diseased tissues taken 
from periodontitis patients, it is known that they are populated by a large number of B 
lymphocytes and plasma cells, thus suggesting local antibody production (Ranney, 
1991; Sims et al., 1991). These cells are seen to differentiate and proliferate in this 
area, and in susceptible subjects this area is also populated by an increased number of 
TH2 cells that have selectively homed to the gingiva to aid in B-cell expansion 
(Seymour et al., 1993). More evidence for local antibody production comes from 
reports indicating the presence of activated complement components in GCF from 
both the classical and alternate pathways (Niekrash and Patters, 1985; Schenkein and 
Genco, 1977). This further indicates the possibility of local IgG synthesis in the 
tissues. 
Many of the studies observing the presence and function of antibody in GCF have 
been particularly involved in looking at antibodies directed against A. 
actin onrycetemcoin itans and P. gingivalis. A study carried out by Ebersole and 
Cappelli (1994) investigated antibodies directed against A. actinomycetemcomitans 
and the presence of different subclasses of antibody in GCF of patients with 
periodontal disease. They compared the findings with those from subjects in health. 
The frequency and distribution of antibody in the GCF indicated a potential role for 
local antibody directed against A. actinomycetemcomitans in relation to colonisation 
and clinical presentation. The results also suggested a relationship between the 
distribution of infection and the levels of antibody directed against A. 
actinomycetemcomitans in GCF. 
The results gleaned from studies observing antibodies directed against P. gingivalis 
give varying reports. For example, Baranowska et al. (1989) reported no difference in 
antibody levels against P. gingivalis in the GCF of periodontitis patients compared 
with health. However, Suzuki et al. (1984), indicated there was an increase in the 
local production of antibodies directed against this micro-organism in patients with 
chronic periodontitis as compared with patients with localised aggressive 
periodontitis. 
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Although the results from a lot of the work carried out in this area indicate that there 
is a local immune response due to the micro-organism in question providing antigenic 
stimulation at a local site, there is also a systemic serum antibody response to the local 
infection. A relationship between the local and systemic antibody levels and 
specificity is thought to exist. Theories have been put forward trying to link the local 
and the systemic immune responses. Three main theories that have been suggested by 
Kinane et al. (1999): (i) local antibody is produced due to continuous antigenic 
challenge, however, this antibody leaves the tissues via the lymphatics and enters the 
circulation becoming systemic; (ii) a systemic response is induced due to a breakdown 
in the tissue integrity of the gingivae, allowing bacteria and antigenic components to 
leave, migrate to the lymph nodes in the circulation, and induce a systemic response; 
(iii) local antigen presenting cells pick up and process antigens in the tissue before 
leaving and homing to systemic lymphoid tissues, where they induce a systemic 
antibody response. 
Studies have reported GCF levels of antibody to be greater than levels found in the 
serum (Ebersole et al., 1985a; Kinane et al., 1993; Tew et al., 1985a). As well as 
being a product of the local immune response, it has also been suggested that serum 
antibody specificity may reflect a local gingival response. This has been suggested 
following studies observing the response to A. actin onrycetemcoin itans in periodontitis 
patients (Ebersole, 1990; Ebersole et al., 1992). 
IgG, IgM and IgA classes of antibodies have been described in GCF (Brill and 
Brönnestam, 1960; Brandtzaeg, 1965) and in the gingival tissues (Brandtzaeg and 
Kraus, 1965; Thonard et al., 1966; Genco et al., 1974). Although these and serum 
antibodies, against individual plaque and Gram negative bacteria have been shown to 
be present in humans with varying degrees of periodontal disease, their specific 
antigenic target remains on the whole elusive. Different subclasses of antibody, 
particularly IgG, carry out various functions, and in general are directed against 
different antigenic molecules. Therefore, a number of studies have been carried out to 
look at the different subclasses of antibody, with the aim of providing further 
information on the nature and target of the immune response. 
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A study carried out by Ebersole and Cappelli (1994) investigated the different 
subclasses of IgG directed against A. actinomycetemcomitans in the GCF of patients 
with periodontal disease. This study showed that IgG3 and IgG4 subclasses were 
particularly increased as compared with the levels seen in the serum. The patterns of 
subclass distribution were quite distinct. In GCF samples, where the antibody levels 
were below those found in the serum, IgG2 levels were found to be high. In GCF 
samples that had antibody levels in the same range as those found in the serum, IgGI 
was strikingly increased. In GCF samples that had elevated levels of antibody 
compared with serum, elevated levels of IgG3 and IgG4 were found overall. Results 
showed that IgG3, IgG4, IgGI and IgG2 antibodies were elevated by 58%, 35%, 25% 
and 25% respectively. The correlation between elevated levels of IgG4 antibody to A. 
actinomycetemcomitans and the presence of the micro-organism in the plaque was 
positive. 
Antibodies in the oral cavity have been detected against non-oral bacteria (Berglund, 
1971; Mallison et al., 1989). Some of the antibodies may be cross-reacting antibodies 
induced to another bacteria in a different part of the body. However, even if this is so 
for a percentage of the antibody response, it is generally accepted that there is a 
specific humoral immune response, with specific antibody produced, that plays a role 
in protection against periodontal disease. 
1.4.13 The systemic antibody response 
The majority of aggressive and chronic periodontitis patients mount a systemic 
humoral immune response to antigens of the infecting bacteria (Ishikawa et al., 1997). 
As discussed previously there are several theories on how a systemic response is 
induced. 
One of the first experiments on this topic was carried out by Genco et al. (1980a). 
This study indicated that there were antibodies directed against sonicate preparations 
of A. actinomycetemcomitans in the sera of patients with localised aggressive 
periodontitis, but not in healthy subjects. Many studies that have been carried out 
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since these early experiments have tended to target the Gram negative anaerobes A. 
actino1nycete1ncontitans and P. gingival s because of their marked association with 
periodontal disease (Socransky and Haffajee, 1990). Systemic antibodies to a large 
number of Gram negative bacteria have been investigated. F. nucleation appears to be 
a regular resident in plaque. Although serum antibodies directed against this bacteria 
seem to be detectable in patients with periodontitis, the titres are not elevated in all 
periodontitis patients (Farida et al., 1986a; Suzuki et al., 1984; Tolo et al., 1981). 
Elevated levels of serum antibody have been detected in selected periodontitis patients 
against E. corrodens (Ebersole et at., 1987; Ebersole and Holt, 1988) and elevated 
IgG antibody levels against C. rectus have been shown in all periodontitis patients 
compared with health (Nisengard et al., 1980). 
Most of the studies attempt to assess the antibody responses to A. 
actinomycetemcomitans and P. gingivalis. A strong correlation has been shown 
between increased levels of antibody to A. actinonrycetemcomitans and localised 
aggressive periodontitis. It is now accepted that this micro-organism is important in 
the causation of aggressive periodontitis. This is because of its high prevalence in the 
disease and the elevated antibody levels in these patients against this bacteria 
(Ebersole et al., 1980; Ebersole et al., 1989; Genco et al., 1980a; Farida et al., 1986; 
Genco et al., 1980b; Tew et al., 1985a). Although in many diseases there appears to 
be considerable variation in responses seen between different populations, global 
results agree that there are elevated levels of serum antibodies to A. 
actinomyceteincomitans in patients with aggressive periodontal disease, particularly 
the localised form. The results of these different geographical studies seem to 
suggest, that the predominant serotype of A. actinomycetemcomitans varies 
(Gunsolley et al., 1988; Gmür and Baehni, 1997; celenligil and Ebersole, 1998). 
Elevated serum antibody titres to P. gingivalis have also been identified in patients 
with aggressive periodontal disease. A large study carried out by Ebersole indicated 
that of the 62 generalised aggressive periodontitis patients observed, 37% of these had 
elevated antibody titres to P. gingivalis, compared with only 25% in control subjects 
(Ebersole et al., 1982a). Similar results were obtained from a study carried out by 
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Mooney and Kinane (1994) who showed that 25% of the generalised aggressive 
periodontitis patients tested had elevated antibody levels. 
In terms of chronic periodontal disease, A. actinomycetemcomitans does not appear to 
be uniformly linked. Many studies have not found any elevated levels of serum 
antibodies to A. actinoniycetenacoinitans in patients with chronic periodontitis 
compared with healthy controls (Doty et al., 1982; Gmür et al., 1986; Listgarten et al., 
1981). Results from investigations by Ebersole et al. (1991a; 1994), have suggested 
that increased titres of serum antibodies are seen, in some but not all, of patients with 
chronic periodontitis. It is thought there is a group of individuals that are more 
susceptible to infection by this bacteria than others, and that in this `at risk' group, A. 
actinomycetemconaitans is capable of initiating disease. 
Although serum antibody titres specific for A. actinolnycetemcomitans may not be 
elevated in patients with chronic periodontitis, many studies have reported increased 
antibody levels in these patients against P. gingivalis (Ebersole et al., 1982a; 
Mansheim et al., 1980; Socransky and Haffajee, 1994). In addition there have also 
been reports indicating a correlation between levels of IgG antibody to P. gingivalis 
and periodontal destruction (Gmür et al., 1986), disease severity (Naito et al., 1987), 
and alveolar bone loss in an elderly population (Wheeler et al., 1994). 
Many studies have tried to evaluate the different subclasses of IgG in the serum of 
periodontitis patients. This information may give an indication of the target of the 
antibody response due to the functional differences noted amongst the different 
subclasses. A number of studies by Ebersole et al. (1985c; 1989) investigated the IgG 
subclass distribution in the serum directed against A. actinonrycetemcomitans and P. 
gingivalis in patients with localised aggressive, generalised aggressive, chronic 
periodontitis and also in healthy subjects. The results showed elevated levels of IgG3 
and IgGI to A. actinonrycetemcomitans in patients with localised aggressive 
periodontitis and elevations in IgG3, IgGI and IgG4 in patients with generalised 
aggressive periodontal disease. Studies have also been carried out to investigate 
levels of IgG2, a subclass that is found frequently in response to polysaccharide 
antigens (Kinane et al., 1999a). Results from these studies indicated that aggressive 
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periodontitis patients seem to have elevated levels of serum IgG2, directed against 
LPS of A. actinomycetemcomitans, and that these antibodies are opsonic for this 
micro-organism (Gmür and Baehni, 1997; Wilson et al., 1995; Wilson and Hamilton, 
1995). 
Elevated levels of IgG2 antibodies have also been found in the serum of chronic 
periodontitis patients against the LPS of P. gingivalis (Schenk and Michaelsen, 1987). 
Moderate amounts of IgGl, IgG3 and IgG4 were also found in the serum of these 
patients. Other studies have shown there to be elevated levels of IgG2, IgGI and IgG4 
to P. gingivalis in patients with generalised aggressive and chronic periodontitis 
(Ebersole et al., 1985c; Farida et al., 1986). 
Evidence exists which may explain why high levels of IgG2 against P. gingivalis and 
A. actinomycetemcoinitans are seen in patients with periodontal disease. Both of these 
micro-organisms are Gram negative bacteria containing both LPS and a capsular 
polysaccharide. As discussed in section 1.6.4 LPS is an immunogenic molecule and 
as IgG2 is predominantly induced in response to polysaccharide antigens it is expected 
that there would be elevated levels of IgG2 in patients mounting a response. In 
respect to the distribution of the other subclasses of IgG, there appears to be enormous 
variation between different populations and between the different forms of the 
disease. 
1.4.14 The cell mediated immune response 
The principal components of the cell mediated arm of the immune system are T cells. 
These lymphocytes are capable of recognising antigens, that are processed and 
presented by antigen presenting cells (APC), in the context of the MHC (Babbitt et al., 
1985; Buus et al., 1987). The MHC is a set of polymorphic genes encoding class I 
and class II cell-surface glycoproteins whose function is to present antigenic peptides 
to CDS+ and CD4+ T cells respectively (Accolla et al., 1995). 
Effector T cells fall into 3 functional classes that detect antigens derived from 
different types of pathogens, presented by the two different classes of MHC molecule. 
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Antigens derived from pathogens that multiply in the cytosol are carried to the cell 
surface by MHC class I molecules and presented to CD8+ cytotoxic T cells. 
Histologically different cell types may be differentiated by cell-surface molecules. 
These can be identified by a specific group of monoclonal antibodies. These 
molecules are known as cluster of differentiation antigens and are designated CD. 
Cells infected with viruses or bacteria that reside in the cytosol are eliminated by 
CD8+ cytotoxic T cells. The function of these cells is to kill infected cells. Naive 
CD8+ T cells can only differentiate into cytotoxic cells. They require more co- 
stimulatory activity to activate them than do CD4+ T cells. This is possibly because 
they are so destructive. Cytotoxic T cells principally act by, release of secretary 
granules onto the surface of a target cell on recognition of an antigen (Janeway and 
Travers, 1994) and the production of IFN-y. 
Antigens derived from extracellular bacteria and toxins are processed within the APC. 
They are carried to the surface by MHC class 11 molecules and presented to CD4+ T 
cells. There are two distinct subsets of CD4+ T cells; THI and TH2. The division of 
CD4+ T cells into subsets is based upon cytokine production (Mossman and Coffman, 
1989). TH I cells secrete both IL-2 and IFN-y when activated by certain types of T- 
dependent antigens so they can enhance cell-mediated responses. The TH2 subset 
produces IL-4, IL-5, IL-10 and IL-13, and thereby promote the humoral immune 
response. THO cells have also been identified and these are thought to secrete IL-4 
and IFN-y. Their role is yet to be confirmed, however, it is thought they may act as a 
precursor cell to T-helper cells yet to have differentiated into either THl or TH2 cells 
(Modlin and Nutman, 1993). Several factors can influence the development of the TH 
subsets and these include the antigen itself, the antigen concentration, the route of 
antigen administration and the antigen presenting cells (Williams et al., 1991; 
Gajewski and Fitch, 1991; Bretscher, 1991). THI cells, called inflammatory CD4+ T 
cells, are specialised to activate macrophages to have a greatly increased ability to kill 
intracellular bacteria. TH2 cells, called helper CD4+ T cells activate antigen-binding 
B cells to differentiate into antibody-secreting cells (Janeway and Travers, 1994). 
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Although much of the literature discusses the importance of the humoral aspect of the 
immune response in periodontal disease, models used in earlier years suggested that 
the initial periodontal lesion is composed mainly of T lymphocytes, with B cells and 
plasma cells predominating at a later stage (Mackler et al., 1977; Seymour et al., 
1982; Seymour et al., 1983). Studies have also reported differences in CD4: CD8 
ratios in lesions and peripheral blood of periodontitis patients (Okada et al., 1982; 
Taubman et al., 1984), compared to healthy controls. This indicates that the cell 
mediated immune system is potentially as important in a discussion of this disease as 
that of the humoral immune response. 
It appears that the immune response in periodontitis takes the following pattern, the 
antigen is picked up by an APC, such as a Langerhans cell at the site of infection. It is 
then carried to a primary lymphoid tissue where presentation to a circulating naive T 
cell takes place. This leads to antigen-specific clonal activation, where some activated 
cells become effector cells and others remain in the circulation as memory cells. 
Naive and memory T cells may be recognised by the markers they express. Naive T 
cells express CD45RA and memory cells CD45RO. 
CD45 is a transmembrane tyrosine phosphatase with 3 variable exons that encode part 
of its external domain. In naive T cells, high molecular weight isoforms CD45RA are 
found. In memory T cells, the variable exons are removed by alternate splicing of 
CD45 RNA and this isoform is known as CD45RO. General dogma indicates that 
memory T cells (CD45RO+) greatly out number (CD45RA+) T cells in periodontitis 
lesions (Gemmel et al., 1992; Yamazaki et al., 1993; Kinane et al., 1999; Lappin et 
al., 1999). However, it has been shown that a proportion of these cells are CD45RA+, 
which suggests reactivation of the memory cell population by specific but as yet 
unidentified antigens in the tissues. It has been reported that memory T cells adhere to 
vascular endothelial cells and augment their permeability to macromolecules (Damle 
and Doyle, 1990). This functional ability of memory T cells may be a dominant factor 
that contributes to the preferential migration of memory T cells into sites of chronic 
inflammation (Pitzalis et al., 1988), such as the diseased gingival tissues. 
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The realisation that T lymphocytes are present in large numbers in the diseased tissues 
of aggressive periodontitis patients and not in health, has led to investigations of the 
numbers, ratios and functionality of T cells in both the peripheral blood and diseased 
tissues of patients with periodontal disease. Studies of peripheral blood T lymphocyte 
subsets in aggressive periodontal disease have revealed a wide variety of contradictory 
results with either depressed CD4+: CD8+ ratios (Kinane et al., 1989b), or a mixture of 
increased and depressed proportions of CD4+: CD8+ cells (Katz et al., 1988) or even 
no correlation with disease (Engel et al., 1984). Studies have also looked at the 
distribution of T cell subsets in tissues. One study reports that the CD4+: CD8+ ratio in 
the tissues of aggressive periodontitis patients and even their families tend to be 
increased (Syrjanen et al. 1984). A study by Stoufi et al. (1987) and one by Celenligil 
et al. (1993), however, clearly states that the ratio is decreased in patients with this 
disease. What is obvious, and further indicated by a study investigating juvenile 
periodontitis (Meng and Zheng, 1989), is that the ratios are highly variable between 
different patients with the same disease, making generalisations and conclusions very 
difficult. What the latter study did suggest however, was that high CD4+: CD8+ ratios 
were seen in those patients with a greater degree of inflammatory cell infiltration, 
while the low CD4+: CD8+ ratio tissues were less inflamed. 
When diseased gingival tissue is removed and the cells extracted, both CD4+ and 
CD8+ lymphocytes are present in large numbers (Stoufi et al., 1988; Taubman et al., 
1984). However, CD4+ cells although prominent, were found at lower levels than in 
the peripheral blood. Overall ratios of CD4+: CD8+ were not found to be altered in 
aggressive periodontitis and chronic periodontitis patients (Marthur and Michalowicz, 
1997), however, in one study these ratios were found to be depressed in patients with 
localised and generalised aggressive periodontitis (Kinane et al., 1989b). 
1.4.15 T cell functions 
1.4.15.1 The role of CD4+ T cells in periodontal disease 
T cell functions in periodontal granulation and gingival tissues can be elucidated by 
the cytokine synthesis profile (Yamamura et al., 1991) (see Table 1.2 for 
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characteristics of cytokines that play an important role in the progression of 
periodontal disease). Although the cytokine profile is a good tool for T cell subset 
investigations, the results reported are often conflicting causing confusion. Often the 
results cannot assess the relative importance of the THI and TH2 subsets. 
Fujihashi et al. (1996), investigated THl and TH2 cytokine mRNA expression by 
CD4+ T cells from diseased gingival tissues. They detected IFN-y, a THI cytokine, 
but failed to detect the TH2 cytokine IL-4, thus indicating a more dominant role for 
TH I cells. Other groups indicated a more dominant role for TH2 cells after detection 
of IL-4, IL-5, IL-6 (Yamazaki et al., 1995; Aoyagi et al., 1995; Manhart et al., 1994) 
and IL-10 (Gemmell et al., 1994). One of the current theories of the TH1/TH2 
paradigm is that both cells have an important but different role. Gemmell et al. 
(1997), have suggested that TH1 cells remain tightly localised at sights undergoing 
active destruction. Whereas, TH2 cells are more widely distributed throughout the 
tissue and typify a more quiescent stage of the disease. In other words the immune 
response in periodontal disease is predominantly TH2 driven with active phases of the 
disease leading to foci of TH1 activity. 
The role of these cell types is that of help for the immune response. TH1 cells, 
characterised often by their production of IFN-y, are important in microbial killing and 
are known to augment cytotoxic T cell functions through their production of IL-2 and 
IFN-y. TH2 cells, however, inhibit much of the work done by TH1 cells. The 
production of IL-4 and IL-10 by these cells inhibits the actions of IFN-y, and hence 
has anti-inflammatory characteristics. The production of IL-4, IL-5 and IL-6 elicits 
and helps maintain the humoral immune response. 
1.4.15.2 Gamma delta T cells 
CD4+ and CD8+ T cells usually express the c43 T cell receptor (TCR). In contrast to 
this, cells expressing the 78 TCR are typically CD3+and CD4- CD8-. T cells bearing 
76 TCRs are a distinct lineage of cells of unknown function. The ligand for this 
receptor is also unknown although attempts to identify the ligands have focused on 
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MHC class-I like proteins, mycobacteria, and heat shock proteins (Haas et al., 1990). 
There has been growing suspicion over the last decade that 76 T cells do not recognise 
antigens in the classic T cell: MHC complex way and that this T cell subset may 
recognise antigens presented by non-classical MHC proteins or members of the CDI 
family of proteins (Haas et al., 1990). 
In peripheral lymphoid tissues, 1-5% of CD3+ cells express the 76 TCR. However, in 
epithelial tissues a much higher percentage of the T cells express this receptor 
(Janeway and Travers, 1994). yb T cells do not appear to have a great diversity in 
their receptors. If 78 T cells found in surface epithelium are examined it can be seen 
that the receptors are essentially homogenous in any one epithelium. One explanation 
for this is that these T cells are part of the non-adaptive process of the immune 
response. Because they have a single receptor and do not re-circulate, could be the 
reason why they recognise alterations on the surface of epithelial cells infected with a 
pathogen, rather than specific features of the pathogen (Janeway and Travers, 1994). 
The role of yS T cells is still in question. They have been reported to lyse various 
cellular targets including chicken erythrocytes, cells treated with mycobacteria or 
staphylococcal enterotoxin A, and various leukaemic cells (Haas et al., 1990). Data 
seems to suggest that these T cells play a protective role in infectious diseases. 
Abnormal cell proportions of 76 T cells have been reported in diseases caused by 
intracellular pathogens, such as leprosy and leishmania (Marthur and Michalowicz, 
1997). High numbers of 76 T cells have been reported in leprosy lesions (Bloom et 
al., 1992), rheumatoid arthritis (Reme et al., 1990), Behcet's syndrome (Fortune et al., 
1990), and in the peripheral blood of patients with measles infections (Haas et al., 
1990). 
The role of y8 T cells in periodontal disease is still not well understood. It has been 
reported that the mean percentage of y6 T cells in the peripheral blood of patients with 
periodontal disease, is similar to the numbers found in healthy controls. However, 
when the data is observed more closely it can be seen that although the mean values 
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are similar, patients with periodontal disease appear to have abnormally high or low 
proportions of 76 cells (Nagai et al., 1993). 
y6 T cells have been routinely identified in diseased periodontal tissues (Lundqvist 
and Hammarström, 1993; Gemmel and Seymour, 1995; Prabhu et al., 1996). They 
have generally been shown to constitute about 1-3% of the CD3+ cells residing in the 
diseased tissues (Gemmel and Seymour, 1995; Kawahara et al., 1995). The numbers 
of these cells have been shown to increase significantly with disease, however, remain 
reasonably low in an environment of moderate to severe inflammation (Gemmel and 
Seymour, 1995). y6 T cells from diseased tissues have been shown to express either 
CD4 or CD8 (Lundqvist et al., 1994), mRNA for IFN-y, TNF-a, TGF-(3 and IL-6. 
However, the cytokine profile is dependent on whether the yb cell expresses CD4 or 
CD8. 
A number of contradictory studies have been reported on the presence of yE T cells in 
healthy tissues. Lundquist and Hammarström (1993), reported that greater than 30% 
of all leukocytes separated from healthy tissues were yb+. They described these cells 
as being y8+, CD4-, CD8- and CD45RA+, hence naive. Contradictory to this, 
Kawahara et al. (1995) reported that when using immunohistochemistry, yb+ cells 
were rarely seen in healthy tissues. 
The role of yb T cells in periodontal disease remains elusive. One theory suggested 
for function of these cells in this disease, is that they may ligate with heat shock 
proteins (HSP) produced by stressed or damaged cells. This could be by binding to 
and destroying damaged or infected epithelial cells (Lundqvist et al., 1994) or even 
stressed bacterial cells. However, whether these cells have a more important role in 
the acute rather than the chronic lesion or vice versa is unknown. 
1.4.16 Natural killer cells 
Natural Killer cells (NK cells) are also said to constitute a large part of the cell 
mediated immune system, although they are classed as a component of the innate 
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immune system. These cells are large granular lymphocytes which are often detected 
by the marker CDI6. This makes actual numbers detected very difficult to report 
since this marker is also found on other peripheral blood lymphocytes and monocytes. 
In contrast to CD8+ cytotoxic T cells, which kill infected targets cells in an antigen- 
specific manner, NK cells kill infected target cells or tumour cells in an antigen-non- 
specific manner (Marthur and Michalowicz, 1997). 
The role of NK cells in periodontal disease at present is unknown. However, there are 
reports of an increase in the numbers of NK cells in the peripheral blood of patients 
with aggressive periodontitis (Celenligil et al., 1990; Watanabe et al., 1993; Kopp, 
1988). Conflicting evidence comes from other studies that have reported no increase 
in the numbers of NK cells found in the peripheral blood of diseased patients when 
compared with health (Zafiropoulos et al., 1990). In the tissues of diseased patients 
an increase of NK cells is seen. This is not surprising since in health very few NK 
cells are present in the gingival tissues. The numbers of NK cells in the tissues are 
seen to increase from health to gingivitis to periodontitis (Wynne et al., 1986; Cobb et 
al., 1989; Fujita et al., 1992). However, the proportion of these cells relative to total 
lymphocyte numbers actually decreases (Cobb et al., 1989). 
The activity of NK cells is increased by soluble mediators such as IL-2, IFN-a, IFN-ß 
and IFN-y. The interferons a and ß are antiviral proteins synthesised and released by 
leukocytes, fibroblasts and virally infected cells and IL-2 and IFN-y are released by 
activated T cells (Benjamini et al., 1996). Surface LPS from Gram negative bacteria 
appears to provide the major activation signal for NK-cell-mediated cytotoxicity in 
periodontal disease (Lindemann, 1988). This leads to NK cell cytotoxic activity 
against host cells. 
1.5 Cytokines in Periodontal Disease 
1.5.1 Interleukin-1 
In the periodontal tissues IL-lß is predominant over IL-la, and compared with 
healthy and stable sites is found at higher levels in active disease (Jandinski et al., 
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1991; Stashenko et al., 1991a). Variations have been noted in the concentrations of 
IL-I between sites in the same individual, this coupled with variations in serum IL-lß 
levels between chronic periodontitis patients and healthy controls, suggests the 
production of this cytokine is at the local level rather than the systemic (Tatakis, 1993; 
Chen et al., 1997). Macrophages, PMN, B cells and fibroblasts secrete IL-1(3, and 
activated keratinocytes and Langerhans cells produce both IL-Ia and IL-I P (Hillmann 
et al., 1995; Jandinski et al., 1991; Gemmel and Seymour, 1998; Takahashi et al., 
1995). 
The production of IL-1 stimulates certain cells to express adhesion molecules. These 
include; fibroblasts, endothelial cells, monocytes and granulocytes (Takahashi et al., 
1994). The expression of adhesion molecules aids the migration of immune cells 
from the capillaries into the inflamed tissues. It has been shown that numerous 
periodontal pathogens can stimulate host cells to produce IL-1 (Gemmel et al., 1992; 
Gemmel and Seymour, 1998). 
IL-I can induce the production of plasminogen activator, IL-6, matrix 
metalloproteinases and PGE2 by gingival fibroblasts. These cells are involved in 
tissue destruction, turnover and remodelling (Richards and Rutherford, 1988). IL-1 
stimulates osteoclasts to resorb bone (Horton et al., 1972), whilst inhibiting bone 
formation (Stashenko et al., 1987). IL-1-mediated bone resorption can be induced by 
periodontopathogens (Ishihara et al., 1991). 
1.5.2 Tumour necrosis factor 
TNF-a, IL-la and IL-lß are all known as pro-inflammatory cytokines and have all 
been identified at higher levels in periodontitis lesions from patients with chronic 
periodontitis compared with healthy sites (Matsuki et al., 1992; Stashenko et al., 
1991b). However, cells containing ILA P were found in much greater numbers than 
those producing TNFa and IL-la (Stashenko et al., 1991b). In contrast to IL-1, only 
very low concentrations of TNFa have been demonstrated in GCF from both chronic 
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and aggressive periodontitis patients (Rossomando et al., 1990; Yavuzyilmaz et al., 
1995). 
High levels of TNFa in periodontal lesions appear to represent an established 
inflammatory and immune response. Salvi and co-workers (1998) examined GCF IL- 
1(3, TNFa and PGE2 levels in type I diabetes mellitus patients with periodontal 
disease. They found that diabetics had significantly increased levels of PGE2 and IL- 
113 but not TNFc , as compared with non-diabetic controls with similar periodontal 
status. In addition, diabetics with moderate to severe disease had almost two-fold 
higher levels of PGE2 and IL- lß compared with diabetics suffering from gingivitis or 
mild periodontitis. 
PGE2 causes increased vascular dilation and permeability. It also stimulates 
macrophages to secrete matrix metalloproteinases and has been shown to trigger bone 
resorption in vitro (Birkedal-Hansen, 1993), thus acting synergistically with IL-1 and 
TNFa. Furthermore it upregulates complement and Fe receptors on the surface of 
monocytes and PMN (Offenbacher, 1996). In inflamed periodontal tissue, 
prostaglandins and leukotrienes are mainly produced by activated macrophages, 
although they can also be produced by fibroblasts. Prostaglandins, especially PGE2, 
comprise the primary pathway of alveolar bone destruction in periodontitis. 
Leukotrienes, especially leukotriene B4, are potent chemoattractants for PMN. 
1.5.3 Interleukin-10 
A role for IL-10 in the progression of chronic periodontitis was suggested by Gemmell 
and Seymour (1998). This study indicated that T cell lines from both the peripheral 
blood of periodontal patients and their gingival tissue, secreted IL-10, but clones 
derived from the peripheral blood of an individual with gingivitis did not. It has also 
been suggested by Stein and co-workers that IL-10 may contribute to auto-immune 
reactions against gingival tissues (Stein and Hendrix, 1996; Stein et al., 1997). 
Gemmell and Seymour (1998) have demonstrated a significantly reduced number of 
IL-10+ CD8+ cells from chronic periodontitis lesions, than from healthy/gingivitis 
sections. They suggested that in gingivitis, IL-10 might suppress inflammation by 
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decreasing macrophage activity, thereby preventing progression to periodontitis. No 
differences were found in the percentage of 1L-10+ CD4+ cells between the two 
disease categories. However, some individuals were found to have higher numbers of 
IL10+ T cells, regardless of disease category. It appears that the overall variation 
between the two diseases entities in IL-10+ CD8+ cells may have been due to 
individual variation in IL-10 secretion patterns, rather than differences in pathogenesis 
between the two disease categories. Further studies are needed to clarify the role of 
IL-10 in periodontal disease. 
In summary, IL-1, IL-6 and TNF are pro-inflammatory cytokines which are detected 
and may be modulated within the periodontium. They are important aspects of the 
host defence system, operating in the periodontal tissues during health, destruction 
and healing phases. Further research may lead to a greater understanding of the roles 
of other members of the cytokine network, in particular IL-10 and various soluble and 
cell-bound receptors and inhibitors of cytokine function, in periodontal disease. These 
molecules are inter-related and are part of the immune, inflammatory, breakdown and 
repair homeostasis ongoing within the periodontium. 
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Table 1.2 The Role of Cytokines in Periodontal Disease 
Cytokine Produced by Role 
Interleukin-1 (IL-1) large quantities " proinflammatory properties 
produced by " mediator of tissue destruction in 
macrophages periodontal disease (Alexander & 
Damoulis; 1994) 
Interleukin-4 (IL-4) activated T cells " inhibits production of IL-I, TNF 
and IL-6 
" an absence of IL-4 in the 
periodontal tissues has been 
suggested to trigger disease 
progression (Fujihashi et al., 
1993, Hirano et al., 1991) 
Interleukin-6 (IL-6) lymphoid and " mediates inflammatory tissue 
non-lymphoid cell destruction 
types. " thought to be an important 
Production is cytokine in B cell differentiation, 
triggered by IL-1, and hence play a role in the 
TNF and IFN-y induction of the elevated B cell 
response in patients with 
periodontal disease (Fujihashi et 
al., 1993) 
Interleukin-8 (IL-8) mononuclear " attracts and activates neutrophils 
monocytes and into the tissues of the 
many of the tissue periodontium, particularly as it is 
cells produced by gingival fibroblasts 
(Takashiba et al., 1992) 
Interleukin-12 (IL-12) monocytes, " Pleiotrophic effects on NK cells 
macrophages, B and T cells in the tissues 
cells and " induces IFN-y production and is 
accessory cells necessary for THI induction 
Tumor Necrosis Factor a macrophages and " similar effects to IL-1 and IL-6 
and P (TNF-a, TNF-ß) lymphocytes 
respectively 
Interferon y (IFN-y) activated T cells " potent inhibitor of IL-1, TNF-a 
I and TNF- 
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1.6 Important Antigens in Periodontal Disease 
1.6.1 Introduction 
The following section is a discussion of immunodominance and the existence of 
immunodominant antigens. The aim of the studies presented in this thesis is to focus 
on the target of the humoral immune response in periodontal disease, and in particular 
the importance of immune response inducing antigens. The subject of 
immunodominance is a controversial one, and the following section will be devoted to 
discussing evidence in the literature for immunodominant antigens in a number of 
diseases. 
There is substantial literature on the humoral immune response detected against 
micro-organisms present within periodontal pockets. However, the significance and 
specificity of the immune response in periodontal disease has proved difficult to 
elucidate. This is due to the large number of putative pathogens in the plaque biofilm, 
and the apparent commensal nature of many of these opportunistic organisms. 
Identification of the immunodominant antigens involved in the disease process would 
be informative especially with respect to: (i) the relative importance of the implicated 
pathogens; (ii) new approaches to immunological diagnosis; (iii) specific bacterial 
virulence determinants; (iv) natural protective responses; and (v) the selection of 
potential candidate antigens for vaccine development. 
The concept of immunodominance is often misused by investigators. Their 
interpretation of data is that specific antigens or epitopes of a micro-organism or 
macromolecule are `immunodominant'. However, little explanation as to the basis of 
the finding and importantly, its significance is provided. 
The phenomenon of `immunodominance' was initially described by Sercarz and 
colleagues (Sercarz, 1989) to provide a framework for explaining the genetic control 
of antibody responses to hen egg lysozyme (HEL). HEL is a globular protein with a 
known 3-dimensional structure. These investigators were able to define antigenic 
epitopes using peptides derived from cyanogen bromide cleavage of this protein. 
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Specifically, immune responses of H-2e mice to HEL were restricted to 3 amino 
terminal residues of the molecule. Wicker et al. (1984), reported that if these 3 
residues were cleaved, 50% of the primary response antibody molecules bound poorly 
if at all to the HEL, and the immunogenicity of the protein was drastically effected. 
The term `immunodominance' was used to describe the predominant immune 
recognition of these 3 amino terminal residues. Sercarz (1989) suggested that for 
efficient and regulated activity of the immune response to a particular antigen, there 
should be a small number of immunodominant epitopes on an antigen. 
The primary, secondary, and tertiary structures of a protein antigen offer a vast array 
of potential epitopes. However, the number recognised by the immune system 
appears to be considerably smaller than the full antigenic repertoire of the immunogen 
(Laver et al., 1990). Some of these antigenic epitopes will dominate the resulting 
specificity of the immune response. This can vary from species to species, and even 
among individuals within a species. They will not only induce a more pronounced 
immune response, but may also suppress the primary immune response to other 
antigenic determinants. Recent studies using a similar experimental system have 
demonstrated the broad heterogeneity of proliferative responses to the 
immunodominant determinants within HEL. The heterogeneity of response was 
suggested to relate to the competitive and regulatory nature of the interaction between 
various factors. These include different MHC molecules, determinant capture by 
antigen presenting mechanisms, and the available T cell repertoire. The authors 
suggested that these results may have important implications for studies of 
autoimmunity, infection and vaccine design in human populations, where 
heterozygosity is the characteristic of the population (Moudgil et al., 1998). 
The basis for the existence of immunodominant epitopes is not well understood. 
Recent findings have shown that peptide competition for MHC binding may not 
represent the most important event in processes leading to immunodominance (Lo- 
Man et al., 1998). T lymphocyte responses to a protein antigen are restricted to a 
limited number of determinants and not to all peptides capable of binding to MHC 
class 11 molecules. 
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Focusing of the T cell immune response is also defined as immunodominance, and has 
been observed with numerous antigens. Recent investigations by Gapin et al. (1998) 
have suggested that dendritic cells play a major role in the immune response against a 
few antigenic determinants. Conversely, B lymphocytes may diversify the T cell 
response by presenting a more heterogeneous set of peptide-MHC complexes. 
Moreover, this T cell focusing has been extended to cellular immune responses, which 
are directed against a narrow set of immunodominant peptides derived from complex 
antigens. The existence of epitopes that are hidden or infrequently targeted by 
immune responses (cryptic epitopes) has also been identified. 
Although the identification of immunodominant epitopes is important for vaccine 
development, understanding immunological reactivity to these cryptic epitopes may 
be important in the development of autoimmunity. Blum et al. (1997) have suggested 
that targeting exogenous antigens into specialised processing compartments within 
antigen presenting cells appears to be important in epitope selection and 
immunodominance. 
The final outcome of the immune response may be an immunochemical phenomenon 
which is related to the protein structure or the host's immunoregulatory mechanisms. 
However, it also appears to be effectively used by various pathogens, as a host evasion 
tactic. This occurs when the microbial immunodominant epitopes are sterically close 
to antigens which have the capacity to demonstrate antigenic diversity and are capable 
of antigenic variation. Thus, they help to conceal the micro-organism from the host 
protective responses (Nara et al., 1998). 
In the field of periodontal research the term `immunodominant antigen' and the 
concept of `immunodominance' have been used imprecisely, are poorly defined and 
often misrepresented. There are multiple reports in the literature, purportedly 
characterising immunodominant antigens of oral micro-organisms, yet no clear 
definition of immunodominance is included. It is not known whether these antigens 
express an epitope that is the focus of the primary immune response, and which is 
essential for the initiation of the response to the antigen and micro-organism (Wicker 
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et al., 1984). Due to the chronic nature of periodontal infections, these subjective 
measures may only be defining the gravimetric quantity of a particular antigen, rather 
than describing a function of its unique antigenicity. 
Thus, the original definition of immunodominance has been distorted to describe a 
microbial antigen to which a predominance of antibody is detected when compared to 
the myriad of other antigens presented by the micro-organism and recognised by the 
host. Investigators should be clearer when reporting results. They should indicate 
whether they have described an antigen to which there is a `detectable antibody 
response' rather than an `immunodominant antigen'. 
Immunodominance and immunodominant antigens have been difficult to study in 
periodontal disease due to the large number of species comprising the microbial 
biofilm at sites of health and disease. Other factors including proposed genetic 
predisposition, behavioural variables such as oral hygiene levels, and environmental 
factors (e. g. smoking and socio-economic factors) have not made the problem any 
simpler. In addition, there is controversy about the nature of the humoral immune 
response itself. Whether the antibody response in this disease is protective or 
contributes to tissue destruction indirectly is unknown. It is reasonable to assume that 
disease activity would be abrogated if the antibody response was effective at 
eliminating or controlling the growth of the micro-organisms present. In contrast the 
antibody response may be harmful to the host if it protects certain bacteria or actually 
causes pathology itself (e. g. hypersensitivity). A study by Mooney et al. (1995), 
reported that patients with periodontal disease who possessed high avidity antibodies 
to oral pathogens, have a better prognosis than patients with low avidity antibodies, 
regardless of whether the latter have a high titre of antibodies or not. This study 
appears to indicate that an effective antibody response is protective. However, 
numerous reports speculate on a possible autoimmune aspect to periodontal disease 
(Brantzaeg and Tolo, 1977; Kristofferson and Tonder, 1973; Hirsch et al., 1988; 
Anusakasathien and Dolby, 1991). There is no conclusive evidence that high levels of 
antibody are protective or indicative of disease. An important factor which must be 
considered is that, patients with periodontal disease are not found to be more 
susceptible to other bacterial infections. They also do not show severe pathology 
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linked to any other diseases. In addition, autoantibodies have not been found to 
predominate in the periodontal lesion, although antibodies to host components, in 
particular collagen (Ftis et at., 1986; Peng, 1988; Hirsch et at., 1988) have been 
reported. Until evidence is found to support the conclusion that the immune response 
is destructive it should be assumed that it is protective. However, the pathology seen 
in this disease is not only due to the direct harmful effects of micro-organisms. 
Production of high levels of pro-inflammatory cytokines (IL-6, IL-8, TNF) has been 
reported, (Tsai et at., 1995; Yavuzyilmaz et al., 1995) which could result in 
considerable tissue destruction. 
A further consideration in periodontal disease, is that critical clinical features of the 
disease are often identified long after the biologic mechanisms have initiated the 
disease process. 
When addressing our current knowledge of the antigens to which a detectable immune 
response in periodontal disease may be directed, one must consider that within a 
complex microbial biofilm, such as the subgingival plaque, it appears that certain 
micro-organisms elicit greater antibody levels (i. e. dominate the immune response) 
than others (Zambon 1996). This characteristic of the host response does not appear 
to depend entirely on the absolute numbers of an individual micro-organism. It may 
be related more to their structural and antigenic components or their pathogenic 
significance (virulence), as well as their distribution within the biofilm and/or host 
tissues. An understanding of the antigens, which elicit a detectable antibody response, 
should contribute to a better understanding of specific bacterial virulence 
determinants, natural protective responses, and even possible strategies for vaccine 
development, or new approaches to immunological screening and diagnosis of the 
disease. 
A survey of the scientific literature on immunodominant antigens in medical 
infectious diseases provides an indication of the significance of this concept for 
identifying potential virulence, diagnostic, or vaccine candidates. In the following 
discussion, selected studies are reviewed to provide examples of the variation in the 
use of the terminology. In addition, the potential limitations of equating detectable 
80 
antibody response with immunodominant antigen and protective immune responses 
are highlighted. 
Examples of reports identifying immunodominant and therefore, candidate diagnostic 
antigens in parasitic infections include studies on Neospora canium (Howe et al., 
1998), Theilera pat-va (Katende et al., 1998), Trypanasonia cruzi (Pereira et al., 1998) 
and Schistosomna inansoni (Chen and Boros 1998). It is clear from the literature that 
an antigenic relationship to similar antigens from other parasites and prevalence of the 
response during infection, is often used as evidence to speculate on the importance 
and function of potentially "important" antigens during infection. Identification of 
important antigens from these types of studies can also lead to a higher degree of 
sensitivity and specificity in diagnosis. Some studies have even uncovered 
information on the disease pathology and progression. For example, Chen and Boros 
(1998) identified that the immunodominant T cell epitope, P38, of Schistosoina 
mansoni, elicited the pulmonary granuloma formation, the disease associated 
hypersensitivity lesion of this infection. 
There have also been a variety of similar studies which focused on dominance in 
bacterial or fungal infections. While the mortality rate for systemic candidosis 
remains high, the diagnosis is somewhat difficult and there has been considerable 
interest in developing a reliable serodiagnostic test. Mathews et al. (1988) identified 
the 47 kDa component of Candida albicans as an `immunodominant antigen' in the 
serology of systemic candidosis. The 47 kDa antigen appears to be immunodominant 
and 92% of patients with candidal antibodies produced a response to an antigen of 47 
kDa. It seems that this antigen is conserved in structure between strains, and an assay 
detecting this antigen would be the basis for a sensitive and specific diagnostic test 
(Mathews et al., 1984,1987). 
Further interesting and important knowledge has been gained from studies involving 
immunodominant antigens and the quest to identify them. The Mycobacterium avium 
complex (MAC) consists predominantly of Mycobacterium avium (M. avium) and 
Mycobacterium intracellulare (Inderlied et al., 1993). MAC members are ubiquitous 
environmental micro-organisms and infection in healthy individuals is rare. However, 
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MAC infection is a major cause of bacterial morbidity and mortality in AIDS patients. 
A recent report by Triccas et al. (1998) suggested, following molecular and 
immunological analyses, that a 35 kDa protein of M. aviuni is a homologue of the 35 
kDa immunodominant antigen of Mycobacterium leprae (Triccas et al., 1996). The 
35 kDa protein of MAC, was confirmed to contain T-cell and B-cell epitopes 
recognised by human immune responses following mycobacterial infection. However, 
it was discovered that immunologically there is an inability to distinguish between 
MAC and Mycobacterium tuberculosis, even though the 35 kDa protein is not 
recognised by tuberculosis patients. Although this is an example of a study where an 
antigen eliciting detectable antibody response is identified, it does not identify a 
potential vaccine candidate or any other markedly positive conclusion. For both 
tuberculosis and mycobacterial infections, early diagnosis is crucial for the prognosis 
of the patients. Therefore, this emphasises a situation where using a detectable 
antibody response for differential diagnosis is of critical importance. 
Studies investigating dominant antigens, even if they are not primarily designed to do 
so, can answer crucial questions. Otitis media is a common problem associated with 
high morbidity, in which a subset of children experience repeated episodes caused by 
nontypeable Haentophilus influenzae (H. influenzae) (NTHI). Murphy and 
Kyungcheol (1997) showed that the principal antibody response in animals to an 
NTHI strain was directed at an immunodominant epitope of the P2 molecule, which is 
the major outer-membrane protein of NTHI. However, this group hypothesised that 
the otitis prone children develop an antibody response to an immunodominant region 
of the P2 molecule, which is strain specific. Therefore, the child's protective response 
is directed exclusively against the infecting strain. These children will experience 
recurrent episodes of otitis media since they have no protection against a new strain. 
The discovery of the dominant antigen associated with this infection has further 
important implications. It contributes to the understanding of the recurrent nature of 
otitis media and provides useful data on a potential vaccine design for this disease. 
As mentioned in the preceding section, the importance of T cell immunodominant 
epitopes is clear and must be distinguished from those eliciting a dominant B cell 
response. Listeria monocytogenes secretes proteins associated with its virulence 
82 
inside infected cells. These are degraded by host cell proteasomes, processed into 
peptides and bound to MHC class I molecules. These antigen epitopes are effectively 
presented to cytolytic T lymphocytes (CTL). Results of Pamer et al. (1997) indicated 
that immunodominant T cell responses cannot be predicted by the prevalence of 
antigens or epitopes. In fact, one of the least prevalent epitopes primes for the 
immunodominant CTL response in mice. 
Above are all examples of the purported significance of identification of 
immunodominant antigens and the potential benefits in medically important 
infections. Utilisation of the antigen(s) to create diagnostic tools, and develop 
vaccines attaches greater value and relevance to the search for these types of antigen. 
The need to identify periodontal pathogens as true aetiological agents in the disease 
process still exist. Many of these candidate pathogens may be merely opportunistic 
and depend on the biofilm "food web" to create the conditions or niche within which 
they can colonise, obtain nutrients and replicate. Thus, these micro-organisms would 
not classically be considered as the true pathogens against which host defence 
mechanisms should be directed. In spite of the potential microbial complexity of this 
disease, a number of candidate species have emerged which are thought to play a role 
in the pathogenesis of periodontal disease. These micro-organisms generally fulfil the 
modified Koch's postulates as described by Socransky and Haffajee (1992). 
Examination of numerous periodontal pathogens has revealed these micro-organisms 
to possess a variety of potential virulence factors and structures that may be crucial to 
their pathogenicity. In the quest for the identification of the important bacterial 
antigens in periodontal disease, a number of different candidate antigens have been 
suggested. 
1.6.2 Outer-membrane proteins 
Much of the periodontal literature applicable to this topic covers studies on the outer- 
membrane proteins (OMP) of periodontal pathogens. OMP of Gram negative bacteria 
may reside on the inner or outer layer, or can span the entire outer-membrane. Gram 
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negative bacteria possess multiple OMP which provide important biological functions, 
such as phage receptors or receptors for uptake of nutritional substrates. Various 
specific microbial antigens have been identified from the outer-membranes of oral 
pathogens to play a role in periodontal disease. However, many studies have 
identified outer-membrane antigens of the same micro-organisms, which remain 
uncharacterised and may be of importance in protection afforded by the adaptive host 
immune response (Watanabe et al., 1989; Califano et al., 1989; Wilson et al., 1991; 
Califano et al., 1992; Page et al., 1992b). These studies have tended to focus on 
either sonicate antigens or OMP which can be sheared from the surface of the bacteria 
(Nakagawa et al., 1995). Since these two preparation methods differ, one could 
identify both antibodies to intracellular antigens, as well as to the surface antigens, 
however, similar results might be expected. It seems unlikely that patients would 
produce an array of antibodies to "inaccessible" intracellular proteins, and more likely 
that antigens eliciting a detectable antibody response would be expressed on the 
microbial surface or as secreted proteins. The majority of the outer-membrane 
components of putative periodontopathogens remain uncharacterised with respect to 
their metabolic or structural functions or their activity as virulence determinants. In 
general, patients with strong responses to these individual antigens often tend to be 
those who have a strong response to the whole bacterial cells. 
Nakagawa et al. (1995) reported detection of antibodies to apparent 
`immunodominant antigens' of P. gingivalis in the sera of chronic periodontitis 
patients. These were specific for antigens of molecular weight 75 and 31 kDa from 
outer-membrane preparations, and a 46 kDa antigen from sonicated extracts of the 
micro-organism. Further studies identified 75,55, and 43 kDa bands in whole cell 
sonicates of P. gingivalis to be `immunodominant antigens' in rapidly progressive 
periodontitis patients (Chen et al., 1995). A similar approach was utilised by Ebersole 
and Steffen (1994). They documented `immunodominant antigens' in outer- 
membrane preparations, from various strains of P. gingivalis. The results identified 
some similarities in antibody recognition of antigen bands across strains, however, a 
striking variability was noticed between the strains. Additionally, variations in 
response patterns were noted to be associated with high and low response patients, 
irrespective of the clinical disease classification. 
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Ebersole et al. (1995) and others (Bolstad et al., 1990; Watanabe et al., 1989; Sims et 
al., 1991) have used Western immunoblot approaches to detect antibody responses 
specific for antigens in the outer-membranes of A. actinomycete? ncomitans. These 
studies revealed a wide variation in responses among individual patients, thus adding 
to the difficulty regarding the identification and/or importance of an antigen(s) that 
dominates throughout a patient population. Alternatively, Flemmig et al. (1996) 
demonstrated IgG/IgA antibody activity in aggressive periodontitis (65%/70%) and 
chronic periodontitis (45%/55%) patients reactive with a 110 kDa OMP of A. 
actinomycetemcomitans. In contrast, control subjects had no IgG and only 5% had 
any IgA antibody activity. This approach exemplifies a strategy whereby a high 
frequency and or level of antibody is detected to a particular antigen in patients versus 
controls, which is then suggested to be an immunodominant antigen. Each of these 
studies aimed to identify immunodominant antigens as macromolecules which may 
play an important role in pathogenesis, and the response to which correlated with 
disease resistance. In fairness to the authors, many of these studies probably identified 
the molecular weight of antigens which elicited a detectable antibody response in this 
disease. However, none of the mentioned studies obtained sufficient evidence to 
describe an immunodominant antigen. 
Importantly, the OMP are uniformly immunogenic and many demonstrate antigenic 
diversity (heterogeneity) (Holt and Bramanti, 1991; Holt and Ebersole, 1991; Mitchel, 
1991). Moreover, environmental changes altering the growth of numerous micro- 
organisms, such as Bordetella pertussis, have been shown to result in antigenic 
modulation of OMP (Robinson et al., 1986). Genco and colleagues (1991) presented 
the concept of the potential importance of antigenic heterogeneity, as a virulence 
strategy for oral micro-organisms. Recent studies by Ebersole and colleagues (1995) 
with A. actinomycetemcomitans, Chen et al. (1995) with P. gingivalis, and Sims et al. 
(1998) with B. forsythus have supported antigenic diversity of these pathogens within 
infected patients. However, there remains minimal information on its potential role in 
virulence within the periodontal microbiota. 
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The previously mentioned studies give examples of strategies which have been used 
and provide examples of some potentially interesting targets. However, they only 
"scratch the surface" in providing an understanding of the antigenic epitopes which 
activate the regulatory T cells. These T cells effectively stimulate regional B 
lymphocytes which could provide a functional host immunity in periodontal disease. 
Current genome sequencing of these pathogens will allow us to visualise the 
organisation of these protein genes. In addition it will enhance studies of genetic and 
antigenic heterogeneity within the population. Sequencing, purification and 
functional studies of these antigens will encourage evaluation of their significance in 
well characterised patient and control populations, as well as in in vitro and in vivo 
models of disease. More importantly, from the perspective of this review it is not 
clear that the concept of a "dominant antigen" is critical to the ultimate goals of this 
research. As mentioned previously, high antibody levels or raised titres to an antigen 
do not necessarily define immunodominance of the antigen. They may instead 
delineate a dominant antibody response. If this response is directed against a `flak 
antigen', (an antigen capable of significant diversity or variation, or having little 
contribution to the pathogenicity of the micro-organism), the detection of a dominant 
antibody response does not inherently describe an immunodominant antigen nor 
provide insight into immune protective responses. 
1.6.3 Fimbriae 
Fimbriae or pili as they are often termed because of their functional and molecular 
homology to pap pili of E. coli (Krogfelt, 1991), are curled single stranded filaments 
with a diameter of approximately 5nm (Ishikawa et al., 1997). They are cell surface 
structures important in adherence and are possibly virulence factors in medically 
significant pathogens. 
Gilsdorf et al. (1989) reported the fimbriae of H. influenzae as being immunogenic. 
Pichichero et al. (1982) detected anti-pilin antibodies in human serum following H. 
influenzae infection. However, many investigators have suggested that fimbriae of H. 
influenzae are not pathogenic when tested in animal models (Kaplan et al., 1983; Stull 
et al., 1984; Mylotte et al., 1985). 
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Early ultrastructural studies clearly identified fimbriae-like structures on the surface of 
numerous oral micro-organisms, including A. actinonrycetenicomrtans, Actinomyces 
spp., P. gingivalis and Prevotella spp. (Cisar et al., 1979; Woo et al., 1979; 
Scannipieco et al., 1983; Rosan et al., 1988; Leung et al., 1989). Therefore, as 
identified for other pathogens, these structures may be of importance in the 
pathogenesis of periodontal disease. The principle work in this area has involved 
detailed studies of these structures in P. gingivalis. 
P. gingivalis has been identified in gingival tissues, which suggests that this micro- 
organism is able to successfully colonise the microbial biofilm in the gingival sulcus 
and cross the epithelial barrier into deeper tissues (Gibson et al., 1964; Saglie et al., 
1988; Sandros et al., 1996). Fimbriae appear crucial for the adherence of micro- 
organisms, such as P. gingivalis, to other members of the microbial plaque and to host 
gingival tissue surfaces. Supportive evidence arises from studies examining 
afimbriate variants of P. gingivalis with diminished capacity to adhere to epithelial 
cells (Genco et al., 1994). Hamada et al. (1994) reported that a fimA mutant of P. 
gingivalis, which lacked surface fimbriae, showed deficient adherence to both 
cultured human gingival fibroblasts and epithelial cells. They concluded that this 
protein structure is essential for the micro-organism to interact with gingival tissues 
(Hamada et al., 1994). 
The functional importance of fimbriae has further been supported by Madianos et al. 
(1997), who described the adhesive and invasive properties of P. gingivalis strains on 
the KB oral epithelial cell line. In this study, a population of a fimbriated strain of P. 
gingivalis demonstrated 50% adherence to the epithelial cells. In addition 10% of the 
bacteria were internalised within 90 minutes of infection of the monolayer. In 
contrast, a mutant strain lacking fimbriae displayed a significantly decreased adherent 
capacity (10%), only 1.5% of the bacteria were internalised. The available literature 
supports the theory that fimbriae of this pathogen are a target of the humoral immune 
response in periodontal patients. However, a lack of antibodies reactive with fimbriae 
has not been identified as increasing disease risk. Condorelli et al. (1998) recently 
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reported detection of IgA antibodies in the GCF of patients with acute recurrent 
periodontitis. The antibodies were specific for the purified 43 kDa fimbrial antigen. 
Malek et al. (1994) used P. gingivalis with an insertional mutation in the gene 
encoding the fimbrillin subunit. They showed that the mutant was unable to adhere to 
salivary pellicle coated tooth surfaces and could not induce bone loss in a gnotobiotic 
rat model. Additionally, an anti-fimbrial monoclonal antibody has been shown to 
block the adherence of P. gingivalis to salivary pellicle-coated tooth surfaces (Genco 
et al., 1994). These two experiments suggest that an absence of antibodies to fimbriae 
may encourage the adherence/colonisation of P. gingivalis and enhance the risk of 
disease onset. 
There is generally no evidence supporting the role of fimbriae as an immunodominant 
antigen in periodontal disease, or other diseases. These studies have described 
dominant humoral immune responses. They do not establish that fimbriae are 
immunodominant antigens. Fimbriae seem to be extremely important in mediating 
adherence to human mucosal surfaces (Beachey, 1981). Therefore, they must be 
considered an attractive candidate for a future vaccine. A study by Brant et al. (1995) 
reported a novel approach to induce protection against different oral micro-organisms, 
that was to define the immunodominant region of fimbrillin and then use synthetic 
peptides to mimic this epitope in a vaccine. This was a novel and theoretically 
excellent approach. However, with hindsight the lack of reports in dental literature 
about human antibody titres directed against fimbriae, coupled with the difficulty of 
extrapolating results from animal models, indicate that there are problems with this 
concept. The utilisation of adhesins as vaccine candidates is not a new idea. Clark et 
al., (1985) developed a model to evaluate the role of fimbriae in the prevention of 
colonisation of teeth by Actinomyces viscosus (A. viscosus). After mice had been 
immunised with both type 1 and type 2 fimbriae, antibodies of isotype IgG and IgA 
were detected. Further challenge with A. viscosus resulted in a significant reduction in 
the number of mice colonised. The results of this early study, indicated that fimbrial 
vaccination may modulate colonisation of oral bacteria. 
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In conclusion fimbriae do not appear to be immunodominant although they do appear 
to be important. The available literature supports the theory that fimbriae of P. 
gingivalis are a target of the humoral immune response in periodontal disease patients. 
This has been delineated in various disease populations, with a general finding of 
increased levels and frequency of serum antibody to the fimbriae or fimbrillin subunits 
(Okuda and Takazoe, 1988; Ogawa et al., 1989a; Genco et al., 1991). Recently, 
Condorelli et al. (1998) reported the detection of IgA antibodies in the GCF of 
patients with acute recurrent periodontitis. The antibodies were specific for the 
purified 43 kDa fimbrial antigen. Thus, it is clear that both a local and systemic 
humoral immune response is generated to this antigen in many periodontitis patients. 
However, evidence that fimbriae are immunodominant antigens in periodontal disease 
or in other infectious diseases is generally lacking. 
1.6.4 Lipopolysaccharide (LPS) 
A major structural feature of all Gram negative bacteria is the LPS macromolecule 
comprising the outer-membrane of these prokaryotes. LPS exhibits a broad spectrum 
of pathophysiological properties. It is a potent immunostimulator and adjuvant, as 
well as being a principal virulence determinant of most Gram negative pathogens. It 
elicits these effects via induction of local and systemic inflammatory reactions. 
The LPS macromolecule is composed of 3 distinct regions; the 0 polysaccharide- 
chain, the core region, and the lipid part, termed lipid-A. The O-Chain anchors LPS 
to the bacterial membrane (Luderitz et al., 1982). This portion of the molecule shows 
enormous structural variability within prokaryotes. It is generally characteristic for a 
Gram negative bacterial species and often represents an antigenically diverse surface 
component of these micro-organisms (Zahringer et al., 1994). The core region of LPS 
is organised into an outer core and an inner core (Holst et al., 1992). The outer core 
region contains neutral sugars and the inner core often contains rare glycose residues. 
Moderate inter-bacterial variability has been suggested to occur in this region. The 
lipid A portion of LPS is linked to the polysaccharide core of the molecule. It is the 
least variable component of LPS (Rietschel et al., 1984) and is generally considered to 
be responsible for the endotoxic, inflammatory and tissue destructive effects of LPS. 
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LPS from oral micro-organisms can penetrate calcified tissue (Aleo et al., 1974) and 
gingival connective tissue (Aleo et al., 1980). Studies have also suggested that LPS 
from oral bacteria may contribute directly to tissue damage and bone resorption 
characteristic of periodontal disease (Hausmann et al., 1970). This early work and 
subsequent studies are based on in vitro cell cultures and therefore, may not 
necessarily apply to the in vivo situation. Nevertheless, proposing a pathogenic role 
for LPS is reasonable since it has been detected in periodontal tissues, even in the 
absence of identifiable bacteria. Large numbers of blebs (e. g. outer-membrane 
vesicles) have been observed associated with several Gram negative oral bacteria. 
These membrane bound, diffusable liposomal-like structures could enhance the 
transfer of LPS to sites distant from the plaque biofilm, such as the periodontal tissues 
(Nisengard and Newman, 1994). 
Numerous studies have demonstrated that the serotype determinants of A. 
actinomycetemcomitans are associated with a high molecular weight LPS-associated 
antigen (Califano et al., 1989) or carbohydrate smear antigen (Califano et al., 1989; 
Sims et al., 1991). In aggressive periodontitis patients with the highest serum 
antibody levels to A. actinomycetemcomitans the predominant antibody specificity is 
to LPS (Okuda et al., 1986; Wilson et al., 1991; Califano et al., 1992; Wilson and 
Hamilton, 1995). LPS is generally thought to exhibit immune stimulating 
characteristics which are T cell independent, and thus principally induce an IgM 
response. However, it is clear that aggressive periodontitis patients produce 
substantial levels of IgG antibody to this antigen from A. actinomycetemcomitans (Lu 
et al., 1993). The level and characteristics of this dominant antibody response 
suggests that an anti-LPS response is a significant marker of A. 
actinoniycetemcomitans infection and existing periodontitis. However, whether LPS 
represents a virulence determinant, a true "dominant antigen", or an antigen to which 
the adaptive immune response can provide protective immunity remains to be proved. 
The literature is replete with studies reporting high titres of serum IgG antibodies to P. 
gingivalis in periodontitis patients compared with healthy controls. However, the 
temporal acquisition of the antibody response relative to colonisation and/or infection 
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has not been clearly described. Thus, animal models have been developed to examine 
the acquisition and specificity of potential protective immunity. A recent study by 
Vasel et al. (1996) reported that immunisation of monkeys with a vaccine containing a 
monkey isolate of P. gingivalis, induced protection against alveolar bone destruction. 
This might be considered surprising since a number of pathogens are considered to be 
associated with the periodontopathic microbial ecology (Socransky and Haffajee, 
1992; Zambon, 1996). In addition, in many periodontitis sites in humans, P. 
gingivalis is undetectable (Mombelli et al., 1991). Further investigation of immune 
and pre-immune sera obtained from monkeys, used immunological analyses including 
ELISA and Western immunoblotting (Vasel et al., 1996). After immunisation the sera 
of the monkeys contained increased antibody levels reactive not only with antigens of 
P. gingivalis, but also with antigens of B. forsythus. Detailed analyses suggested that 
the binding of serum antibodies was a specific, adaptive response to the LPS in the 
immunogen, since little reactivity was detected in the pre-immune sera. Thus, the 
antibodies induced by LPS from P. gingivalis appeared to be cross-reactive with the 
LPS of B. forsythus, and could contribute to a more general modification of plaque 
ecology. 
These observations are similar to those obtained by other investigators examining LPS 
in non-oral Gram negative bacteria. For example, Seifert et al. (1996) reported the 
generation of a human monoclonal antibody that recognised a conserved epitope 
shared by LPS molecules of different Gram negative bacteria. This indicated a high 
degree of cross-reactivity of antibody across different bacterial species. The epitope 
recognised by the human monoclonal IgM antibody (i. e. LPD5H4) was located in the 
lipid A portion of the LPS molecule. Importantly, the monoclonal IgM antibody was 
shown to partially neutralise LPS activities of Salmonella minnesota, Salmonella 
typhimurium, E. coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Neisseria 
meningitidis. The binding specificity of LPD5H4 is only a small step in the search for 
the existence of immunodominant epitopes in the conserved regions of LPS. 
However, it does provide an indication of the potential for broad cross-reactivity of 
antibodies against LPS molecules of different bacterial genera. This phenomenon 
should be considered when documenting the role of LPS as an antigen in periodontal 
disease. 
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Preston et al. (1996) have reported that although many would assume LPS to be the 
major glycolipid in the cell wall of Gram negative bacteria, in fact lipooligosaccharide 
(LOS) is. LOS and LPS both share lipid A in their structure (Griffiss et al., 1995). 
Therefore, if lipid A is the immunodominant portion of these glycolipids it could 
result in even broader cross-reactivity. Nevertheless, polyclonal anti-E. coli lipid A 
antibodies have been shown to cross-react with a large variety of free lipid A 
molecules. However, antibodies to lipid A do not cross-react with intact LPS in vitro, 
indicating that either the cross-reacting lipid A epitopes are not expressed or that the 
epitopes are cryptic (Zahringer et al., 1994). These reports often evaluated 
monoclonal antibodies of murine or human lineage. A cautionary note was proved by 
Freudenberg et al. (1989) who suggested that ELISA determinations of relatively 
adhesive antibodies, such as IgM, to amphiphilic molecules, such as lipid A, can often 
lead to false positive results interpreted as cross-reactivity. It has also been shown 
that LOS from pathogenic Neisseria and Haemophilus species contain terminal 
tetrasaccharides that are homologous to paragloboside (Preston et al., 1996). Thus, it 
is feasible that LOS of oral bacteria could be recognised similarly by the host, and 
present shared epitopes as a strategy to evade the immune response. 
With certain periodontopathogens, the detectable antibody response to these types of 
antigens may provide some useful diagnostic information. The validity of targeting 
LPS from oral pathogens as an immunodominant antigen is still fraught with 
unknowns. Studies need to be carried out in the future to identify if naturally 
protective responses to LPS exist. If they do, the information may be of importance in 
prevention or intervention through vaccine implementation. 
1.6.5 Heat shock proteins 
Heat shock proteins (HSP) or stress induced proteins are produced by both prokaryotic 
and eukaryotic cells in response to various insults, such as a sudden increase in 
temperature (Kaufmann, 1990). HSP function to protect the cell during these adverse 
environmental changes. As well as being molecular chaperones (Georgopoulos, 
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1992), it has recently been suggested that they are important in host immune responses 
and the pathogenesis of disease (Panchanathan et al., 1998). 
Immunoreactivity of HSP was initially recognised by the homology between a highly 
immunoreactive 65 kDa protein of Mycobacterium and a 60 kDa HSP of E. coli 
(Shinnick et al., 1988; Thole et al., 1988). It was suggested that this protein was also 
related to a strongly immunoreactive antigen found in virtually all Gram negative 
bacteria. Immunoreactive proteins in many prokaryotes have been identified which 
show homology to HSP, especially the HSP90, HSP70, HSP60 and low molecular 
weight families (Shinnick et al., 1991). The HSP70 family is highly conserved, with 
the amino acid sequence of the human HSP70 having 50% identity with the E. coli 
and 73% with the Drosophila HSP70 family. There have been reports demonstrating 
that some bacterial HSP are immunogenic proteins (Buchmeier et al., 1990; Wu et al., 
1994; Perez-Perez, 1996). 
Tang et al. (1997) studied the immunodominant nature of Salmonella typhi HSP60 
(GroEL). This report showed that HSP of pathogens are "immunodominant" antigens 
and targets of the host immune response. These results were in agreement with other 
studies and were confirmed by substantial production of antibody to these antigens. 
Further studies indicating the importance, and purported immunodominance of HSP 
include investigations of GroEL and GroES of Camphylobacter jejuni (Wu et al., 
1994) and Mycobacterium leprae (Mehra et al., 1992). These reports supporting an 
important role for HSP and host responses to these antigens in other infectious 
diseases, naturally lead to an evaluation of the potential role of these macromolecules 
in periodontitis. 
A recent study by Ando et al. (1995) examined the production of HSP by the 
periodontal pathogens: A. actinomycetemcomitans; Eikenella corrodens; 
Fusobacterium nucleatum; P. intermedia; Prevotella nigrescens; Prevotella 
melaninogenica and Treponema socranskii. All of the HSP produced by these 
bacteria reacted with anti-Yersina enterocolitica HSP60 antibodies and/or monoclonal 
antibodies to the 65 kDa HSP of Mycobacterium. Additionally, these authors 
investigated soluble HSP in inflamed gingival tissue of chronic periodontitis patients. 
93 
Gingival homogenate samples from 3 of 4 patients reacted with anti-human HSP60 
and anti-bovine brain HSP70. However, none of the homogenate samples reacted 
with antibodies against bacterial HSP. 
Maeda et al. (1994), cloned a HSP60 (GroEL) homologue from P. gingivalis using the 
E. coli GroEL gene as a probe. The sequence of this P. gingivalis GroEL HSP 
showed about 59% amino acid identity with E. coli GroEL and the 65 kDa 
Mycohacterium tuberculosis antigen, as well as with the human HSP60 sequence. An 
immunogen immunoblot analysis, using purified P. gingivalis GroEL, revealed that it 
was recognised by antibody in 8/10 sera from periodontitis patients, and in 3/9 healthy 
controls. These findings are consistent with the association of P. gingivalis with 
periodontitis. In addition these antibodies are present in response to a low level, 
continuous or transient exposure of the healthy subjects to P. gingivalis GroEL and 
GroEL homologues from many other micro-organisms, or even host molecules. 
Hinode et al. (1998), attempted to address the cross-reactive potential of HSP. They 
evaluated the N-terminal amino acid sequences of GroEL (HSP60 family) and DnaK 
(HSP70 family) like proteins from P. gingivalis, A. actinomycetemcomitans and B. 
forsythus, in relation to potential cross-reactivity of antibodies. Antibodies specific 
for DnaK-like proteins appeared to be primarily induced against non-conserved 
epitopes of the protein. The DnaK-like proteins from P. gingivalis and B. forsythus 
reacted only very weakly with antibodies specific for the DnaK of E. coli. However, a 
clear cross-reactivity between antibodies raised to GroEL-like proteins of P. 
gingivalis, A. actinomycetemcoin itans and E. coli was detected. This indicated that a 
significant portion of the antibodies induced against GroEL-like proteins are directed 
at epitopes conserved across bacterial genera. Why antibodies are produced in 
response to conserved epitopes of one HSP and to primarily non-conserved epitopes 
of another HSP is unknown. This could be a strategy adopted by the pathogens to 
increase their virulence. It may be a subversion of host responses by alteration of the 
efficiency of antigen processing and presentation by the host immune system. 
A summary of the literature with respect to the role of HSP in the host response of the 
periodontium suggests two main opinions; One view proposed by Ando et al. (1995) 
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is that periodontopathic bacterial HSP antigens form immune complexes with local 
antibodies, which activate or exacerbate the inflammatory response, enhancing tissue 
damage. However, the lack of detection of bacterial HSP in gingival homogenate 
samples, and evidence of host derived HSP emphasises the potential for chronic 
inflammation to stress local tissues during destructive periodontitis (Kaufmann, 
1990). The second view is that antigenic cross-reactivity poses a potential problem in 
evaluating HSP as immunodominant antigens of these pathogens. The term "common 
antigens" is indicative of their highly conserved nature. As discussed previously with 
LPS it may be difficult to ascertain if the detection of a host immune response 
documents: (i) the induction of elevated antibodies to a particular HSP of the oral 
bacterial pathogen under investigation; or (ii) cross-reacting antibodies elicited by 
other commensal or pathogenic bacteria, or even autoantibodies to human HSP. 
Bangsborg et al. (1989) reported the problems in documenting dominant serological 
reactions using HSP, as they induce antibodies that are strongly cross-reactive. 
However, antibodies against HSP have been implicated as "immunodominant" in 
various autoimmune diseases including Systemic Lupus Erythematosus (Jarjour et al., 
1991) and rheumatoid arthritis (Van Eden, 1990). 
This is clearly an exciting area of investigation in the microbial pathogenesis of 
periodontal disease. Nevertheless, creative experimental designs and approaches will 
be required to identify the functional importance of these immune responses. In 
addition, the significance of HSP to oral bacterial virulence strategies, and the 
justification for considering these immunogens in vaccine development will need to 
be evaluated. 
1.6.6 Leukotoxin 
A number of Gram negative bacteria produce an array of diffusable protein molecules 
which belong to the repeats-in-toxin (RTX) family of bacterial exotoxins. These 
exotoxins are cytolytic proteins which are generally heat labile, induce tissue necrosis 
and can be used to stimulate protective immune responses (e. g. tetanus toxoid) 
(Nisengard and Newman, 1994). Members of the RTX exotoxin family are involved 
in a variety of different bacterial infections and target different cell types and tissues 
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specific for the associated disease entities. There are a number of features that are 
possessed by all members of this family, including: (i) the genetic organisation; (ii) 
certain structural features; and (iii) functional features such as haemolytic, leukotoxic 
and leukocyte-stimulating activities. 
Of the oral micro-organisms associated with periodontitis, A. actinonrycetemcomitans 
produces a leukotoxin which is a member of the RTX family. This is heat labile, 
soluble and was initially reported because of its ability to destroy PMN (Baehni et al., 
1979; Baehni et al., 1980). However, recent studies indicate that it activates apoptotic 
processes in a variety of cell types (Mangan et al., 1991; Kato et al., 1995; Korostoff 
et al., 1998). At high concentrations, leukotoxin appears able to bind to a PMN target 
cell membrane, to form pores in the membrane and to kill the cell through osmotic 
lysis. This releases intracellular lysosomal products and exacerbates tissue damage. 
Initial studies of antibody responses to A. actinomycetemcomitans sonicate antigens 
and leukotoxin in humans suggested that the characteristics of the responses generally 
paralleled each other (Ebersole, 1990). Importantly, patients with A. 
actinomycetemcomitans infections generally demonstrated extreme elevations in 
antibody to this antigen (Ebersole et al., 1991 a; Califano et al., 1989; Gunsolley et al., 
1991), suggesting that it was a strong immunogen. This has been confirmed in rodent 
models (Shenker et al., 1993). The human response showed elevated leukotoxin 
antibody consistently in localised aggressive periodontitis patients (McArthur et al., 
1981; Tsai et al., 1981; Ebersole et al., 1983). With regard to the issue of 
immunodominance, a crucial point is that the antibody to the leukotoxin was not a 
dominant antibody response in these patients. As mentioned previously, the main 
response was to LPS and serotype determinants of A. actinomycetemcomitans. It was 
concluded that LPS is an immunodominant antigen. Therefore, the response to this 
molecule, should be the focus of efforts to immunologically interfere with the 
pathogenicity of A. actinomycetemcomitans. The biologic relevance of leukotoxin as 
a virulence factor has not been clearly demonstrated in vivo. Nevertheless, recent 
genotypic studies support the concept that A. actinomycetemcomitans isolates which 
have an altered promoter region, resulting in enhanced leukotoxin production, are 
most frequently associated with disease sites in selected populations (DiRenzo et al., 
1994; Haubek et al., 1995). Recent data suggests that leukotoxin antibody levels may 
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be more discriminatory than antibody to the whole bacteria (Califano et al., 1997). 
Furthermore, one report has suggested that leukotoxin challenge of a human immune 
system reconstituted into mice, induced antibodies which correlated with some 
protection from lesion formation (Shenker et al., 1993). To conclude, the reactivity of 
humans to leukotoxin cannot be considered a `dominant' response. However, there 
appear to be `dominant epitopes' on this antigen which can consistently elicit antibody 
in infected subjects which appears to ameliorate the effects of this toxin. 
Consequently, the use of antibody to leukotoxin as a biomarker of an immunological 
target in periodontal disease seems worthy of continued investigation. 
1.6.7 Cysteine proteases 
The cysteine proteases of P. gingivalis clearly contribute to the physiological function 
of this asaccharolytic bacterium. They are of great importance in the nutrition and 
growth of the micro-organism (Kesavalu et al., 1997). They also appear to play a 
crucial role in the survival of the bacteria through proteolytic elimination of opsonins 
at the bacterial cell surface (Cutler et al., 1993; Schenkein et al., 1995), via 
degradation of host response communication molecules including cytokines and 
chemokines (Steffen et al., 1999). These enzymes also appear to correlate with 
pathogenicity of the bacteria (Curtis et al., 1993; Feuille et al., 1996; Kesavalu et al., 
1998). They aid the adherence of P. gingivalis to erythrocytes (Nishikata et al., 1991; 
Curtis et al., 1993; Pike et al., 1996), neutrophils (Lala et al., 1994), fibronectin 
(Lantz et al., 1991a), fibrinogen (Lantz et al., 1991b), collagenous substrata (Naito et 
al., 1988), as well as to other bacteria (Ellen et al., 1992). These proteases can also 
directly contribute to the induction and alteration of the inflammatory response 
(Potempa and Travis, 1996). 
Curtis et al. (1996) studied 3 types of cysteine proteases associated with P. gingivalis, 
each demonstrating a specificity for arginine containing peptide bonds (RgpA-1, 
RgpA-1A and RgpA-IB). Similar reports have provided evidence of additional 
cysteine proteases with varied specificity, which are produced by this pathogen (Bedi, 
1994; Chen et al., 1992; Pavloff et al., 1995). In order to illustrate the relationship 
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between these proteases and the host response to P. gingivalis, there follows a review 
of the antigenic features RgpA-1. 
RgpA-1 or HRgpA is a heterodimer of approximately 50 kDa, which is composed of 
an a and ß segment or chain. RgpA-1 A is a monomer of a free a segment and RgpA- 
lB appears to be a post-transcriptionally modified form of the a segment (Curtis et 
al., 1996). One study by Curtis et al. (1993), used polyvalent rabbit antiserum raised 
against RgpA-IA. They demonstrated a recognition of all 3 protease types, indicating 
that the a chains are immunochemically related. However, 4 of 5 representatives 
from a panel of monoclonal antibodies recognised only RgpA-1. This indicated 
specificity for the (3 segment portion of this protease, which is the non-catalytic part of 
the enzyme. The a segment bears the protease active site. The ß segment has a 
primary sequence similar to that of adhesins and haemagglutinins of other molecules 
and micro-organisms. Why the immune response is directed towards the seemingly 
non-destructive portion of the enzyme remains unknown. The ß segment appears 
important in adherence. Therefore, the host may target antibodies towards this portion 
to block attachment and access of the protease to the host cells or proteins. 
Alternatively, the ß segment may have other unknown functions which also increase 
its immunogenicity. In contrast, this may be a deliberate ploy of the bacteria to 
increase its virulence potential by diverting antibody responses to a less-relevant 
portion of the enzyme. 
Nevertheless, these proteases, are implicated in periodontal disease, and induce the 
production of specific IgG in humans. As mentioned above, P. gingivalis appears to 
be effective in neutralising humoral elements of host defence. It uses trypsin-like 
proteases which degrade all isotypes of immunoglobulins (Gregory et al., 1992) and 
many complement factors (Schenkein, 1988). Additionally, these proteases have been 
shown to give P. gingivalis the ability to degrade many human proteins (Kilian, 1981). 
Thus, clarifying the relationship between the systemic response to this antigen(s) and 
disease progression would appear useful, since this appears to be an important 
virulence factor enabling this bacteria to avoid host immune defences. Moreover, 
other reports have demonstrated the effective binding of IgG to virulent bacteria such 
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as P. gingivalis, has a crucial role in complement activation and also in the 
opsonisation and phagocytosis of this organism (Cutler et al., 1991a, b). Increased 
antibody levels to a trypsin-like protease produced by P. gingivalis was identified in 
early studies of humoral immune responses in periodontitis patients (Ismaiel et al., 
1988). Aduse-Opoku et al. (1995), recently characterised a cell surface or extra- 
cellular arginine-specific protease antigen (i. e. related to the trypsin-like protease 
activity). This group also characterised this protease as a functionally important target 
of the host immune response (Curtis et al., 1996). It has recently been demonstrated 
that active immunisation of non-human primates with a cysteine protease (e. g. 
porphypain-2) elicited significant antibody responses in the animals (Mortiz et al., 
1998). It also altered the microbial ecology in disease states, and significantly 
affected the progression of bone loss in the animals. Booth and Lehner (1997) have 
also produced a murine monoclonal antibody to P. gingivalis which retarded re- 
colonisation of deep pockets by this pathogen in periodontitis patients. Interestingly, 
this antibody inhibited the hemagglutination of red blood cells, which is related to 
certain functions of the cysteine proteases of P. gingivalis. 
Importantly these relatively few human studies have generally shown an increased 
prevalence of antibody to these proteases in periodontitis patients. However, the 
antibody levels were clearly not dominant in the response to this pathogen. This 
finding highlights the potential uncertainty in the field when identifying critical 
antigens relative to antibody levels and functional capacity to protect the host. 
However, this aspect of the host-parasite interaction will remain a high profile 
research area with the goal of evaluating pathogenic mechanisms of P. gingivalis, as 
well as a potential immunologic targets. 
1.6.8 Superantigens 
Increased knowledge of the molecular mechanisms for cell co-operation and the cell 
surface molecules required for adaptive immune induction, has revealed that not all 
antigens which bind to the MHC class II complex are presented as peptides in the 
peptide binding groove. Hence, they do not result in the development of a specific 
immune response by the conventional method. One such class of antigens, identified 
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within various bacterial and viral protein repertoires, has been termed superantigens 
(Janeway and Travers, 1994). 
Superantigens are not processed by antigen presenting cells and are not presented by 
MHC molecules in the conventional manner. Instead of binding to the peptide 
binding groove of the MHC molecule, superantigens bind directly to the lateral 
surface of both the MHC class II molecule and the Vß region of the TCR. The 
superantigen is recognised solely by the V region of the ß chain of the TCR (Kappier 
et al., 1989). In contrast, to conventional antigen processing and presentation, the a 
chain V region and the DJ junction of the ß chain have little or no effect on 
superantigen recognition. This recognition process gives superantigens the capability 
of stimulating a large number of T cells (4-5% of the T cell population) in a non- 
specific manner (Kappler et al., 1989). This reaction with a large number of T cells 
gives rise to the characteristics associated with superantigens: (i) pyrogenic effects in 
excess of those produced by LPS; (ii) inhibition of immunoglobulin synthesis; and 
(iii) interference with LPS clearing by the liver causing a massive increase in the 
lethality of bacterial LPS (Daniel and Van Dyke, 1996). 
Superantigens are known to be produced by a number of pathogenic micro-organisms, 
including some found in the oral cavity. However, to date no clear role for 
superantigens in periodontal disease has been demonstrated. Mathur et al. (1995) 
investigated superantigen like activities of putative periodontopathogens in both 
periodontally healthy and diseased subjects. Co-culturing peripheral blood 
mononuclear cells with P. intermedia resulted in an increased expression of V(32+, 
V135+ and V06+ cells in both healthy and diseased subjects. However, similar 
treatment with either P. gingivalis or A. actinomycetemcomitans showed no changes 
in the Vß TCR repertoire. Studies by Nakajima et al. (1996) and Zadeh and Kreutzer 
(1996) which involved profiling gene expression in gingival tissues, suggested that 
expression of the Vß family in tissue borne T cells was not random. However, 
limiting an explanation for this finding to superantigen processes does not account for 
a skewing towards particular Vß receptor families. This could be due to the presence 
of bacteria in the subgingival plaque biofilm selectively stimulating cells of a 
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particular V(3 receptor family (Mathur et al., 1995). Alternatively, homing of cells to 
the diseased tissue may be mediated, in part, by Vß expression (Taubman et al., 
1994). In addition, retention of specific T cells in the tissues may be due to the 
characteristics of their VP receptors and the presence of specific antigens. Therefore, 
our knowledge reflects a number of ill-defined and poorly understood processes, 
especially as related to the existence and importance of superantigens in periodontal 
disease. A more detailed evaluation of the available studies provides equally 
conflicting results. Vß8 cells are over expressed (Zadeh and Kreutzer, 1996) or under 
expressed (Nakajima et al., 1996). Alternatively, Petit and Stashenko (1996) 
demonstrated that extracts of periodontopathic bacteria do not stimulate T cells at all 
in a superantigenic manner when tested in a murine model. It is not clear if these 
conflicting reports are due to different types of superantigens, different sampling 
strategies, or even just variation in patient populations. The disparate findings need to 
be clarified in order to define the utility of the Vß chains as markers of superantigen 
activity within the host-parasite interactions, in periodontal disease. 
However, one might reconsider whether there is an a priori case for emphasising the 
contribution of superantigens in periodontal disease. This disease has been described 
as a chronic infection involving an ongoing humoral immune response, shown by the 
presence of predominantly antibody secreting cells in the periodontal lesion (Kinane 
& Lindhe, 1997). In contrast, infections in which the pathogens present superantigens 
as part of their virulence strategy, are generally acute, with a rapid onset of symptoms, 
and immunoglobulin production is usually suppressed. This profile is not observed in 
periodontitis and systemic pyrogenic activity (another characteristic of infections with 
superantigen possessing micro-organisms) is an exceptional occurrence in 
periodontitis patients. Therefore, at present it is questionable whether a role for 
superantigens is consistent with the characteristics of this disease. 
1.6.9 Other strategies for identifying immunodominant antigens 
A recent study (Kawai et al., 1998) attempted to identify an immunodominant antigen 
in chronic periodontitis using monoclonal antibodies. Mouse monoclonal antibodies 
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were raised against crude antigen preparations of P. gingivalis. The antigenic 
specificity of the monoclonal antibodies were then compared with those of serum 
antibodies detected in chronic periodontitis patients and healthy subjects. Binding of 
one monoclonal antibody was inhibited by serum antibody molecules present in all 
chronic periodontitis patients. This serum antibody was absent in the polyclonal 
antibody population in the control subjects however. The inference was that the P. 
gingivalis antigenic epitope identified by this murine monoclonal antibody could 
represent an important immunogen in humans infected with this pathogen. The 
antigen recognised by this monoclonal antibody was demonstrated on the cell surface 
of P. gingivalis, and the epitope was composed of carbohydrate residues independent 
of the LPS antigen. Thus, new technological and conceptual advances will continue 
to challenge existing paradigms of immunodominant antigens in periodontal disease, 
and provide additional tools for addressing this important concept. 
As mentioned previously, the aim of this text is to provide an overview of the 
approaches and strategies which have been used in the past and those which are 
currently being employed in periodontal infections, to examine the concept of 
immunodominant antigens. It appears there is no clear way ahead for the concept of 
immunodominance in periodontal disease research. This polymicrobial infection is 
complex due to the intertwining of the relationships within the microbial ecology. 
The plethora of host and microbial variables may make successful exploitation of any 
interventive strategy, based on the immunodominance concept, difficult to implement 
in this disease. This concern is exemplified by the breadth of studies supplying 
disparate findings regarding the antigenic specificity of dominant host responses to the 
putative pathogens. The identification of immunodominant antigens may be relevant 
if additional supportive knowledge is gained in the future. In this case it is suggested 
that utilisation of these critical antigens for screening and diagnosis of the disease, as 
well as using them as targets for vaccine development, will not only be feasible, but 
desirable. 
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1.7 Pathogenesis of Periodontal Disease 
1.7.1 Introduction 
The normal pink in colour and firm in consistency healthy gingiva should be free from 
histological evidence of inflammation (figure 1.2). But this is rarely the case, and 
however healthy an individuals gingiva may be, when seen through the microscope 
they are always slightly inflamed due to the ever present plaque bacteria (figure 1.3). 
The inflammatory cells which have infiltrated the healthy gingiva are predominantly 
PMN that are associated with the junctional epithelium, and lymphocytes that are 
found in the subjacent connective tissue (Page and Schroeder, 1976). All the 
characteristics of the inflammatory response, as previously described, are seen in the 
gingiva even in health. These include; increased vascular permeability and 
accumulation of fluid, plasma proteins and leukocytic cells into the gingival crevice 
region, to create GCF. The reason for the migration of cells into the junctional 
epithelium as well as the crevice is due to the production of cytokines and various 
other products by the host and bacteria. This subject is discussed in more detail in 
section 1.4. 
A further indication that inflammation is present in a `healthy' gingiva is that 
upregulation of the adhesion molecules ICAM-1 and ELAM-1 have been shown in 
health (Moughal et al., 1992; Kinane et al., 1991). 
Although, as discussed above, an inflammatory response is thought to occur even in 
health, a balance has to be maintained for the gingiva to remain `healthy'. Although 
bacterial plaque is present and the host responds to it by initiating an inflammatory 
response, the micro-organisms and the host are probably in equilibrium with each 
other. However, the gingiva stops being classified as `healthy', and gingivitis follows 
when the micro-organisms in the plaque initiate a substantial inflammatory response. 
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1.7.2 Gingivitis 
Gingivitis can occur after 10-20 days of plaque accumulation. It is detected due to 
redness and swelling of the tissues which have an increased tendency to bleed on 
probing. Histologically, there has been a massive influx of fluid and cells into the 
tissues. Dilation of arterioles, capillaries and venules increases hydrostatic pressure 
within the microcirculation leading to increased intercellular gaps between adjacent 
capillary and endothelial cells. The cells that migrate into the tissues are mainly 
lymphocytes, macrophages and PMN. Experimental work, particularly studies 
involving dogs (Lindhe and Rylander, 1975) have shown that when there is a cellular 
infiltrate, lymphocytes are found to adhere to the collagen matrix as they are possibly 
primed to periodontally relevant antigens, and therefore, remain in the tissues (Kinane 
and Lindhe, 1997). The PMN which infiltrate the tissues tend to migrate into the 
gingival sulcus and do not remain in the tissues. 
In addition to the influx of inflammatory cells into the tissues, there is increased flow 
of plasma proteins, antibodies, complement proteins and protease inhibitors into the 
area (Payne et al., 1975; Schroeder et al., 1975). The flow of GCF also increases, so 
that toxins and substances released from microbes are washed out of the tissues and 
the gingival crevice. As the inflammatory response to the plaque bacteria increases 
there is also a marked expression of adhesion molecules to assist the migration of 
leukocytes out of the blood vessels, and into the tissues and crevice (Kinane and 
Lindhe, 1997). 
After approximately 7 days the lesion is referred to as the early gingival lesion (Page 
and Schroeder, 1976) (figure 1.4). In the early gingival lesion, lymphocytes and PMN 
are the prominent infiltrating cells and very few plasma cells are noted at this time 
(Listgarten and Ellegaard, 1973; Payne et al., 1975; Seymour et al., 1983; Brecx et al., 
1987). At this stage the inflammatory cell infiltrate comprises approximately 15% of 
the connective tissue volume. However, due to fibroblast degeneration and collagen 
destruction that occurs in the tissue, further inflammatory cell infiltration can occur as 
space is created. 
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It is not known how long the gingivitis lesion remains like this or when it returns to 
health or progresses to an increased inflammatory state. There appears to be a 
significant variation between individuals however, probably based on individual 
predispositions and susceptibility. 
If the plaque remains present, the inflammatory state continues and becomes 
exacerbated. Continuation of the inflammatory response sees the influx of further 
exudative fluid, inflammatory cells and plasma proteins. The tissues become even 
more swollen and oedematous (Löe and Holm-Pedersen, 1965), however, at this stage 
there is no bone loss nor apical epithelial migration evident. According to the 
classification determined by Page and Schroeder (1976) the lesion is termed the 
established lesion (figure 1.5). The main difference between the early and established 
lesion is not only the progression of the inflammatory immune response, but the 
established lesion contains many more mature plasma cells. Prominent infiltration of 
PMN is also observed in the junctional and sulcular epithelium (Brecx et al., 1988; 
Lindhe et al., 1980; Okada et al., 1983). The latter may proliferate and migrate into 
the infiltrated connective tissue, along the root surface and extend deeper into the 
connective tissue. The gingival sulcus deepens and the coronal portion of the 
junctional epithelium is converted into `pocket lining' epithelium. This is not 
attached to the tooth surface and has a heavy leukocyte infiltrate, predominantly made 
up of neutrophils which eventually migrate across the epithelium into the gingival 
crevice or pocket. 
It is thought that two different types of established lesion exist. One is thought to be a 
more stable lesion that can remain this way for long periods of time, and the second is 
much more aggressive and converts to progressive destructive lesions (Lindhe et al., 
1975; Page et al., 1975). 
1.7.3 Periodontitis 
The advanced gingival/periodontal lesion is the final stage of the disease. The 
advanced lesion differs from the established lesion by alveolar bone loss being 
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evident. There is also evidence of extensive fibre damage and apical migration of the 
junctional epithelium (Lindhe et al., 1980; Listgarten and Hellden, 1978; Seymour and 
Greenspan, 1979; Seymour et al., 1979). The inflammatory immune response 
continues to progress, and the inflammatory cell infiltrate extends laterally and 
apically into the connective tissue. Epithelium layers are broken down, re-growing at 
a more apical location. Pocket formation occurs, bone is resorbed and granulation 
tissue forms, which is heavily vascularised and full of antibody producing plasma 
cells (Kinane and Lindhe, 1997). Plasma cells are the predominant cell type in the 
advanced lesion (Garant and Mulvihill, 1972) (figure 1.6). 
The progression of the inflammatory response continues in the presence of plaque 
bacteria and the microbes that have continued to inhabit the niches that have been 
created through tissue damage and the frustrated inflammatory response. When no 
oral hygiene improvements are made or treatment pursued the situation is worsened. 
Microbes will continue to produce noxious substances, the host inflammatory 
response will be perpetuated and tissue damage will continue. This is seen by 
continuous deepening of pockets, extending granulation tissue lesions, continuous 
bone and ligament loss and eventually loss of the teeth (Kinane and Lindhe, 1997). 
The progression from gingivitis to periodontitis varies in time between individuals. 
Brecx et al. (1988) suggested that at least 6 months is required for gingivitis to 
progress to periodontitis in the normal situation. The reason some individuals go on 
to develop periodontitis and others do not and the length of time this takes in different 
patients is thought to be multifactorial. Seymour et al. (1979) suggested that it is a 
shift from B cell to T cell dominance that causes the transition from gingivitis to 
periodontitis. This theory has been contested by a number of authors (Gillett et al., 
1986; Page, 1986) and it is generally accepted that an advanced lesion is 
predominantly a plasma cell lesion (Garant and Mulvihill, 1972; Kinane and Lindhe, 
1997). 
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Figure 1.2 The pristine gingiva 
Figure 1.2 shows a pristine gingiva which is almost free from histological evidence of 
inflammation. This is rarely seen in health. 
Figure 1.3 The normal healthy gingiva 
Figure 1.3 shows a normal healthy gingiva. This picture of microbial colonisation 
due to ever present plaque bacteria is usually seen in health. Inflammatory cells have 
begun to infiltrate the junctional epithelium and connective tissue. These are mainly 
PMNs, monocytes, macrophages and lymphocytes. 
Figure 1.4 The early gingival lesion 
Figure 1.4 shows the early gingival lesion. This is thought to occur after 
approximately 7 days. The number of infiltrating inflammatory cells has increased 
and comprises about 15% of the connective tissue volume. The infiltrate is mainly 
PMNs, macrophages, monocytes and lymphocytes. Very few plasma cells are seen. 
Figure 1.5 The established gingival lesion 
Figure 1.5 shows the established gingival lesion. The inflammatory immune response 
has progressed, and the connective tissue is comprised of 10-30% plasma cells. 
Clinically marked proliferation of the junctional epithelium is seen, however, bone 
loss and apical epithelial migration are not evident. 
Figure 1.6 The advanced lesion 
Figure 1.6 shows the advanced lesion seen in periodontitis. The inflammatory cell 
infiltrate has progressed laterally and apically and is comprised of predominantly 
plasma cells. Clinically there is evidence of extensive fibre damage, apical migration 
of the junctional epithelium and bone loss. Figures adapted from Kinane and Lindhe 
(1997). 
1.8 Risk Factors 
1.8.1 Introduction 
The term "risk factor" can be defined as "an aspect of personal behaviour or lifestyle, 
an environmental exposure, or an inborn or inherited characteristic, which on the basis 
of epidemiological evidence is known to be associated with a health related condition" 
(Last, 1988). Therefore, the presence of a risk factor implies that there is an increased 
chance of the disease occurring. 
Periodontal disease is not a consequence of pathogens alone, and these are not 
sufficient on their own to cause the disease (Socransky and Haffajee, 1992). The 
presence of micro-organisms is a crucial factor, but the progression of the disease is 
related to host based risk factors. 
1.8.2 Age 
There can be little doubt that the prevalence of periodontal disease increases with age 
(Salvi et al., 1997). However, it is not clear if age leads to increased susceptibility or 
that there are cumulative factors which control the onset of periodontitis. Homing et 
al. (1992), reported that age is a risk factor for periodontal disease. However, other 
authors (Holm-Pederson et al., 1975; Machtei et al., 1994) have indicated that this is 
not the case before the age of 70 years, and until this age the rate of periodontal 
destruction is the same throughout adulthood. 
1.8.3 Low Socio-economic status 
Low socio-economic status is generally associated with more severe periodontitis and 
data from the U. S. public health service (1965,1979) indicates this. However, in 
studies where periodontal status is adjusted for oral hygiene and smoking, the 
associations between lower socio-economic status and more severe periodontal 
disease are not observed (Grossi et al., 1994; Grossi et al., 1995). 
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1.8.4 Smoking 
There has been a substantial amount of literature reporting the detrimental effect of 
smoking on periodontal health. There is a consistent indication that smoking is a risk 
factor for periodontal disease and there is a positive correlation between attachment 
loss and smoking (Arno et al., 1959; Ah et al., 1994; Bergstrom, 1989; Haber, 1994; 
Haber and Kent, 1992; Haber et al., 1993; Horning et al., 1992; Preber and Berström, 
1990). In many of the studies on this subject, multivariate analyses are carried out to 
ensure that smoking is an independent risk factor for periodontal disease, and that any 
results showing a correlation are not due to poor oral hygiene, plaque, socio-economic 
status or any other risk factor. The risk for periodontitis is considerable if an 
individual uses tobacco products, with estimated ratios being of the order 2.5 to 7.0 or 
even greater for smokers compared with non-smokers (Salvi et al., 1997). 
The mechanisms by which smoking affects periodontal status is not very well 
understood (Haber, 1994). Studies have indicated that the occurrence, relative 
frequency, or combinations of micro-organisms associated with destruction do not 
differ between smokers and non-smokers (Preber et al., 1992). However, perhaps 
smoking has a direct effect on the inflammatory and immune mechanisms. On this 
theme, smokers with periodontal disease have less clinical inflammation (Feldman et 
al., 1983) and gingival bleeding (Bergstrom and Floderus-Myehed, 1983) compared 
with non-smokers. The biological effect on the inflammatory immune response due to 
smoking could be as a result of the by-products of tobacco such as nicotine, which 
causes local vasoconstriction reducing blood flow, oedema and clinical signs of 
inflammation. 
1.8.5 Systemic disease 
There is strong evidence that periodontal disease enhances the risk for many systemic 
diseases, including atherosclerosis, heart disease, stroke and the births of infants with 
low birth weight (Beck et al., 1996; Offenbacher et al., 1996). There is also evidence 
that certain systemic diseases can adversely effect host defence systems and, therefore, 
act as a risk factor for gingivitis and periodontitis. 
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Neutropenic states have been associated with rapidly progressive forms of periodontal 
disease (Miller et al., 1984). Radiographs taken in some cases have indicated 
involvement of the periodontal tissues, showing bone loss around the primary and 
secondary teeth (Miller et al., 1984). 
There is an association between the disease leukocyte adhesion deficiency (LAD) and 
periodontal disease. Patients suffering from this disease have an abnormal gene that 
codes for the family of adhesion molecules called the leukocyte integrins. Patients 
with this deficiency have a dramatically increased susceptibility to infections and 
suffer from a very severe form of periodontal disease that can lead to premature loss 
of deciduous and permanent teeth (Crawford, 1994). 
Diabetes Mellitus has been linked to an increased risk of periodontal disease (Bacic et 
al., 1988; Bartolucci and Parkes, 1981; Belting et al., 1964; Grossi et al., 1994; 
Hugoson et al., 1989). Type I diabetes mellitus is also known as insulin dependent 
diabetes mellitus, and commonly develops before 30 years of age. Type II, or non- 
insulin dependent diabetes mellitus is usually found to develop after the age of 40 
years. A strong correlation has been found between aggressive periodontitis and type 
I diabetes mellitus, especially in patients with raised blood glucose levels (Bissada et 
al., 1982; Cutler et al., 1991; Manouchehr-Pour et al., 1981a; Manouchehr-Pour et al., 
1981b). Type II diabetes has also been linked with periodontal disease (Beck et al., 
1990; Grossi et al., 1994). However, differences in oral health between type I and 
type II diabetes occur and may be related to differences in glycaemic control, age, 
duration of disease or periodontal susceptibility (Salvi et al., 1997). Well-controlled 
diabetics are more likely to be like non-diabetics in their periodontal status, and those 
with poorly controlled diabetes are likely to be more susceptible to disease (Mealey, 
1996). 
1.8.6 Other possible risk factors 
Preliminary studies have indicated an association between stress, distress and coping 
behaviour (Moss et al., 1996). The rationale behind many of the studies investigating 
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a link between periodontal disease and the psychoemotional state are that these factors 
can lead to depression of immune responsiveness to putative periodontopathogens. 
1.8.7 Genetics 
Many studies have been reported over the past few years regarding a possible genetic 
basis for periodontal disease, and many of these studies have been reviewed (Hart, 
1994; Hart, 1996; Hart and Komman, 1997; Michalowicz, 1994; Aldred and Bartold, 
1998). The generally accepted dogma at present is that the aggressive forms of 
periodontitis have a heritable pattern with a single gene disorder (Aldred and Bartold, 
1998). With regards to chronic periodontitis, there is a split in opinion, with a general 
surmise being that there is little genetic influence in the clinical manifestation of this 
disease opposing recent evidence that suspects a genetic susceptibility associated with 
the disease (Aldred and Bartold, 1998). 
The exact genetic link with both aggressive and chronic forms of periodontal disease 
have yet to be identified. More work has been carried out investigating the link with 
aggressive periodontal disease, and although many studies have been undertaken the 
conjectures made from these have not been fully accepted. Specific chromosomal 
anomalies have been investigated, and the outcomes appear to indicate that even with 
a small disease entity such as localised aggressive periodontal disease, there is 
probably considerable genotype heterogeneity even if the clinical manifestations 
appear to be very similar. This can be observed by the fact that different groups 
carrying out genetic linkage studies have found such varying results (Boughman et al., 
1986; Roulsten et al., 1985; Hart et al., 1993; Wang et al., 1996). 
Studies have also been carried out to investigate a link between periodontal disease 
and genetic markers of a more general nature. Again, most reports made are 
controversial on this issue. A number of studies have associated HLA antigens with 
generalised aggressive periodontitis (Katz et al., 1987; Reinholdt et al., 1977; Shapira 
et al., 1994), however, others have found no association at all (Cullinan et al., 1980; 
Saxen and Koskimies, 1984). 
113 
Other genes have been suggested to be linked with periodontal disease including; the 
gene responsible for IgG2 production (Marazita et al., 1994; Marazita et al., 1996), 
FcyRIIa receptor (Wilson and Kalmar, 1996), prostaglandin endoperoxidase synthase 
1 and other components of the cyclooxygenase pathway (Hart and Kornman, 1997) 
and IL-1 (Kornman et al., 1997). 
1.9 Aims and Objectives 
1.9.1 Introduction 
Many microbial pathogens have been proposed as playing a role in the induction of 
the immune response in periodontal disease. The aim of the thesis was to investigate 
the target of the humoral immune response in patients with chronic periodontitis. 
This was achieved by a number of studies following a logical progression. The first 
study investigated the systemic immune response by examination of the target of 
serum antibodies in patients with chronic periodontitis. The project then developed to 
investigate the target of the local immune response and to achieve this 3 different 
techniques were utilised: hybridoma production; ELISPOT; and 
immunohistochemistry. 
1.9.2 Aims of Chapter 3-A Comparison of the changes in the humoral immune 
response to antigens of periodontal pathogens following periodontal therapy 
The aims of this part of the overall project were to: 
1) investigate the effect of periodontal treatment in patients with chronic 
periodontitis on polyvalent immunoglobulin, IgG and IgA titres against whole 
fixed periodontal pathogens; 
2) Investigate the effect of periodontal treatment on antibody titres to a large panel of 
antigenic targets including whole fixed bacteria, outer-membrane protein 
preparations and purified antigens; 
3) Compare clinical and immunological parameters in chronic periodontitis patients 
before and after periodontal treatment; 
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4) Investigate the phenomenon of cross-reactivity by examining cross-reacting 
antigens to 4 periodontal pathogens. 
1.9.3 Aims of Chapter 4- Immortalised B cells from periodontal disease patients 
The aims of this part of the overall project were to examine the feasibility of creating 
monoclonal antibodies from humans with periodontal disease by the: 
1) Expansion of B cells numbers by utilisation of the CD40 system; 
2) Fusion of human peripheral blood B lymphocytes and tissue plasma cells with a 
suitable partner to obtain hybridomas; 
3) Successful culture and cloning of antibody secreting hybridomas; 
4) Screening of monoclonal antibodies specific for periodontal pathogens. 
1.9.4 Aims of Chapter 5- Analysis of the target of antibody secreting cells from 
diseased tissue of chronic periodontitis patients by ELISPOT 
The aims of this section of the project were: 
1) Examination of the target of antibody secreting cells isolated from tissue taken 
from chronic periodontitis patients; 
2) Comparison of the number of specific cells detected against 4 periodontal 
pathogens. 
1.9.5 Aims of Chapter 6- Detection of antibody-bearing plasma cells in periodontitis 
granulation and gingival biopsy tissue 
In this part of the thesis the aim was to: 
1) Develop a technique to determine the specificity and numbers of plasma cells 
present in tissue sections; 
2) Examine the specificity of antibody bearing plasma cells in sections of diseased 
tissue taken from patients with chronic periodontitis; 
3) Compare the number and specificity of plasma cells in granulation and gingival 
tissue samples detected using a panel of whole fixed periodontal pathogens, 
sonicates and purified antigens. 
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1.9.6 Layout of the thesis 
The following chapter covers the source of the equipment and chemicals used in the 
various projects undertaken in this thesis. It also describes the basic methodology and 
buffers used. Following chapter 2, the thesis has been divided into 4 further chapters 
which describe individual studies: Comparison of the changes in the humoral immune 
response to antigens of periodontal pathogens following periodontal therapy (chapter 
3); Immortalised B cells from periodontal disease patients (chapter 4); Analysis of the 
target of antibody secreting cells from diseased tissue of chronic periodontitis patients 
by ELISPOT (chapter 5); and Detection of antibody-bearing plasma cells in 
periodontal granulation and gingival biopsy tissue (chapter 6). In each of these 
chapters the relevant introduction and literature review, methodology, results and 
discussion of the results are presented. The organisation of this thesis is intended to 
clarify the separate studies for the reader, as they are fundamentally different and if 
grouped together could be confusing. These chapters are followed by a brief final 
chapter (chapter 7) which summarises the findings of this thesis and discusses them in 
the context of the aims of the overall project and the available literature on this 
subject. 
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Chapter 2. Materials and Buffers 
2.1 Introduction 
The following chapter describes the materials and methodology for making the buffers 
used routinely during the experiments presented in this thesis. Methods which are 
specific to the individual chapters are found detailed in the methods section of the 
relevant chapter. 
2.2 Materials 
The following list comprises the consumables used in the experiments presented in 
this thesis and their sources. 
2.2.1 Chapter 3 materials 
PCP-12 Probe - Hu-Friedy Mfg Co., Chicago, U. S. A. 
Florida Probe - Florida Probe Corporation, Florida, U. S. A. 
Non-heparinised 7ml vacutainers - Becton Dickinson Vacutainer Systems Europe, 
Meylan, France. 
Fastidious anaerobe agar - LAB M, Bury, U. K. 
Tryptic soy agar - Mast Diagnostics, Merseyside, U. K. 
Horse blood -E&0 Laboratories, Bonnybridge, U. K. 
N-acetylmuramic acid - Sigma Chemical Company Limited, Poole, U. K. 
Columbia blood agar - Mast Diagnostics, Merseyside, U. K. 
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Sodium chloride (NaCl) - BDH Limited, Poole, England, U. K. 
Potassium dihydrogen orthophosphate (KH2PO4) - BDH Limited, Poole, England, 
U. K. 
Di-sodium hydrogen orthophosphate 2-hydrate (Na2HP04.2H20) - BDH Limited, 
Poole, England, U. K. 
Potassium chloride (KCl) - BDH Limited, Poole, England, U. K. 
Ethylenediaminetetracetic acid (EDTA) - BDH Limited, Poole, England, U. K. 
Sodium hydroxide (NaOH) - BDH Limited, Poole, England, U. K. 
Formal saline - BDH Limited, Poole, England, U. K. 
Sodium azide (NaN3) - Sigma Chemical Company Limited, Poole, U. K. 
Tris base - Sigma Chemical Company Limited, Poole, U. K. 
Phenol red - Sigma Chemical Company Limited, Poole, U. K. 
Sodium lauryl sarcosinate (SDS) - Sigma Chemical Company Limited, Poole, U. K. 
BCA protein assay kit - Pierce & Warriner, Chester, U. K. 
Immunlon 1B 96 well plates - Dynex Technologies, VA, USA. 
Sodium carbonate (Na2CO3) - BDH Limited, Poole, England, U. K. 
Sodium hydrogen carbonate (NaHCO3) - BDH Limited, Poole, England, U. K. 
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Hydrochloric acid (HC1) - BDH Limited, Poole, England, U. K. 
Polyoxyethylene sorbitan monolaurate (Tween 20) - Sigma Chemical Company 
Limited, Poole, U. K. 
Lyophilised bovine serum albumin (BSA) - Sigma Chemical Company Limited, 
Poole, U. K. 
Skimmed milk powder - Marvel, Premier Beverages, Stafford, UK. 
Biotinylated goat-anti-human immunoglobulin A- Sigma Chemical Company 
Limited, Poole, U. K. 
Biotinylated goat-anti-human immunoglobulin G- Sigma Chemical Company 
Limited, Poole, U. K. 
Biotinylated Goat-Anti-Human Polyvalent Immunoglobulin (IgA, IgG, IgM): Sigma 
Chemical Company Limited, Poole, U. K. 
Extravadin peroxidase - Sigma Chemical Company Limited, Poole, U. K. 
TMB peroxidase substrate - Kirkegaard & Perry Laboratories, Maryland, U. S. A. 
MRX II plate reader - Dynex Technologies, VA, U. S. A. 
N-tris[Hydroxymethyl]methyl-2-aminoethanesulfonic acid (TES) - Sigma Chemical 
Company Limited, Poole, U. K. 
L-1-Chloro-3-[4-tosylamido]-7-amino-2-heptanone-HC1 (TLCK) - Sigma Chemical 
Company Limited, Poole, U. K. 
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Leupeptin - Sigma Chemical Company Limited, Poole, U. K. 
2.2.2 Chapter 4 materials 
Citrate treated 7ml vacutainers - Becton Dickinson Vacutainer Systems Europe, 
Meylan, France. 
L-cells - Schering-Plough, Dardilly, France 
CRL-1668 cells - American Type Culture Collection, VA, U. S. A. 
Foetal calf serum (FCS) - Gibco Life Technologies Limited, Paisley, U. K. 
Penicillin - Gibco Life Technologies Limited, Paisley, U. K. 
Streptomycin - Gibco Life Technologies Limited, Paisley, U. K. 
L-Glutamine - Gibco Life Technologies Limited, Paisley, U. K. 
Sodium pyruvate - Gibco Life Technologies Limited, Paisley, U. K. 
RPMI 1640 medium - Gibco Life Technologies Limited, Paisley, U. K. 
G-418 - Gibco Life Technologies Limited, Paisley, U. K. 
Iscoves medium - Gibco Life Technologies Limited, Paisley, U. K. 
Mitomycin-C - Sigma Chemical Company Limited, Poole, U. K. 
Crystal violet concentrate - Pro lab Diagnostics, Merseyside, U. K. 
Acetic acid - BDH Limited, Poole, England, U. K. 
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6 well plates - Gibco Life Technologies Limited, Paisley, U. K. 
Histopaque-1077 - Sigma Chemical Company Limited, Poole, U. K. 
Falcon tubes - Becton-Dickinson, Cowley, U. K. 
Glacial acetic acid - BDH Limited, Poole, England, U. K. 
Nigrosin - Sigma Chemical Company Limited, Poole, U. K. 
Sodium azide - Sigma Chemical Company Limited, Poole, U. K. 
Sheep red blood cells - Scottish Antibody Production Unit, Carluke, U. K. 
2-aminoethylisothiouronium bromide (AET) - Sigma Chemical Company Limited, 
Poole, U. K. 
Sterile saline - BDH Limited, Poole, England, U. K. 
Anti-human CD40 - Ancell Corporation, Bayport, MN, U. S. A. 
Human interleukin-4 - ICN Biomedicals Limited, Oxon, U. K. 
Dispase - Gibco Life Technologies Limited, Paisley, U. K. 
Jockliks MEM medium - Gibco Life Technologies Limited, Paisley, U. K. 
41µm nylon net filters - Millipore (U. K) Limited, Watford, U. K. 
Neubauer haemocytometer - Sigma Chemical Company Limited, Poole, U. K. 
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Polyethylene glycol 1500 (PEG 1500) - ICN Biomedicals Limited, Oxon, U. K. 
HAT concentrate - Sigma Chemical Company Limited, Poole, U. K. 
Transferrin - Sigma Chemical Company Limited, Poole, U. K. 
Insulin - Sigma Chemical Company Limited, Poole, U. K. 
Ouabain - Sigma Chemical Company Limited, Poole, U. K. 
HT concentrate - Sigma Chemical Company Limited, Poole, U. K. 
Cell culture flasks (various sizes) - Gibco Life Technologies Limited, Paisley, U. K. 
2.2.3 Chapter 5 materials 
Multiscreen HA membrane-bottomed plates - Millipore Limited, Watford, U. K. 
Tetanus toxoid - Evans Medical Ltd., Leatherhead, U. K. 
Fungizone - Gibco Life Technologies Limited, Paisley, U. K. 
HRP-conjugated avidin-D - ICN Biomedicals Limited, Oxon, U. K. 
3-amino-9-ethylcarbazole (AEC) tablets - Sigma Chemical Company Limited, Poole, 
U. K 
N, N-Dimethylformamide - Sigma Chemical Company Limited, Poole, U. K. 
Sodium acetate (CH3COONa. 3H20) - BDH Limited, Poole, England, U. K. 
0.20µm filter - Millipore (U. K) Limited, Watford, U. K. 
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2.2.4 Chapter 6 materials 
Paraffin wax - Bayer PLC., Newbury, U. K. 
Silane-coated glass slides - BDH Limited, Poole, England, U. K. 
Haematoxylin stain - BDH Limited, Poole, England, U. K. 
Aluminium potassium sulphate (AIK(SO4)2) - BDH Limited, Poole, England, U. K. 
Sodium iodate (NaIO3) - BDH Limited, Poole, England, U. K. 
Citric acid (C(OH)(COOH)(CH2COOH)2. H20) - BDH Limited, Poole, England, U. K. 
Choral hydrate (CC13CH(OH)2) - BDH Limited, Poole, England, U. K. 
Calcium chloride (CaC12) - BDH Limited, Poole, England, U. K. 
Eosin - BDH Limited, Poole, England, U. K. 
Xylene - Genta Medical, Leeds, U. K. 
Ethanol - BDH Limited, Poole, England, U. K. 
3% Hydrogen peroxide - Sigma Chemical Company Limited, Poole, U. K. 
Methanol - BDH Limited, Poole, England, U. K. 
Goat serum - Scottish Antibody Production Unit, Carluke, U. K. 
F(ab)2 fragments of goat anti-human IgG - Sigma Chemical Company Limited, Poole, 
U. K. 
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Papain - Sigma Chemical Company Limited, Poole, U. K. 
Biotin labelled fab fragments of goat anti-human lgG - Sigma Chemical Company 
Limited, Poole, U. K. 
Biotin avidin HRP complex - Vector laboratories Inc., Burlingame, U. S. A 
Developing solution - Vector laboratories Inc., Burlingame, U. S. A 
Glycergel - Dako, Ely, Cambridgeshire, U. K. 
Biotinamidocaproate N-Hydroxysuccimimidine ester (Biotin) - Sigma Chemical 
Company Limited, Poole, U. K. 
2.3 General Buffers 
Phosphate Buffered Saline (PBS): 8g NaCI, 0.2g KH2PO4,1.44g Na2HPO4.2H20, 
0.2g KCI, dissolved in 800ml of distilled H2O. This was then made up to I litre and 
stored at 4°C for a maximum of I week (pH 7.4). 
Phosphate Buffered Saline containing 1mM disodium EDTA (PBSE) : 8g NaCl, 
0.2g KH2PO43 1.44g Na2HPO4.2H20,0.2g KCI, were dissolved in 800m1 of distilled 
H20.371mg EDTA was then added and the solution was made up to I litre and 
stored at 4°C for a maximum of I week. The pH was adjusted when necessary with 
5M NaOH to pH 7.4. 
O. IM Sodium Carbonate Buffer containing 0.02% NaN3: 1.36g Na2CO3,7.35g 
NaHCO3,200mg NaN3 were dissolved in 950m1 of distilled H2O. The pH was 
adjusted to 9.2 using IM NaOH. 
Tris Buffered Saline (TBS): 8g NaCI, 0.2g KCI, 3g Tris base were dissolved in 
800m1 distilled H2O. 0.015g of Phenol red was added and the pH of the mixture was 
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adjusted to 7.4 with 1M HCI. Distilled H2O was then added to make the volume up to 
1litre and the solution was stored at room temperature. 
0.5% Sarkosyl: 0.5g w/v sodium lauryl sarcosinate (SDS) was dissolved in distilled 
H20. 
Coating Buffer (CB): 1.59g Na2CO3,2.93g NaHCO3 was dissolved in 800m1 
distilled H20. The pH was adjusted to 9.6 at just under I litre, by adding IM HCl up 
to 1 litre in a volumetric flask. It was stored in a sterilised bottle at 4°C for a 
maximum of 1 week. 
Incubation Buffer (IB): 8g NaCl, 0.2g KH2PO4,1.44g Na2HPO4.2H20,0.2g KCI, 
0.5g Tween 20 dissolved in 800ml of distilled H20. Ig BSA was layered on the 
surface and allowed to dissolve slowly. The volume was adjusted to I litre with 
distilled H2O, then mixed and stored at 4°C for a maximum of 1 week (pH 7.4). 
Wash Buffer (WB): This was prepared at 10 times the concentration of incubation 
buffer (nil BSA) and stored at room temperature. It was diluted 1/10 immediately 
before use. 
N-tris[Hydroxymethyl]methyl-2-aminoethanesulfonic acid (TES) buffer: 229.2g 
TES, 372.24g EDTA and 0.2g (w/v) SDS were dissolved in 100ml distilled H20. The 
buffer was stored at 4°C for a maximum of 1 week. 
Complete Medium: 50m1 foetal calf serum (FCS), 5ml penicillin (100001U), 5m1 
streptomycin (10000µg/ml), 5ml L-Glutamine (200mM), 5m1 sodium pyruvate 
(1mM), RPMI 1640 to 500m1. 
CRL 1668 culture medium: 100m1 FCS, 10m1 L-Glutamine (400mM), G-418 at a 
final concentration of 200µg/m1, Iscoves medium to 500m1. 
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Phosphate Buffered Saline containing 1mM disodium EDTA (Versene): 8g NaCI, 
0.2g KH2PO4,1.44g Na2HPO4.2H20,0.2g KCI, dissolved in 800ml of distilled H20- 
3.7 1g EDTA was then added and the solution was made up to I litre and stored at 4°C 
for a maximum of 1 week. The pH was adjusted when necessary with 5M NaOH to 
pH 7.4. 
White cell counting fluid: 0.05% crytstal violet stain dissolved in 1% acetic acid. 
Nigrosin in 7% acetic acid: 7m1 glacial acetic acid, 0.05g nigrosin, 0. lg sodium 
azide dissolved in saline made up to a volume of 100ml. Filtration through filter 
paper. 
0.143M 2-aminoethylisothiouronium bromide (AET) solution: 0.402g of AET 
dissolved in 10ml of distilled water, to pH 9.0 with 5M NaOH. 
HAT (5x10-3M hypoxanthine, 2x10-5M aminopterin, 8x104M thymidine) 
selection medium (HAT): I vial HAT concentrate dissolved in 10ml of RPMI 1640 
medium, 100ml Foetal Calf Serum (FCS), 5ml glutamine (200mM), 5ml penicillin 
(10000IU), 5m1 streptomycin (10000µg/ml), 1.25m1 transferrin (2mg/ml) 1.25m1 
insulin (2mg/ml), Ouabain to final concentration lmM, then addition of RPMI 1640 
to 500m1. 
HT (5x10-3M hypoxanthine, 8x10-4 M thymidine) medium (HT): 1 vial HT 
concentrate , 
dissolved in 10ml of RPMI 1640 medium, 100ml Foetal Calf Serum 
(FCS), 5ml glutamine (200mM), 5m1 penicillin (10000IU), 5ml streptomycin 
(10000µg/ml), 1.25m1 transferrin (2mg/ml), 1.25m1 insulin (2mg/ml), then addition of 
RPMI 1640 to 500m1. 
Phosphate buffered saline containing 0.1% tween-20 (PBS-T): 8g NaCl, 0.2g 
KH2PO49 1.44g Na2HPO4.2H20,0.2g KCI, 0.5g Tween 20 dissolved in 800m1 of 
distilled H20, and made up to I litre and stored at 4°C for a maximum of 1 week (pH 
7.4) 
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Phosphate buffered saline containing tween and foetal calf serum (PBS-T-FCS): 
8g NaCl, 0.2g KH2PO49 1.44g Na2HPO4.2H20,0.2g KCI, 0.5g Tween 20 dissolved in 
800m1 of distilled H20, and made up to 1 litre. 5% FCS was then added. The buffer 
was used on the day that it was prepared only. 
O. 1M sodium acetate buffer (pH 4.8-5.0): 40.81g CH3COONa. 3H20 was dissolved 
in 800ml distilled H2O. The pH was then adjusted with glacial acetic and the volume 
made up to 1 litre with distilled H2O. 
Chromogen substrate: I tablet of 3-amino-9-ethylcarbazole was dissolved in 2m1 N, 
N-Dimethylformamide. 60m1 of 0.1M sodium acetate buffer, (pH 4.8-5.0) was then 
added and the solution was filtered through a 0.20µm filter. 
10% Buffered formaldehyde: 1 part buffered formaldehyde concentrate: 4 parts 
distilled H20. 
Mayers Haematoxylin: 2.5g of haematoxylin stain was dissolved in 2500ml of 
distilled H2O using gentle heat. 125g of aluminium potassium sulphate was then 
added and dissolved. 0.5g sodium iodate, 2.5g citric acid and 125g chloral hydrate 
was then added, the solution was heated to boiling point for 5 minutes and then cooled 
and filtered. 
1% Eosin: 2.5g CaC12 was dissolved in 500ml of distilled H2O. 5g of eosin was then 
added and dissolved. 
Blocking serum: 120µl goat serum was added to 5ml of PBS. 
Biotin avidin HRP complex mixture: 2 drops of solution A added to 5ml PBS, mix, 
then 2 drops of solution B were added, mix. It is imperative that this solution is 
prepared 30 minutes before use. 
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Developing solution: 2 drops of buffer added to 5m1 of distilled water, mix, 4 drops 
of DAB, mix, 2 drops of H202, mix. 
100mM phosphate buffer: 5.3g NaCl, 0.13g KH2PO45 0.96g Na2HPO4.2H20,0.13g 
KCI, dissolved in 800ml of distilled H20. This was then made up to I litre and stored 
at 4°C for a maximum of 1 week (pH 7.4). 
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Chapter 3. A Comparison of the Changes in the Humoral 
Immune Response to Antigens of Periodontal Pathogens 
Following Periodontal Therapy 
3.1 Introduction 
The existence of a humoral immune response in periodontal disease is a generally 
accepted fact. Numerous studies have been carried out over the last few decades, 
suggesting that elevations in the humoral immune response are associated with 
increasing severity of disease (Genco et al., 1980b, Mouton et al., 1981, Tolo and 
Brandtzaeg, 1982, Listgarten et al., 1981, Ebersole et al., 1982b, Naito et al., 1984, 
Tew et al., 1985a). These studies suggest a relationship exists between specific 
periodontopathic microbiota and antibody levels to the bacteria in both serum and 
GCF. 
The existence of a systemic humoral immune response to a variety of oral bacteria is 
well documented in subjects with different forms of periodontal disease (Taubman et 
al., 1982). This is probably simply because microbial challenge generally induces 
antibody production and high titres indicate current or previous infection. One of the 
major difficulties in evaluating the antibody response in periodontal disease has been 
the antigenic complexity of periodontopathic bacteria. If investigations could lead to 
the identification of major immunogenic proteins and antigens, and could characterise 
the immune responses elicited more clearly, there may be a better understanding of the 
host parasite interactions in periodontal disease. 
The immune response has been studied in different forms of periodontal disease, 
various age groups, and against a range of pathogens and antigens, and attempts have 
been made to draw conclusions or detect differences. An important consideration is 
the interaction between periodontal pathogens and the immune response of the host, 
which is a dynamic one. Hence, temporal relationships and alterations may exist in 
systemic antibody levels and relate to infection, treatment and active episodes of 
disease. Indeed, epidemiological investigations have suggested that only a subset of 
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the population is susceptible to severe periodontitis, and while in some of these 
individuals the disease appears to proceed as a chronic progressive destruction, in 
others the disease presents itself in phases which can be periods of active or inactive 
disease, or even remission (Socransky et al., 1994). 
Although the nature of the humoral immune response is not fully understood, the host 
response may provide a sensitive indicator of the flora found in the oral cavity, 
particularly in the gingival sulcus (Tew et al., 1985b, Tew et al., 1985c, Vandesteen et 
al., 1984). As well as providing information about the residing bacteria, the humoral 
immune response has been suggested as a means of differentiating between distinct 
periodontal disease states. High correlations between disease activity and antibody 
titres have been reported for a number of micro-organisms. A high degree of 
association has been reported for A. actinomycetemcomitans and localised aggressive 
periodontitis (Altman et al., 1982, Astemborski et al., 1989, Ebersole et al., 1982b) 
and P. gingivalis and chronic periodontitis (Mouton et al., 1981). Thus, diagnostic 
differentiation of the periodontal disease forms has been suggested for both 
periodontal microbiology and humoral immunology. 
Due to the nature of periodontal disease, it is virtually impossible to obtain a serum 
sample to investigate antibody targets and titres pre-disease. As a result, it is very 
difficult to draw conclusions and identify associations between disease severity, 
disease forms, antibody titres and micro-organisms. Even if a high correlation 
between disease severity and antibody titre is identified, numerous subjects possess 
antibody titres that fall above or below the ranges that identify health and disease, and 
quite often this is irrespective of their periodontal health status. Antibody titres of 
individuals not affected by periodontal disease ("normal") vary enormously. This 
difficulty is compounded by the fact that most of the putative periodontal pathogens 
can be found in healthy subjects (Loesche and Syed, 1978, Loesche et al., 1985) and 
antibody titres against pathogens can be identified even in the absence of periodontal 
disease (health) (Doty et al., 1982). Furthermore, it is often difficult to identify what 
point in the disease process individuals are at, especially if they do not present with 
disease until late on in life. 
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Due to all of these sources of variation between subjects, a number of studies have 
investigated relative changes in antibody titres against various micro-organisms, by 
assessing the success of a particular stage of periodontal therapy. These studies, 
discussed below, attempt to monitor the microbial flora of periodontal patients by 
assessing the host response. However, there are conflicting reports about the change 
in antibody level after treatment. 
Aukhil et al. (1988) observed serum antibody titres of patients with chronic 
periodontal disease before and after periodontal treatment, against a number of oral 
micro-organism sonicate preparations. They reported a general reduction in the mean 
antibacterial titres following treatment. However, the intervals during which the 
decreases in antibody titres occurred were not the same for each micro-organism 
studied. Naito et al. (1987), reported a decrease in the serum antibody titre of 
periodontally diseased patients to P. gingivalis post-treatment. A decrease in titre was 
also reported by Mouton et al. (1987). This study reported the existence of two 
subgroups within the periodontitis subjects studies. The distinction between the 
subgroups was a difference in antibody reactivity against P. gingivalis. One subgroup 
were IgA negative and had IgM and IgG titres not significantly higher than healthy 
subjects. The second subgroup were IgA positive and showed IgM and IgG levels 
much higher than those of the first subgroup. The latter group showed a 55% decrease 
in antibody titres 5-7 months after treatment. Sandholm and Tolo (1987), also 
observed serum antibody levels to 4 periodontal pathogens pre- and post-treatment in 
aggressive periodontitis. Although they observed decreased antibody titres post- 
treatment in 25% of the subjects tested, in the remaining 75%, they reported unaltered 
antibody levels. More recently Horibe et al. (1995) reported a study on the effect of 
periodontal treatments on IgG titres against 7 different periodontopathic bacteria. Of 
the 7 bacteria tested, this group showed a significant decrease in antibody titres post- 
treatment against P. gingivalis and P. intermedia. However, no difference in titres 
between pre- and post-treatment were reported against Prevotella loescheii, F. 
nucleatum, A. actinomycetemcomitans, Eikenella corrodens and Caphocytophga 
ochracea. 
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The majority of the above studies report a decrease in antibody titre following 
treatment, however, some results indicated no difference in titre pre- and post- 
treatment against some of the bacteria tested. The studies reported are often carried 
out for different lengths of time and are difficult to compare. Ebersole and Holt 
(1991) noted that treatment can decrease serum IgG antibody levels to certain micro- 
organisms, in both aggressive and chronic periodontitis patients, however, they 
indicated that these changes were noted to take up to 8-10 months post-treatment and 
were quite specific for selected micro-organisms in individual patients. 
In contrast to these studies, reports have been made of investigations that have 
indicated an increase in serum antibody titres to various micro-organisms following 
treatment. Ebersole and Holt (1991b) reported that 60% of periodontitis patients 
demonstrated increased titres against various periodontal pathogens post-treatment. 
Sjöström et al. (1994) examined IgG titres to A. actinomycetemcomitans in 30 patients 
with aggressive periodontitis. They reported a significant increase in titres at 6-12 
months after beginning treatment. Mooney et al. (1995), also reported an increase in 
antibody titre post-treatment. However, this study is slightly different and cannot be 
directly compared with those above that suggest a decrease in titre following 
treatment, as it observed the dynamics of the immune response to P. gingivalis and A. 
actinomycetemcomitans in patients that were divided into subgroups. The group 
divisions were based on the subject's baseline IgG antibody levels to P. gingivalis or 
A. actinomycetemcomitans. The patients were labelled seropositive or seronegative. 
Being labelled seropositive for a micro-organism meant the subject had an IgG titre to 
an organism >2 times the control median. The study carried out by Mooney et al. 
(1995), along with a similar study by Chen et al. (1991), added an extra factor that 
included antibody avidity as well as antibody titre, and thus do not show antibody 
titres post-treatment alone. Chen et al. (1991) looked at antibody titres and avidities 
pre- and post treatment against P. gingivalis whole cell sonicates, LPS and protein 
fractions. Again, in this study there were two groups, sero-positive and sero-negative 
patients. The results indicated that following treatment, there was a decrease in 
antibody titre against the antigens in the seropositive group and an increase in titre in 
the sero-negative group. There was an increase in antibody avidity to the antigens 
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tested in both groups. Mooney et al. (1995), reported a significant increase in avidity 
of IgG to P. gingivalis in the seropositive group, but no increase in titre (i. e. no 
change). An increase in titre was reported for the sero-negative group. They also 
reported a significant increase in titre against A. actinomycetemcomitans, but again in 
the sero-negative group only. The studies reported by Mooney et al. (1995) and Chen 
et al. (1991) therefore, suggest that the characteristics of the humoral immune 
response to various pathogens may be quite different and depend on the 
immunological status of the patient prior to treatment, a factor which may not have 
been considered in many of the previously discussed studies. An increase in antibody 
titre in seronegative patients could be due to the `inoculation' theory suggested by 
Ebersole et al. (1985d). Although the seronegative patients had a low antibody titre to 
the antigens prior to treatment, these antibodies may have been a low level presence of 
cross-reacting antibodies, and as a result of treatment, an antibody response may have 
been mounted following induction of the primary immune response to these Gram 
negative bacterial antigens. Chen et al. (1991) suggested that the increase in antibody 
avidity in both groups of patients could be due to the treatment having an effect on 
antibody responsiveness. They suggest that treatment leads to a reduction in antigenic 
load, which in turn leads to a selection of clones of B lymphocytes that produce 
antibodies of higher avidity. 
The aim of the first part of the overall project was to investigate the humoral immune 
response in a group of chronic periodontitis patients against a panel of whole micro- 
organisms. In addition, responses to OMP and a sample of what are considered the 
more potentially important antigens from these micro-organisms. The micro- 
organisms used in this study were: P. gingivalis; A. actinomycetemcomitans; P. 
intermedia; B. forsythus and T. denticola. The OMP of P. gingivalis, A. 
actinomycetemcomitans, P. intermedia and B. forsythus were also used as well as the 
antigens: HSP60 (of P. gingivalis); LPS (of P. gingivalis); leukotoxin (of A. 
actinomycetemcomitans) and the ß segment of RgpA protease (of P. gingivalis). The 
literature regarding these micro-organisms and antigens, and therefore, the reason why 
they have been selected has been discussed already in the introduction to this thesis. 
Although studies of this nature have previously been carried out, no study has yet 
observed the titres against all of these targets in one study group so as to permit 
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comparisons. The study has been performed on a group of patients scheduled for 
treatment for chronic periodontitis and antibody titres have been observed pre- and 
post-treatment. 
The second part of this study was investigating the cross-reactivity between a number 
of these micro-organisms. Of the putative periodontal pathogens generally accepted 
to play a role in the pathogenesis of periodontal disease, all are Gram negative bacteria 
with the exception of the spirochaetes. Therefore, these different species will possess 
a certain amount of homology, with structural features of surface components being 
chemically very similar and possessing similar immunobiological properties. If these 
surface components are immunogenic and play a role in the induction of the immune 
response, perhaps there is some cross-reactivity occurring between antibodies induced 
against one pathogen and a structurally very similar surface component of another 
pathogen. Although numerous studies have been carried out to investigate serum 
antibody titres against individual periodontopathogens, there does not appear to be a 
large pool of literature regarding the question of cross-reactivity between the putative 
periodontopathogens. 
Evidence can be seen in the literature however, to suggest that this idea is worth 
investigating. A study carried out by Kinane et al. (1993) observed specific 
immunoglobulin titres to P. gingivalis and A. actinomycetemcomitans in the sera and 
GCF of 20 patients with periodontitis. As part of the study they carried out 
adsorptions of the sera against A. actinomycetemcomitans and Haemophilus 
aphrophilus (H. aphrophilus). The adsorbed sera were then assessed for specific 
antibody to A. actinomycetemcomitans. The analysis gave a mean reduction in the 
anti-A. actinomycetemcomitans IgG of 68% and adsorption against H. aphrophilus 
gave a similar reduction in the anti-A. actinomycetemcomitans IgG of 63%. Thus the 
authors suggested that there are cross-reacting antibodies to these two species. 
Moreover, the results of the study suggested a strong correlation between serum IgG 
and IgM levels to these two bacteria, indicating cross-reactivity between antibodies 
directed against these pathogens. 
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A study by Vasel et al. (1996) reported immunisation of monkeys with a vaccine 
containing a monkey isolate of P. gingivalis that induced protection against alveolar 
bone destruction. These workers investigated immune and pre-immune sera obtained 
from the monkeys, using ELISA and Western immunoblotting. The results of the 
study indicated that following immunisation with killed P. gingivalis, the sera of the 
monkeys contained increased antibody levels reactive with P. gingivalis and also B. 
forsythus. Detailed analyses suggested that the binding of serum antibodies was a 
specific, adaptive response to the LPS in the immunogen, since little reactivity was 
detected in the pre-immune sera. Thus, the antibodies induced by LPS from P. 
gingivalis appeared to be cross-reactive with the LPS of B. forsythus. 
Further to the above study other investigations have suggested cross-reactivity 
between antibodies against LPS in non-oral Gram negative bacteria. Seifert et al., 
(1996) reported the generation of a human monoclonal antibody that recognised a 
conserved epitope shared by LPS molecules of different Gram negative bacteria, 
indicating a high degree of cross-reactivity of antibody across different bacterial 
species. 
Hinode et al. (1998) reported a clear cross-reactivity between antibodies raised to 
GroEL-like proteins of P. gingivalis, A. actinomycetemcomitans, and E. coli, 
indicating that a significant portion of the antibodies induced against GroEL-like 
proteins are directed at epitopes conserved across bacterial genera. 
Thus, there is evidence indicating cross-reactivity between antigens of different Gram 
negative bacteria. The aim of the second part of this serum antibody study was to 
investigate cross-reactivity between 4 periodontal pathogens, P. gingivalis, A. 
actinomycetemcomitans, P. intermedia and B. forsythus. Serum was used that had 
been taken from 9 individuals suffering from chronic periodontitis and was adsorbed 
against one bacteria before the antibody titres against all 4 pathogens was tested in an 
ELISA. 
Previous adsorption studies that have been undertaken mainly involving only two 
micro-organisms (Vasel et al., 1996; Kinane et al., 1993; Seifert et al., 1996). It was 
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felt that this only revealed part of the cross-reactivity story and that additional cross- 
reactivity testing would provide more information on P. gingivalis, A. 
actinomycetemcomitans, B. forsythus and P. intermedia. This investigation is 
therefore, of interest as the extent of cross-reactivity between more than two putative 
periodontopathogens is being investigated in a single study. 
3.2 Methods Part 1: Enzyme Linked Immunosorbent Assay 
3.2.1 Subjects and blood samples 
Prior to the commencement of these studies, ethical approval was obtained from the 
Glasgow Dental Hospital Ethics Committee. Subjects participating in these studies 
were informed of the protocol and consent was obtained. All patients taking part in 
the investigation were free to withdraw from the study at any time. Twenty five 
subjects, 11 males and 14 females, with a mean age of 47.3 + 7.6 years (mean + S. D 
(range = 36-66 years), were enrolled in the study. Seven of the subjects were 
smokers, 18 were non-smokers. The subjects were patients attending Glasgow 
University Dental Hospital. The criteria for inclusion was that patients had advanced 
periodontal disease with probing depths (P. D. ) of >5.0 mm in at least 2 non-adjacent 
sites per quadrant. Site selection was carried out at the screening visit, where full 
mouth periodontal pocket charting was performed using a PCP-12 periodontal probe. 
Wherever possible, one site in each quadrant over 5 mm in depth, without furcation 
involvement, was selected for inclusion in the study. These subjects had no history of 
systemic conditions which could influence the course of periodontal disease, had not 
received antibiotic treatment during the previous 3 months, and had received no prior 
periodontal treatment. 
At the baseline appointment, P. D. and bleeding on probing (BOP) at these sites were 
assessed with the Florida probe (Gibbs et al., 1988) and blood samples taken. Twenty 
one millilitres of venous blood were collected from the anterior cubital region using 
butterfly needles and 3x7 ml non-heparinised vacutainer tubes. The blood was 
allowed to clot overnight at 4°C. It was then centrifuged at 750 xg for 15 minutes and 
the serum was separated, aliquoted and stored at -80°C until required for ELISA 
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analysis. Patients were treated by an experienced periodontist and given a course of 
Hygiene Phase Therapy (HPT). This included oral hygiene instruction, quadrant 
scaling and root planing under local anaesthesia. 
The subjects were reassessed with conventional probing charts after HPT. A blood 
sample was taken and P. D. and BOP measurements were recorded at the 4 pre- 
selected sites with the Florida probe 138.9 +55.4 days (mean + S. D. ), range = 56 - 280 
days, after initial sampling. 
3.2.2 Antigen preparation 
1) Whole fixed Bacteria 
P. gingivalis NCTC 11834 and P. intermedia ATCC 25611 were grown under 
anaerobic conditions (85% N29 10% H2,5% C02) on fastidious anaerobe agar (FAA). 
B. forsythus ATCC 43037 was also grown under anaerobic conditions in tryptic soy 
agar supplemented with 7% horse blood and 10µg/ml N-acetylmuramic acid. A. 
actinomycetemcomitans ATCC 29523 (serotype A) was grown in 5% CO2 and 95% 
air on columbia blood agar. All bacteria were grown at 37°C. A. 
actinomycetemcomitans was harvested after 48 hours, P. gingivalis and P. intermedia 
after 5 days and B. forsythus after 7 days. T. denticola ATCC 35405 were cultured in 
medium OMIZ-pat + 1% human serum, and were a kind gift from Dr. C. Wyss, Institut 
fur Orale Mikrobiologie, Zurich, Switzerland (Wyss et al., 1997). 
All bacterial cells were harvested into phosphate buffered saline containing 1mM 
disodium EDTA (PBSE), washed by centrifugation at 200 xg for 10 minutes, and 
fixed for 1 hour at room temperature in 10% formal saline. The cells were then 
washed twice in PBSE and once in 0.1 M sodium carbonate-bicarbonate buffer 
containing 0.02% NaN3 at pH 9.6. Fixed cells were stored at 4°C until use. 
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2) Outer-membrane Protein Preparation 
The preparation of the outer-membrane antigens was carried out using a method 
modified from that of Schryvers et al. (1988). P. gingivalis, A. 
actinomycetemcomitans, P. intermedia and B. forsythus were grown as described 
above. The bacteria were harvested into PBSE and centrifuged at 10,000 xg for 20 
minutes. The pellet was then resuspended in tris buffered saline (TBS) and washed a 
further twice, as described above before being resuspended. The cells were sonicated 
for 10 pulses at 200W for 10 seconds, with a 2-minute cooling period between each 
pulse. Centrifugation was then carried out for 15 minutes at 8000 rpm at 4°C. The 
supernatant was removed and transferred into sterile ultracentrifuge tubes. 
Ultracentrifugation was then carried out for 1 hour at 40,000 rpm at 4°C and the pellet 
resuspended in 0.5% sarkosyl and retained at 4°C overnight. Ultracentrifugation was 
then carried out as above and the pellet resuspended in distilled water. 
The protein concentrations were determined using the BCA protein assay kit. 
3) Purified Antigen Preparation 
Heat Shock Protein 60 of P. gingivalis 
The heat shock protein 60 (HSP60) (of P. gingivalis) was purified according to Maeda 
et al. (1994), and was a kind gift from Dr. H. Maeda, Department of Periodontology 
and Endontology, Okayama University Dental School, Okayama, Japan. 
Leukotoxin of A. actinomycetemcomitans 
The leukotoxin (of A. actinomycetemcomitans) was purified in accordance with the 
protocol reported by Tsai et al. (1984) with modifications and was a kind gift from Dr. 
J. Korostoff, Leon Levy Research Center for Oral Biology, University of 
Pennsylvania, Philadelphia, USA. 
Lipopolysaccharide of P. gingivalis 
Lipopolysaccharide of P. gingivalis W50 was purified according to the method 
described by Darveau and Hancock (1983) and was a kind gift from Professor M. 
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Curtis, Department of Oral Microbiology, Medical research Council Pathogenesis 
Group, St. Bartholomews and The Royal London School of Medicine and Dentistry, 
London, UK. 
The (3 segment of the RgpA protease of P. gingivalis 
Domains of the RgpA protease of (P. gingivalis) were prepared as an N-terminal 
(His)6 fusion protein as described by Slaney et al. (2000) and was a kind gift from 
Professor M. Curtis. 
3.2.3 Analysis of sera samples by Enzyme Linked Immunosorbent Assay (ELISA) 
Specific antibody titres were measured using enzyme-linked immunosorbent assay 
(ELISA) by the method of Ebersole et al. (1980). 
The plates were pre-washed 3 times with coating buffer and coated overnight with the 
antigen at 4°C using 100µl per well. Immulon lB plates were used because of their 
low protein-binding characteristics and low non-specific background. The antigens 
were coated onto the surface of the wells at a concentration which had been 
determined as optimum to coat these plates. These concentrations were P. gingivalis 
and P. intermedia whole cells; 0.05 at OD600, A. actinomycetemcomitans and B. 
forsythus whole cells; 0.02 at OD600, T. denticola whole cells; 0.001 at OD600, P. 
gingivalis and A. actinomycetemcomitans OMP; 10µg/ml, P. intermedia and B. 
forsythus OMP; 0.5µg/ml, lipopolysaccharide (P. gingivalis); 4µg/ml, leukotoxin (A. 
actinomycetemcomitans); 0.5µg/ml, HSP60 (P. gingivalis) and RgpA (3 segment (P. 
gingivalis); 2µg/ml. Control wells for each aspect of the ELISA process were 
arranged around the outside of the plates. 
The ELISA plates were removed from the refrigerator and washed 4 times, then 4 
more, 4 times again and lastly once more with wash buffer (4x4x4x 1). The non- 
specific binding sites were blocked with 100µl per well of incubation buffer (IB) 
containing 5% skimmed milk powder for 1 hour at 37°C. The plates were then 
washed twice and once again (2x 1) before addition of the sera. 
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Human sera collected from the study patients were diluted 1/200 using 113.50µl of 
sera were added to each well and incubated at 37°C for 90 minutes. Each serum was 
tested in duplicate and the sera samples from the same patient at different time points 
were tested on the same plate. Following incubation with the sera the plates were 
washed 4x4x4xl. Afterward the plates were incubated at 37°C for 60 minutes with 
Biotin-goat-anti-human IgG at 1/2000 dilution in IB. The plates were then washed 
4x4x4x1 and then incubated for 60 minutes at 37°C with 1/2000 dilution of extravidin 
peroxidase. After washing 4x4x4xl, the reactions were visualised using 100µ1 per 
well of TMB Peroxidase substrate and stopped after 5-10 minutes, depending on the 
speed of the reaction, using 50pl per well of 0.12M HC1. 
The reactions were read using a Dynex Technologies MRX II plate reader at 630nm 
with a reference at 490nm and the results printed out. The duplicate results were 
averaged and the nonspecific background binding was subtracted. The final titre was 
expressed as O. D. units as has been done in numerous other studies (Suzuki et al., 
1984; Murray et al., 1989; Sandholm and Tolo, 1987; Cridland et al., 1994). The raw 
data was analysed in this study as the data being compared was obtained from the 
same 96 well plate in every case. Therefore, as all titres being compared were 
obtained at the same time point, it was not necessary to use a standard curve to correct 
for different variables. This study is comparative, rather than quantitative, therefore, 
the units are arbitrary. As such, converting the data into ELISA units would be an 
unnecessary data processing step. 
3.2.4 Statistical methods 
The data obtained from this study revealed that the values were adequately normalised 
by blotplots, although in a number of cases there were a few outliers. As the data was 
normalised, analyses of mean responses were undertaken using the statistical package 
Minitab, and parametric tests were used to assess relationships. Means, standard 
deviations and ranges are presented. 
Mean values for pocket depths of the subjects were used. Significance levels for all 
tests were p< _ 
0.05, unless otherwise stated. 
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3.3 Methods Part 2: Adsorptions 
3.3.1 Subjects and blood samples 
Prior to the commencement of these studies, ethical approval was obtained from the 
Glasgow Dental Hospital Ethics Committee. All patients taking part in the 
investigation were free to withdraw from the study at any time. Nine Subjects, 5 
males and 4 females, were enrolled in this study. The subjects were patients attending 
Glasgow University Dental Hospital and they had a mean age of 45.2 + 11.3 years 
(mean + S. D. ) (range = 29-60 years). The criteria for inclusion was as previously 
reported 3.2.1. 
The blood was collected and stored as reported in 3.2.1. 
3.3.2 Antigen preparation 
P. gingivalis NCTC 11834, P. intermedia ATCC 25611, B. forsythus ATCC 43037 
and A. actinomycetemcomitans ATCC 29523 (serotype A) were grown as described in 
3.2.2 
All bacterial cells were harvested into PBSE, washed by centrifugation at 200 xg for 
10 minutes. The bacterial pellet was then resuspended in PBS containing TLCK at 
50µg/ml and Leupeptin at 0.1mg/ml. The cells were sonicated on ice using a 
Microson Ultrasonic Cell Disrupter for a1 minute period, with a 1-minute cooling 
period following. This was repeated 10 times. The cell suspension was then 
microcentrifuged for 10 minutes at 13,000 rpm, before the supernatant was discarded 
and the cell pellet was resuspended in PBS again containing TLCK and leupeptin, at 
the same concentrations as described above. 
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3.3.3 Adsorption of samples 
The plates were pre-washed 3 times with TES buffer and coated overnight with the 
antigen at 4°C using 100µl per well. Immulon IB plates were used because of their 
low protein-binding characteristics and low non-specific background. Sonicates of P. 
gingivalis, A. actinomycetemcomitans, P. intermedia and B. forsythus were coated 
onto the surface of the wells at a concentration of 10µg/ml, which had previously been 
reported to be optimal (Vasel et al., 1996). The sonicate preparations were diluted in 
CB. 
The following day the plates were washed with WB before the addition of human 
serum diluted 1/100 in TES buffer. The plates were incubated for 1 hour with 
agitation at 37°C, before the serum was transferred to coated wells that had not been 
used and incubated for a further hour at 37°C. This was repeated 5 times. The serum 
was then moved to a fresh batch of pre-coated wells and the plate was incubated at 
4°C overnight. 
The following day, the serum was again moved to a fresh batch of pre-coated wells 
and incubated for 1 hour at 37°C with agitation, this was repeated 4 times to give a 
total of 10 x1 hour incubations. 
The serum was then removed from all of the wells and stored at 4°C until use. 
The whole experiment was carried out in duplicate but instead of coating the plates 
with antigen they were coated with CB alone. This was so all of the serum samples 
could be sham absorbed as well as absorbed against the antigens. 
3.3.4 Analysis of sera samples by Enzyme Linked Immunosorbent Assay (ELISA) 
Serum antibody titres were measured using ELISA as described in 3.2.3. Each sample 
was assayed in triplicate. 
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The antigens were coated onto the surface of the wells at a concentration of 10µg/ml. 
Controls for each aspect of the ELISA process were arranged in the wells around the 
outside of the plates. 
Human sera, both absorbed and sham-absorbed were used at 1/100 dilution. 
The triplicate results were averaged and the final titre expressed as O. D units. 
3.4 Results 
3.4.1 Results of part 1 of the study: Enzyme Linked Immunosorbent Assay 
The mean age of the subjects was 47.3 + 7.6 years (mean + S. D. ). The length of 
treatment that each individual experienced varied quite extensively. The mean length 
of time between the taking of the first and second samples was 138.9 + 55.4 days 
(mean + S. D. ), however, the range was 56 to 280 days, which makes it difficult to use 
the length of treatment parameter in statistical analyses. 
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Table 3.1 Polyvalent immunoglobulin titres for before and after treatment and 
the differences between these (O. D. units) 
Mean S. D. Mean S. D. Mean S. D. 95% CI of p- 
BT AT Difference Difference value* 
(BT-AT) (BT-AT) 
PD 5.99 1.00 4.37 1.20 1.62 0.98 (1.22, <0.001 
2.02) 
Pg 0.89 0.27 0.90 0.27 0.00 0.09 (-0.04, 0.87 
0.04) 
Aa 0.32 0.22 0.34 0.23 0.02 0.14 (-0.08, 0.47 
0.04) 
Pi 0.82 0.25 0.79 0.24 0.03 0.10 (-0.01, 0.14 
0.07) 
Bf 0.23 0.10 0.22 0.10 0.01 0.11 (-0.04, 0.63 
0.06) 
Td 0.28 0.12 0.25 0.13 0.03 0.10 (-0.01, 0.16 
0.07) 
Pg OMP 0.52 0.19 0.51 0.17 0.02 0.07 (-0.01, 0.18 
0.05) 
Aa OMP 0.72 0.14 0.73 0.15 0.01 0.07 (-0.03, 0.55 
0.02) 
Pi OMP 0.73 0.24 0.73 0.22 0.00 0.10 (-0.04, 0.91 
0.04) 
Bf OMP 0.46 0.15 0.46 0.12 0.00 0.10 (-0.04, 0.82 
0.05) 
Aa LTX 0.75 0.39 0.75 0.38 0.00 0.11 (-0.04, 1.0 
0.04) 
Pg 0.25 0.14 0.25 0.12 0.01 0.06 (-0.02, 0.63 
LPS 0.03) 
Pg 0.24 0.12 0.23 0.09 0.01 0.06 (-0.01, 0.39 
HSP60 0.04) 
Pg RgpA 0.18 0.10 0.16 0.12 0.02 0.10 (-0.02, 0.34 
0.06) 
*p-value for hypothesis test of no difference between before treatment and after 
treatment (paired t-test). 
BT - before periodontal treatment, AT - after periodontal treatment, PD - pocket 
depth, Pg - P. gingivalis, Aa - A. actinomycetemcomitans, Pi - P. intermedia, Bf - B. 
forsythus, Td - T. denticola, Ec - E. coli, OMP - outer-membrane proteins, Aa LTX - 
Leukotoxin (of A. actinomycetenicomitans), Pg LPS - Lipopolysaccharide (of P. 
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gingivalis), Pg HSP60 - Heat shock protein 60 (of P. gingivalis), Pg RgpA -P 
segment of RgpA protease (of P. gingivalis). 
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Figure 3.1 Plot of polyvalent immunoglobulin titres pre- and post-treatment 
against P. gingivalis 
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Figure 3.2 Plot of polyvalent immunoglobulin titres pre- and post-treatment 
against P. gingivalis OMP 
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Figure 3.3 Plot of polyvalent immunoglobulin titres pre- and post-treatment 
against the ß segment of RgpA (of P. gingivalis) 
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Table 3.1 shows the data collected for the pocket depths recorded pre- and post- 
treatment and the changes in these following treatment. Again the ranges of pocket 
depths were quite large both pre-and post-treatment, however, statistical analysis 
shows that there is a highly significant decrease in pocket depth following treatment. 
Table 3.1 also shows the data collected following analysis of the serum by ELISA 
against the panel of micro-organisms antigen preparations before and after treatment. 
The polyvalent immunoglobulin titres (IgA, IgG and IgM) are expressed in O. D. units. 
Statistical analyses of these results indicate that there was no significant change in 
antibody titre following treatment for antibody levels against any of the micro- 
organisms or antigens tested. When the data is analysed in graphical form for each of 
the micro-organisms and antigens for a number of the targets outliers can be observed. 
Figure 3.1 shows the plot of polyvalent immunoglobulin titres pre- and post-treatment 
against P. gingivalis. For each of the different analyses carried out, the graph for 
antibody titres for P. gingivalis will be used to show a representative sample of 
results. Other graphs are only shown to indicate a point of interest or a significant 
result. 
Figure 3.2 shows the plot of polyvalent immunoglobulin titres pre- and post treatment 
for the 25 patients against the OMP of P. gingivalis and it can be seen that there are 
two outliers, patients 12 and 18. If these two patients are excluded from the statistical 
analysis, there is a significant decrease in antibody titre following treatment against 
this antigen preparation (mean difference = 0.021, S. D. = 0.046,95% CI = 0.00,0.04, 
p-value = 0.04). However, there seems to be no valid reason either clinically or 
experimentally, to exclude these 2 patients from the analysis and hence, the overall 
results indicate that there is no significant change in antibody titre following 
treatment. 
Figure 3.3 which shows the plot polyvalent immunoglobulin titre pre- and post- 
treatment against the 1 segment of RgpA (of P. gingivalis), also indicates an outlier. 
When this subject is removed from the statistical analysis, a significant decrease in 
titre can be seen following treatment (mean difference = 0.03, S. D. = 0.07,95% CI = 
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0.00,0.06, p-value = 0.03), however, again there is no valid reason to exclude this 
subject from the analysis, and hence the overall data suggests no change in antibody 
titre against this antigen following treatment. 
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Figure 3.4 Boxplot of the difference between pre- and post-treatment antibody 
titres against LPS 
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Figure 3.4 shows a box plot for the difference in antibody titres against LPS before 
and after treatment. It can be seen that 6 outliers appear to be slightly skewing the 
data. When all 6 of the subjects are removed from the analysis, there is still no 
significant difference between pre- and post treatment antibody titres. On removal of 
the 6 outliers the p-value for the difference in titres becomes larger. For a few of the 
micro-organisms and antigens, the boxplots showed a number of outliers, however, 
removal of them did not lead to a significant result, except for the incidents of P. 
gingivalis OMP and RgpA as discussed previously. 
Patient I appeared to be an outlier on analysis of antibody titre change against a 
number of different micro-organisms and antigens. This patient always showed a 
decrease in antibody titre following treatment. The reason for this is not clear. It is 
noted, however, that patient (number) 1 had a pre-treatment pocket depth of 5.65mm 
and a final pocket depth of 5.45mm indicating that any decrease in pocket depth and 
improvement was insignificant. However, no conclusions can be made from this 
individual alone, and there was no significant correlation between change in pocket 
depth and change in antibody titre following treatment when all subjects were 
observed together (see table 3.3 below). 
151 
Table 3.2 Polyvalent immunoglobulin, IgG and IgA titres before and after 
treatment and comparisons of these for P. gingivalis, A. actinomycetemcomitans, 
P. intermedia, B. forsythus and T. denticola 
Mean 
BT 
S. D. Mean 
AT 
S. D. Mean 
Difference 
(BT-AT) 
S. D. 95% CI of 
Difference 
(BT-AT) 
p- 
value 
Pg 
Poly Ig 0.89 0.27 0.90 0.27 -0.01 0.09 (-0.04,0.04) 0.87 
IG 1.03 0.35 1.05 0.36 0.02 0.08 (-0.05,0.02) 0.35 
IgA 0.34 0.29 0.35 0.28 -0.01 0.07 (-0.03,0.02) 0.74 
Aa 
Poly Ig 0.32 0.22 0.34 0.23 0.02 0.14 (-0.08,0.04) 0.47 
IgG 0.32 0.28 0.35 0.31 0.03 0.10 (-0.01,0.07) 0.11 
IgA 0.06 0.06 0.06 0.06 0.00 0.03 (-0.01,0.01) 0.89 
Pi 
Pol Ig 0.82 0.25 0.79 0.24 0.03 0.10 (-0.07,0.01) 0.14 
IgG 0.86 0.30 0.85 0.28 0.01 0.10 (-0.05,0.03) 0.65 
IgA 0.16 0.10 0.16 0.10 0.00 0.07 (-0.03,0.03) 0.85 
Bf 
Poly Ig 0.23 0.10 0.22 0.10 0.01 0.11 (-0.06,0.04) 0.63 
IG 0.14 0.08 0.14 0.08 0.00 0.07 (-0.03,0.02) 0.76 
IA 0.06 0.05 0.06 0.04 0.01 0.04 (-0.02,0.01) 0.50 
Td 
Poly Ig 0.28 0.12 0.25 0.13 0.03 0.10 (-0.01,0.07) 0.16 
1G 0.20 0.09 0.17 0.08 0.03 0.09 (-0.07,0.01) 0.15 
IgA 0.07 0.05 0.06 0.03 0.01 0.04 (-0.03,0.01) 0.31 
* p-value for hypothesis test of no difference between before treatment and after 
treatment (paired t-test). 
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Figure 3.5 Plot of IgG pre- and post-treatment against P. giizgivalis 
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Figure 3.6 Plot of IgA titres pre- and post-treatment against P. gingivalis 
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Table 3.2 shows the results for the titres of polyvalent immunoglobulin, IgG and IgA 
against P. gingivalis, A. actinomycetemcornitans, P. interinedia, B. forsythus and T. 
denticola pre- and post-treatment. The mean highest antibody titres were either 
polyvalent or of the isotype IgG, and the lowest IgA in most cases. No significant 
differences between any of the isotypes (polyvalent, IgG and IgA) were noted 
following treatment. Figure 3.5 shows the plot of the IgG titres pre-and post- 
treatment against P. gingivalis. Figure 3.6 shows the plot of the IgA titres pre- and 
post-treatment against P. gingivalis. 
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Table 3.3 The correlation between change in pocket depth and change in 
antibody titre following treatment 
Correlation between change in pocket 
depth (mm) and change in antibody titre 
(O. D. units) against: 
Correlation 
coefficient 
95% Cl for 
correlation 
coefficient 
p-value* 
Pg -0.073 (-0.46,0.33) 0.728 
Aa 0.300 (-0.11,0.62) 0.146 
Pi -0.099 (-0.48,0.31) 0.639 
Bf 0.566 0.22,0.79) 0.003 
Td -0.040 (-0.43,0.36) 0.849 
Pg OMP 0.063 (-0.34,0.45) 0.766 
Aa OMP -0.059 (-0.44,0.34) 0.780 
Pi OMP -0.122 (-0.49, -0.29) 0.562 
Bf OMP -0.197 (-0.55,0.22) 0.346 
Aa LTX -0.204 (-0.55,0.21) 0.328 
Pg LPS -0.105 (-0.48,0.30) 0.616 
P HSP60 0.133 (-0.28,0.50) 0.527 
Pg RgpA 0.245 (-0.17,0.58) 0.239 
*p-value for hypothesis test of no correlation/correlation coefficient equal to zero 
(Pearson product moment coefficient of correlation) 
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Figure 3.7 Plot of change in pocket depth against change in antibody titre for B. 
forsythus 
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Figure 3.8 Plot of change in pocket depth against change in antibody titre for P. 
gingivalis 
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Table 3.3 shows the correlation between change in pocket depth and antibody titre 
against the micro-organisms and antigens tested following treatment. There is a 
significant correlation (non zero correlation) between change in pocket depth and 
antibody titre against B. forsythus, post-treatment. The correlation coefficient for this 
relationship is 0.566, implying that as the change in pocket depth increases, the 
change in antibody titre also increases. The graph suggests that the larger the decrease 
in pocket depth following treatment, the greater is the positive change in titre and 
hence the greater the increase in titre. Figure 3.7 shows that there is a correlation 
between change in antibody titre to B. forsythus and change in pocket depth. The 
graph is further evidence of a correlation. A positive correlation, although not 
significant can also be seen for change in pocket depth and change in titre against A. 
actinomycetemcomitans. Therefore, it is difficult to explain why there is a positively 
skewed correlation for A. actinomycetemcomitans and B. forsythus whole cells, but 
not for A. actinomycetemcomitans and B. forsythus OMP or A. 
actinomycetemcomitans leukotoxin. 
One might remark that since 13 comparisons were made against pocket depth, i. e. one 
comparison for each antigen, some investigators might suggest the Bonferroni's 
approach (Glantz, 1981) to "correct" the individual p-values to ones more appropriate 
for the situation in which multiple, related tests are performed. Therefore, the only 
results that are significant in table 3.3 are those for which the uncorrected p-values are 
< 0.015. As the only significant result of change in pocket depth against change in 
antibody titre to B. forsythus has a p-value of 0.003, the Bonferroni's approach has no 
effect in this case. Figure 3.8 shows the plot of change in pocket depth against change 
in antibody titre against P. gingivalis. 
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Table 3.4 To show the correlation between pre-treatment pocket depth and pre- 
treatment antibody titre 
Correlation between pre-treatment 
pocket depth (mm) and pre-treatment 
antibody titre (O. D. units) against: 
Pearson product 
Moment 
Correlation 
coefficient 
95% CI for 
correlation 
coefficient 
p- 
value* 
Pg 0.465 ( 0.09,0.73) 0.019 
Aa 0.573 ( 0.23,0.79) 0.003 
Pi 0.149 (-0.26,0.51) 0.477 
Bf -0.219 (-0.57,0.19) 0.293 
Td -0.074 (-0.46,0.33) 0.725 
Pg OMP 0.333 (-0.07,0.64) 0.104 
Aa OMP 0.388 (-0.01,0.68) 0.055 
Pi OMP 0.054 (-0.35,0.44) 0.799 
Bf OMP -0.026 (-0.42,0.37) 0.900 
Aa LTX 0.339 (-0.06,0.65) 0.097 
Pg LPS 0.332 (-0.07,0.64) 0.104 
Pg HSP60 0.057 (-0.35,0.44) 0.786 
Pg RgpA -0.291 (-0.62,0.12) 0.158 
*p-value for hypothesis test of no correlation/correlation coefficient equal to zero 
(Pearson product moment coefficient of correlation) 
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Figure 3.9 Plot of pre-treatment pocket depth against pre-treatment antibody 
titre for A. actinomycetemcomitans 
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Table 3.4 shows the correlation between pre-treatment pocket depth and pre-treatment 
antibody titre. Statistical analysis has indicated there is significant correlation (non 
zero correlation) between pre-treatment pocket depth and pre-treatment antibody titres 
against P. gingivalis, A. actinomycetemcomitans and A. actinomycetemcomitans OMP 
preparation. The correlation coefficient for P. gingivalis is 0.465 and 0.573 for A. 
actinomycetemcomitans. Although, the p-values are significant (0.019 and 0.003 
respectively), the correlation's are not strong. The correlation coefficient for pre- 
treatment pocket depth and pre-treatment antibody titre against A. 
actinomycetemcomitans OMP preparation is not significant. The correlation 
coefficient is 0.388 and the p-value is 0.055, however, the confidence interval is -0.01, 
0.68. This indicates that there is a correlation, however, this is not significant. All 3 
of the correlation's are positive, indicating that increased pre-treatment pocket depths 
can be correlated with increased pre-treatment antibody titres against P. gingivalis, A. 
actinomycetemcomitans and A. actinomycetemcomitans OMP preparation. Figure 3.9 
shows the plot of pre-treatment pocket depth against pre-treatment antibody titre to A. 
actinomycetemcomitans. It can be seen from the graph that there are 2 outliers. When 
examined these patients are not young, i. e. there is no chance that they may be 
suffering from aggressive periodontitis instead of chronic periodontitis, and therefore, 
the reason for them being outliers is not clear. 
Again some investigators may suggest that the Bonferroni's approach to "correct" the 
individual p-values would be appropriate in this situation. If it is used, then the p- 
value is < 0.015 which means that only the correlation between pre-treatment pocket 
depth and antibody titre against A. actinomycelemcomitans is significant. 
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Table 3.5 To show the correlation between length of treatment and change in 
antibody titre following treatment 
Correlation between length of treatment 
and Change in antibody titre following 
treatment against: 
Correlation 
coefficient 
95% Cl for 
correlation 
coefficient 
p-value* 
Pg -0.102 (-0.48,0.31) 0.629 
Aa 0.008 (-0.39,0.40) 0.969 
Pi 0.241 (-0.17,0.58) 0.245 
Bf -0.201 (-0.55,0.21) 0.335 
Td -0.032 (-0.42,0.37) 0.879 
Pg OMP 0.280 (-0.13,0.61) 0.175 
Aa OMP 0.218 (-0.19,0.56) 0.296 
Pi OMP -0.005 (-0.40,0.39) 0.980 
Bf OMP 0.174 (-0.24,0.53) 0.404 
Aa LTX 0.092 (-0.31,0.47) 0.663 
Pg LPS 0.003 (-0.39,0.40) 0.988 
Pg HSP60 -0.522 (-0.76, -0.16) 0.007 
Pg RgpA -0.101 (-0.48,0.31) 0.632 
*p-value for hypothesis test of no correlation/correlation coefficient equal to zero 
(Pearson product moment coefficient of correlation). 
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Figure 3.10 Plot of length of treatment against change in antibody titre for heat 
shock protein 60 (of P. gingivalis) 
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Figure 3.11 Plot of length of treatment against change in antibody titre for P. 
gingivalis 
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The correlation between change in antibody titre following treatment against various 
micro-organisms and antigens and the length of treatment undergone by the subjects is 
shown in table 3.5. There is a significant correlation recorded (non zero correlation) 
for the change in antibody titre following treatment against HSP60 (of P. gingivalis) 
and the length of treatment experienced by the subjects. The correlation coefficient is 
-0.522 implying that as the length of treatment increases, the change in antibody titre 
decreases. This relationship can be seen more clearly in figure 3.10. This figure 
shows the plot of length of treatment against the change in antibody titre to HSP60 (of 
P. gingivalis). It can be seen from the graph that there is a trend towards a negative 
correlation and that if the treatment is shorter than approximately 125 days, the change 
in antibody titre is positive (above zero) i. e. an increase in antibody titre following 
treatment. A period of treatment of above 125 days or more seems to lead to a change 
in antibody titre that is negative (below zero) i. e. a decrease in antibody titre following 
treatment. This correlation is still significant following application of the 
Bonferroni's approach. Figure 3.11 shows the plot of length of treatment against 
change in antibody titre to P. gingivalis. 
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3.4.1.1 Relationship between treatment and antibody titres 
An analysis of the 25 patients before and after treatment can be seen in tables 3.1 - 
3.6. The analyses looked at the effect of treatment on polyvalent immunoglobulin 
titres against a large panel of bacteria and antigens, and 3 different isotypes of 
immunoglobulin; polyvalent immunoglobulin, IgG and IgA against 5 whole putative 
periodontopathogen preparations. The analyses suggests that the treatment did not 
have an effect on antibody titres against the micro-organisms and antigens tested in 
this study and that there was no significant difference between antibody titres before 
and after treatment. 
The data in table 3.1 shows the highest titres of polyvalent immunoglobulin were 
specific for P. gingivalis and P. intermedia whole fixed bacteria, and the antibody 
titres against purified antigens such as LPS, HSP60 and the ß segment of RgpA were 
significantly lower. 
Levels of 3 different isotypes of immunoglobulin were investigated before and after 
treatment for 5 whole fixed putative periodontopathogens. Analysis showed no 
significant difference between pre- and post-treatment titres for any of the isotypes 
against any of the micro-organisms. The IgA titres before and after treatment were 
extremely low when compared with the titres of polyvalent immunoglobulin and IgG. 
The levels of polyvalent immunoglobulin and IgG were very similar, and in some 
cases the IgG levels were slightly, but not significantly, higher than the levels of 
polyvalent immunoglobulin. 
Although the results are not presented, analysis did show that the change in antibody 
titre against most of the micro-organisms and antigens tested correlated significantly 
with their corresponding pre-treatment antibody titre. The correlations were all 
positive, indicating that an increased pre-treatment titre against a particular antigen 
can be correlated with an increased change in antibody titre against that antigen 
following treatment. 
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3.4.1.2 Relationship of pocket depths and antibody titres 
An analysis was performed to assess whether there was a correlation between change 
in pocket depth and change in antibody titre following treatment (table 3.1) and 
between pre-treatment pocket depth and pre-treatment antibody titre against the 
various micro-organisms and antigens (table 3.1). No strong correlations were found. 
Although the results are not shown, analysis was carried out to investigate a 
correlation between pre-treatment pocket depths and change in antibody titre against 
all of the micro-organisms and antigens. No significant correlations were found. 
3.4.1.3 Other Parameters 
Changes in antibody titre against the micro-organisms and antigens tested were 
analysed according to smoking status. The results indicate that there is no difference 
in the change in antibody titres for smokers and non-smokers. 
The changes in antibody titre against the micro-organisms and antigens tested when 
analysed according to gender were also examined. The results indicated no significant 
difference in change of antibody titres following treatment between males and 
females. 
Change in antibody titre following treatment, for any of the micro-organisms or 
antigens tested, was examined against the age of the subjects at the beginning of the 
study. Analyses were carried out to assess whether there were any correlations 
between age, change in pocket depth and length of treatment. No correlations were 
found to be significant. 
3.4.2 Results of Part 2 of the study: Adsorptions 
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Table 3.6 The median percentage reduction in antibody titre following 
adsorption compared to the sham adsorbed sera 
Median Percentage Range 
Reduction in Antibody Titre 
Against P 
Sera Adsorbed 65.33 50.00 - 82.40 
against P 
Sera Adsorbed 72.42 40.88 - 86.83 
against Aa 
Sera Adsorbed 61.35 34.03 - 84.73 
against Bf 
Sera Adsorbed 75.00 29.56 - 87.56 
against Pi 
Against Aa 
Sera Adsorbed 73.72 25.12 - 86.75 
against P 
Sera Adsorbed 75.19 58.75 - 89.96 
against Aa 
Sera Adsorbed 62.53 26.05 - 89.94 
against Bf 
Sera Adsorbed 74.66 21.86 - 85.20 
against Pi 
Against Bf 
Sera Adsorbed 47.79 2.05-73.27 
against P 
Sera Adsorbed 52.13 34.00 - 73.43 
against Aa 
Sera Adsorbed 50.85 26.44 - 70.79 
against Bf 
Sera Adsorbed 48.92 13.85 - 72.61 
against Pi 
Against Pi 
Sera Adsorbed 60.91 18.85 - 90.92 
against Pg 
Sera Adsorbed 67.16 25.08 - 91.01 
against Aa 
Sera Adsorbed 63.47 19.62 - 85.10 
a ainst Bf 
Sera Adsorbed 79.83 35.00 - 89.95 
against Pi 
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Figure 3.12 Plot of the median percentage reduction in antibody titre against P. 
gingivalis following adsorption against P. gingivalis, A. actinomycetemcomitans, 
B. forsythus and P. intermedia when compared to the titre observed against the 
sham adsorbed sera 
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Figure 3.13 Plot of the median percentage reduction in antibody titre against A. 
actinomycetemcomitans following adsorption against P. gingivalis, A. 
actinomycetemcomitans, B. forsythus and P. intermedia when compared to the 
titre observed against the sham adsorbed sera 
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Figure 3.14 Plot of the median percentage reduction in antibody titre against B. 
forsythus following adsorption against P. gingivalis, A. actinomycetemcomitans, B. 
forsythus and P. intermedia when compared to the titre observed against the 
sham adsorbed sera 
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Figure 3.15 Plot of the median percentage reduction in antibody titre against P. 
intermedia following adsorption against P. gingivalis, A. actinomycetemcomitans, 
B. forsythus and P. intermedia when compared to the titre observed against the 
sham adsorbed sera 
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Table 3.6 shows the median percentage reduction in antibody titre against P. 
gingivalis, A. actin oinycetem coin itans, B. forsythus and P. intermedia following 
adsorption. The median reduction is given as a percentage of the serum antibody titre 
for the sham adsorbed sera. The sham adsorbed sera gives a value of the antibody 
titre following the process of adsorption. No antibodies should have been lost due to 
specific binding, however, some may have been lost due to non-specific binding to the 
plastic wells of the plate. Sham adsorbed sera was designated to be 100%, and the 
median percentage reduction values were given as a percentage of this value. The 
table also shows the range values, which are wide, showing a lot of variation between 
the values. 
When titres against P. gingivalis were measured, 65.33% of the antibody titre had 
been lost when the sera had been adsorbed against P. gingivalis itself, 72.42% when 
adsorbed against A. actinomycetemcomitans, 62.35% against B. forsythus and 75% 
against P. intermedia. 
Titres against A. actinomycetemcomitans showed that when compared with the sham 
adsorbed sera, 75.19% had been adsorbed out against A. actinomycetemcomitans 
itself, 73.72% against P. gingivalis, 62.53% against B. forsythus and 74.66% against 
P. intermedia. 
Titres against B. forsythus showed that when compared with the sham adsorbed sera 
50.85% had been adsorbed against B. forsythus, 47.79% against P. gingivalis, 52.13% 
against A. actinomycetemcomitans and 48.92% against P. intermedia. 
When titres were measured against P. intermedia, 79.83% was adsorbed out against P. 
intermedia itself, 60.91% was adsorbed against P. gingivalis, 67.16% against A. 
actinomycetemcomitans and 63.47% against B. forsythus. 
3.5 Discussion 
It is generally accepted that periodontal treatments, including scaling and root planing, 
are highly effective in the treatment of periodontal disease (Badersten et al., 1981, 
171 
Lindhe et al., 1982, Morrison et al., 1980). Numerous reports have attributed the 
success of scaling and plaque control with qualitative and quantitative changes in the 
microflora associated with periodontal disease (Genco et al., 1969, Socransky, 1970, 
Socransky et at., 1982). Further to this, numerous reports have also considered the 
effect of treatment on immunological parameters, many of which are discussed below. 
The first part of this study set out to examine the effects of periodontal treatment on 
the titres of serum antibodies specific for a range of bacteria, and antigen preparations. 
Titres were measured pre-and post-treatment in 25 patients with chronic periodontitis. 
The results presented here suggest that periodontal treatment does not have an effect 
on serum antibody titres against P. gingivalis, A. actinomyceteincomitans, P. 
intermedia, B. forsythus, T. denticola, the OMP of P. gingivalis, A. 
actinomycetemcomitans, P. intermedia and B. forsythus and the purified antigens; 
HSP60 (of P. gingivalis), LPS (of P. gingivalis), leukotoxin (of A. 
actinomycetemcomitans) and the I segment of RgpA protease (of P. gingivalis), 
within the time period measured in this study. 
A study carried out by Murray et al. (1989) examined the humoral immune response 
against P. gingivalis in treated and untreated patients with chronic periodontitis. The 
results of this study suggested that serum IgG levels were significantly higher in 
subjects with chronic periodontal disease that had not received treatment, compared 
with subjects that had received treatment. Murray et al., explained their results as 
supporting the notion that removal of antigen by subgingival root planing, i. e. those 
receiving treatment, results in a decline in serum antibody levels. This suggests that 
treatment has an effect on serum antibody titres against periodontal micro-organisms. 
Murray et al. (1989), therefore, appear to agree with numerous studies that have been 
reported in the literature, suggesting that periodontal treatment leads to a decrease in 
antibody titre. The problem with the study by Murray et al. (1989), is that by having 2 
subject groups, one treated and one untreated it is difficult to know or say that the 
treated group had a lower antibody titre due to treatment, and that they did not have a 
lower antibody titre before they received any treatment. From the knowledge that 
every individual has their own distinctive immune repertoire, it is clear that the 
humoral immune responsiveness of patients will vary in any study. Therefore, it is 
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difficult to conclude anything from the study described above. For this reason in the 
present study, only one group of patients were examined, and the antibody titres for 
the one group of subjects were taken before and after treatment, to be sure that any 
effects seen, were due to treatment alone. 
Another parameter that needs to be taken into account when considering the extensive 
literature on this theme is the length of treatment. The period of time that occurs 
between the first and second samples being taken varies enormously between studies. 
The average length of treatment, i. e. the period of time between the 2 samples being 
taken in the current study was approximately 5 months, with a range of 2-10 months. 
In terms of other studies on this topic this is quite a short period of time. 
Aukhil et al. (1988) carried out a longitudinal study on 24 subjects with periodontal 
disease. The study was carried out to investigate the effect of treatment on serum 
antibody titres against 10 plaque micro-organisms, including P. gingivalis, P. 
intermedia and T. denticola. The antibody titres to the micro-organisms were 
measured at 5 different time points; pre-treatment, post hygienic phase, post-surgical 
phase, maintenance phase -1 year, maintenance phase -2 years. The results of this 
study, in general indicated that periodontal treatment leads to a decrease in antibody 
titre. However, many of the subjects were reported to be resistant to change in 
antibody titres. The time between treatment and occurrence of significant changes in 
antibody titres exceeded one year. 
Mouton et al. (1987) also carried out a longitudinal study to investigate the effects of 
treatment on serum antibody titres against P. gingivalis in patients with chronic 
periodontitis. In this study samples were taken at various time intervals between 13 to 
33 weeks post-treatment, and then at one year post-treatment. The overall conclusion 
was again that there was a decrease in antibody titres following treatment. Although 
as above, the year time point showed a very significant decrease in titre, a significant 
decrease in titre was seen approximately 5 months after treatment. The decrease was 
shown to be progressive. At 5 months after treatment, the results showed the serum 
antibody titres were reduced to 55% of the pre-treatment value and at 1 year post- 
treatment, the levels were reduced to 41% of the pre-treatment levels. It must be 
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noted, however, that even at a reduction to 41 % of the pre-treatment levels, these titres 
were still 6 times higher than those of periodontally healthy subjects tested. 
Tolo et al. (1982) also made a report on the antibody titres pre- and post periodontal 
treatment. This study investigated the effect of treatment on IgG, IgA and IgM levels 
in the serum against 7 periodontopathogens. Except for P. gingivalis, no significant 
changes in titres were recorded against any of the pathogens, when the serum titres 
were measured 1 year post-treatment. Successful treatment was said to be correlated 
with a significant decrease in titre against P. gingivalis. 
Sandholm and Tolo (1986), looked at the effect of treatment on serum antibody levels 
in 12 aggressive periodontitis patients. The length of the treatment, i. e. the time 
between the first and second sample was 16-32 months. As already discussed, it is 
possible, that the length of time following treatment, (that is the time variation in 
taking the second sample) may be crucial with regards to measuring the effects of 
treatment on antibody titres. Therefore, with such a small number of subjects, 16-32 
months is a very large time scale on which to be comparing parameters. 
The results of the study reported by Sandholm and Tolo (1986), indicated that 
minimal alterations were observed in the levels of antibodies to P. gingivalis, 
Capnocytophaga ochracea and Eubacterium saburreum, however, a decrease in 
antibody titre against A. actinomycetemcomitans was recorded after treatment. This 
decrease was only seen in 3 of the 12 patients, admittedly a quarter of the subject 
population, but conclusions cannot really be made on the results from 3 subjects. 
Further to this, this study reports that 75% of the patients had low or not detectable 
levels of IgG antibodies to P. gingivalis and E. saburreum. If most of the patients had 
undetectable IgG levels, it is difficult to properly interpret this study, particularly as 
IgG is the most prominent immunoglobulin isotype in the serum, and IgA and IgM 
levels would always be expected to be extremely low in the serum of an individual 
with a chronic infection. 
Horibe et al. (1995) compared the serum antibody titres against 7 
periodontopathogens before and after treatment. The post-treatment sample was taken 
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6.9 months on average after the first sample. This study reported that titres against P. 
gingivalis and P. intermedia were significantly reduced following treatment, whilst 
the titre to the remaining 5 bacteria, showed no significant treatment-related change. 
It is very difficult to compare longitudinal studies of this kind. Many differences that 
cannot be controlled exist between studies, including patients compliance with the 
protocol, the timing of the study and length of treatment, as previously discussed. 
Further to this, variations in bacteria and antigen preparation could have an effect on 
the results seen. For example, examination of formalin-stable epitope recognition 
may provide very different results from those of "native" preparations. 
In part 1 of the presently reported study antibody titres pre- and post-treatment were 
examined against a large panel of targets. The initial studies examined the antibody 
titres against 5 formalin fixed putative periodontal pathogens; P. gingivalis, A. 
actinomycetemcomitans, P. intermedia, B. forsythus and T. denticola. The polyvalent 
immunoglobulin, IgG and IgA titres were measured for these. None of the titres of 
immunoglobulin isotypes changed after treatment. For P. gingivalis, A. 
actinonycetemcomitans and P. intermedia there was no significant difference in the 
polyvalent immunoglobulin titres and the titres of IgG. For B. forsythus and T. 
denticola the IgG titres were slightly lower than the polyvalent immunoglobulin titres. 
The titres of IgA against all of the micro-organisms were very low, just above the 
background measurement. The low levels of IgA in the serum is not surprising given 
the mucosal nature and "local" arm of the IgA response. The titre of IgA was so low 
that no confident conclusions could be drawn, however, the analyses that were carried 
out indicated no change in titre post-treatment. 
As the levels of IgA were so low, a large proportion of the antibodies measured 
against the antigenic targets were obviously of the IgG isotype. However, as 
mentioned above, the titres of IgG for most of the micro-organisms were not 
significantly different from the polyvalent immunoglobulin titres, or on a number of 
occasions were slightly lower. Therefore, polyvalent immunoglobulin titres were 
measured in this study, to ensure that any changes, which may be significant were 
caught. 
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The overall results suggest that there was no significant change in antibody titre after 
periodontal treatment, and therefore, do not agree with much of the literature 
discussed above. In many of the studies a change in titre was only found to be against 
I or 2 of the micro-organisms tested and the antibodies to the rest of the targets tested 
remained the same post-treatment. Although the overall results are of "no change", a 
few results obtained from this study were interesting and merit discussion. 
Table 3.3 shows the correlation between change in pocket depth and change in 
antibody titre. There was a positive correlation when change in pocket depth was 
correlated with change in antibody titre against B. forsythus whole cells. The 
correlation co-efficient was 0.566 (p=0.003) indicating that the correlation is 
significant. The change in pocket depth following treatment is always negative i. e. a 
decrease in pocket depth, if the treatment is successful. Therefore, these results 
suggest that a relationship may exist between the success of treatment and the change 
in antibody titre against B. forsythus. 
A number of studies have previously suggested that successful periodontal treatment, 
either hygiene phase therapy or surgery, are accompanied by a decrease in the 
frequency of microbiological detection of levels of B. forsythus (Haffajee et al., 1995; 
Haffajee et al., 1997; Socransky and Haffajee, 1993). In terms of previous studies 
regarding the effects of periodontal treatment on the immunological parameters of 
individuals with disease, there are very few reports. Studies of the humoral immune 
response to Gram negative organisms have tended to concentrate on P. gingivalis and 
A. actinomycetemcomitans. For this reason it is very difficult to hypothesise about a 
role for B. forsythus in chronic periodontal disease. However, the results of this study 
suggest that perhaps further studies into the effects of treatment on the humoral 
immune response against B. forsythus, maybe of interest. 
An interesting result was suggested from the analysis of the correlation between 
length of treatment and change in antibody titre to HSP60 (of P. gingivalis). The 
correlation appears to be significant and negative, indicating that the shorter the length 
of treatment the greater the change in antibody titre. As discussed in the results, it 
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seems that a treatment period of less than 125 days, leads to a positive change in 
antibody titre i. e. an increase in antibody titre following treatment, but a treatment 
period of 125 days or more leads to a decrease in titre. These results are interesting in 
terms of the inoculation theory suggested by Ebersole et al. (1985d). The results of 
their study indicated that scaling could lead to a significant increase in circulating 
antibodies to various periodontal pathogens and that the peak levels were seen 2 to 4 
months following treatment. Therefore, the negative correlation seen between length 
of treatment and antibodies to HSP60 is possibly in agreement with the results of 
Ebersole et al. (1985d). This result suggests that perhaps we should be concentrating 
our attention on the time period of before 125 days after treatment, when an increase 
in antibody titre may indicate which pathogens are of importance. 
Further studies regarding the length of treatment would be of interest. A longitudinal 
study observing the antibody titre of individuals every 2-4 weeks following treatment, 
up to 6 months would provide us with more knowledge of the effect of treatment on 
the immunological responses. Patient compliance may be difficult to achieve for such 
a study. 
A large number of predominantly Gram negative bacterial species, possibly 5 to 7 or 
more (Schenk, 1985), have been implicated in the aetiology of periodontal disease. 
The rationale behind the second part of this study comes from the fact that many 
reports have suggested that there are shared antigens amongst the suspected 
pathogens. Hence it is of interest to investigate how much of the immune response in 
this disease is directed against these antigens. Studies that report an antibody titre 
measured against an individual bacterium often do not consider that some of these 
antibodies could in fact have been induced against a different bacterium and are cross- 
reacting. 
A study by Vasel et al. (1996) investigated the cross-reactivity between antibodies 
against P. gingivalis and B. forsythus. The approach of their work was different to the 
study presented here, however, the results obtained suggest that cross-reactivity does 
exist. The study by Vasel et al., investigated this theory using pre- and post-immune 
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serum taken from monkeys following immunisation with P. gingivalis, and 
demonstrated a clear cross-reactivity between P. gingivalis and B. forsythus. 
A study by Kinane et al. (1993) has also shown cross-reactivity. Antibody titres 
against A. actinomycetemcomitans following adsorption against A. 
actinomycetemcomitans and H. aphrophilus were measured and the percentage mean 
reduction in the titre compared with the sham adsorbed sera. Sera adsorbed against A. 
actinomycetemcomitans showed a 68% reduction in titres against A. 
actinomycetemcomitans itself and sera adsorbed against H. aphrophilus showed a 
similar reduction of 63%. Therefore, most of the reactivity to A. 
actinomycetemcomitans could be removed by adsorption with both organisms, 
suggesting cross-reactivity between antibodies to these 2 different species. 
This study suggests that there is cross-reactivity between P. gingivalis, A. 
actinomycetemcomitans, P. intermedia and B. forsythus. The results indicate that in 
general the same percentage of antibodies were adsorbed out against each of the 
different micro-organisms and this tended to be around 60-80% of the antibodies. The 
percentage of antibodies adsorbed out against B. forsythus seemed to be slightly lower 
than for the other 3 micro-organisms, around 40-50%. The range values for all of the 
results showed a large variation, however, making it difficult to note any real 
differences. The large variation seen in the values could have been due to the 
different antibody titres in the different patients, thus this fact makes it more difficult 
to compare the results as a group. 
It was noted that for serum that had been adsorbed against P. gingivalis there was a 
higher percentage reduction in antibody titre against P. intermedia and A. 
actinomycetemcomitans than P. gingivalis itself. This seems impossible, as there 
cannot be a higher percentage of antibodies cross-reactive with P. gingivalis, found in 
the patient, than against P. gingivalis itself. Likewise, the same situation was seen 
when antibodies were adsorbed against B. forsythus. A higher percentage reduction in 
titre was seen against A. actinomycetemcomitans than B. forsythus itself. The reason 
for this is not clear, however, as previously mentioned the range of the values is very 
wide, and hence there is probably no significant difference between values. The 
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results of this study indicate that the immune response against all 4 of the periodontal 
pathogens tested is very similar and there appears to be a significant amount of cross- 
reactivity occurring. There appears to be approximately the same percentage of cross- 
reactivity between all combinations of the micro-organisms, except for possibly B. 
forsythus which appears to have a slightly lower percentage of cross-reacting 
antibodies against it. 
The data was analysed to see if there were any correlations between the percentage 
reduction in antibody titre against the 4 periodontal pathogens and pocket depth of the 
patients at the beginning of the study, smoking status and age of the patients. No 
correlations were found. In addition, no groupings were noted between either antigens 
or in patients. 
The apparent involvement of so many microbial agents in periodontal disease makes 
identification of the important ones so difficult. In addition, the situation is made 
more complex by the variations that exist between the immune repertoires of every 
individual. The significance of risk factors and the effects that they have on an 
individuals immune response is also unclear. 
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Chapter 4. Immortalised B Cells From Periodontal Disease 
Patients. 
4.1 Introduction 
The discovery, development and exploitation of human monoclonal antibodies has 
had a tremendous impact on medical research and now contributes greatly to 
diagnostics and therapeutics. Human monoclonal antibody production has permitted 
scientists to make huge advances in many areas including: the search for specific and 
therapeutic antibodies against human tumours; the production of well tolerated serum 
replacements such as anti-rhesus factor D, tetanus, hepatitis immunoglobulin and 
other antibodies against infectious diseases; our knowledge of the B cell repertoire in 
health and disease giving us significant insights into autoimmunity (Gigliotti et al., 
1984; Van Meel et al., 1985; Stricker et al., 1985; Atlaw et al., 1985; Bron et al., 
1984). 
The first description of monoclonal antibody secreting cell lines were reported by 
Kohler and Milstein (1975). From this first description, rodent monoclonal 
experiments progressed rapidly and have been applied to a wide variety of biological 
problems of importance. However, whilst the initial studies to produce human 
antibody secreting B cell lines was heralded with much enthusiasm, (Croce et al., 
1980; Olsson and Kaplan, 1980; Steinitz et al., 1977) the available methods carry 
many technical problems that remain unsolved. Unfortunately, the generation of 
stable human B cell lines which secrete specific monoclonal antibodies is not yet as 
routine as the generation of murine monoclonal antibodies. 
One aim, as mentioned above, for the production of monoclonal antibodies is to 
increase our knowledge of the B cell repertoire and its targets. The discriminating 
power of polyvalent serum antibody has limitations. An antigen usually has many 
epitopes leading to the production of anti-sera, which is made up of a mixture of 
antibodies all with varying specificity's for all the epitopes. Furthermore, 
immunisation with an antigen leads to the expansion of various populations of 
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antibody-forming lymphocytes. To observe and investigate these cells is difficult. 
These cells can only be maintained in culture for a short period of time, so it is 
impossible to grow normal cells and obtain clones that produce antibodies of a single 
specificity (Benjamini et al., 1996). Kohler and Milstein (1975) saw an answer to this 
problem and it involved the use of a population of malignant plasma cells. Malignant 
cells are `immortal' and can thus remain in culture for years. They took a malignant 
plasma cell population that was deficient in the enzyme hypoxanthine phosphoribosyl 
transferase (HPRT). This cell population would die unless they were introduced to 
HPRT. They then fused these cells with antibody producing cells that were able to 
produce HPRT. The nuclei of the two cell types fused, giving the hybridoma cells the 
characteristics of both. Hence, these hybrids were able to manufacture 
immunoglobulins as well as survive in culture. The hybrids were grown in a specific 
cell culture media, that malignant cells would not survive in without the HPRT 
enzyme. Thus allowing the separation of the hybrids from dead malignant cells. 
When utilising this method for production, screening is then carried out to identify 
hybrids synthesising a specific antibody, which are then cloned. 
Cell hybridisation methods are mainly classified into three different categories: (i) 
hemagglutinating virus of Japan (HVJ); (ii) Polyethylene glycol (PEG) fusion; and 
(iii) electrofusion. 
HVJ can agglutinate cells that have HVJ receptors on their cell membrane and cause 
efficient cell fusion. HVJ is not, however, really used for preparing hybridomas 
because of the possibility that the virus genome may influence hybrid cells. It is also a 
very complex procedure. The method was originally reported by Okada et al, (1957) 
and showed that animal cells could efficiently be fused using HVJ. 
Polyethylene glycol (PEG) is a widely used method because of its simplicity. The 
action of PEG is complex, but in brief, it causes localisation of membrane proteins, 
allowing direct interaction of lipid bilayers of both cells, making cell fusion easier 
(Shirahata et al., 1998). 
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The electrofusion methodology was developed by Zimmerman (1982). Due to 
electronic pulses the cell membrane structures are disturbed allowing fusion. The 
cells have to be brought into close proximity of each other to be successful, therefore, 
to establish close cell-cell adherence, dielectrophoresis of the cells is performed using 
sign waves. This causes the cells to align according to the waves and adhere to each 
other. Cell fusion is then triggered by the application of electronic pulses. 
Electrofusion has an advantage over the popular PEG method in that a much smaller 
number of cells are required, often a limiting factor when working with human cells, 
however, electrofusion apparatus is expensive and complex (Shirahata et al., 1998). 
As mentioned previously, many problems arise in the production of human 
monoclonal antibodies. One of the limitations experienced is the choice of lymphoid 
tissue for fusion. Animal work tends to use murine tissue and thus the experiments 
are not limited by the availability of immune lymphocytes. In murine work, if antigen 
substances are available in excess, are non-toxic and sufficiently immunogenic, 
immunisation strategies can be optimised to ensure sufficient immune cells are 
obtained for fusion (James and Bell, 1987). Obviously, when dealing with human 
subjects, the amount and characteristics of the immunogen that can be injected are 
much more stringently monitored and there is much more difficulty with safety and 
ethical issues. 
Another difficulty encountered in human work is deciding what the correct time 
period is to harvest the cells following immunisation. This is important as it can 
influence their state of differentiation and proliferation (James and Bell, 1987), 
however, this is difficult to study due to practical reasons. Studies have indicated that 
the optimum time for harvesting peripheral blood cells is 6-7 days (Bogard et al., 
1985) and 3 days post-boosting for murine spleen cells (Schwaber et al., 1984). It 
must be noted however, that monoclonal antibodies have been produced using 
lymphocytes harvested 1-3 months post boosting (Boyd et al., 1984; Tiebout et al., 
1984; Tiebout et al., 1985; Thompson et al., 1986). 
As mentioned previously, human hybridoma production is difficult due to the low 
numbers of specific B cells available for fusion, particularly when working with 
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peripheral blood B lymphocytes. In un-immunised patients, the B cells are known to 
be in low frequency and often also in a resting state which is incompatible with 
successful fusion. It is known that most fusion partners fuse efficiently only with 
proliferating B lymphocytes at an undefined stage of differentiation (Johnson and Rao, 
1970; Andersson and Melchers, 1978). Therefore, in an attempt to increase the 
efficiency of fusion a number of methods have been developed. In vitro immunisation 
has been attempted (Borrebaeck, 1989; Borrebaeck et al., 1988), but the rarity of 
antigen-specific B cells is still a problem, and is not feasible in the case of molecules 
which are poor immunogens. 
4.1.2 Epstein-Barr transformation 
Human lymphocytes can be immortalised by fusion with a myeloma cell line as 
already discussed. They can also be immortalised by a second completely different 
method called viral transformation. The virus used in this technique is Epstein-Barr 
virus (EBV) and it is usually obtained from the supernatant of the marmoset cell line 
B95-8 in culture (Millar and Lipman, 1973). EBV is a herpes virus and the receptor 
for EBV on human lymphocytes is the CR2 complement receptor (C3d) (Frade et al., 
1985). Binding of EBV to the CR2 receptor on human B lymphocytes can lead to 
insertion on the EBV genome thus causing transformation of the human cells. EBV is 
a potent polyclonal activator for human B cells, it is thought that EBV mediated 
activation also induces proliferation and clonal expansion of autonomous cell lines 
and differentiation into immunoglobulin secreting cells (Rosen et al., 1977; Campling 
et al., 1987; Gordon and Graeme, 1988). EBV transformed cells, therefore, can 
provide a continual source of immortalised cells for studying B cell-related 
phenomena. 
EBV can bind to and penetrate all B cells, however, not all B cells are transformed. 
Also it has been shown that activation of B cells can be achieved using killed EBV or 
by addition of antibody directed against the CR2 receptor, thus activation and 
transformation are obviously two different events (James and Bell, 1987). There has 
been some confusion regarding the population of cells that are susceptible to 
transformation. Arran et al. (1984) suggested that the population of cells that are 
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susceptible to transformation are a small high density resting population that give rise 
to IgG and IgA secreting populations. Opposing this view Chan et al. (1986) have 
suggested that the population of cells susceptible to transformation is an activated 
large cell population that are destined to secrete IgM. Which one of these theories is 
correct is unknown, perhaps both are. Many studies suggest a bias towards IgM 
secreting cells, agreeing with the theory of Chan et al. (1986), however IgG and IgA is 
still found to be secreted by some cell lines. It is thought that only 0.1-5% of 
peripheral blood lymphocytes infected with EBV are activated to secrete 
immunoglobulin, and this tends to be predominantly of the IgM isotype. Furthermore, 
often cells transformed with EBV grow poorly and are low rate immunoglobulin 
secretors (Niedbala and Stott, 1998). 
Experimental work carried out by Kozbor et al. (1982), combined the techniques of 
cell transformation with fusion to obtain hybridomas secreting antibodies against 
tetanus toxoid. It is often suggested that fusion of peripheral blood lymphocytes is 
unsuccessful because they are not in an actively dividing state. When the cells are not 
actively dividing the nuclei of the peripheral blood lymphocytes do not fuse with the 
nuclei of the myeloma cells (Burnett et al., 1985). However, following EBV 
treatment, even if transformation does not occur, the cells become activated increasing 
their chance of successful fusion. The antibodies secreted following fusion are 
thought to be representative of the antibodies being produced by the transformed cell 
lines at the time of fusion. 
4.1.3 The CD40 system 
The CD40 system allows expansion of the B cell population obtained, and further 
isolation of individual proliferating, differentiating B cell clones (Banchereau et al., 
1991; Banchereau and Rousset, 1991). Stimulation of resting B cells in this system is 
an alternative to the EBV method to expand the B cell population before fusion. 
CD40 is an integral membrane protein found on the surface of B lymphocytes, 
dendritic cells, follicular dendritic cells, hematopoetic progenitor cells, epithelial cells 
and carcinomas (Banchereau et al., 1994). The ligand of CD40 (CD40L) is expressed 
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on activated T cells, mostly CD4+ but also some CD8+ as well as basophils and mast 
cells. Cross-linking of CD40 with anti-CD40 or CD40L induces strong proliferation 
of B cells and addition of IL-4 or IL-13 allows the generation of factor-dependent 
long-term normal human B cell lines and the secretion of antibody following isotype 
switching (Banchereau et al., 1994). 
Banchereau and colleagues (1991) reported that IL-4 and monoclonal antibodies to 
human CD40, when presented in a cross-linked fashion by Ltk- cells (transfected 
mouse fibroblasts expressing FcyRIUCDw32) (Peltz et al., 1988), permit 
establishment of factor-dependent long-term human B cell lines. Therefore, these 
factors can exert a direct proliferative effect on B cells when presented appropriately. 
The initial studies on this technique reported that within 5 weeks, the initial B cell 
population had expanded 150-400 times, and that 20-30% of the resting B cells 
stimulated by this procedure can generate B cell clones of 50 to a few hundred cells 
after 15 days of culture. 
The advantages of using the CD40 system before fusion is that the system can 
enhance the number of actively dividing and differentiating B lymphocytes and induce 
class switching giving higher fusion efficiency. CD40 is thought to be advantageous 
over EBV transformation in that EBV cultures frequently grow poorly, producing 
unstable cell lines that secrete low levels of IgM antibodies. The CD40 system is 
thought to give higher fusion efficiency and induce class switching to IgG (Niebala 
and Stott, 1998). This system does however, suffer from the disadvantage that the 
rescued cells are the product of polyclonal activation and are therefore, 
unrepresentative of the activated B cell population in vivo, however, this is also the 
case for EBV transformed B cells. 
As previously discussed in the general introduction of this thesis, there is little doubt 
that gingivitis and periodontitis are caused by plaque micro-organisms. The 
predominance of the B cells and plasma cells in periodontal lesions, and the often 
increased antibody titres seen in the serum directed against putative periodontal 
pathogens, underlines the importance of the humoral immune response in the 
pathogenesis of these diseases. However, little is known about the specificity of the 
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antibodies raised against the antigens, derived from the bacteria responsible for 
disease. The aim of the present study was to investigate in detail the target of the 
antibody response in patients with periodontal disease. In order to do this, the task 
was to produce human monoclonal antibodies from immortalised B cells isolated from 
the granulation tissue of diseased sites and the peripheral blood of patients with 
current periodontal disease. These antibodies were then screened using the ELISA 
technique against a series of oral pathogens. A number of techniques were employed 
to achieve this. Firstly, human peripheral blood B cells were expanded in the CD40 
system and then fused with a heteromyeloma cell line by the method of PEG fusion. 
Secondly, B cells isolated from granulation tissue, taken from diseased sites in 
periodontitis patients were fused directly using PEG. 
4.2 Methods 
4.2.1 Subjects 
The subjects used in this study were patients attending Glasgow University Dental 
Hospital. The criteria for inclusion in the study was that they were suffering from 
advanced chronic periodontitis. Twenty one millilitres of venous blood were 
collected from the anterior cubital region using butterfly needles and 3x 7m1 blue- 
capped citrate treated Vacutainer tubes. 
The inclusion criteria for the subjects from which granulation tissue samples were 
taken, was that they were receiving surgery as part of their periodontal therapy. 
Granulation tissue was removed during surgery, which was carried out by an 
experienced periodontist, and immediately placed into sterile RPMI medium. The 
sample was stored at 4°C until use. 
4.2.2 Cell culture 
Culture of L-cells. 
L cells were cultured in a 75cm2 flask at 37°C, 5% CO2 in complete medium. The 
medium was changed every 4 days. 
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Culture of CRL 1668 cells. 
Cultures were maintained by the addition or replacement of fresh CRL 1668 culture 
medium every 2 to 3 days. The cells were cultured in a 75cm2 flask at 370C, 5% CO2. 
4.2.3 The CD40 system 
Irradiation of the L cells was carried out to arrest cell division. The cells were 
incubated at 37°C for 3-4 hours with 1Oµg/ml Mitomycin-C. The flask was then 
treated with 10ml of versene to remove adherent cells, and centrifugation was then 
carried out at 200 xg for 10 minutes. The cells were then washed 3 times in RPMI 
1640. 
The cells were then enumerated in white cell counting fluid using a Neubauer 
haemocytometer and resuspended at 5xl04cells/ml of complete medium. 3.5ml of 
cells suspension per well (1.75xl05cells/well) was then placed into a6 well plate, and 
the plate was incubated overnight at 37°C, 5% CO2 to allow cell adherence to the 
bottom of the wells. 
4.2.4 Lymphocyte preparation 
The blood was collected from subjects using 3x 7m1 citrate treated vacutainers 
following treatment. 10-15m1 of blood was then layered on top of 10ml of 
Histopaque-1077, in a sterile falcon tube, and centrifuged at 400 xg for 30 minutes. 
Following centrifugation half of the plasma layer was removed, aliquoted and stored 
at -80°C for future testing and the other half was discarded. 
The mononuclear cell layer was then transferred using a Pasteur pipette into a clean 
sterile flacon tube and PBS was added to increase the volume to 50ml. Further 
centrifugation was then carried out at 200 xg for 20 minutes. The supernatant was 
then discarded and the pellet was again resuspended in 50ml of PBS, and again 
centrifugation was carried out at 200 xg for 10 minutes. Following this the 
supernatant was again discarded before the pellet was washed twice under the same 
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centrifugation conditions in RPMI 1640. The pellet was then resuspended in 1 ml of 
RPMI and a cell count carried out in nigrosin in 7% acetic acid. 
4.2.5 Preparation of 2-aminoethylisothiouronium bromide (AET) -treated sheep red 
blood cells (SRBC) 
Sheep red blood cells (SRBC) were washed 5 times in sterile saline. This constituted 
centrifugation at 200 x g, for 10 minutes and resuspension of the pellet in 20m1 of 
sterile saline 5 times. 0.143M AET solution was prepared and filtered, and then I 
volume of washed packed SRBC was mixed in a sterile falcon tube with 4 volumes of 
AET solution. This mixture was then incubated at 37°C for 15 minutes; however, 
mixing at every 5 minute interval was carried out. 
The cells were then centrifuged at 200 xg for 10 minutes and washed 5 times in ice 
cold saline, and once in RPMI 1640. The cells were then made up to a 10% solution 
in RPMI containing 10% FCS. This suspension can be stored for up to 5 days. 
4.2.6 T cell depletion 
Following cell counting the lymphocytes were prepared at 2x106cells/ml of RPMI 
medium. The AET treated SRBC were prepared at a concentration of 0.5%. Equal 
volumes were then mixed together and incubated for 15 minutes at 37°C, with mixing 
at every 5 minute interval. The suspension was then centrifuged at 200 xg for 10 
minutes and then incubated on ice for 30 minutes. The pellet was then resuspended 
by gentle shaking in the same supernatant. The suspension was then layered on to 
15ml of Histopaque-1077 and centrifuged at 300 xg for 30 minutes. The interface of 
B cells was then removed and washed twice in RPMI. 
The cells were counted in nigrosin in 7% acetic acid. 
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4.2.7 Expansion of the B cell numbers by the Banchereau method 
B cells were added to the adhered L cells at a ratio of 10: 1, therefore, 1.75x10' B cells 
were added into each of the wells of the 6 well plate. As the volume of medium in 
each of the wells was required to be kept to a minimum and due to further additions 
lml of medium was removed from each well before the addition of the B cells. Since 
the majority of the L cells should have become adherent to the surface of the well, 
they were in little danger of being discarded. 
Anti-human CD40 monoclonal antibody was then added at a concentration of 20ng/ml 
and human IL-4 at a concentration of 100u/ml. The 6 well plates were then incubated 
at 37°C, 5% C02 for 5 days, before the cells were fed using complete medium. 
After 11 days the cells were removed, centrifuged at 200 xg for 10 minutes and 
counted using nigrosin in 7% acetic acid. 
4.2.8 Enzymatic dissociation of granulation tissue 
Surgically removed granulation tissue was placed in a sterile 25m1 universal. The 
tissue was then cut into 1-2mm3 segments using sterile scissors. The tissue was then 
washed twice with RPMI 1640 medium, by centrifugation at 200 xg for 10 minutes. 
Cells were then dissociated from the tissue by use of Dispase. 
Eight millilitres of Jockliks MEM containing dispase at 3mg/ml (pH 7.4) was added 
to the universal containing the tissue. The universal was then incubated at 37°C for 90 
minutes with continuous stirring. The medium containing the cells was separated 
from the tissue by filtration using 41µm nylon net filters and mixed with excess RMPI 
1640 medium. 
The cells were harvested by centrifugation at 200 xg for 10 minutes before being 
resuspended in Iscoves medium and stored on ice. The cells were then placed on a 
mini gradient containing Iml of Histopaque-1077. Centrifugation was then carried 
out at 400 xg for 20 minutes, and the interface of cells was collected, washed and 
189 
resuspended in Iscoves medium. The cells were then enumerated in white cell 
counting fluid using a Neubauer haemocytometer. T cell depletion was then carried 
out using SRBC as previously described for the peripheral blood lymphocytes. 
4.2.9 PEG fusion 
Twenty four hours prior to fusion the macrophage feeder layer required for cell 
survival was prepared. Macrophages were obtained by peritoneal lavage of a 
BALB/C mouse. The cells were counted using white cell counting fluid in RPMI 
1640 medium (without phenol red) containing 10% FCS, penicillin, streptomycin and 
L-Glutamine at 4x105cells/ml. The cells were then dispensed into 96 well flat 
bottomed plates at 50µl/well, ignoring the outside wells of the plate. These plates 
were then incubated overnight at 37°C, 5% COz. 
The following day the fusion was carried out. The fusion partner cells, CRL- 1668 
cells were transferred to a 50m1 centrifuge tube. The lymphocytes were also 
transferred into a 50m1 centrifuge tube, and both tubes were centrifuged at 200 xg for 
5 minutes. The supernatants were discarded. The cells were then resuspended in Iml 
of serum free RPMI 1640 medium. Nine hundred microlitres of nigrosin was 
transferred into 2 separate microcaps and one was labelled partner and one 
lymphocyte. One hundred microlitres of each of the cell suspensions were then 
transferred into these containers, and each sample was counted using a Neubauer 
haemocytometer. The volume of each cell suspension was then adjusted with serum 
free RPMI 1640 medium to give a density of 106 cells/ml. 
Equal volumes of each cell suspension was then transferred to a sterile 50m1 
centrifuge tube, and this was topped up with serum free RPMI 1640. Centrifugation 
was then carried out at 200 xg for 5 minutes and the supernatant discarded. The tube 
was then placed into a small water bath at 37°C. Using a1 ml pipette, I ml of PEG was 
added to the cell pellet over a 1-minute time interval, whilst mixing the PEG into the 
cells with the pipette tip. The cell suspension was mixed for a further minute in the 
water. Again using a1 m] pipette, 1 m] of serum free RPMI 1640 was added to the cell 
suspension, again over a minute. 
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Twenty millilitres of serum free RPMI 1640 was then added to the cell suspension 
over 5 minutes, starting slowly, dropwise at first then faster as the PEG was diluted 
out. The cells were then centrifuged at 200 xg for 5 minutes and the supernatant 
discarded. The cells were then resuspended in 30-50ml of HAT medium, and then 
cells dispensed into the 96 well flat-bottomed plates that contained the mouse 
peritoneal macrophages, that had been prepared the previous day. The wells were 
topped up with HAT medium. 
The plates were then incubated at 37°C and 5% CO2 for 6 days undisturbed. On day-6 
the plates were examined under a microscope to note any wells that had hybrid 
growth. The next day, half of the supernatant from the wells was aspirated and the 
wells were topped up with HT medium. 
The HT medium was then changed every 2-3 days for 7 days, and following this the 
cells were cultured in culture medium. When sufficient growth was apparent, the 
supernatant was screened using the ELISA technique to investigate the production of 
antibodies by the hybrids specific for P. gingivalis, A. actinonryceterncomitans, B. 
forsythus, P. intermedia and T. denticola, whole fixed bacteria. 
Growth was correlated with antibody activity, and the cells were removed from any 
wells in which the surface was covered. Initially these cells were split among 2-4 
wells in a fresh plate, then the growth was monitored and the cells were expanded into 
8 wells of a 96 well plate, then 4 wells of a 24 well plate, then a 25cm2 flask and then 
a 75cm2 flask. 
The cell supernatants were constantly checked to make sure that antibody secretion 
was maintained. 
4.2.10 Growth and preparation of bacteria 
P. gingivalis NCTC 11834, P. intermedia ATCC 25611, B. forsythus ATCC 43037 
and A. actinomycetemcomitans ATCC 29523 (serotype A) were grown and fixed as 
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described in 3.2.2. T. denticola ATCC 35405 were cultured in medium OMIZ-pat + 
I% human serum, and were a gift from Dr. C. Wyss, Institut fur Orale Mikrobiologie, 
Zurich, Switzerland (Wyss et al., 1997). 
4.2.11 Analysis of hybridoma supernatants by the Enzyme Linked Immunsorbent 
Assay (ELISA) 
Analysis of the antibody production by the hybridomas was analysed by ELISA as 
described in 3.2.3. Instead of the addition of sera, the hybridoma supernatant was 
added to the wells at this step. 
4.3 Results 
4.3.1 L-cell culture 
The growth of the L cells did not lead to any difficulties at all. The cells grew 
extremely quickly and were subcultured every 3-4 days. The cells were cultured in 
complete RPMI medium in 5% CO2 at 37°C. 
4.3.2 CRL-1668 cell culture 
The heteromyeloma cell line CRL-1668 ATCC was much more difficult to culture. 
The cells were extremely sensitive to any fluctuations in temperature or CO2 level. 
These cells were also very sensitive to cell density and had to be maintained very 
strictly between 4x105 and 106 cells per ml of culture medium. This cell line was 
cultured in Iscoves medium containing FCS (20%), L-glutamine (4mM) and G418 
(200µg/ml) to stabilise its human chromosome complement. 
4.3.3 The CD40 system 
In these studies we activated peripheral blood lymphocytes taken from patients with 
chronic periodontitis in the CD40 system. Stimulation of peripheral blood 
lymphocytes by the CD40 system dramatically increased the number of actively 
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dividing and differentiating B lymphocytes. The cells grew in tight clusters and the 
clusters were observed every 2 days. The numbers of cells increased constantly until 
days 10-11, when the cells were counted and then fused with the heteromyeloma cell 
line. 
Figure 4.1 shows a culture of the L cells and figure 4.2 shows a culture of the CRL- 
1668 cells. Figure 4.3 and 4.4 show cultures of B cells in the CD40 system. 
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Figure 4.1 
a$ Si . 
Figure 4.1 shows L cells in culture. (Magnification x400) 
Figure 4.2 
Figure 4.2 shows CRL-1668 heteromyeloma cells in culture. (Magnification x400) 
Figure 4.3 
Figure 4.3 shows cells being cultured in the CD40 system. This photograph was 
taken on day 3 of culture. A cluster of B cells can be seen proliferating in the centre 
of the field. (Magnification x400) 
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Figure 4.4 shows cells being cultured in the CD40 system. This photograph was 
taken on day 11. Numerous large clusters of B cells can be seen. 
(Magnification x400) 
4.3.4 Cell fusion 
After cell fusion, hybridoma formation was successful. The hybrids were visible by 
the eye as growing colonies by about day 10 following fusion. In wells that contained 
growing colonies, cloning was carried out by the limited dilution method. When the 
cloned cells had grown to visible colony size again the supernatant was removed from 
each well and screened for the presence of specific antibodies against periodontal 
pathogens. Antibodies specific to P. gingivalis, A. actinomycetemcomitans, P. 
intermedia, B. forsythus and T. denticola were screened for. 
The screening stage was reached for peripheral blood lymphocytes of 5 patients 
expanded in the CD40 system and then fused using PEG, and for directly fused B 
lymphocytes isolated from granulation tissue for 6 patients. In all of the II 
experiments antibodies specific for the 5 pathogens were identified, and the clusters of 
cells were cloned. However, antibody production failed to continue and was not 
detected after 3-5 weeks of culture in all of the cases. Therefore, in all of the 
experiments, although fusion was achieved, and cloning was successful, the 
hybridomas stopped producing antibodies or had died after a period of a few weeks. 
4.4 Discussion 
The results obtained in this study are disappointing and unfortunately continuation of 
this project was not justified due to the lack of success following on from the 
laborious work that was carried out in this study. Although, no monoclonal antibodies 
were obtained, I feel that the rationale behind the project and the aims of the study 
were important to discuss and thus should be included in this thesis. 
Two main techniques were employed and two different sources of lymphocytes were 
used. The CD40 system was used to expand the number of lymphocytes that were 
obtained from the peripheral blood of periodontitis patients. By following the 
methodology described by Niedbala and Stott (1998) the CD40 system was optimised 
for antibody production, culture conditions and the concentration of IL-4 and anti- 
CD40 antibody used. Cells that had been cultured with IL-4 and anti-CD40 presented 
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on Ltk- cells, were viable and grew in tight clusters. The cultures were kept for 10-11 
days and provided regular enrichment of the culture medium. This resulted in a 3-5- 
fold increase of input B cells within the culture period of 10-11 days. Following 
expansion of the B lymphocyte numbers, cell fusion was carried out with the 
heteromyeloma cell line. 
The second method used in this study involved direct fusion between B lymphocytes 
isolated from granulation tissue samples taken from patients with chronic 
periodontitis and the heteromyeloma cell line CRL 1668. 
The first method involving amplification of peripheral blood lymphocytes in the 
CD40 system, followed by fusion, was carried out on 5 patients as previously 
mentioned. However, it was then decided to move the study towards direct fusion of 
B lymphocytes from diseased tissue. Although a small number of human 
heteromyelomas have been shown to be relatively stable, not all B cells fuse equally 
well. Schwaber et al. (1984) suggested that the differentiation state of the B cell 
seems to affect its ability to fuse. Glassy (1993) reported that small unstimulated 
memory cells are resistant to fusion, while larger activated B cells fuse more readily. 
Granulation tissue from individuals with periodontal disease is thought to contain 
large numbers of B lymphocytes and plasma cells which are thought to comprise a 
significant portion of the local cellular infiltrate (Seymour et al., 1979). These B 
lymphocytes are thought to be large activated cells. In addition, since the frequency of 
antigen-specific B cells in human peripheral blood is very low, the number of 
activated B lymphocytes specific to periodontal pathogens present in the tissues would 
be expected to be higher. 
Peripheral blood B lymphocytes are much more easily obtained from diseased patients 
and one blood sample can provide a large number. In addition, the number of B 
lymphocytes taken from the blood, can be amplified with use of the CD40 system, as 
in this system human resting B cells enter a state of sustained proliferation resulting in 
clonal expansion. Therefore, peripheral blood lymphocytes are the best source for 
practical and ethical reasons. However, peripheral blood lymphocytes do not make 
the best fusion partners. In the mouse it has been suggested that lymphocytes isolated 
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from tissues make better fusion partners than those from peripheral blood. Further to 
this it has been proposed that peripheral blood does not contain enough antigen 
reactive B cells in the appropriate state of differentiation and proliferation, and 
contains too many suppressor and cytotoxic cells and not enough antigen presenting 
and T helper cells (James and Bell, 1987). 
A study carried out by celenligil and Ebersole (1997) to examine responses to A. 
actinomycetemcomitans in patients with chronic periodontitis compared to health, 
involved the examination of B cells that had been immortalised using EBV. The 
rationale for the study was to investigate whether immortalised B cells could 
potentially be used to study the host humoral immune response in this disease. The 
results of this study suggested B cells from both diseased patients and controls, were 
capable of being immortalised and that EBV transformation led to the proliferation 
and differentiation of B cells to give IgM, IgG and IgA secreting cell lines. An 
elevated frequency of IgM producing cells was reported and in addition, a higher 
proportion of immunoglobulin producing cells were found in the periodontitis patients 
compared with the normal controls. Thus celenligil and Ebersole suggested that 
either periodontitis patients demonstrate a higher proportion of immunoglobulin 
producing cells, or that the circulating B cell pool in periodontitis patients is enriched 
for the subset that are EBV transformable. The study went on to investigate the 
effects of polyclonal B cell activators, including LPS of A. actinomycetemcomitans on 
antibody production by EBV transformed cells. 
This study is one of the first in the periodontal disease research area involving human 
cell transformation. EBV transformation is a useful tool for providing a resource of 
cells for studying human B lymphocytes in health and disease. The elevated 
frequency of IgM producing cells noted in this study is not surprising as many studies 
in this field have reported a bias in IgM secreting cells. EBV transformation can be 
used either alone, as in the study by celenligil and Ebersole (1997), or combined with 
cell fusion. 
Plasma cells within the gingival tissues have been shown to produce antibody that is 
specific for micro-organisms in the subgingival plaque (Ebersole, 1990; Ebersole and 
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Taubman, 1994). Local humoral immune responses are implicated in the 
pathogenesis of periodontitis (Pulver et al., 1978; Stem et al., 1981; Torabinejad et 
al., 1981; Matthews and Mason, 1983; Smith et al., 1987) and B cells which are 
predominant in the lesions locally produce IgG, lower amounts of IgA and small 
quantities of IgM, as detected by immunofluorescence techniques (Pulver et al., 1978; 
Stern et al., 1981; Torabinejad et al., 1981). 
Studies have shown that infiltrating lymphocytes are more likely to arise through 
selective homing to the diseased tissues than by local cell division (Takahashi et al., 
1996). In addition, this study suggested that the plasma cells in the tissue samples 
observed were among the most active secretary cells in the gingiva. Therefore, it is 
thought that antibody-bearing cells specific for periodontal pathogens home to the site 
of infection, stay there if they meet relevant antigen or other stimuli, and once resident 
remain active, secreting antibodies in a response against the offending pathogenic 
bacteria. 
Therefore, in theory to study the target of antibody-bearing cells that are present in the 
diseased tissue of individuals with periodontal disease, would appear to be a direct 
way of examining what has induced the immune response to begin with. The aim of 
the project was to fuse antibody-bearing cells from diseased periodontal tissue with a 
heteromyeloma fusion partner. A murine fusion partner was not chosen as the aim of 
the project was to produce human monoclonal antibodies that could be characterised 
fully. A few very satisfactory murine partner cell lines have been developed however, 
this is not the case for human partner lines. The fusion rates achieved when using 
mouse myelomas as partners are significantly higher than those achieved with human 
partners in comparative experiments (Cote et al., 1983; 1984; 1986). In this study a 
heteromyeloma cell line was used as a partner for the fusions. This was chosen as it 
was more humanised than a mouse partner cell line, however, when using 
heteromyeloma cell lines there is always the chance that the heterohybrids may reject 
human chromosomes. Thompson et al. (1986) did report, however, that the loss of 
antibody secreting lines due to genetic instability is no worse in heterohybrids than in 
murine hybrids, hence it was decided that a heteromyeloma was a good choice of 
fusion partner. 
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Fusion is complex and extremely technique sensitive and reports have suggested that 
the success of the technique can depend on minor technical details such as a particular 
batch of PEG, the pH of the PEG when it is in contact with the cells and the length of 
time that the cells stay in contact with the fusion partner (Lane et al., 1984; Davidson 
and Gerald, 1976). In addition, it is generally accepted that many technical problems 
still remain to be solved in terms of successfully fused cell lines that grow well for I 
to 2 months before their antibody titre suddenly declines (James and Bell, 1987). In 
the present study, it appeared that fusion was successful, however, the cell line did 
cease antibody production before cloning could be carried out. 
In spite of the numerous difficulties encountered in monoclonal antibody production, 
this technology has huge potential. Various human monoclonal antibodies have been 
produced to date, many of which have been developed with prophylaxis and therapy 
in mind and are, therefore, directed against a wide range of bacterial, viral, erythrocyte 
and tumour antigens. The technique has great potential which will only expand and 
may eventually provide us with valuable tools for future diagnostics, therapy and 
research. 
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Chapter 5. Analysis of the Target of Antibody Secreting 
Cells From Diseased Tissue of Chronic Periodontitis Patients 
By ELISPOT 
5.1 Introduction 
Development of the ELISPOT assay was originally based upon the haemolytic plaque 
assay developed by Jerne and Nordin (1963). The development of the haemolytic 
plaque assay began a new era of detection that permitted antibody analyses to be 
undertaken at the cellular level. It allowed cellular immunoglobulin secretion to be 
assessed as well as analysis of the regulatory mechanisms that control the expansion 
of antibody-producing cell populations. The assay was originally developed to detect 
cells secreting complement-binding antibodies against erythrocytes. The use of 
haemolysis as a signal in this method necessitates the application of complement and 
red blood cells. Both of these components limit the selection of antigens and 
antibodies that can be used or assayed. Experimental failures and inconsistent results 
are generally related to the difficulties experienced when trying to efficiently couple 
antigens to red blood cells (Golub et al., 1968; Pasanen and Mäkelä, 1969; Jerne et 
al., 1974). 
The ELISPOT technique was developed simultaneously by two different groups; 
Czerkinsky et al. (1983) first coined the term ELISPOT and immunohistochemically 
showed a spot-forming cell, and Sedgwick and Holt (1983) also reported development 
of the assay, but called it the ELISA-plaque. Since the development of the assay, 
other names have described the method, such as spot-ELISA and ELISA-spot, 
however, the generally accepted name is the ELISPOT. The development of the 
technique combined the principles of the ELISA and the plaque forming assay. 
However, unlike the ELISA technique, where the final quantification is done by a 
spectrophotometer at a defined wavelength, ELISPOT is usually counted manually 
using a stereo-microscope. The technique can be very time-consuming and laborious 
if there are large numbers of spots, and there is a certain amount of subjectiveness 
when counting. For these reasons computer-assisted methods have been developed to 
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aid counting (Cui and Chang., 1997; Herr et al., 1997; Vaquerano et al., 1998). The 
benefits that ELISPOT has over its precursor, is that adsorption of antigens to 
hydrophobic plastic surfaces is much simpler and easier to accomplish than trying to 
couple antigens to erythrocytes, which is the main limitation of the haemolytic plaque 
assay. Further to this, adsorption of antigens to plastic surfaces results in this step 
being stable for a much longer period of time. 
Since the introduction of the ELISPOT assay it has been utilised to investigate a 
number of different cell products. It has become well established for studying 
cytokine-secreting cells (Herr et al., 1997; Hagiwara et al., 1996; Karttunen et al., 
1995; Merville, 1993) as well as antibody secreting cells in response to infections and 
vaccination. A lot of the work reported on ELISPOT has looked at antibody-secreting 
cells in infections that have entered the body via the mucosa such as Salmonella and 
Campylobacter (Kantele et al., 1988), typhoid fever (Murphy, 1993) and infection 
with Shigella (Murphy, 1993; Orr et al., 1992). The ELISPOT technique has also 
been utilised in studies examining urinary tract infections (Kantele et al., 1994), otitis 
media (Nieminen et al., 1996), gastritis (Sugiyama et al., 1995) and some viral 
infections such as rotavirus gastro-enteritis (Kaila et al., 1992), influenza (Mäkelä et 
al., 1995) and HIV (Lee et al., 1989; Nesheim et al., 1992). 
The ELISPOT technique has also been used to assess the efficiency of vaccines. This 
technique allows the response induced by the vaccine to be studied at the cellular 
level. Thus the results are not effected by any pre-existing antibodies that may be 
present in the serum of the vaccinated subjects. It has been suggested that vaccines 
given by a mucosal route may not increase serum antibody titres, whereas effects can 
be observed on a cellular level, by identifying antibody-bearing cells (Kantele and 
Mäkelä, 1991), therefore, the ELISPOT is a useful tool. The ELISPOT technique has 
been used in studies observing antibody secreting cells following many vaccine 
strategies including those against tetanus toxoid (Stevens et al., 1979), influenza 
(Yarchoan et al., 1981) and hepatitis B (Cupps et al., 1984). 
A complex inflammatory and immune response is involved in the progression of 
periodontitis. Tissue activity within the diseased periodontium comprises epithelial 
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and connective tissue turnover, and cellular activity that occurs continuously 
throughout the disease process which is associated with infiltrating inflammatory cells 
(Page and Ammons, 1974; Page and Schroeder, 1976). Previous work has suggested 
that B and T cells accumulate in large numbers in the periodontal tissues, and 
Takahashi et al. (1997) demonstrated that there are numerous plasma cells in 
periodontitis gingiva. They reported that IgG producing plasma cells predominate in 
periodontitis gingiva, with IgA and IgM producing cells being present, but in low 
numbers. It has been suggested that the humoral immune response is protective in the 
pathogenesis of periodontal disease, and if this is the case, the target or targets of the 
antibody secreting cells found in periodontal lesions are clearly of interest and may 
indicate the specific microbes involved in this disease. 
Ogawa et al. (1989b) analysed the isotype and subclass of antibodies produced by 
single cells directed against fimbriae and LPS of P. gingivalis isolated from gingival 
tissues of patients with periodontal disease. The study was carried out using the 
ELISPOT technique. The periodontitis patients were divided into 3 groups: slight; 
moderate; and advanced chronic periodontitis. The total number of plasma cells 
increased in relation to the severity of disease, and the major antibody isotype detected 
in all subjects was IgG followed by IgA. The results of the study indicated that levels 
of antibody secreting cells, or spot forming cells, were higher to fimbriae than to LPS, 
which were found to be present in lower numbers. These results came as a surprise 
since it is generally assumed that LPS in gingival plaque induces polyclonal antigen- 
specific responses. The reasons for this is not clear. It is faesible that LPS of P. 
gingivalis is not very immunogenic, as it has been shown to differ chemically from 
LPS from other Gram negative bacteria (Mansheim et al., 1978, Koga et al., 1984). 
The overall results of this study, indicated that high levels of immunoglobulin, most 
notably of the IgG isotype and less, but significant, IgA subclasses are produced 
locally in diseased sites. The study also indicated that cells can be isolated from 
diseased gingival tissues, and used to investigate the target of the antibodies produced 
by these cells. This technique clearly permits us to study more closely the local 
immune response induced in this disease. 
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A further study was carried out by the same group (Ogawa et al., 1991), to investigate 
anti-fimbriae responses in individuals with chronic periodontitis. The study compared 
mononuclear cells isolated from diseased and healthy sites of individuals with chronic 
periodontitis. Results were correlated with levels, isotypes and subclasses of anti- 
fimbriae antibodies found in the sera and those produced by peripheral blood 
mononuclear cells of the same subjects. Thus the study was a direct comparison of 
the local immune response versus the systemic. The results of this study suggested 
that serum antibodies to periodontal bacteria are derived from local stimulation of B 
cells in inflamed gingiva. Hence, indicating a need to examine the local immune 
response in this disease, as it may provide more details about the pathogens and 
antigens that are inducing the immune response, that begins locally and leads to 
systemic immunity. 
Our understanding of the function of the immune response locally within the tissues is 
incomplete, for example we are unsure as to whether the plasma cells, found in large 
numbers in lesions, in diseased periodontal tissues are producing relevant or totally 
non-specific antibodies to periodontal bacteria. Work carried out on gingiva of 
periodontitis patients indicates that the infiltrating lymphocytes are more likely to 
arise through selective homing, than by local cell division (Takahashi et al., 1996), 
hence indicating the plasma cells present in the lesion are there for a specific reason, 
probably producing specific antibody. 
Many studies have indicated that antibodies directed against putative 
periodontopathogens are present in the serum and GCF of individuals with 
periodontitis. Some studies suggest that titres are elevated in these patients compared 
with healthy individuals. It is generally accepted that systemically antibodies are 
being produced against periodontal bacteria and play a role in the host protective 
system. Controversy lies, however, in how much the local immune response reflects 
the systemic specificity. 
The present study is an investigation, utilising the ELISPOT technique, into the target 
of antibody secreting plasma cells isolated from granulation tissue taken from 
diseased patients. Moscow and Poison (1991) suggested that experiments carried out 
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on superficial gingival biopsies may not be a true reflection of the disease progression 
in the deeper granulation tissues. Therefore, the present study is an investigation of 
the targets of some of the plasma cells isolated from granulation tissue taken from 
patients with advanced chronic periodontitis. The specific aim of this study was to 
identify whether antibody-bearing cells removed from these lesions were secreting 
antibody specific for the putative periodontopathogens P. gingivalis, A. 
actinomycetemcomitans, P. intermedia and B. forsythus. 
5.2 Methods 
5.2.1 Patients and tissue samples 
The subjects included in this study were 5 patients attending Glasgow University 
Dental Hospital. The criteria for inclusion was that they had advanced periodontal 
disease and were receiving surgery as part of their periodontal therapy. During 
surgery, which was carried out by an experienced periodontist, granulation tissue was 
removed and immediately placed into sterile RPMI medium. The tissue sample was 
then stored at 4°C until use. 
5.2.2 Antigen preparation 
P. gingivalis NCTC 11834, P. intermedia ATCC 25611, B. forsythus ATCC 43037 
and A. actinomycetemcomitans ATCC 29523 (serotype A) were grown as described in 
3.2.2. 
Bacterial sonicate preparations were prepared as described in section 3.3.2. 
The protein concentrations of the bacterial sonicate preparations were determined 
using the Pierce BCA protein assay kit. 
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5.2.3 Enzymatic dissociation of granulation tissue 
Surgically removed granulation tissue from each subject was placed in a sterile 25m1 
universal. The tissue was then cut into 1-2mm3 segments using sterile scissors, 
washed twice with RPMI 1640 medium, and then centrifuged at 200 xg for 10 
minutes. Cells were then dissociated from the tissue. 
8ml of Jockliks MEM containing dispase at 3mg/ml (pH 7.4) was added to the 
universal containing the tissue. The universal was then incubated at 37°C for 90 
minutes with continuous stirring. The medium containing the cells was separated 
from the tissue by filtration using 41µm nylon net filters and mixed with excess RPMI 
1640 medium. 
The cells were harvested by centrifugation at 200 xg for 10 minutes before being 
resuspended in Iscoves medium and stored on ice. The cells were then placed on a 
mini gradient containing Iml of Histopaque-1077. Centrifugation was then carried 
out at 400 xg for 20 minutes, and the interface of cells was collected, washed and 
resuspended in Iscoves medium. The cells were then enumerated in white cell 
counting fluid using a Neubauer haemocytometer. 
5.2.4 Enumeration of specific immunoglobulin producing cells by ELISPOT 
Multiscreen 96 well HA membrane-bottomed plates designed specifically for the 
ELISPOT technique were used in this experiment. The wells were coated with l00µ1 
of phosphate buffered saline (PBS) containing sonicated bacterial antigens of P. 
gingivalis, A. actinomycetemcomitans, P. intermedia and B. forsythus at a 
concentration of 10µg/ml. Tetanus toxoid was diluted in PBS and added at a 
concentration of 20pg/ml. This was the control. The plates were then incubated 
overnight at 4°C. The following day the plates were washed with 200µl/well of PBS 
containing 0.1% Tween-20 (PBS-T) for 5 minutes. The plates were emptied by 
flicking and then they were washed twice with 200µI/well of PBS. The wells were 
blocked with 200µl/well of Iscoves modified Dulbecco's medium supplemented with 
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5% foetal calf serum (FCS), penicillin (10000M) and streptomycin (1000µg/m1) at 
room temperature for 1 hour. 
One hundred microlitres was then replaced with medium just prior to addition of the 
single cell suspension. The 100µl cell suspension obtained from the granulation tissue 
digest, described above, was then added to the wells. Two different concentrations of 
cells were used throughout the experiment; lx108 and 5x107 cells/ml. The plates were 
then incubated at 37°C for 5 hours. Care was taken not to disturb the plates during 
this incubation period as it may cause "double image" spots to form. 
After 5 hours the plates were emptied by flicking, the wells were then washed 3 times 
with 200µl/well with PBS and 3 times with 200µl/well with PBS-T. Biotinylated 
anti-human IgG was then diluted 1: 1000 in PBS-T-FCS and 100 µl/well was added to 
the plates. The plates were incubated overnight at 4°C. Following the overnight 
incubation the plates were washed 4 times with 200µl/well PBS-T and then 
100µ1/well of HRP-conjugated avidin-D was added. This was diluted to a final 
concentration of 5µg/ml with PBS-T-FCS. The plates were then incubated for 1 hour 
at room temperature. The wells were then washed 3 times with 20041/well PBS-T, 
followed by 3 times with 200µl/well PBS. 100m] per well of chromogen substrate 
was then added and left for 3 to 8 minutes or until red spots could be visualised. The 
reaction was stopped by washing the plate with running tap water. The plates were 
then blotted dry. 
The nitrocellulose discs covering the bottom of the wells were then removed. They 
were then photographed and the spots enumerated using a stereo-microscope equipped 
with a vertical overhead white light. The results represent the number of spots 
counted per well. 
5.2.5 Statistical methods 
The data was statistically analysed by the Friedman's test using the Minitab statistical 
package. This test was chosen as it compares the number of cells detected against 
207 
different antigens, when observations have been repeated on the same subjects. In 
addition, this test makes no assumptions about the distribution of the data. It was not 
satisfactory just to reject the hypothesis and conclude that not all the ELISPOT results 
were not identical, therefore, a multiple comparison procedure suitable for use after 
the Friedman's test was carried out (Daniel, 1978). 
The Wilcoxon Signed Rank test was used to compare the median paired differences 
between the results obtained when 108 and 5x 107 cells/ml were added. This test was 
chosen as it allowed the comparison of the differences (108 minus 1x107 cells/ml) for 
each antigen separately whilst still taking into account that the data has been collected 
from the same subjects. 
5.3 Results 
Many different preliminary experiments were carried out in this area. Three of four 
different protocols for the ELISPOT technique were carried out and numerous 
problems were experienced. Experiments at the beginning were carried out to try and 
get the technique working correctly and these involved studies such as enumeration of 
the number of peripheral blood lymphocytes bearing antibody to tetanus toxoid in 
healthy individuals following a tetanus vaccination. The results presented in this 
chapter are the results obtained from the most successful protocol that was examined. 
Establishing the technique was extremely time consuming and laborious, however, the 
results presented in this study are the beginning of a project that should be continued 
to look at a greater number of chronic periodontitis patients. 
Figures 5.1 a-5.4b Show examples of ELISPOT results obtained. 
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Figure 5.1a 
Figure 5.1a shows spots indicating plasma cells isolated from granulation tissue 
bearing antibodies on their surface specific for P. gingivalis. As measured by the 
ELISPOT technique. (Magnification x10) 
Figure 5.1b 
Figure 5.1b. Negative control for P. gingival is. (Magnification xl 0) 
Figure 5.2a 
Figure 5.2a shows spots indicating plasma cells isolated from granulation tissue 
bearing antibodies on their surface specific for A. actinomycetemcomitans. As 
measured by the ELISPOT technique. (Magnification x10) 
Figure 5.2b 
Figure 5.2b. Negative control for A. actinomycetemcomitans. (Magnification xl0) 
Figure 5.3a 
Figure 5.3a shows spots indicating plasma cells isolated from granulation tissue 
bearing antibodies on their surface specific for P. intermedia. As measured by the 
ELISPOT technique. (Magnification x10) 
Figure 5.3b 
Figure 5.3b. Negative control for P. intermedia. (Magnification x10) 
Figure 5.4a 
Figure 5.4a shows spots indicating plasma cells isolated from granulation tissue 
bearing antibodies on their surface specific for B. forsythus. As measured by the 
ELISPOT technique. (Magnification xl0) 
Figure 5.4b 
Figure 5.4b. Negative control for B. forsythus. (Magnification x10) 
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Figure 5.5 shows the median number of ELISPOTs counted against the sonicate 
preparations of the 4 periodontal bacteria tested and the control. This plot shows the 
results of the experiments when B lymphocytes separated from diseased granulation 
tissue were added into the wells at a concentration of 1x 108 cells/ml. Figure 5.6 
shows the median number of ELISPOTs counted against the 4 bacteria and the 
control. This plot shows the results of the experiment when B lymphocytes were 
added into the wells at a concentration of 5x107 cells/ml. 
Figures 5.5 and 5.6 show very similar patterns. The line on the graphs indicates the 
median values. There is a pattern that can be seen that indicates that the highest 
number of ELISPOTs is detected against B. forsythus, increasing from P. gingivalis, 
A. actinomycetemcomitans and falling again for P. intermedia. The patterns seen are 
very similar for both cell concentrations, however, the pattern is suggesting that there 
are a lower number of ELISPOTs detected against the antigens when 5x107 cells/ml 
g are added compared to 10. 
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Table 5.1 To show the median number of ELISPOTs enumerated against the 
periodontal bacteria tested 
Median 
(108) 
Interquartile 
Range 
Range p-value of 
Friedman's test* 
Pg 66.1 54.8-74.0 48.0-74.5 
Aa 73.0 49.0-89.0 39.0-91.5 
Pi 73.0 61.5-78.0 55.0- 81.0 0.01 
Bf 81.0 72.6-84.8 68.6-88.5 
Control 25.5 17.7-31.0 13.0-35.0 
Median 
(5x107) 
Interquartile 
Range 
Range p-value of 
Friedman's test* 
Pg 46.50 37.5 - 57.3 29.5-65.0 
Aa 53.00 42.0-61.8 40.5-65.0 
Pi 52.00 44.5-60.5 39.0-61.0 0.007 
Bf 61.70 49.4-70.5 46.8-75.0 
Control 21.00 15.2-25.8 10.0-28.0 
* p-value for hypothesis of test of no difference in the number of ELISPOTs detected 
against different antigens for each cell concentration independently. 
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Table 5.2 To show the median difference in the number of ELISPOTs 
enumerated for the two different cell concentrations 
Median Difference 
(108 - 5x107 
cells/ml) 
Interquartile Range 
of Differences 
p-value* for test of 
median difference 
equal to 0 
Pg 16.6 12.3-23.3 0.059 
Aa 20.0 7.0-27.3 0.106 
Pi 21.0 9.5-25.0 0.059 
Bf 10.5 6.5-35.4 0.059 
Control 3.0 2.0 - 6.5 0.059 
* p-value for hypothesis test of no difference in the number of ELISPOTs detected 
against an antigen for two different cell concentrations. 
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Table 5.1 shows the median values for the number of ELISPOTs enumerated against 
the four periodontal pathogens and the control for the two different cell counts. 
Table 5.2 shows the median difference in the number of ELISPOTs counted for the 
two different cell concentrations added. 
Statistical analysis of the results using the Friedman's test was carried out for the 2 
different concentrations of cells separately. Both showed p-values of < 0.05. This 
indicates that there are differences in the numbers of ELISPOTs detected between at 
least 2 micro-organisms for both cell concentrations. On observation of the results in 
tabular form, it appears that the median number of cells detected for the control 
tetanus toxoid is lower than the median number of ELISPOTs detected against any of 
the periodontal pathogens, as expected. The graphical representation of the results 
suggests that the trend for the number of ELISPOTs detected against the micro- 
organisms when 108 cells/ml are added is very similar to the trend when 5x107 
cells/ml are added. By observing figures 5.5 and 5.6 it does seem that the number of 
cells detected when 5x107 cells/ml are added is lower than when 108 cells/ml are 
added. This is suggested by the shift that is seen in the boxplots, i. e. the boxplot for 
5x107 cells/ml has shifted down compared with the one for 108 cells/ml. 
Further analysis was carried out using a follow-up multiple comparisons procedure 
(Daniel, 1978). The results indicated that when 108 cells/ml were added, there is a 
significant difference between the number of ELISPOTs detected against A. 
actinomycetemcomitans and tetanus toxoid and between B. forsythus and tetanus 
toxoid. The analysis also suggested that when 5x107 cells/ml were added there was a 
significant difference between the number of ELISPOTs detected against A. 
actinomycetemcomitans and tetanus toxoid and between B. forsythus and tetanus 
toxoid. These were the only significant differences found. 
The results of the Wilcoxon Signed Rank test on the paired differences in the number 
of ELISPOTs detected between the 2 different concentrations of B lymphocytes used 
indicated that there was a borderline significant difference between the number of 
ELISPOTS detected for P. gingivalis, B. forsythus, P. intermedia and tetanus toxoid. 
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There was no significant difference in the number of ELISPOTs detected when 109 
and 5x107 cells/ml were added against A. actinomycetemcomitans. 
5.4 Discussion 
The ELISPOT technique is a cell-based immunoassay, which means that various 
inhibitors present in biological fluids, such as serum, are absent and hence cannot 
interfere. Further to this, the quantification of this method is based on cell numbers, 
and not arbitrary values, which are much more easily understood. Differences 
between high and low antibody secretors can also be disregarded with this method. 
The ELISPOT was used to examine the number of antibody secreting cells specific to 
putative periodontal pathogens. The cells were isolated from granulation tissue taken 
from individuals with chronic periodontitis. The number of cells bearing antibody to 
P. gingivalis, A. actinomycetemcomitans, P. interniedia and B. forsythus and tetanus 
toxoid were enumerated. 
Tetanus toxoid was used as a control, to ensure that binding was due to specific 
interactions between antibodies on the surface of cells and the antigens. Tetanus 
toxoid was chosen after preliminary studies were carried out to ensure that the 
technique could be undertaken with this particular antigen preparation. The antibody- 
bearing cells being utilised in this study were isolated from granulation tissue taken 
from patients with chronic periodontitis. Granulation tissue is highly vascularised 
tissue, full of inflammatory infiltrate. This area of tissue is very rich in immune cells. 
It has been reported that at least 50% of the cells in chronic periodontitis lesions are 
plasma cells (Kinane and Lindhe, 1997). One would suppose that the majority of the 
antibody-bearing cells found in the tissues are specific for periodontal micro- 
organisms associated with the disease. Therefore, the reason for choosing tetanus 
toxoid as the control is because there should be very few antibody-bearing cells 
specific for Clostridium tetani in a periodontitis lesion. Blood vessels are present in 
the tissues, and since most individuals have immunity to tetanus toxoid, it provides a 
useful control in discounting the fact that we may be merely measuring cells from the 
circulation and that the interactions are specific to the tissues. 
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The median number of spots against tetanus toxoid enumerated were 25.5 and 21.0 for 
108 cells/ml and 5x 107 cells/ml respectively. Whether these spots are formed due to a 
small number of cells present in the periodontal tissues specific for or cross-reacting 
with tetanus toxoid, or that they represent non-specific background binding, is not 
clear. In addition, Clostridium tetani is a Gram negative bacillus, so the formation of 
spots due to cross-reactivity of antibodies cannot be disregarded. 
The results suggest that there is no significant difference between the number of 
antibody-bearing cells in the granulation tissue against the 4 periodontal pathogens 
tested. In addition, the statistical analysis indicates that there is only a significant 
difference between the control and A. actinomycetemcomitans and B. forsythus. This 
is very difficult to accept because when the median values are observed, it does appear 
that there is a large difference between the number of ELISPOTs enumerated against 
the periodontal pathogens and tetanus toxoid. Further to this, one would certainly 
expect there to be a difference between the number of ELISPOTs detected against the 
periodontal pathogens and the number detected against the control. The reason for 
this is probably the small sample size. The multiple comparison analyses that were 
carried out, made 10 pairway comparisons based on 5 people. They also compared 
sum of ranks instead of median values. In addition, the data range is wide, which 
cannot be corrected for with a sample size of 5. 
Therefore, although the statistical analysis does not indicate that there is a significant 
difference, it can be seen from table 5.1 that there does appear to be a difference 
between the numbers of ELISPOTs detected against the periodontal pathogens and the 
control tetanus toxoid. This suggests that a significant proportion of the ELISPOTs 
enumerated for the periodontal pathogens which are due to specific binding and are 
not non-specific or due to another phenomenon like those detected against tetanus 
toxoid. 
The statistical analysis indicates that there is a borderline significant difference 
between the number of ELISPOTs detected when 108 and 5x107 cells/ml were added. 
The results indicate that for P. gingivalis, B. forsythus, P. intermedia and tetanus 
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toxoid, there are significantly more ELISPOTs enumerated when 108 cells/ml are 
added compared to when 5x 107 cells/ml are added. It is expected that there would be 
a greater number of ELISPOTs detected when a greater number of cells per well are 
added. Further evidence for this, as already discussed, is seen by the shift in the 
boxplots in figures 5.5 and 5.6, where there is an obvious shift to a decrease in the 
number of ELISPOTs enumerated when 5x 107 cells/ml were added compared to 108 
cells/ml. 
Although statistical analysis of the results is important and various differences were 
significant. It must be stressed that in this study positive results were obtained. 
ELISPOTs were detected against the 4 periodontal pathogens tested, indicating that 
antibody-bearing plasma cells specific to P. gingivalis, A. actinomycetemcomitans, P. 
intermedia and B. forsythus are present in the granulation tissue of the patients in this 
study. This indicates that there is a local immune response directed against these 
periodontal pathogens occurring in the chronic periodontitis lesion of these patients. 
The importance of this phenomenon is that the ELISPOT technique could be utilised 
to observe antibody specificity in the local immune response of this disease. It could 
further be used for studies examining other diseases, where tissue can be removed 
ethically and the antibody-bearing cells isolated for investigation. Examining the 
target of the local immune response in periodontitis patients may provide us with 
knowledge of the specific immune response and its target. Answers to these kind of 
enigmas would lead to research into a new era, in terms of vaccine development and 
diagnostic tools. 
This study utilises the ELISPOT technique to examine the bacterial target of antibody- 
bearing cells isolated from the granulation tissue of patients with chronic 
periodontitis. The main limitation experienced with the use of the technique was the 
need for a high number of cells. Much of the literature describes the use of the 
ELISPOT technique in enumeration of antibody-bearing cells following 
immunisation. Cox et al. (1994) reported a study that examined the number of 
antibody-bearing cells specific for the influenza virus over a time period directly 
following immunisation. Eight blood samples were taken during the period up to 22 
days following immunisation. The aim was to examine the time course of appearance 
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of influenza antibody secreting cells in the circulation of individuals following 
vaccination. The mean number of specific antibody-bearing cells in the circulation 
peaked as high as 606 + 283 cells (mean + S. D. ) per 500,000 cells assayed. In the 
present study, it was not expected to obtain a sample containing such a high number 
of antibody-bearing cells. 
Blood samples would not have been useful in this study, as the length of time since 
the onset of chronic periodontitis in the patients was unclear, but certainly it was much 
greater than the initial primary immune response stage, which would be a matter of 
weeks. The number of cells in the circulation bearing antibody specific for 
periodontal pathogens would have been low and the chance of getting even one "hit" 
would have been extremely small. For this reason granulation tissue samples were 
chosen. 
Very little information exists regarding the use of the ELISPOT technique in the 
periodontal literature. A study by Kusumoto et al. (1993) identified P. gingivalis 
fimbriae specific antibody secreting cells in the lymphoid tissues of mice. Hirsch et 
al. (1988) utilised the ELISPOT technique to enumerate antibody secreting cells 
specific for types I-Vi collagen in periodontal tissues. Ogawa et al. (1989b) analysed 
the distribution of IgM, IgG and IgA secreting cells in gingival tissues from subjects 
with periodontal disease using the ELISPOT technique. In addition, Ogawa and co- 
workers, have also carried out studies utilising the ELISPOT technique to investigate 
the number of antibody-bearing cells specific to fimbriae and LPS of P. gingivalis 
(Ogawa et al., 1989a; Ogawa et al., 1991). 
Although those latter studies were investigating the target of the human response, 
most of the studies in the literature utilise the ELISPOT technique for other purposes. 
The aim of the current study was to use the technique to investigate the target of the 
immune response, specifically to look at the number of antibody-bearing cells specific 
to 4 putative periodontopathogens. Many preliminary studies were carried out to 
optimise different factors, including experiments to optimise the concentration of 
bacteria used for coating and for the number of lymphocytes added. Problems were 
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encountered when whole fixed bacterial preparations were utilised, and background 
staining was very high. 
Future studies are justified in this area, and would include a similar study with a much 
larger subject number. In addition, the technique could be used to investigate the 
presence of antibody-bearing cells specific for purified antigens and eventually for 
single antigenic epitopes. 
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Chapter 6. Detection of Antibody-Bearing Plasma Cells in 
Periodontitis Granulation and Gingival Biopsy Tissue 
6.1 Introduction 
The central theme of this thesis is the humoral immune response and its important role 
in periodontal disease. Numerous investigations have focused on the immunological 
parameters of body fluids such a peripheral blood or GCF. However, there is much 
less literature on the local immune response at the site of the lesion. Furthermore, 
studies on serum antibody levels or characterisation of peripheral blood lymphocytes 
in patients, may not reflect the activity of cells present in the periodontal lesion and 
gingival tissues. 
Histological studies on inflammatory periodontal lesions were first published as early 
as the start of the last century (Zamensky, 1902; Hopewell-Smith, 1911). With the 
advent of improved microscope technology during the 1920's more detailed 
histopathological analysis of these tissues were reported (Box, 1924; James and 
Counsel, 1927; Gottlieb, 1927; Becks, 1927). Much work has been carried out since 
these early studies, and as laboratory techniques have been developed the knowledge 
of the disease histopathology has grown. It may be noted however, that the early 
structural observations are still considered accurate by many investigators. 
The major pathological features of periodontal diseases are: (i) apical migration of 
epithelial attachment; (ii) an accumulation of inflammatory infiltrate within the 
periodontal pocket tissues; (iii) breakdown of connective tissue fibres anchoring the 
root to alveolar bone; and (iv) resorption of the marginal portion of the alveolar bone 
which eventually results in bone loss. The clinical and histopathological stages of 
health to periodontal disease were systematically defined originally by Page and 
Schroeder (1976), who developed a classification system to categorise the different 
stages of the disease process. However, much of this work was carried out on animal 
and adolescent biopsies, so for this reason the following discussion will use the more 
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recent system published by Kinane and Lindhe (1997), which is based on that of Page 
and Schroeder. 
The system reported by Kinane and Lindhe (1997) classifies the disease progression 
from health to advanced periodontal disease. The classification system includes: the 
pristine gingiva (Figure 1.2), which is histological perfection; the normal healthy 
gingiva (Figure 1.3); early gingivitis (Figure 1.4); established gingivitis (Figure 1.5); 
and periodontitis (Figure 1.6). 
The pathogenesis of the different stages are discussed elsewhere in this thesis. Of 
importance to this study is the histopathogenesis of periodontal disease. It is accepted 
that gingival tissues removed from individuals suffering from inflammatory 
periodontal disease, contain large numbers of lymphocytes and plasma cells, which 
are found in additional numbers with increasing severity of periodontal disease 
(Zachinsky, 1954; Brill 1960; Zachrisson, 1968; Payne et al., 1975). Much work has 
been carried out to enumerate the plasma cells present in diseased tissues from 
patients with advanced periodontal disease, as compared with the number of 
lymphocytes present. The results of work carried out by different investigators are not 
in agreement, and do not present a clear picture. 
Lindhe et at. (1973) reported that the cellular infiltrate of diseased tissues is 
predominantly made up of plasma cells. Wittwer et al. (1969) and Angelopoulas 
(1973) reported that the number of plasma cells was equivalent to or in some cases 
was exceeded by, the number of lymphocytes. Platt et al. (1970) reported that there 
are approximately 5 times more lymphocytes than plasma cells present. Mackler et al. 
(1977) carried out a study to try and define the relative distribution of lymphocytes 
and plasma cells by investigating 3 different types of tissues. The tissues were 
gingival biopsies taken from areas characterised as clinically normal, mild gingivitis 
and periodontitis. Mackler et al., (1977) reported a difference in cellular profile 
between the mild gingivitis biopsies and those from periodontitis sites. The cellular 
profile of the gingivitis biopsies was characterised by non-immunoglobulin-bearing 
lymphocytes and very few plasma cells. Therefore, the non-immunoglobulin-bearing 
lymphocytes could either be T lymphocytes or immature B lymphocytes or a 
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combination of both (MacDermott et al., 1975). In contrast to the cellular profile 
from the gingivitis biopsies, Mackler et al. (1977) reported that the cellular profile of 
the periodontal tissue biopsies was different, and mainly consisted of 
immunoglobulin-bearing lymphocytes and plasma cells. The number of 
immunoglobulin-bearing lymphocytes exceeded the number of plasma cells. 
More recently Liljenberg et at. (1994), compared plasma cell densities in sites with 
active progressive periodontitis, and in sites with deep pockets and gingivitis but no 
significant attachment loss over a2 year period. The density of plasma cells (51.3%) 
was significantly increased in active sites compared to inactive sites (31 %), indicating 
that plasma cells are more dominant in the advanced lesion. 
Although studies investigating the numbers of immunoglobulin-bearing lymphocytes 
and plasma cells in the tissues seem to be numerous, it is important to consider the 
function and target of these cells. The products of B cells and plasma cells in the 
tissues include antibodies which may be active against components and metabolites of 
periodontal pathogens (Brandtzaeg, 1966), which may result in immunopathology and 
tissue destruction (Carvel and Carr, 1982; Genco et al., 1974). Further to this, 
examination of plasma cells and their targets in the diseased tissues, which are 
specific to the infection and have undergone affinity maturation and migration to the 
site, may lead us to a clearer idea of the more important pathogens and immune 
response inducing antigens. 
Several studies using a variety of techniques to investigate local defence mechanisms 
and their specificity have been carried out over the last few decades. 
Schneider et al. (1966) carried out a study to demonstrate that there is a local defence 
mechanism, present in gingival tissues, of adults with marginal gingivitis and 
periodontitis against bacteria present in the adjacent sulcus or pocket to the site of the 
tissue taken. Firstly, bacterial samples were taken from the sulci of inflamed gingiva 
and placed in acridine orange dye. Immediately following this, gingival biopsies were 
taken from the same area as the bacterial sample had been taken. Frozen sections of 
the biopsies were adhered to glass slides by the warmth of a finger. This avoided the 
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use of tissue adherent that could interfere with the analysis process. The first 
investigation carried out was of the reaction of one of the sections from each biopsy 
with fluorescein conjugated rabbit anti-human globulin globulin. This was to 
demonstrate specific staining of immunoglobulins in these diseased gingival tissues. 
Intense fluorescence was seen predominantly in the connective tissue. Staining was 
also seen within the cytoplasm of the perivascular plasma cells. The second part of 
the study utilised further serial sections from the biopsies. The acridine orange 
stained bacterial suspensions, prepared at the beginning of the study, were added to 
each section and incubated, before washing and the addition of rabbit anti-human 
globulin globulin conjugated to fluorescein isothiocyanate. Some of the sections were 
stained firstly with the fluorescein conjugated rabbit anti-human globulin globulin and 
then allowed to incubate with the acridine orange stained bacteria. The results 
showed that the bacteria reacted with the tissues in areas of high antibody 
concentration, indicating specific antibody-antigen reactions. The specificity was 
confirmed by the fact that there were also reactions seen between gingival tissues 
taken from one individual and the bacteria taken from another. Once the gingival 
tissues had been reacted with rabbit anti-human globulin globulin the bacterial 
reactions were inhibited as the antigen-antibody sites were blocked. This provided 
evidence that the binding of the bacteria to the tissues was specific. In most of the 
sections observed, individual plasma cells were also seen to be reacting with bacteria. 
The bacteria could be observed as single cells lined up around the periphery and 
overlying the cytoplasm of plasma cells. Although, this study showed that there are 
specific interactions between antibodies present in the tissues and antigens, the 
specificity of the bacteria and bacterial targets was not investigated. Further to this, 
the bacterial sample taken from the sulcus may not have contained any of the 
"relevant" or putative periodontal pathogens. Many antibodies could be present in the 
tissues that have migrated in with the exudative fluid during the inflammatory 
reaction. They may not be specific for the bacteria added for the experiment and may 
have bound to non-specific moieties present on the surface of the bacteria such as 
lectins. Such interactions are known to occur between some strains of E. coli and 
murine lymphocytes (Mayer et al., 1978). The fact that bacterial samples taken from 
other individuals reacted, and that the staining in the serial sections always seemed to 
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be in exactly the same area, even though the bacterial samples were heterogeneous, 
appears to further indicate this. 
Periodontal disease is a chronic disorder which is multifactorial, and there are a 
number of pathogens, with similar antigenic moieties that play a role in the induction 
of the immune response. The gingival tissues and periodontium are anatomically 
distinct and whether the immune response involved in periodontal lesions is mucosal, 
systemic or both is unclear. 
Two years later Schonfeld and Kagan (1982) determined the percentage of plasma 
cells in initial and advanced lesions, from sections of gingival tissue biopsies taken 
from periodontitis patients, that were directed against A. viscosus, strain ATCC 27044 
and T14-V, P. gingivalis and A. actinomycetemcomitans. The methodology used in 
this study was as theirs described previously (Schonfeld and Kagan, 1980). The 
results suggested an important role for P. gingivalis in the pathology of periodontal 
disease. In every tissue section studied, 10 initial lesions and 16 advanced periodontal 
lesions, at least 50 plasma cells were located. There was no significant difference in 
the binding of A. viscosus or A. actinomycetemcomitans between initial or advanced 
lesions, and the binding of these pathogens to specific plasma cells was quite low. 
However, the binding of P. gingivalis was seen in all of the advanced lesions, but only 
in 40% of the initial lesions, and a much higher number of plasma cells in the 
advanced lesions bound P. gingivalis. The low specificity towards the other putative 
pathogens tested remained unclear. It could be that the antigens associated with these 
particular bacteria are not powerful immunogens. The results obtained from this study 
seem to emphasise the importance of P. gingivalis in the pathogenesis of periodontal 
disease. Numerous other studies have indicated that patients with chronic 
periodontitis possess high titres of serum antibody to P. gingivalis (Slots and 
Listgarten, 1988; van Winkelhoff et al., 1988a; Moore et al., 1991; Mouton et al., 
1981), therefore, it seems that the specificity of the systemic immune response is 
reflected locally (or vice versa). 
The aim of the present study was to determine the specificity and numbers of plasma 
cells for bacterial antigens present in gingival and granulation tissue sections taken 
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from individuals with chronic periodontitis. The number of specific plasma cells in 
gingival and granulation tissue sections were enumerated for P. gingivalis, A. 
actinomycetemcomitans, P. intermedia, B. forsythus and T. denticola. The number of 
plasma cells that bound E. coli were also enumerated as a control to investigate the 
phenomenon of natural or non-immunologically mediated binding. The experiments 
were further carried out with sonicate preparations of P. gingivalis, A. 
actinomycetemcomitans, P. intermedia and B. forsythus, and the purified antigens 
leukotoxin (of A. actinomycetemcomitans), HSP75 (of P. gingivalis) and the ß 
segment of the RgpA protease (of P. gingivalis). The specificity of the interactions 
between the bacteria and the plasma cells was demonstrated by control studies where 
a blocking step was included which consisted of the addition of a vast excess of fab 
fragments of goat anti-human IgG. 
The methodology required for this study was challenging to develop because of the 
need to counteract and discount any binding through the Fc portions of antibodies 
with any other cell types present, and ensure that all binding detected was specifically 
with the Fab portions of antibodies. It was novel and different from previous studies 
because of the need to use Fab fragments to blockade the specific interactions between 
labelled bacteria and the antibody secreting cells. The use of a biotin system, with its 
inherent amplification, means that there is no requirement for the use of fluorescence 
microscopy, making it a much easier, sensitive and quicker method. 
6.2 Methods 
6.2.1 Preparation of Fab fragments of goat anti-human IgG 
F(ab)2 fragments of goat anti-human IgG were obtained and digested with Papain. 
0.5m1 of lmg/ml F(ab')2 fragments were incubated with 5µg of Papain contained in 
125µ1 of beaded agarose. The incubation was carried out for 30 minutes at 37°C with 
agitation. Centrifugation was then carried out at 6000 rpm for 5 minutes and the 
supernatant removed and transferred to a sterile tube, and stored at 4°C until use. 
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6.2.2 Subjects and samples 
Granulation and gingival tissue specimens were obtained from 5 patients attending 
Glasgow Dental Hospital. The criteria for inclusion in the study was that they were to 
be suffering from advanced chronic periodontal disease and were receiving surgery as 
part of their periodontal therapy. During surgery, carried out by an experienced 
periodontist, granulation and gingival tissue was removed. The tissue was 
immediately fixed in 10% buffered formaldehyde at room temperature and 
subsequently processed and embedded in paraffin wax. Serial sections, 4µm thick 
were prepared on silane-coated glass slides using haematoxylin and eosin staining 
before immunohistochemistry was undertaken. 
The following 3 sections, 6.2.3,6.2.4 and 6.2.5 are a description of the 3 different 
methodologies that were used during the development of the technique. The 
beginning of the development process was method 1 and changes were made and the 
technique progressed through methods 1 to 2 and eventually to 3. The results were 
obtained by method 3, however, a description of the development method protocols 
are included for completeness and so that the reader can form a good understanding of 
the development of the technique. 
6.2.3 Method 1 
6.2.3.1 Bacteria preparation. 
P. gingivalis NCTC 11834, P. intermedia ATCC 25611, B. forsythus ATCC 43037 
and A. actinomycetemcomitans ATCC 29523 (serotype A) were grown and fixed as 
described in 3.2.2. T denticola ATCC 35405 were cultured in medium OMIZ-pat + 
1% human serum, and were a gift from Dr. C. Wyss, Institut fur Orale Mikrobiologie, 
Zurich, Switzerland (Wyss et al., 1997). 
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6.2.3.2 Immunohistochemistry 
The sections were firstly deparafinised by immersion in Xylene x2, then in 99% 
Ethanol x2 and in 95% Ethanol all for 5 minutes each. The sections were then washed 
in distilled H2O, and PBS x2, again for 5 minutes each. The sections were then 
treated with 3% Hydrogen peroxide (H202) in Methanol for 15 minutes. The sections 
were then washed in distilled H2O for 5 minutes twice. The sections were then 
microwaved in 1mM EDTA (pH 8) for 5 minutes x3, and then allowed to cool to 
room temperature before being washed for 5 minutes in PBS. 
The slides were wiped dry and 200µl of blocking serum was then layered onto each 
section and incubated for 20 minutes at room temperature. The blocking serum was 
then tipped off the sections and 200µl of fixed bacteria at a concentration of 1.5x l 08 
bacterial cells/ml diluted in blocking serum was layered onto all but one section and 
incubated for 1 hour at room temperature. For counting purposes the bacteria were 
stained using nigrosin and counted in a Neubauer chamber under oil immersion. The 
sections were then washed twice in PBS-T for 5 minutes followed by a wash for 5 
minutes in PBS. The sections were then wiped dry and 200µl of Fab fragments of 
goat anti-human IgG was added at a concentration of 0.05mg/mI, to block any 
endogenous IgG, to all but one section (a different section from the minus antigen 
section) and incubated for 1 hour at room temperature. 
A sample of human serum taken from a patient with untreated chronic periodontal 
disease which was obtained previously and stored at -20°C, was diluted 1/200 in 
blocking serum. The sections were washed twice in PBS-T for 5 minutes and then 
once in PBS, again for 5 minutes. 200µl of the diluted human serum was then layered 
onto each section and they were incubated at room temperature for 30 minutes. The 
sections were then again washed x2 in PBS-T and xl in PBS, for 5 minutes each. 
200µl of Biotin labelled Fab fragments of goat anti-human IgG at a concentration of 
0.05µg/ml in PBS was then added to all sections and incubated at room temperature 
for 30 minutes. 
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A biotin avidin HRP complex mixture was then prepared and allowed to stand at 
room temperature for 30 minutes. The sections were then washed x2 in PBS-T for 5 
minutes and then xl in PBS, again for 5 minutes. 20Oµl of the Biotin avidin HRP 
complex mixture was then placed onto each section, and the slides were incubated at 
room temperature for 30 minutes. The sections were the washed x2 in PBS-T for 5 
minutes and with PBS for 5 minutes. 
Developing solution was then prepared, and 300µl was placed onto each section. The 
sections were incubated at room temperature for 2-7 minutes. The reaction was 
checked during this period by viewing the sections at low power under the 
microscope. When the reaction was complete the sections were washed in tap water 
several times and were then counter-stained in Mayers haematoxylin for 10 minutes. 
The sections were then washed several times in tap water and mounted in hot 
glycergel with a 22mm x 22mm cover slip. 
6.2.4 Method 2. 
6.2.4.1 Antigen preparation. 
The bacteria were cultured and fixed as described in 3.2.2. Human serum taken from 
a patient suffering from adult periodontitis was diluted 1/100 in PBS and then taken 
and heat treated in 10mM EDTA for 30 minutes at 56°C. The fixed bacteria were 
then incubated with the heat treated serum for 30 minutes at 37°C. The incubated 
preparation was then micro-centrifuged at 7000 rpm for 3 minutes and then washed in 
PBS x2. The preparation was then used at 1/50 dilution in goat serum. 
6.2.4.2 Immunohistochemistry 
The sections were deparafinised and prepared as described in section 6.2.3.2 
The slides were wiped dry and 200µl of blocking serum was layered onto each section 
and incubated for 20 minutes at room temperature. The blocking serum was tipped 
off and 200µl per section of the antigen preparation added to all of the sections except 
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one, and incubated for 1 hour at room temperature. The sections were again washed 
x2 in PBS-T and xl in PBS, for 5 minutes each. 200µl of Biotin labelled Fab 
fragments of goat anti-human IgG at a concentration of 0.05µg/ml in PBS was added 
to all sections and incubated at room temperature for 30 minutes. 
A biotin avidin HRP complex mixture was prepared and allowed to stand at room 
temperature for 30 minutes. The sections were then washed x2 in PBS-T for 5 
minutes and then xl in PBS, again for 5 minutes. 200µl of the Biotin avidin HRP 
complex mixture was placed onto each section, and the slides were incubated at room 
temperature for 30 minutes. The sections were washed x2 in PBS-T for 5 minutes and 
with PBS for 5 minutes. 
Developing solution was then prepared, and 3O0µ1 was placed onto each section. The 
sections were incubated at room temperature for 2-7 minutes, and the reaction was 
checked during this period by viewing the sections at low power under the 
microscope. When the reaction was complete the sections were washed in tap water 
several times and were then counter-stained in Mayers haematoxylin for 10 minutes. 
The sections were washed several times in tap water and mounted in hot glycergel 
with a 22mm x 22mm cover slip. 
6.2.5 Method 3 
6.2.5.1 Antigen preparation 
(a) Fixed bacteria. 
The bacteria were cultured and fixed as described in section 3.2.2. 
(b) Sonicates. 
P. gingivalis, A. actinomycetemcomitans, P. intermedia and B. forsythus were grown 
as described as above in 3.2.2. Sonicated bacterial preparations of these were 
prepared as described in 3.3.2. 
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The protein concentrations were determined using the Pierce BCA protein assay kit. 
(c) Purified antigens 
Leukotoxin of A. actinomycetemcomitans 
leukotoxin of A. actinomycetemcomitans was purified as described in section 3.2.2. 
The leukotoxin was a kind gift from Dr. J. Korostoff, Leon Levy Research Center for 
Oral Biology, University of Pennsylvania, Philadelphia, USA. 
The 0 segment of the RgpA protease of P. gingivalis 
Domains of the RgpA protease of P. gingivalis was prepared as previously described 
in section 3.2.2. 
The 3 segment of RgpA which was used in this study was a gift from Professor M. 
Curtis. 
HSP75 of P. gingivalis 
HSP75 (of P. gingivalis) was purified and prepared according to the method described 
by Hinode et al. (1996). This antigen was a kind gift from Dr. D. Grenier, Universite 
Laval, Quebec, Canada. 
6.2.5.2 Biotinylation of bacteria and bacterial sonicates 
25µg Biotinamidocaproate N-Hydroxysuccimimide ester (Biotin) was diluted into 1 ml 
DMF, which was then further diluted 1: 5 with 100mM phosphate buffer. 5mg of 
sonicated bacteria and 3x109 fixed bacterial cells were mixed with 200µ1 of the Biotin 
solution and incubated at room temperature for 3-4 hours with agitation. The bacterial 
suspension was then centrifuged at 13,000 rpm for 3 minutes, washed x3 with PBS 
and stored at 4°C until used. 
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6.2.5.3 Biotinylation of purified antigens 
100µg Biotinamidocaproate N-Hydroxysuccimimide ester (Biotin) was added to 20µg 
of purified antigen and dissolved in a final volume of lml of sterile H20. Dialysis 
tubing was boiled in 10mM EDTA for 10 minutes. This was repeated 3 times. The 
dialysis tubing was thoroughly rinsed in distilled H20. lml of biotin and antigen 
solution was then placed inside a piece of dialysis tubing that had been tied at both 
ends. The tubing was then placed inside a large beaker containing PBS with 10mM 
EDTA with constant stirring. This was incubated at 4°C for 12 hours. Following this 
the dialysis tubing was then placed into a fresh beaker containing only PBS and 
incubated at 4°C for a further 12 hours with constant stirring. This step was repeated 
a further 4 times. The contents of the dialysis tubing was removed after all the 
necessary incubations had been carried out, and placed into aI ml microcap tube. 
Microcentrifugation was then carried out at 13,000 rpm for 10 minutes. The 
supernatant was removed and stored at 4°C until use. This method was used for 
biotinylation of the antigens leukotoxin (of A. actinomycetemcomitans), HSP75 (of P. 
gingivalis) and the ß segment of the protease RgpA (of P. gingivalis). 
6.2.5.4 Immunohistochemistry 
The sections were deparafinised and prepared as described in section 6.2.3.2. 
200µl of blocking serum was then layered onto each section of half the slides and 
incubated for 20 minutes at room temperature. Blocking serum containing fab 
fragments of goat anti-human IgG at a concentration of 0.05mg/ml was added to the 
other half of the slides and these sections were then also incubated at room 
temperature for 20 minutes. These slides were to act as negative controls. The 
blocking serum was then tipped off and 200µl of biotin labelled antigen was added to 
each section. Whole bacteria were added at a concentration of 3x10' cells/ml, 
sonicate preparations at 100µg/ml and purified antigens at a concentration of 1 pg/ml. 
Incubation was carried out for 1 hour at room temperature. The sections were then 
again washed x2 in PBS-T and xl in PBS, for 5 minutes each. 
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A biotin avidin HRP complex mixture was prepared and allowed to stand at room 
temperature for 30 minutes. The sections were washed x2 in PBS-T for 5 minutes and 
then xl in PBS, again for 5 minutes. 200µl of the Biotin avidin HRP complex 
mixture was placed onto each section, and the slides were incubated at room 
temperature for 30 minutes. The sections were then washed x2 in PBS-T for 5 
minutes and with PBS for 5 minutes. 
Developing solution was prepared, and 300µl was placed onto each section. The 
sections were then incubated at room temperature for 2-7 minutes. The reaction was 
checked during this period by viewing the sections at low power under the 
microscope. When the reaction was complete the sections were washed in tap water 
several times and were counter-stained in Mayers haematoxylin for 10 minutes. The 
sections were then washed several times in tap water and then mounted in hot 
glycergel with a 22mm x 22mm cover slip. 
Method 3 was chosen to be used as it was the most successful, and hence is the 
method that was used for further experiments which will be reported subsequently. 
6.2.6 Data collection and analysis 
Sections were examined under a light microscope, and the presence of positively 
stained cells was confirmed by the appearance of cell surface brown staining with the 
morphology of human leukocytes. Six microscopic fields at x200 magnification were 
chosen for counting in each of the 5 sections for each micro-organism, for purified 
antigens and for each of the tissue types. Serial sections were chosen as far as 
possible for each different antigen used, so comparable fields could be identified and 
counted. Once cell counts were complete median and standard deviation values of the 
population were calculated. 
The data was statistically analysed by the Friedman's test using the Minitab statistical 
package. This test was chosen as it is used to compare the number of cells specific for 
the different antigens when observations have been repeated on the same subjects. In 
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addition, this test makes no assumptions about the distribution of the data. It was not 
satisfactory just to reject the hypothesis and conclude that not all the cell counts were 
not identical, therefore, a multiple comparison procedure suitable for use after the 
Friedman's test was carried out (Daniel, 1978). 
The Wilcoxon Signed Rank test was used to compare the median of the paired 
differences of the results for the granulation tissue samples minus the results from the 
gingival tissue samples. This test was chosen as it allowed the comparison of the 
differences (granulation tissue cell count for a particular antigen - gingival tissue cell 
count for the same antigen) for each antigen separately whilst still taking into account 
that the data has been collected from the same subjects. 
6.3 Results 
Figures 6.1-6.6 show examples obtained from experiments investigating the number 
of specific antibody-bearing cells against P. gingivalis, A. actinomycetemcomitans, P. 
intermedia, B. forsythus, T. denticola and E. coli whole fixed bacterial cells in 
granulation tissue sections. Figures 6.7-6.9 shows examples obtained from 
experiments investigating the number of specific antibody-bearing cells against 
HSP75 (of P. gingivalis), leukotoxin (of A. actinomycetemcomitans) and the (3 
segment of RgpA (of P. gingivalis) in granulation tissue sections. 
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Figure 6.1a 
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Figure 6.1b 
Figure 6.1a shows granulation tissue plasma cells bearing antibodies to P. gingivalis. 
Figure 6.1b shows the control, inhibition of specific P. gingivalis antibody 
interactions using Fab' fragments of goat anti-human immunoglobulin. 
(Magnification x200) 
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Figure 6.2a shows granulation tissue plasma cells bearing antibodies to 
A. actinomycetemcomitans. Figure 6.2b shows the control, inhibition of specific 
A. actinomycetemcomitans antibody interactions using Fab' fragments of goat anti- 
human immunoglobulin. (Magnification x200) 
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Figure 6.3a shows granulation tissue plasma cells bearing antibodies to P. intermedia. 
Figure 6.3b shows the control, inhibition of specific P. intermedia antibody 
interactions using Fab' fragments of goat anti-human 
(Magnification x200) 
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Figure 6.4a shows granulation tissue plasma cells bearing antibodies to B. forsythus. 
Figure 6.4b shows the control, inhibition of specific B. forsythus antibody interactions 
using Fab' fragments of goat anti-human immunoglobulin. (Magnification x200) 
Figure 6.3b 
immunoglobulin. 
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Figure 6.5b 
Figure 6.5a shows granulation tissue plasma cells bearing antibodies to T. 
denticola. 
Figure 6.5b shows the control, inhibition of specific T. denticola antibody 
interactions 
using Fab' fragments of goat anti-human 
immunoglobulin. (Magnification x200) 
Figure 6.6a Figure 6.6b 
Figure 6.6a shows granulation tissue plasma cells bearing antibodies to 
E. coll. Figure 
6.6b shows the control, inhibition of specific 
E. coli antibody interactions using Fab' 
fragments of goat anti-human immunoglobulin. (Magnification x200) 
Figure 6.7a 
Figure 6.7a shows granulation tissue plasma cells bearing antibodies to HSP60 (of P. 
gingivalis). (Magnification x 200) 
Figure 6.7b 
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Figure 6.7b shows the control, inhibition of specific HSP60 (of P. gingivalis) antibody 
interactions using Fab' fragments of goat anti-human immunoglobulin. 
(Magnification x 200) 
Figure 6.8a 
Figure 6.8b 
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Figure 6.8b shows the control, inhibition of specific leukotoxin (of 
A. actinomycetemcomitans) antibody interactions using Fab' fragments of goat anti- 
human immunoglobulin. (Magnification x200) 
Figure 6.9a 
of RgpA (of P. gingivalis). (Magnification x200) 
Figure 6.9b 
(of P. gingivalis) antibody interactions using Fab' fragments of goat anti-human 
immunoglobulin. (Magnification x200) 
Figure 6.9a shows granulation tissue plasma cells bearing antibodies to the 0 segment 
Figure 6.9b shows the control, inhibition of specific the ß segment of RgpA protease 
Figure 6.10 Plot of number of specific antibody-bearing cells per field against 
different concentrations of whole fixed bacteria used. Magnification x200 for 
granulation tissue sections from patients with chronic periodontitis (n=1). 
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Figure 6.10 shows the number of cells per field against the 3 different concentrations 
of whole fixed bacteria. There is an indication of a peak in the number of cells 
counted per field, when a concentration of 1x107 bacterial cells/section (1.5x10s 
cells/ml) is used. As the concentration of whole fixed bacteria added is further 
increased, there is a decrease in the number of antibody-bearing cells detected. The 
experiment was therefore, carried out using 1x10' bacterial cells/section. These are 
the results of a preliminary experiment that was carried out to identify the optimum 
concentration of the biotinylated bacterial cells to use in the study. The aim was to 
establish the optimum concentration for each bacteria to identify the concentration 
which gives a compromise between low background staining with adequate staining 
intensity of the appropriate cells. The experiment was performed in triplicate on one 
set of granulation tissue sections. 
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Figure 6.11 Plot of number of specific antibody-bearing cells per field against 
different concentrations of purified antigen. Magnification x200 for granulation 
tissue sections from patients with chronic periodontitis (n=1). 
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Figure 6.11 shows the number of cells per field against 3 different concentrations of 
purified antigens. These results were obtained from a preliminary experiment that 
was performed in triplicate on one set of granulation tissue sections. A positive 
correlation is evident between the antigen concentration and the number of cells 
counted per field. This indicates that the higher the concentration of antigen used, the 
greater the number of specific antibody-bearing cells are detected. The highest 
number of cells are detected when a concentration of 1µg/ml of antigen is used. The 
graph suggests that at this concentration a plateau is beginning to be established and 
hence this is the optimal concentration to use in the experiment. The aim of this 
preliminary study was to establish the optimum concentration for each antigen to 
ascertain the level which gives a compromise between low background staining with 
adequate staining intensity of the appropriate cells. The results suggest that the 
number of cells per field detected against P. intermedia is significantly higher than the 
number detected against B. forsythus in this individual patient. However, when the 
results from all of the patients are observed, there is no significant difference for the 
numbers of cells detected against P. intermedia and B. forsythus. 
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Table 6.1 Median figures for cells per field bearing antibody to the whole 
bacterial cells and purified antigens tested. Magnification x200 for granulation 
tissue sections taken from patients with chronic periodontitis (n=5). 
Median Interquartile 
Range 
Range p-value of 
Friedman's 
test* 
Pg 81.0 37.5 - 141.0 36.0- 150.0 
Aa 21.0 17.0-37.5 16.0-50.0 
Pi 93.0 30.0- 121.5 26.0- 130.0 
Bf 95.0 26.2 - 123.0 25.5 - 125.0 0.002 
Td 16.0 14.0-26.5 12.0-33.0 
Ec 9.0 5.5-15.0 3.0- 17.0 
Pg HSP75 116.2 56.7- 134.1 11.1 - 134.2 
Aa LTX 113.2 65.0- 119.5 20.8- 121.3 
Pg RgpA 0 - 
Table 6.2 Median figures for cells per field bearing antibody to the whole 
bacterial cells and purified antigens tested. Magnification x200 for gingival 
tissue sections taken from patients with chronic periodontitis (n=5). 
Median Interquartile 
Range 
Range p-value of 
Friedman's 
test* 
Pg 36.0 18.5-37.7 15.0-39.3 
Aa 16.0 10.9-17.0 9.3-18.0 
Pi 29.0 24.5-32.8 22.0-33.0 
Bf 26.0 20.4-37.7 15.7-49.0 0.006 
Td 12.0 11.0- 14.0 11.0- 15.0 
Ec 9.0 5.5- 11.9 3.0- 12.5 
Pg HSP75 48.2 18.4-67.5 9.8-78.0 
Aa LTX 17.0 11.9-43.0 10.0-54.8 
Pg RgpA 0 - - - 
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For all of the subjects, the number of cells detected against RgpA was zero, thus there 
was no variability in the number of cells detected against RgpA across subjects. For 
this reason it was decided that the RgpA data should be omitted from the statistical 
analysis to enable suitable comparisons to be made, using the Friedmans's analysis. 
Table 6.1 shows the median number of specific antibody-bearing plasma cells 
detected in granulation tissue against the 6 whole fixed bacteria tested and the purified 
antigens HSP75 (of P. gingivalis), leukotoxin (of A. actinomycetemcomitans) and the 
(3 segment of RgpA (of P. gingivalis) in granulation tissue. The results represent the 
median of the results obtained from 5 patients. The results of the Friedmans analysis 
suggest that for at least one antigen there are a larger number of specific plasma cells 
identified than for at least one other antigen (p = 0.002). The number of cells detected 
by the addition of E. coli constituted the controls. A small median number (9.0) of 
cells was detected, suggesting that there is some non-specific binding or cross- 
reactivity occurring. Cross-reactivity is possible between antibodies induced against 
periodontal pathogens and specific for an epitope found on other Gram negative 
bacteria. 
Table 6.2 shows the median number of specific antibody-bearing plasma cells 
detected in gingival tissue against the 6 whole fixed bacteria tested and the 3 purified 
antigens. The results of the Friedmans analysis suggest that for at least one antigen 
there are a larger number of specific plasma cells identified than for at least one other 
antigen (p = 0.006). The number of cells detected bearing antibody specific to E. coli 
was small (9.0), again suggesting that there is some non-specific binding or cross- 
reactivity occurring. 
Experimental work was carried out on sonicated bacterial preparations of P. 
gingivalis, A. actinomycetemcomitans, P. interniedia, B. forsythus, T denticola and E. 
coli. The results showed positively stained antibody-bearing cells being detected, 
however, the background staining was very high. It was very difficult to decipher if 
staining was due to specific interactions or non-specific binding. Observation of the 
stained sections suggested that the sonicate preparations had bound non-specifically to 
the tissue sections. The results of these experiments are not included in this chapter as 
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the technique is demonstrated much better with the results of the whole fixed micro- 
organisms and the purified antigens. 
Further analysis was carried out using a suitable follow up multiple comparisons 
procedure (Daniel, 1978). The results of this test suggested that in the granulation 
tissue samples there was a significant difference in the number of cells bearing 
antibodies specific to P. gingivalis and E. coli. In addition there was also a significant 
difference (borderline) between the number of cells detected against B. forsythus and 
E. coli, P. intermedia and E. coli, leukotoxin (of A. actinomycetemcomitans) and E. 
coli and HSP75 (of P. gingivalis) and E. coli. 
Multiple comparison analysis indicated that in the gingival tissue sections there was a 
significant difference (borderline) between the number of cells detected against P. 
gingivalis and E. coli, P. intermedia and E. coli, B. forsythus and E. coli and HSP75 
(of P. gingivalis) and E. coli. 
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Table 6.3 Median differences in the number of cells per field for the micro- 
organisms and purified antigens tested in the granulation and gingival tissue 
samples. Magnification x200 for granulation and gingival tissue sections taken 
from patients with chronic periodontitis (n=5). 
Median Difference 
(Granulation - 
Gingival Tissue) 
Interquartile Range 
of Differences 
p-value for test of 
Median Difference 
equal to 0 
Pg 59.0 12.0-103.4 0.05 
Aa 8.70 4.25-20.5 0.05 
Pi 66.0 -0.8-94.0 0.05 
Bf 69.0 0.6-90.7 0.18 
Td 5.0 0.0-15.0 0.14 
Ec 4.0 -3.7-4.8 0.69 
Pg HSP75 75.3 5.1 -96.2 0.11 
Aa LTX 99.1 26.2- 101.9 0.11 
Pg RgpA - - - 
250 
Table 6.3 shows the median differences in the number of cells detected for the 2 
different tissue types (granulation minus gingival). The Wilcoxon Signed Rank test 
was utilised to examine the paired differences in the number of cells detected against 
the micro-organisms and antigens tested in the 2 different tissue types. Table 6.3 
shows the p-values which suggest that there is a significant difference in the number 
of cells detected against P. gingivalis, A. actinomycetemcomitans and P. intermedia 
between the granulation and gingival tissue samples. Therefore, a significantly higher 
number of cells specific for P. gingivalis, A. actinomycetemcomitans and P. 
intermedia were detected in the granulation tissue samples compared with the gingival 
tissue samples. There was no statistically significant difference in the number of cells 
detected in the granulation and gingival tissue samples against B. forsythus, T 
denticola, E. coli, HSP75, leukotoxin and the ß segment of RgpA. 
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Table 6.4 Mean figures for the percentage of the plasma cells per field specific 
for the antigens tested. Magnification x200 for granulation and gingival tissue 
sections taken from patients with chronic periodontitis (n=5). 
Granulation Tissue Gingival Tissue 
Mean S. D. Mean S. D. 
% of leukocytes 52.3 6.6 23.3 3.1 
which are plasma 
cells 
% plasma cells 10.0 6.4 8.8 3.1 
bearing antibody 
specific to Pg 
% plasma cells 3.0 1.9 4.7 1.8 
bearing antibody 
specific to Aa 
% plasma cells 9.5 6.3 8.8 2.6 
bearing antibody 
specific to Pi 
% plasma cells 9.3 6.3 8.3 3.7 
bearing antibody 
specific to Bf 
% plasma cells 2.2 1.2 3.9 1.4 
bearing antibody 
specific to Td 
% plasma cells 1.7 0.8 3.1 1.8 
bearing antibody 
specific to Ec 
% plasma cells 11.1 6.1 14.5 10.3 
bearing antibody 
specific to HSP 
% plasma cells 10.8 5.1 8.6 7.0 
bearing antibody 
specific to LTX 
% plasma cells 0 0 0 0 
bearing antibody 
specific to RgpA 
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To express the results in a more relevant context the number of plasma cells were 
enumerated so that the percentage of leukocytes that were plasma cells could be 
calculated. Further to this the percentage of plasma cells that were being detected for 
each of the antigens were also determined, in both the granulation and gingival 
tissues. This enabled a comparison between the 2 tissue types of the percentage of 
cells for an antigen, adjusting for the size of inflammatory infiltrate. Table 6.4 shows 
the percentage of the plasma cells specific for each antigen used in the study. The 
values seen are the mean values. The counts were obtained by counting 6 fields of 
each section at x200 magnification. 
As can be seen from the table of results 52.3 + 6.6% (mean + S. D. ) of the infiltrate in 
the granulation tissue is made up of plasma cells, whereas in the gingival tissue the 
figure is only 23.3 + 3.1% (mean + S. D. ). Therefore, the ratio of plasma cells to other 
leukocytes is much higher in the granulation tissue than the gingival tissue. The 
number of cells detected to be bearing antibody against P. gingivalis, A. 
actinomycetemcomitans and P. intermedia in the granulation tissue was found to be 
higher than the number of cells specific to these micro-organisms in the gingival 
tissue samples. However, when table 6.4 is observed it can be seen that when the 
counts are expressed as a percentage of the number of plasma cells per field, the 
percentage of the cells bearing antibodies to these micro-organisms do not appear to 
be significantly different in the 2 tissue types. The value for the percentage of plasma 
cells bearing antibodies to all of the micro-organisms and purified antigens tested 
shows no difference between the granulation and gingival tissue samples. 
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Table 6.5 Mean figures for the percentage of plasma cells per field specific for 
the whole bacterial cells and antigens tested for each of the patients individually. 
Magnification x200 for granulation and gingival tissue sections taken from 
patients with chronic periodontitis (n=5). 
Mean figures for the percentage of the plasma cells per field bearing specific 
antibody to: 
GRANULATION TISSUE 
Patient Pg Aa Pi Bf Td Ec HSP LTX 
1 12.7 2.0 11.2 11.6 1.1 2.1 12.9 11.3 
(±5.6) (±0.8) (±7.2) (+7.1) (+1.2) (±1.9) (±5.2) (+3.7) 
2 19.0 6.3 12.4 12.4 2.6 2.8 16.7 15.3 
(+6.7) (±1.9) (+7.3) (+5.0) (+1.6) (±1.3) (+49) (+2.9) 
3 4.2 2.1 3.2 3.0 1.9 0.9 1.3 2.4 
(+1.9) (+0.8) (+1.3) (±1.9) (+0.7) (±0.6) (+0.8) (+1.9) 
4 3.7 1.5 3.1 2.5 1.4 1.2 9.6 10.6 
(+2.3) (±0.9) (+2.2) (+1.5) (±1.2) (+1.3) (±2.3) (±1.2) 
5 10.7 3.1 17.6 16.8 4.1 1.6 15.0 14.3 
(±4.1) (±0.5) (±8.3) (±7.0) (±1.3) (±0.7) (±3.6) (±4.5) 
GINGIVAL TISSUE 
Patient Pg Aa Pi Bf Td Ec HSP LTX 
1 14.0 6.4 11.9 14.5 5.1 5.0 28.8 20.0 
(+13) (±6.8) (±10) (+6.2) (±5.3) (±5.3) (±26) (+18) 
2 8.3 4.4 6.4 6.2 2.8 2.0 11.3 4.2 
(+3.0) (±1.8) (±2.3) (+3.4) (±0.9) (+1.1) (+2.8) (±2.0) 
3 5.5 3.0 10.8 8.9 3.6 1.5 21.4 10.4 
(±6.7) (±3.1) (±4.4) (+5.9) (+4.0) (+2.9) (+15) (±4.3) 
4 8.0 3.0 6.3 6.0 2.4 1.9 6.1 3.2 
(+1.5) (±2.0) (+1.0) (+2.1) (+0.8) (+0.6) (+3.2) (±1.4) 
5 8.4 6.7 8.8 5.8 5.8 5.0 4.8 5.3 
(+5.8) (±5.9) (±6.9) (+3.3) (+4.4) (±5.5) (+7.1) (+8.2) 
254 
Figure 6.12a Pie chart to show the percentage of plasma cells specific for each 
antigenic target tested in the granulation tissue sample of patient 1. 
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Figure 6.12b Pie chart to show the percentage of plasma cells specific for each 
antigenic target tested in the gingival tissue sample of patient 1. 
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Figure 6.13a Pie chart to show the percentage of plasma cells specific for each 
antigenic target tested in the granulation tissue sample of patient 2. 
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Figure 6.13b Pie chart to show the percentage of plasma cells specific for each 
antigenic target tested in the gingival tissue sample of patient 2. 
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Figure 6.14a Pie chart to show the percentage of plasma cells specific for each 
antigenic target tested in the granulation tissue sample of patient 3. 
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Figure 6.14b Pie chart to show the percentage of plasma cells specific for each 
antigenic target tested in the gingival tissue sample of patient 3. 
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Figure 6.15a Pie chart to show the percentage of plasma cells specific for each 
antigenic target tested in the granulation tissue sample of patient 4. 
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Figure 6.15b Pie chart to show the percentage of plasma cells specific for each 
antigenic target tested in the gingival tissue sample of patient 4. 
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Figure 6.16a Pie chart to show the percentage of plasma cells specific for each 
antigenic target tested in the granulation tissue sample of patient 5. 
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Figure 6.16b Pie chart to show the percentage of plasma cells specific for each 
antigenic target tested in the gingival tissue sample of patient 5. 
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Table 6.5 shows the mean percentages (+ S. D. ) of the plasma cells specific for each of 
the antigen targets for each of the 5 patients individually. The mean values are of 6 
fields per section of granulation and gingival tissue sample. 
Figures 6.12-6.16 represent these values as pie charts, indicating the percentage of 
plasma cells whose antigenic targets are unidentified. As can be seen from the pie 
charts the percentage of cells specific for P. gingivalis, P. intermedia and B. forsythus, 
all seem to be approximately at the same ratio for each patient i. e. if there is a high 
percentage of cells specific for P. gingivalis, there is also a high percentage for P. 
intermedia and B. forsythus. Although the statistical analysis indicated that there was 
no significant difference between the number of plasma cells detected against any of 
the antigenic targets tested, in some individuals there appears to be a higher 
percentage of cells specific for P. gingivalis, P. intermedia and B. forsythus compared 
to A. actinomycetemcomitans and T. denticola. The percentage of plasma cells whose 
target is unidentified varies between patients, however, there does not appear to be a 
correlation between the percentage of cells unidentified and the tissue type. In 3 out 
of the 5 patients however, the main antigenic target or ""unknown" does not seem to 
have been picked up at all in this study. 
6.4 Discussion 
While it is generally accepted that bacteria are the primary factors in the induction of 
the inflammatory state, little is known about the bacterial specificity of lymphocytes 
and plasma cells in the diseased gingival and periodontal tissues. The aim of this 
study was to investigate the target of these cells found in 2 different tissue types; 
granulation and gingival tissue. Of the 3 different methods tested in this study method 
3 proved to be the most successful. 
Method 1 involved the addition of whole formalin fixed bacteria directly on to the 
section, followed by the addition of goat anti-human IgG Fab fragments to block any 
endogenous or unbound IgG. A sample of human serum taken from a patient with a 
an antibody titre previously determined by ELISA as "high" to the putative 
periodontal pathogens utilised in this study was then added to the sections. The 
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rationale being that antibodies in the serum would bind the bacteria that remained 
bound to antibodies on the surface of plasma cells in the section. Biotin labelled Fab 
fragments of goat anti-human IgG were then added, to detect bound serum antibodies, 
before amplification and detection of the signal by the addition of biotin avidin HRP 
complex and then developing solution. Biotin labelled Fab fragments were used 
instead of whole antibodies in the remote possibility that aggregated biotinylated 
antibodies would bind to Fc receptors. One potential problem with this method was 
that when the antigen bound antibodies on the surface of the plasma cell, epitopes of 
the antigen were engaged for binding to occur. Detection of this antigen-antibody 
complex was by the addition of human serum antibodies that also had to bind the 
antigen. Not all epitopes of the antigen were available for binding to the serum 
antibodies. If the serum antibodies that were added for detection purposes were 
specific for the epitopes that were not available, detection would not have occurred. 
Further to this, although blocking serum was added at the beginning of the experiment 
to hinder any non-specific binding sites, it cannot be guaranteed that all were blocked. 
Human serum antibodies could bind these unbound sites through Fc interactions, 
possibly leading to a false detection signal. 
Method 2 was developed with the aim of reducing the number of steps in the protocol. 
In this method a sample of serum taken from a high antibody titre patient with 
periodontal disease was heat treated and then incubated with the formalin fixed 
bacteria. This allowed the addition of the antigen and the serum antibody to be added 
in one step. The problems experienced in the first method were still not solved by this 
method, as all of the epitopes on the antigen surface were still not available. Whereas 
before they were not all available for the human serum antibodies, in this method they 
were not all available to the antibodies on the surface of the plasma cells in the tissue 
sections. Again, there was no certainty that there were no interactions between the Fc 
portions of the human serum antibodies and other cells in the tissue with Fc receptors. 
Method 3 involved direct biotinylation of the antigen, which was then added directly 
to the section. Detection was achieved through the addition of biotin avidin HRP 
complex mixture. This method was less laborious, time consuming and complicated, 
and more accurate than methods I and 2. Furthermore, all of the epitopes on the 
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surface of the antigen were available for binding to specific plasma cells and there was 
no addition of a further step that could lead to non-specific Fc interactions. The 
experiment allowed specific binding of antibody on the surface of plasma cells to 
antigen. The antigen had already been biotinylated, and therefore, amplification and 
detection was carried out in 2 simple steps. The one problem experienced was that 
although blocking serum was added at the beginning of the experiment, there was a 
certain amount of non-specific binding of the antigen to the section. More 
background staining, and hence non-specific binding was seen when sonicate 
preparations were used. The purified antigens showed very little non-specific binding. 
Investigations carried out by Schneider et al. (1966) utilised fluorescein conjugated 
rabbit anti-human globulin globulin to demonstrate specific staining of 
immunoglobulins in diseased gingival tissue sections. Further to the detection of 
immunoglobulins, acridine orange stained bacterial suspensions were added on to the 
sections to observe if these bacterial preparations were bound by the detected 
immunoglobulins. The methods of Schonfeld and Kagan (1980) utilised bacteria that 
were labelled with rhodamine, which is a fluorochrome, and these were added onto 
gingival tissue sections taken from periodontitis patients. 
Although method 3 is quite similar to the methods described by these workers there is 
a difference in the detection method. The methods used by Schneider et al., (1966) 
and Schonfeld and Kagan (1980; 1982) utilised fluorescence to detect binding 
between antibodies on the surface of plasma cells and antigens, whereas in this study, 
biotin was used as the detection agent. In this study the Vectastain Elite ABC kit was 
used. The principles of this kit are based on avidin, a 68,000 molecular weight 
glycoprotein having an extremely high affinity (1015M-1) for biotin. As the affinity of 
this interaction is over 108 times higher than that of antibody for most antigens it is 
essentially irreversible. In addition the biotin/avidin system can be effectively 
exploited because avidin has 4 binding sites for biotin and most proteins, including 
antibodies and enzymes, can be conjugated with several molecules of biotin. The 
advantages of using biotin are that it provides a permanent record of the results, 
whereas fluorescence is known to fade after approximately 7 days. Also the biotin 
avidin HRP complex mixture provides an amplification step which can be magnified 
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further by the addition of avidin labelled anti-avidin. Fluorescence cannot be 
amplified, and therefore, provides a weaker signal. 
A further difference between this work and those of Schonfeld and Kagan (1980, 
1982) and Schneider et al. (1966) is that they used frozen tissue sections whereas 
paraffin embedded sections were used in this study. A preliminary experiment was 
carried out to examine the immunohistochemistry of a frozen specimen compared 
with a matched paraffin embedded section. One piece of granulation tissue was taken 
and divided into 2 pieces, one piece was frozen and the other paraffin embedded. This 
experiment was carried out in triplicate. The results showed that there was no 
significant difference in cell numbers detected in the 2 different types of section. 
Therefore, paraffin embedded sections were used in this study, as they have several 
advantages over frozen sections. They can be stored for many years and are easier to 
cut in thin sections (4µm) allowing the same cells to be apparent on adjacent cut 
sections. Thin sections hold an added advantage in that they require shorter 
incubation times for optimal staining. In addition, the morphology seen in paraffin 
embedded sections is much better than in frozen sections and they are much easier to 
obtain, as an archive of paraffin embedded sections can be retained. Paraffin sections 
are superior to frozen sections, as long as they are completely de-paraffinised before 
immunohistochemistry is performed. Ensuring that all of the antigenic epitopes are 
unmasked is important, however, this is not experienced with frozen sections. The 
preliminary study indicates that the epitopes of the paraffin embedded sections are 
being efficiently unmasked. 
Preliminary experiments were carried out to establish the optimum concentration for 
each antigen. Various concentrations were attempted to ascertain a concentration 
which gives a compromise between low background staining with an adequate 
staining intensity of the appropriate cells. For the whole fixed bacteria 3 different 
concentrations were used 1x107,2x 107 and 3x 107 bacterial cells/section. Figure 6.10 
shows that for P. gingivalis, A. actinomycetemcomitans, and P. intermedia there was a 
peak number of antibody-bearing cells detected when the antigen was used at a 
concentration of 1x 107 bacterial cells/section. It was therefore, decided that this 
concentration would be used for all of the experiments. Three concentrations; 0.2,0.5 
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and 1.0µg/ml were tested for the purified antigens. The concentration of 1.0µg/ml 
was chosen to be used, as on average a higher number of antibody-bearing cells were 
detected. 
The results suggest that the number of antibody-bearing cells detected per field 
specific for P. gingivalis were significantly higher than detected in the granulation 
tissue for E. coli. The number of cells detected against B. forsythus, P. intermedia, 
leukotoxin (of A. actinomycetemcomitans) and HSP75 (of P. gingivalis) were also 
found to be significantly higher (borderline) than the number of cells detected against 
E. coli. In addition, the results for the gingival tissue samples suggest that the number 
of cells specific for P. gingivalis, P. intermedia, B. forsythus and HSP75 (of P. 
gingivalis) are significantly higher (borderline) than detected for E. coli. 
The number of cells per field found in the gingival tissue sections specific for P. 
gingivalis, A. actinomycetemcomitans and P. intermedia are significantly lower than 
those found in the granulation tissue section. The numbers of cells detected against 
the other periodontal pathogens appeared to be lower, however, this was not justified 
statistically. They are not significantly lower, even though on observation of the 
median values they appear to be the range values for these counts are large. 
E. coli was used in the experiment as a control. E. coli is a Gram negative bacteria, 
but not a periodontal pathogen, so was utilised to address the issues of non-specific 
binding and cross-reactivity. There was a small number of cells detected against E. 
coli which could be due to non-specific binding, however, it seems more likely that it 
is due to the binding of E. coli to plasma cells bearing cross-reacting antibodies on 
their surface. As discussed in the general introduction of this thesis, many antigens 
e. g. LPS and HSP, have homology between species. Although the numbers of cells 
detected against E. coli were very small, because of the multiple comparison analysis 
which is comparing the cell numbers against 9 different antigenic targets for only 5 
subjects, the results do not suggest a significant difference in the numbers of cells 
detected against E. coli and all of the periodontal pathogens and antigens, however, it 
was the case for a number of those tested. Although, statistically this therefore, does 
not suggest full confidence in the technique, when the numbers of cells detected 
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against E. coli are examined they are extremely low. In addition, most of the micro- 
organisms and antigens are found to have statistically more specific cells against them 
when compared to the number recorded against E. coli. Interestingly, the median 
number of cells detected against E. coli is almost the same in the granulation and 
gingival tissue sections, further suggesting that these cells are due to non-specific 
binding. 
In this study, a number of antibody-bearing cells specific for the purified antigens 
HSP75 (of P. gingivalis), leukotoxin (of A. actinomycetemcomitans) and the ß 
segment of the RgpA protease of (P. gingivalis) were examined. In the granulation 
and gingival tissue sections there was a high number of cells detected against HSP75 
and leukotoxin. There was no significant difference between the numbers of cells 
detected for these 2 different purified antigens. There were no cells detected against 
the ß segment of RgpA in either tissue types. 
Table 6.4 shows the percentage of the plasma cells in a field that are specific to each 
micro-organism and antigen tested. The results suggest that a significantly higher 
percentage of the leukocytes in granulation tissue are plasma cells when compared 
with gingival tissue. The mean percentage of the infiltrate in granulation tissue that 
was made up of plasma cells was 52.3% ± 6.6% (mean + S. D. ) compared to 23.3% + 
3.1 % (mean ± S. D. ) for gingival tissue. 
Granulation tissue is highly vascularised, full of inflammatory infiltrate and found 
adjacent to the bone. Gingival tissue is more superficial, associated with the 
periodontal pocket and often referred to as infiltrated connective tissue. Therefore, 
due to the nature of the 2 tissue types one would expect a greater percentage of 
antibody-bearing cells to be detected in the granulation tissue. This area of tissue is 
very rich in immune cells. In periodontitis, it has been reported that 50% of the cells 
in the established lesion are plasma cells. In addition several investigators have 
shown that the inflammatory cell infiltrate in human chronic periodontal lesions is 
predominated by lymphocytes and plasma cells (Lindhe et al., 1980; Mackler et al., 
1977; Page and Schroeder, 1976). The results of this study are in agreement with 
these reports. 
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The percentage of the plasma cells specific for all of the whole micro-organisms and 
the purified antigens is the same for the granulation and gingival tissue samples. 
Thus, the percentage of the total number of plasma cells specific to P. gingivalis in the 
granulation tissue is not significantly different from the percentage of the total number 
of plasma cells in the gingival tissue samples. Therefore, although when looking at 
the mean number of plasma cells per field it appears that there is a significantly higher 
number of plasma cells specific to P. gingivalis in granulation tissue samples when 
compared to gingival tissue, the percentage of the infiltrate that is specific to P. 
gingivalis is not significantly different. 
The results of the number of cells specific to HSP75 and leukotoxin suggested cell 
numbers, similar to those found against P. gingivalis whole bacteria, in granulation 
tissue samples. The high numbers of cells bearing antibodies to leukotoxin does not 
correlate with the results of the experiments with the whole fixed bacteria A. 
actinomycetemcomitans. There was a high number of cells detected against 
leukotoxin in the granulation tissue samples, and a moderate number in the gingival 
tissues. However, leukotoxin is an antigen taken from the surface of A. 
actinomycetemcomitans, and there were very few cells found to be bearing antibody 
specific for this micro-organism. One would expect there would be a correlation 
between the number of cells found to be bearing antibody against a purified antigen, 
and the whole bacteria that it were taken from. Examination of formalin-stable 
epitope recognition may provide different results to examination of "native" antigen 
preparations. Important epitopes may be destroyed or changed during the fixing 
process, and may no longer recognised by specific antibodies. In addition, leukotoxin 
is a much smaller molecule than that of the whole bacteria A. actinomycetemcomitans. 
The much higher number of cells detected against leukotoxin perhaps highlights a 
problem of steric hindrance that is experienced on addition of the whole bacterial 
cells. Addition of purified antigens possibly leads to a more sensitive detection 
technique. If this is true, the number of cells detected against the whole bacterial cells 
is possibly an under estimation, and there could be a higher percentage of plasma cells 
specific for the whole micro-organisms in general. 
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For all of the subjects tested there were zero cells detected against the ß segment of 
the RgpA protease (of P. gingivalis). It has previously been reported that the (3 
segment is the immunogenic portion of this protease (Curtis et al., 1993). IgG 
antibodies specific for this portion of RgpA have been detected in the serum of 
patients with periodontal disease, e. g. in chapter 3 of this thesis. However, it has been 
reported that the (3 segment of RgpA has a primary sequence similar to that of 
adhesins and haemagglutinins of other molecules and micro-organisms (Curtis et al., 
1993). Therefore, it should be considered that perhaps the serum antibodies are cross- 
reacting with this segment of the P. gingivalis protease as there does not appear to be 
any evidence of a local immune response in the diseased tissues of periodontitis 
patients against this antigenic target. The lack of detection of antibody-bearing cells 
to this antigen could however, be due to there not being many in the tissues, either 
way this is an area requiring further research. 
Figures 6.12-6.16 show the percentages of plasma cells specific for the whole 
bacterial cells P. gingivalis, A. actinomycetemcomitans, P. intermedia, B. forsythus 
and T. denticola. The percentages of cells detected against E. coli, HSP75 (of P. 
gingivalis) and leukotoxin (of A. actinomycetemcomitans) were not included in the pie 
charts. The percentages of cells detected against E. coli were not included as it is 
thought that the cells shown to be specific for this micro-organism are possibly cross- 
reacting antibody-bearing cells. The percentages of cells detected against leukotoxin 
and HSP75 were also not included as some of these cells could possibly have been 
counted as being specific for any of the other Gram negative bacteria tested in the case 
of HSP75, and against A. actinomycetemcomitans in the case of leukotoxin. 
The results obtained from this study do not appear to agree with those reported by 
Kagan (1980). Kagan utilised the method developed by Schonfeld and Kagan (1980) 
to examine the percentage of plasma cells specific to P. gingivalis in initial/early 
lesions compared with the percentage in established/advanced lesions. The gingival 
tissue samples cannot really be compared with the early/initial lesion samples, as there 
is not enough information in the report to allow this. However, the results from the 
established/advanced lesion samples can be compared with the results from the 
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granulation tissue samples. Kagan reported that 31.6% of the plasma cells in the 
established/advanced lesions were specific to P. gingivalis, whereas this study 
reported a mean percentage of only 9.8%. Kagan suggested that a percentage of 
31.6% was high, although this could have been due to the small sample size. The 
results indicated that established/advanced lesions were examined for only 3 subjects, 
which was small. Further to this, the number of plasma cells counted in total in the 
study carried out by Kagan (1980) was extremely low, much lower than the number 
reported in this study and also that reported in the study by Mackler et al. (1977). 
This study was carried out using granulation and gingival tissue sections, to determine 
if the target of the antibody-bearing cells in these different tissues differed or 
exhibited any different patterns. Lappin et al. (1999) looked at the relative 
proportions of leukocytes in granulation tissues samples in patients with chronic and 
aggressive periodontitis, and compared these with numbers obtained from gingival 
tissues. The results of this study suggested that B cells in the gingiva and the 
granulation tissue are long lived cells, and the B cells from both tissue types behave in 
a similar fashion. Therefore, it was of interest to compare the targets of the antibody- 
bearing cells from both tissue types. 
The results of the experiments that attempted to detect plasma cells bearing antibodies 
with sonicated bacterial preparations were not included in this study. The experiments 
utilising sonicated bacterial preparations showed much more background staining than 
seen when whole micro-organisms and purified antigens are used. These results 
suggested that some of the binding may have been non-specific and hence, it was 
difficult to differentiate between specific and non-specific binding to the sections. 
Sonicated bacterial preparations resulted in the exposure of many molecules that are 
not on the surface of an organism. Whether some of these are carbohydrate moeties 
that are "sticky" and can non-specifically adhere on to the tissue is unknown. 
It is considered that the methodological approach to this study has achieved interesting 
results particularly as the study was largely developmental. This is not a standard 
technique and hence, many preliminary experiments were carried out in the 
developmental stages for each part of the technique, such as optimisation of antigen 
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concentrations, blocking techniques, use of frozen and fixed tissue and compete 
labelling of antigens. Unlike conventional immunohistochemical techniques where 
cells are detected by the use of antibodies, this approach is aimed at achieving the 
opposite. The technique is based on the rationale that by the addition of antigen, the 
detection of antibody-bearing cells will be accomplished. The resulting data at this 
point is difficult to utilise in a quantitative manner, as one will never be certain that all 
of the antibody-bearing cells are being detected. In fact, the number of cells detected 
against leukotoxin compared with the number detected against A. 
actinomycetemcomitans suggests that all of the cells are not being detected. Further to 
this, although the preliminary experiment was carried out to compare paraffin 
embedded with frozen sections, one can never be totally certain that all of the epitopes 
have been unmasked. Therefore, although the method described in this chapter has 
proved successful and is a great achievement in terms of a qualitative study, whether it 
can be used quantitatively is more debatable. 
Method 3 used in this study, is a newly developed method that could prove useful for 
the examination of the target of antibody-bearing cells in diseased tissues from all 
areas of the body, and in certain infections this could play a role in diagnosis and 
choice of therapy. This is a little more difficult in the polymicrobic situation of 
periodontal disease, however, if a larger study were carried out, possibly on 
individuals in health, with gingivitis and periodontal disease, more patterns may 
emerge on the target of antibodies in the tissues at different stages of disease. Of 
course, there are always difficulties in such studies, to gain ethical approval for the 
removal of tissues from individuals in health and with gingivitis. 
In the study, the results suggested that in both granulation and gingival tissue samples, 
a high proportion of the antibody-bearing cells were specific for the putative 
periodontal pathogen P. gingivalis. There is a higher load of P. gingivalis associated 
with active periodontal lesions, than inactive (Dzink et al., 1988; Walker and Gordon, 
1990), and following breakdown after treatment, large proportions of P. gingivalis 
have been found at sites, indicating an important role for the species in pathogenesis 
of recurrent disease. Therefore, from this study it seems that P. gingivalis is important 
in the induction of the humoral immune response at the site of infection. Antibody- 
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bearing cells specific for the other periodontal pathogens tested were also identified. 
There was no statistical significance difference found between the numbers of cells 
detected against P. gingivalis, A. actinomycetemcomitans, P. intermedia, B. forsythus 
and T denticola. However, observation of the cell figures on an individual level 
indicates that the numbers of cells specific for P. gingivalis, A. 
actinomycetemcomitans and T Denticola were markedly different. With a sample 
size of 5, and with large variations between subjects it is difficult to detect statistically 
significant differences which could possibly emerge in a study with a larger 
population. 
Analysis of the results from this study proved interesting. It was felt to be an 
achievement to develop a technique such as this one, that has so much potential. It is 
a specific detection method, that could potentially provide results using purified 
antigens and even specific antigenic epitopes on serial sections of tissue. Molecular 
biological work investigating the antigenic target in individuals that have induced a 
humoral immune response in periodontal disease could potentially utilise this 
technique to test consecutive epitopes of a particular antigen. In addition, progress 
with the technique could lead to a potential diagnostic tool. Investigations utilising 
this technique to examine the percentage of the plasma cell infiltrate specific for a 
particular bacteria, and on a larger scale the percentage that is unidentified is exciting. 
The use of purified antigens which are smaller and possibly more sensitive could be 
the future for this technique. 
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Chapter 7. Methodological Considerations and General 
Conclusions 
This chapter attempts to do two things, firstly, it deals with the methodological 
considerations and secondly it brings together the results and discussions from the 
previous four chapters to a final conclusion. 
7.1 Methodological considerations 
Sample size 
The first study carried out to investigate the effect of periodontal treatment on 
antibody titres against a panel of microbial targets was based on a sample size of 25. 
This sample size was similar, and in some cases larger, than those of studies 
previously published (Tolo et al., 1982; Sandholm and Tolo, 1986; Mouton et al., 
1987; Horibe et al., 1995; Mooney et al., 1995). 
The second part of that study investigating the cross-reactivity between micro- 
organisms was based on a sample size of 9 people. In addition, the ELISPOT 
technique and immunohistochemical studies were carried out both on 5 subjects. The 
numbers of subjects involved in these studies are small. It was felt that these numbers 
were sufficient to pilot the techniques used, to get a general feel for the results and 
observe any trends. However, statistical analysis was difficult with such a small 
sample size, and although the most suitable analysis possible was undertaken, the 
power of the analysis was weak. 
7.2 Conclusions 
In chapter 3 the effect of treatment on the serum antibody titres of patients with 
chronic periodontitis was examined. The overall conclusion from this study was that 
there was no significant difference between the antibody titres measured before and 
after periodontal treatment. There could be several reasons for this. Firstly, it could 
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be that the microbial targets used in the study are not causing disease. The panel of 
micro-organisms and antigen preparations used were, however, extensive and made 
up of a number of the putative periodontal pathogens (Zambon, 1996). Secondly, it 
could be that the organisms were not eliminated by the treatment, however, this again 
is unlikely as there was significant clinical improvement seen in the patients following 
treatment. It could be that the numbers of organisms remained at a level sufficient to 
maintain antigenic stimulus but not enough to cause disease, or perhaps that they were 
present at sites in the mouth where treatment was not carried out. The reason for not 
detecting a change in antibody titre following treatment, could, however, be due to the 
time chosen for sampling, hence the length of treatment as discussed in chapter 3. A 
final reason which could explain the results obtained is that there could be cross- 
reactive antigens that have the ability to maintain levels of antibodies in the absence 
of the infecting organisms. The subject of cross-reactivity was investigated therefore, 
in the second part of chapter 3. 
The second part of chapter 3 examined pre-treatment serum antibody titres in patients 
with chronic periodontitis. The study investigated cross-reactivity between antibodies 
specific for one periodontal pathogen against three other periodontal micro-organisms. 
The results of this experiment suggest that there is cross-reactivity between P. 
gingivalis, A. actinomycetemcomitans, P. intermedia and B. forsythus. The results 
indicate that when serum is adsorbed against one micro-organism e. g. P. gingivalis, 
approximately 60-80% of the antibodies against the other 3 periodontal pathogens (A. 
actinomycetemcomitans, P. intermedia and B. forsythus) have also been adsorbed out, 
indicating a high level of cross-reactivity between the 4 periodontopathogens. Similar 
results were found for all of the pathogens except B. forsythus which seemed to have 
less cross-reactivity with the other micro-organisms. 
Chapter 3 was an investigation into the systemic humoral immune response of patients 
with chronic periodontitis. The systemic immune response is often examined by 
observation of serum antibody titres. It is useful as it is thought to reflect the local 
immune response and because blood is obtained easily and gives a full patient 
immunological assessment as contrasted with GCF which is very much site specific. 
However, following the study carried out in chapter 3, the natural progression was to 
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begin to investigate the local immune response, to try and gain a clearer understanding 
of the target of the humoral immune response in periodontal disease. Therefore, the 
remaining studies described in this thesis concerned the local immune response, 
examined by observation of granulation and gingival tissue, removed from 
periodontally diseased patients during surgery. Histopathological techniques have 
indicated that diseased tissues taken from periodontitis patients are populated by a 
large number of B lymphocytes and plasma cells, thus suggesting local antibody 
production (Ranney, 1991; Sims et al., 1991). Therefore, the rationale behind the 
studies carried out in chapters 4,5 and 6 was that examination of the antibody bearing 
cells in the diseased tissues of periodontitis patients will lead to knowledge of the 
pathogenic target inducing their production, more efficiently than observation of 
antibodies found in the serum. Theories have been put forward (Kinane et al., 1999a) 
suggesting possible ways of linking the local and systemic immune responses, 
however, they all stem from the induction of an immune response against an antigenic 
stimulus in the periodontal tissues. 
The general conclusions that were made following the study entitled `Immortalised B 
cells from periodontal patients' described in chapter 4 are really more a discussion of 
the technical complexities of this endeavour and the hypothesis driving this study. 
The aim of the study was to produce monoclonal antibodies from the peripheral blood 
and granulation tissue of patients with chronic periodontal disease. Expansion of 
numbers of peripheral blood B lymphocytes was successful using the CD40 system, 
and with both expanded peripheral blood lymphocytes and antibody-bearing cells 
isolated from granulation tissue, fusion with a heteromyeloma partner was also 
successful. Following fusion, antibody production was monitored and screened for 3- 
4 weeks but in all of the 11 experiments carried out, antibody production stopped at 3- 
4 weeks and did not return. This is a problem that is often experienced when utilising 
this technique as discussed in chapter 4. 
The ELISPOT technique was utilised in chapter 5 to investigate the specificity of 
antibody bearing cells isolated from the granulation tissue of patients with chronic 
periodontal disease. The number of antibody bearing plasma cells specific for the 
putative periodontal pathogens P. gingivalis, A. actinomycetemcomitans, P. 
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intermedia and B. forsythus were enumerated. In addition, the number of cells that 
were detected against the control, tetanus toxoid, were also counted, to examine the 
specificity of the technique. Two different concentrations of cells were used in the 
study. 
The results showed that the only statistically significant differences in cell number 
were between, A. actinomyceteincomitans and tetanus toxoid and B. forsythus and 
tetanus toxoid for both cell concentrations. Median values indicated that the number 
of cells detected against tetanus toxoid appeared to be much lower than detected 
against the periodontal pathogens, however, the differences were not all found to be 
statistically significant, probably due to the low sample size of 5. 
This study indicated that, the ELISPOT is a technique that can be utilised to study the 
target of cells isolated from periodontal tissues and hence, the local immune response 
induced in individuals with periodontal disease. In addition, it has suggested that 
there is no significant difference between the numbers of cells bearing antibodies to 
the four periodontal pathogens P. gingivalis, A. actinomycetemcomitans, P. 
intermedia and B. forsythus. Chapter 3 indicated a high percentage of cross-reactivity 
between these pathogens. Therefore, we cannot confirm that when an antibody 
bearing cell is detected against one micro-organism, it has not been initially induced 
against another micro-organism. 
For this reason the technique in chapter 6 was developed. The aim of this study was 
again the detection of antibody-bearing cells in the tissues of patients with periodontal 
disease, however, the technique developed held a number of advantages over that of 
the ELISPOT. Firstly, the specially designed 96 well ELISPOT plates were extremely 
variable with regard to the bacterial preparations and antigens that were able to bind to 
them. Fixed bacteria and the purified antigens tested did not bind successfully to the 
plates and the experiments were unsuccessful when these preparations were used. In 
addition, enumeration of the ELISPOTs was quite difficult. With regard to the 
problem discussed above, the further advantage of the immunohistochemical 
technique developed in chapter 6, was that when serial sections were used, it was 
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possible to detect whether antibodies on the surface of plasma cells were binding and 
hence cross-reacting with a number of micro-organisms. 
The study described in chapter 6 examined paraffin embedded gingival and 
granulation tissue sections taken from chronic periodontitis patients. The results 
indicated that the number of cells bearing antibody to E. coli was significantly lower 
than to the majority of the putative periodontal micro-organisms and antigens tested, 
indicating that this technique was specific. 
The results of this study firstly indicated that a novel technique had been developed 
that was able to detect antibody-bearing cells against whole fixed 
periodontopathogens and purified antigens from some of these. The technique was 
based on the biotin-avidin system making it inexpensive, easy to use and not labour 
intensive. The results indicated that there was no significant difference in the number 
of cells detected against any of the whole fixed micro-organisms tested and the 
purified antigens leukotoxin (of A. actinomycetemcomitans) and HSP75 (of P. 
gingivalis) in either of the tissue types. No cells were detected to be specific against 
the ß segment of the RgpA protease (of P. gingivalis). 
The results further indicated that there were significantly more cells detected against 
P. gingivalis, A. actinomycetemcomitans and P. intermedia in the granulation tissue 
compared with the gingival tissue. However, the numbers of cells specific for a 
particular antigenic target were then expressed as a percentage of the total plasma cell 
infiltrate and when the percentages were observed it became clear that there was no 
difference in the percentage of cells specific to a particular micro-organism in the 
different tissue types. The difference lay in the size of the infiltrate and, therefore, the 
number of plasma cells that had permeated into the tissues. These results were, 
therefore, consistent with the ELISPOT results which suggested that in general there 
is no significant difference between the number of cells bearing antibody to the 
different micro-organisms and antigens tested. The percentages of plasma cells 
specific for each of the targets were presented in the form of a pie chart for each 
subject individually. It was very interesting that the results could be expressed in this 
form, firstly because it gives the reader a clearer idea of the number of cells specific 
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for a particular target, and secondly because it allows the percentage of plasma cells 
whose target is unidentified to be highlighted. 
7.3 Suggestions for future research 
7.3.1 Examination of the effect of treatment on the humoral immune response 
As discussed in chapter 3, it is very difficult to compare studies performed by 
different groups, as the length of treatment appears to vary so much. To truly measure 
the effects of treatment on the immune response, it would be interesting to analyse 
serum samples at much shorter time intervals following treatment. For example if a 
serum sample was taken every 2-4 weeks following treatment for a time period of 6 
months. Examination of samples taken like this would allow the dynamics i. e. any 
increases or decreases in titre to be noted over time. 
7.3.2 Further work on monoclonal antibody production 
The aim of the monoclonal antibody production study was novel but proved too 
complex at this time. Obtaining monoclonal antibodies produced by the protocol 
described in chapter 4 could in future provide some interesting results. If monoclonal 
antibodies were produced and the antigen binding portion of these sequenced, it could 
lead to identification of the antigenic target that has induced the immune response, 
whether it be a known antigen or not. 
7.3.3 Detection of antibody-bearing plasma cells in granulation and gingival tissue 
The technique developed in this study has potential and should be utilised in studies of 
other chronic infectious diseases not only periodontitis. In terms of the study 
described in chapter 6, it would be interesting to compare tissue taken from patients 
with different disease forms (e. g. gingivitis, aggressive periodontitis, chronic 
periodontitis), and see if there are differences in the immune infiltrate between these 
different disease entities. In addition, analysis of immunoglobulin isotypes and 
examination of further antigens would be of interest. Cross-reactivity studies could 
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also be carried out by utilising serial sections. This technique could also be used to 
further observe the percentages of the plasma cell infiltrate specific to a particular 
antigenic target. Having the ability to be able to do this could prove valuable in the 
future as it puts the results into a more understandable context. The technique should 
be utilised to look at a larger panel of purified antigens. A study specifically 
investigating the phenomena of cross-reactivity is also very important and this 
technique would be an excellent tool to do this with. 
7.4 Concluding remarks 
The future identification of the target or targets of the humoral immune response in 
periodontal disease could have wide-ranging implications. They could potentially 
include the possibility of new diagnostics, prophylactics and therapeutics. Whether 
antibody responses to specific antigens are markers of disease susceptibility or activity 
is currently unclear. Progress is, however, being made in identifying marker antigens 
and species out of the 300-400 bacterial species identified in microbial plaque. 
The studies presented in this thesis have provided an insight into how the antigenic 
targets of plasma cells in periodontitis may be elucidated. The results reported show 
the development of a new detection technique that can be used to identify plasma cells 
directly that are bearing antibodies to a particular antigenic target. The results also 
emphasise the uses of techniques such as the ELISPOT, another method that can be 
utilised to investigate the target of the immune response in periodontal disease. As 
well as highlighting aspects regarding technical issues, the studies reported in this 
thesis have addressed the issues of cross-reactivity between Gram negative bacteria, 
the target of antibodies being produced locally in diseased tissues of periodontitis 
patients and responses to antigens that have previously been described as 
immunodominant such as LPS, leukotoxin and HSP. 
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Microbial immune targets in periodontal disease. M. PODMORE, * 
D. F. LAPPIN,. l. MOONEY & D. F. KINANE. (University of Glasgow Dental 
School, UK) 
The immune response against periodontal pathogens is considered important in 
periodontal disease. Knowledge of the microbial targets for serum and crevicular 
fluid antibodies is crucial in the development of diagnostic techniques and for 
immunisation strategies. The aim of the study was to examine the microbial targets of 
peripheral humoral immune cells in ten patients affected by severe chronic 
periodontitis (35 to 65 years of age). ELISPOT assays were used to measure the 
presence of antibody producing cells in patients with periodontal disease. This assay 
has provided useful preliminary data which will assist in the identification of 
immunodominant antigens against which the humoral immune response in this 
disease is directed. A second approach was to utilise cell culture supernatants from 
Epstein-Barr virus (EBV) transformed pre-B cells from patients with periodontal 
disease which were screened by ELISA for antibodies against Porphyromonas 
gingivalis, Actinohacilhu actinomycetemcomitans, Prevotella intermedia and 
Bacteroides forsythus. After screening 500 EBV transformed wells for each patient 
we detected between 15 and 30 positive wells for each of the three putative 
periodontal pathogens tested. These EBV transformed clones were combined with a 
human myeloma cell line to form discrete hybridomas capable of producing 
monoclonal antibodies. Thus human monoclonal antibodies can be produced from 
pre-B cells of periodontitis patients and a proportion are directed against neriodontal 
pathogens. 
The effect of periodontal therapy on the humoral immune response in patients 
with chronic periodontal disease. M. PODMORE, * I. B. DARBY & D. F. 
KINANE. (University of Glasgow Dental School, UK) 
Numerous bacteria and the host humoral immune response to their antigens have been 
implicated in the pathogenesis of periodontal disease. The aim of this study was to 
assess the effect of initial periodontal therapy on 25 untreated adult periodontitis 
patients, and specifically assess the patient's serum antibody titres to a range of 
bacteria and specific antigens. The antigenic targets investigated were the whole fixed 
bacteria of Porphi'romonas gingivalis (P. g), Actinobacillus actinomycetemcomitans 
(A. a), Prcwotc'lla intcrmedia (P. i), Treponema denticola (T. d) and Bacteroides 
forsl't{rus (B. f), crude outermembrane protein preparations of P. g, A. a, P. i and B. f and 
various purified antigens thought to play a role; Leukotoxin (A. a), Lipopolysaccharide 
(P. g), Heat shock protein 60 (P. g) and RIA protease (P. g). Antibody titres were 
assayed by ELISAs. Following the initial therapy the average reduction in pocket 
depth was 2.1 mm (+ 0.9). In addition, specific antibody titres increased after 
treatment for all whole bacteria and antigens tested, for example, the antibody titre to 
P. g whole cells before treatment was 0.510 ELISA units (± 0.180) and after treatment 
was 0.927 ELISA units (± 0.334). This increase was statistically significant (P<0.05). 
Interestingly, P. g outer membrane protein preparations had a 119% increase in titre 
whereas antibodies to Lipopolysaccharide from P. g increased by only 25.1%. 
In conclusion, periodontal therapy influenced the magnitude of the humoral immune 
response to all of the putative periodontal pathogens and specific antigens tested. 
Initial periodontal treatment does not increase antibody titres to certain periodontal 
pathogens and their antigens to the same extent and this may indicate the relevance of 
certain candidate antigens in the disease process. 
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ABSTRACT: The humoral arm of the immune system provides protection from many medically significant pathogens. The antigenic 
epitopes of the pathogens which induce these responses, and the subsequent characteristics of the host response, have been exten- 
sively documented in the medical literature, and in many cases have resulted in the development and implementation of effective 
vaccines or diagnostic tests. There is a substantial body of literature on the humoral immune response in periodontal disease, which 
is targeted at micro-organisms present within periodontal pockets. However, the significance and specificity of the immune 
response in periodontal disease have proved difficult to elucidate, due to the large number of potential pathogens in the plaque 
biofilm and the apparent commensal nature of many of these opportunistic pathogens. This review addresses our current knowl- 
edge of the approaches and strategies which have been used to elucidate and examine the concept of immunodominant antigens 
in medical infections and, more recently, periodontal disease. An identification/understanding of the immunodominant antigens 
would be informative with respect to. (i) the relative importance of the implicated pathogens, (ii) new approaches to immunologi- 
cal diagnosis, (iii) specific bacterial virulence determinants, (iv) natural protective responses, and (v) the selection of potential vac- 
cine candidate antigens. We conclude that immunodominance of antigens in periodontal disease may be relevant to our under- 
standing of periodontal disease pathogenesis, but due to the complexity and diversity of the 'pathogenic microbial ecology', it is 
currently an enigmatic topic requiring a multidisciplinary approach linking clinical, microbiological, and immunological investiga- 
tions. We also conclude, after assessing the literature available on the topic of immunodominance, that it is a term that, if used, 
must be clearly defined and understood, since it is often used loosely, leading to a general misinterpretation by readers of oral and 
medical literature. 
Key words. Immunodorninance, periodontitis, oral pathogens, antigens, detectable antibody response. 
(I) Definition of the Term 
"Immunodominant Antigen" 
ýn dealing with this topic, we must first define the term 
Immunodominance'. This concept is often misused by 
vestigators who go on to provide data and an interpretation 
at specific antigens or epitopes of a micro-organism or 
ý', acromolecule are 'immunodominant', with little explana- 
)n as to the basis of the finding and, importantly, its signif- 
I 'ance. The term 'immunodominance or immune dominance' 
as initially coined by Eli Sercarz (1989) to provide a frame- 
vork for describing the immune response gene control of 
antibody responses to hen egg lysozyme (HEL). FIEL is a 
, obular protein with a known three-dimensional structure, 
,, hich enabled these investigators to define antigenic epi- 
'ipes using peptides derived from cyanogen bromide cleav- 
ý5e of this protein. Specifically, immune responses of H-2h 
'nice to HEL were restricted to a domain at the amino termi- 
'ýus of the molecule-in fact, to 3 amino terminal residues. 
nicker et al. (1984) reported that if these 3 residues were 
'-leaved, 50% of the primary response antibody molecules 
', ound poorly if at all to the HEL, and therefore, the immuno- 
-,, nicity of the protein was 
drastically affected. The term 
mmunodominance' was used to describe the predominant 
rnmune recognition of these 3 amino terminal residues. 
,, ercarz (1989) thus suggested that, for efficient and regulat- 
ed activity of the immune response to a particular antigen, 
there should be a small number of immunodominant epi- 
topes on an antigen. 
The primary, secondary, and tertiary structures of a protein 
antigen present a vast array of potential epitopes, however, the 
number recognized by the immune system appears to be consid- 
erably smaller than the full, potentially antigenic repertoire of the 
immunogen (Laver et al, 1990). Some of these antigenic epitopes 
will dominate the resulting specificity of the immune response, 
which can vary from species to species and even among individ- 
uals within a species, and will not only induce a more pro- 
nounced immune response, but may also suppress the primary 
immune response to other antigenic determinants Recent stud- 
ies with a similar experimental system have demonstrated the 
broad heterogeneity of proliferative responses to the immuno- 
dominant determinants within HEL. The heterogeneity of 
response was suggested to relate to the competitive, as well as 
regulatory, nature of the interaction among various factors, 
including different Major Histocompatibility Complex (MtiC) 
molecules, determinant capture by antigen-presenting mecha- 
nisms, and the available T-cell repertoire. The authors suggested 
that these results, while directed toward focused studies of an 
isolated protein, may have important implications for studies of 
autoimmunity, infection, and vaccine design in human popula- 
tions, where heterozygosity is the characteristic of the population 
(Moudgil et a[_ 1998) The basis for the existence of immunodom- 
inant epitopes is less well-understood. Recent findings have 
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gun that peptide cornpelition for MI IC binding my not repre- 
'the most irnpoit, int event in processes leadint; to immuno- 
minance (Lo-Man it of , 
I99ttf As his been noted with the 
ilting antibody to it particular protein antigen, T-lymphocyte 
; cnses to a protein antigen are restricted to a limited number 
determinants and not to all peptides capable of binding to 
-1C class II molecules This 1orusing of the T-cell immune 
'Aonse is also defined is imtnunodominance and has been 
: served with numerous , rntigens Recent investigations by 
in et at ( 1998) hive suggested t h, it dendrit is cells play a major 
e in the focusing of the nnnrune response against it few anti- 
c determinants, while It-lymphoyte's may diversify the T-cell 
'5ponse by present inl; i Hinre heterogeneous set of peptide- 
complexes Moreover, this "I'-cell focusing; has been extend- 
to cellular immune responses, which are directed against it 
arrow set of irnmunoriomin, rnt peptides derived from complex 
'ýtigens. The existence of epitopes that are hidden or infrequent 
? gets of immune responses (cryptic epitopes) has also been 
'entified. Although the identification of immunodominant epi- 
? es is important for vaccine development, an understanding of 
ýmunologicaI reactivity to these cryptic epitopes may be impor- 
'? t in the development of . rutoimmunity Plum et al. ( 1997) have 
Jggested that targeting exogenous antigens into specialized 
recessing compartments within antigen-presenting cells 
Spears to be important in epitope selection and immunodomi- 
Oce The final outcome of the immune response may be an 
'tmunochemical phenomenon that is related to the protein 
ructure or the host's immunoregulatory mechanisms, however, 
also appears to be effectively used by various pathogens as it 
')st evasion tactic 'T'his occurs when the microbial immuno- 
'iminant epitopes are sterically close to antigens which have the 
, pacity to demonstrate inl igenie diversily or are capable of anti- 
"nic variation Thus, they help to conceal the micro-organism 
m the host-protective responses (Nara et at , 
I998) (AO) 
In the field of periodontal research, the term 'immunodomi- 
unce' has been used imprecisely, and is poorly defined arid 
ten misrepresented-There irre multiple reports in the literature 
-urportedly charrcterizintg immunodominarnt antigens of oral 
r'icro-organisms, yet no clear definition of what is meant by 
munodornin, ince is included, arid the terra is used to describe 
e detection of r high in[ibody liter in in Il, ISA, or substantial 
, ttibody reactivity torn anti}venue molecule that has been visu- 
lized on ,r Western imrnrniohlot Studies by Califano et al (1992) 
A l3oulsi et ir! (1'l')(ß) provide examples of investigations mis- 
sing the term 'Inimunodomina art antigens' in their reports of 
! udies on Actinohacilluu tu ti numywti'mcumilans and I'orphyrononas 
ngiva(is antibody levels in patients I)o Ihese antigens truly 
xpress rin c'pitopc' that is the focus of the primary immune 
55spons(,, .riet which is essential for the initiation of the response 
') the antigen rid micro-organism? (Wickert, ( at, 1984) The obvi- 
ýus answer is that currently we do not know Due to the chronic 
ature of periodontal infections, these objective measures may 
nly be defining the gravimetric quantity of a particular antigen, 
li'ather than describing a function of its unique antigenicity Thus, 
he original definition of immunodominance has been distorted 
'i describe it microbial antigen to which it predominance of anti- 
't'idy is detected when compared with the myriad other antigens 
, resented by the inic_ro-organism and recognized by the host. For 
the purposes of this review, we utilize the term 'detectable anti- 
'jody response' to overcome these difficulties and to avoid con- 
`usion when addressin;; the periodontal humoral immune 
response reports 
(11) The Complexities 
of the Periodontitis Humoral Immune Response 
Periodontal disease is a multifactorial disease with a complex 
polymicrobial etiology. This not only varies between various 
forms of clinical disease, but may also vary at the individual 
patient level. For example, a subject may exhibit a disease 
process associated with a different species or consortia of bacte- 
ria at different disease sites, or recurrent disease exacerbations 
may occur in the context of infection and/or emergence of differ- 
ent pathogenic bacterial species/consortia temporally in the site. 
In this regard, periodontal disease has been difficult to study, due 
to the large number of species comprising the microbial biofilm 
at sites of health and disease, proposed genetic predispositions, 
behavioral variables such as adoption of oral hygiene, and envi- 
ronmental factors (i. e., smoking, and hormonal and socio-eco- 
nomic factors). In addition to these factors, the nature of the 
humoral immune response itself is also controversial. Whether 
the antibody response in this disease is protective or in fact a 
facet of the pathology is unknown one would think that disease 
activity would be abrogated if the antibody response was effec- 
tive at eliminating or controlling the growth of the micro-orga- 
nisms present. That is of course not to say that all pathology seen 
in this disease is directly due to the harmful effects of micro- 
organisms. Production of high levels of pro-inflammatory 
cytokines (IL-6, IL-8, TNF) has been reported (Tsai et al., 1995; 
Yavuzyilmaz et al., 1995), which could result in considerable tissue 
destruction. In this review, however, we are dealing with the 
humoral antibody response in periodontal disease and hence will 
not discuss this issue further. A further consideration in perio- 
dontal disease is that critical clinical features of the disease are 
often identified a substantial period after the biologic processes 
have initiated the disease course. 
(111) Immune Responses in Polymicrobial Infections 
This review addresses our current knowledge of the antigens to 
which a detectable immune response in periodontal disease may 
be directed. However, in addressing this complex issue, one must 
consider that within a complex microbial biofilm, such as the 
subgingival plaque, it appears that selected micro-organisms 
elicit greater antibody levels (i e., dominate the immune 
response) than others (Y. ambon, 1996). This characteristic of the 
host response does not appear to depend entirely on the 
absolute numbers of an individual micro-organism, but may be 
more related to their structural and antigenic components or 
their pathogenic significance (virulence), as well as their distri- 
bution within the biofilm and/or host tissues. An understanding 
of the antigens, which elicit a detectable antibody response, 
should contribute to a better understanding of specific bacterial 
virulence determinants, natural protective responses, and even 
possible strategies for vaccine development, or new approaches 
to immunological screening and diagnosis of the disease. 
(IV) Immunodominance in Microbial Diseases 
A survey of the scientific literature on immunodominant antigens 
in medical infectious diseases provides an indication of the sig- 
nificance of this concept for identifying potential virulence, diag- 
nostic, or vaccine candidates. In the following discussion, we 
have reviewed carefully selected studies to provide examples of 
the variation in the use of the terminology, as well as the poten- 
tial limitations if one equates detectable antibody response with 
immunodominant antigen and protective immune responses. 
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Examples of studies identifying immunodominant and there- 
candidate diagnostic antigens in parasitic infections include 
. 
lies on Neospora canium (Howe et at., 1998). Theilera parva 
tende et at., 1998), Trypanosoma cruzi (Pereira et at., 1998), and 
1istosoma mansoni infection (Chen and Boros, 1998). It is clear 
'-m the literature that often an antigenic relationship to similar 
gens from other parasites, and prevalence of the response 
t. ring infection, is used as evidence to speculate on the impor- 
ce and function for potentially "important" antigens during 
ection. Also, identification of important antigens from these 
'es of studies can lead to a higher degree of sensitivity and 
ecificity in diagnostic documentation. Some studies have even 
, overed information on the disease pathology and progres- 
:n For example, Chen and Boros (1998) identified that the 
`rnunodominant T-cell epitope, P38, of Schistosoma mansoni elicit- 
the pulmonary granuloma formation, which is a disease-asso- 
: ted hypersensitivity lesion of this infection. 
There have also been several similar studies which focused 
dominance in bacterial or fungal infections. The mortality 
e for systemic candidosis remains high. However, the diagno- 
is somewhat difficult, and there has been considerable inter- 
in developing a reliable serodiagnostic test. Mathews et al. 
88) identified the 47-kDa component of Candida albicans as an 
'nmunodominant antigen' in the serology of systemic candido- 
These investigators suggested that the 47-kDa antigen 
eems to be immunodominant, and 92% of patients with candi- 
mýl antibodies produced a response to an antigen of 47 kDa 
`4athews et al., 1984,1987). Therefore, it was proposed that this 
: Itigen is conserved in structure between strains, and an assay 
1etecting this antigen would be the basis for a sensitive and 
,, ecific diagnostic test. 
Further interesting and important knowledge has been 
: sned from studies involving immunodominant antigens and 
e quest to identify them. The Mycobacterium avium complex 
1', IAC) consists predominantly of Mycobacterium avium and M. intra- 
%'lulare (Inderlied et al., 1993). MAC members are ubiquitous envi- 
`: nmental micro-organisms, and infection in healthy individuals 
I: rare. However, MAC infection is a major cause of bacterial mor- 
"Aity and mortality in AIDS patients. A recent study by Triccas et 
ý' (1998) reported, after a molecular and immunological analy- 
-ýs, that a 35-kDa protein of M. aviurn is a 
homologue of the 35- 
'Da immunodominant antigen of M. leprae (Triccas et at., 1996). 
`ie 35-kDa protein of MAC was confirmed to contain T-cell and B- 
°II epitopes recognized by human immune responses following 
., 1cobacterial infection, but it was discovered that, immunologi- 
ýIly, there is an inability to distinguish between MAC and M. 
+berculosis, even though the 35-kDa protein is not recognized by 
Jberculosis patients. Although this is an example of a study 
here an antigen eliciting detectable antibody responses is iden- 
`led, it does not lead us to a potential vaccine candidate or any 
her markedly positive conclusion, For both tuberculosis and 
Ycobacterial infections, early diagnosis is crucial for the prog- 
isis of the patients, and therefore emphasizes a situation where 
-ýe use of a 
detectable antibody response for differential diagno- 
is critical. 
Studies investigating dominant antigens, even if they are not 
'. rimarily designed to do this, can answer crucial questions. Otitis 
edia is a common problem associated with high morbidity, in 
, ihich a subset of children experience repeated episodes caused 
,i non-typeable Hernophilus influenzae (NTHI). Murphy and 
'/ungcheol (1997) have shown that the principal antibody 
'-, ponse in animals to an NTHI strain was directed at an 
immunodominant epitope of the P2 molecule, which is the major 
outer membrane protein of NTHI. However, what this group 
hypothesized is that the otitis-prone children develop an anti- 
body response to an immunodominant region of the P2 mole- 
cule, but that this region is strain-specific. Therefore, the child's 
protective response is directed exclusively at the infecting strain, 
and hence, he/she will experience recurrent episodes of otitis 
media, since he/she has no protection against a new strain. The 
discovery of the dominant antigen associated with this infection 
has further important implications, in that it contributes to our 
understanding of the recurrent nature of otitis media, and pro- 
vides useful data on a potential vaccine design for this disease. 
As mentioned in the preceding section, the importance of T- 
cell immunodominant epitopes is clear and must be distin- 
guished from those eliciting a dominant B-cell response. Listeria 
monocytogenes secretes proteins associated with its virulence in the 
infected cells, which are degraded by host cell proteasomes, (AO) 
processed into peptides, and bound to MHC class I molecules. 
These antigen epitopes are effectively presented to cytolytic T- 
cells (CTL). Interestingly, results of Pamer et at. (1997) indicated 
that immunodominant T-cell responses cannot be predicted by 
the prevalence of antigens or epitopes. In fact, one of the least 
prevalent epitopes primes for the immunodominant CTL 
response in mice. 
These are all examples of the purported significance of iden- 
tification of immunodominant antigens and the potential bene- 
fits in medically important infections. Utilization of the antigen(s) 
to create diagnostic tools and develop vaccines attaches greater 
value and relevance to the search for these types of antigens. 
(V) Periodontal Pathogens 
Concerns about identifying periodontal pathogens as true etio- 
logical agents in the disease process still exist. Many of these 
candidate pathogens may be merely opportunistic and depend 
on the biofilm "food web" to create the conditions or niche with- 
in which they can colonize, obtain nutrients, and replicate. Thus, 
these micro-organisms would not classically be considered as the 
true pathogens to which host defense mechanisms should be 
directed. In spite of the potential microbial complexity of this 
disease, several candidate species have emerged which are 
thought to play a role in the pathogenesis of periodontal disease. 
These micro-organisms generally fulfill the modified Koch's pos- 
tulates as described by Socransky and Haffajee (1992). 
Examination of numerous proposed periodontal pathogens 
has resulted in the determination that these micro-organisms 
possess a variety of potential virulence factors and structures that 
may be crucial to their pathogenicity. In the quest for the identi- 
fication of the more important bacterial antigens in periodontal 
disease, different research groups report, sometimes with con- 
flicting results, different potential candidate antigens. 
(A) OUTER MEMBRANE PROTEINS 
Much of the periodontal literature applicable to this review topic 
covers studies on the Outer Membrane Proteins (OMPs) of perio- 
dontal pathogens. OMPs of Gram-negative bacteria may reside 
on the inner or outer layer, or can span the entire outer mem- 
brane. Gram-negative bacteria possess multiple OMPs which pro- 
vide important biological functions, such as phage receptors or 
receptors for uptake of nutritional substrates. In this regard, vari- 
ous specific microbial antigens have been identified from the 
outer membranes of oral pathogens, and have been suggested to 
play a role in periodontal disease. However, many studies have 
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'Ified outer membrane antigens of the same micro-orga- 
-s, which remain uncharacterized and may be of importance 
='otection afforded by the adaptive host immune response 
'anabe et al., 1989; Califano et al., 1989,1992; Wilson et al., 
(AQ) Page et at., 1992). These studies have tended to focus 
: ther sonicate antigens or Outer Membrane Proteins which 
3e sheared from the surfaces of the bacteria (Nakagawa et a! , Since these two preparation methods differ in the fact that 
produces just surface antigens and one consists of the $ 
rity of the antigens of the bacteria, both internal and exter- 
ýne could estimate both antibodies to intracellular antigens, 
, ell as to the surface antigens. Similar results, however, might 
expected. It seems unlikely that patients would produce an 
#,; of antibodies to "inaccessible" intracellular proteins, and 
re likely that antigens eliciting a detectable antibody response 
Id be expressed on the microbial surface or as secreted pro- 
's The majority of the outer membrane components of puta- 
periodontopathogens remain uncharacterized with respect 
Heir metabolic or structural functions or their activity as viru- 
'e determinants. In general, patients with strong responses to 
>e individual antigens often tend to be those who have a 
! 'eng response to the whole bacterial cell. 
Nakagawa et at. (1995) reported detection of antibodies to 
tarent 'immunodominant antigens' of P. gingivalis in the sera of 
t periodontitis patients, which were specific for antigens of 75 
31 kDa molecular weight from outer membrane preparations, 
a 46-kDa antigen from sonicated extracts of the micro-orga- 
m. Further studies identified 75-, 55-, and 43-kDa bands in 
'' )le-cell sonicates of P. gingivalis to be 'immunodominant anti- 
"'s' in rapidly progressive periodontitis patients (Chen et at., 
`15). A similar approach was utilized by Ebersole and Steffen 
They documented 'immunodominant antigens' in outer 
mbrane preparations from various strains of P gingivalis. The 
-, alts identified some similarities in antibody recognition of 
`"gen bands across strains; however, a striking variability was 
ced between the strains. Additionally, variations in response 
'terns were noted to be associated with high- and low-response 
ý'; ents, regardless of the clinical disease classification. 
Ebersole et al. (1995) and others (Watanabe et at., 1989; 
stad et al., 1990; Sims et al., 1991) have used Western 
rnunoblot approaches to detect antibody responses specific 
antigens in the outer membranes from A. actinornycetemcorni- 
Interestingly, these studies revealed a striking variability in 
ponces among individual patients, thereby posing a potential 
ma regarding the identification and/or importance of an anti- 
that dominates throughout a patient population. 
'srnatively, Flemmig et al. (1996) demonstrated IgG/IgA anti- 
. diy activity in Early Onset Periodontitis (EOP) (65%/70%) and 
lt Periodontitis (AP) (45%/55%) patients reactive with a 110- 
O MP of A. actinornycetemcomitans. In contrast, control subjects 
no IgG, and only 5% had any IgA antibody activity. This 
"proach exemplifies a strategy whereby a 
high frequency and/or 
'I of antibody is detected to a particular antigen in patients vs. 
-'troll, which is then suggested to be an immunodominant 
"'igen. Each of these studies aimed to identify immunodomi- 
: rit antigens as macromolecules which may play an important 
1, in the pathogenesis of periodontal 
diseases, and to correlate 
response with disease resistance. In fairness to the authors, 
yny of these studies probably identified the molecular weight 
antigens which elicited a detectable antibody response in this 
ease, but none of these studies obtained sufficient evidence 
'lirative of the presence of an immunodominant antigen. 
Importantly, the OMPs are uniformly immunogenic, and 
many demonstrate antigenic diversity (heterogeneity) (Holt and 
Bramanti, 1991, Holt and Ebersole, 1991; Mitchel, 1991). (AO) 
Moreover, environmental changes altering the growth of numer- 
ous micro-organisms, such as Bordetella Pertussis, have been shown 
to result in antigenic modulation of outer membrane proteins 
(Robinson et al., 1986). Genco and colleagues (1991) presented the 
concept of the potential importance of antigenic heterogeneity as 
a virulence strategy for oral micro-organisms. Recent studies by 
Ebersole and colleagues (1995) with A. actinomycetemcomitans, Chen 
et at. (1995) with R gingivalis, and Sims et a!. (1998) with B. fürsythus 
have supported antigenic diversity of these pathogens within 
infected patients, but there remains minimal information of its 
potential role in virulence within the periodontal microbiota. 
The previously mentioned studies are representative of 
strategies which have been used and provide examples of some 
potentially interesting targets. However, they only "scratch the 
surface" in providing an understanding of the antigenic epitopes 
which activate the regulatory T-cells and effectively stimulate 
regional B-lymphocytes which could provide a functional host 
immunity in periodontal disease. Current genome sequencing of 
these pathogens will allow us to visualize the organization of 
these protein genes, as well as enhancing studies of genetic and 
antigenic heterogeneity within the population. Sequencing, 
purification, and functional studies of these antigens will encour- 
age evaluation of their significance in well-characterized patient 
and control populations, as well as in in vitro and in vivo models of 
disease. More importantly, from the perspective of this review, it 
is not clear that the concept of a 'dominant antigen' is critical to 
the ultimate goals of periodontal research. As mentioned previ- 
ously, high antibody levels or frequency to an antigen does not 
necessarily define immunodominance of the antigen, but rather 
delineates a dominant antibody response. If this is directed to a 
'flak antigen', an antigen capable of significant diversity or varia- 
tion, or having little contribution to the pathogenicity of the 
micro-organism, the detection of a dominant antibody response 
does not inherently describe an immunodominant antigen or 
provide insight into immune-protective responses 
(B) FIMBRIAE 
The available literature supports that fimbriae of P. gingivalis are a 
target of the humoral immune response in periodontal disease 
patients, although a lack of antibodies reactive with fimbriae in 
patients has not been defined as increasing disease risk. This has 
been delineated in various disease populations, with a general 
finding of increased levels and frequency of serum antibody to 
the fimhriae or fimbrillin subunits (Okuda et al., 1988, (AO) Ogawa 
et al., 1989, Genco e( al., 1991 ). Recently, Condorelli et al. (1998) 
reported the detection of IgA antibodies in the gingival crevicular 
fluid (GCF) of patients with acute recurrent periodontitis. The 
antibodies were specific for the purified 43-kDa fimbrial antigen. 
Thus, it appears clear that both a local and a systemic humoral 
immune response are generated to this antigen in many perio- 
dontitis patients. Evidence that firnbriae are immunodominant 
antigens in periodontal disease, or in fact in other infectious dis- 
eases, is generally lacking. 
(C) LIPOPOLYSACCHARIDE 
Numerous studies have demonstrated that the serotype deter- 
minants of Aa ctinomycetemcomitans are associated with a high- 
molecular-weight LPS-associated antigen (Califano et al , 
198 9) 
or carbohydrate smear antigen (Califano et al., 1989, Sims et al, 
Cril Rev Oral E3ioI Med 12(2)-000-000 (2001) 
'; i. Interestingly, in Early Onset Periodontitis (EOP) patients 
the highest serum antibody levels to A. actinornycetemcomi- 
the predominant antibody specificity is to the LPS (Okuda 
al, 1986; Wilson, 1991; Califano et al., 1992, Wilson and 
rnilton, 1995). Moreover, while LPS has generally been 
aught to exhibit immune-stimulating characteristics which 
T-cell-independent, and thus induce principally an IgM 
aonse, it is clear that EOP patients produce substantial lev- 
of IgG antibody to this antigen from A. actinomycetemco nitans 
et al., 1993). This antibody also demonstrates apparent sub- 
: )s specificity, in that it is primarily/exclusively of the IgG2 
. class (Lu et al., 1993). The level and characteristics of this 
iinant antibody response suggest that an anti-LPS response 
significant marker of A. actinomycetemcomitans infection and 
sting periodontitis. However, whether the LPS represents a 
'Jlence determinant, a true immunodominant antigen, or an 
'igen to which the adaptive immune response can provide 
. tective immunity remains to be delineated. 
The literature is replete with studies reporting a significant 
-valence of periodontal disease patients with high titers of 
'+um IgG antibodies to P gingivalis, although the temporal acqui- 
on of the antibody response relative to colonization and/or the 
`ectious processes associated with this micro-organism have 
ý. t been clearly delineated. Thus, strategies involving animal 
Aels have been developed to examine the acquisition and 
Qcificity of potential protective immunity. A recent study by 
Esel et al. (1996) reported that immunization of monkeys with a 
iccine containing a monkey isolate of P. gingivalis induced pro- 
41tion against alveolar bone destruction. 
Consequently, the validity of targeting LPS from oral 
'dhogens as an immunodominant antigen 
from the perspective 
identifying naturally protective responses for the purpose of 
evention or intervention through vaccine implementation is 
il fraught with critical unknowns. Nevertheless, it appears that, 
least with certain periodontopathogens, the detectable anti- 
'ody response to these types of antigens may provide some use- 
.I diagnostic information. 
(D) HEAT-SHOCK PROTEINS 
. '! tidies supporting the importance of Heat-shock Proteins 
have 
`en reported in the periodontal literature for some time. 
munoblot analyses with purified P gingivalis GroEL revealed 
at it was recognized by antibody in 8/10 sera from patients test- 
and in only 3/9 healthy controls (Maeda et al., 1994). Evidence 
this nature, however, does not warrant a further discussion of 
'is antigen in a review looking at immunodominance. 
(E) LEUKOTOXIN 
'=riodontitis patients with A. actinomycetemcomitans infections 
'nerally demonstrated extreme elevations in antibody to 
"ikotoxin (Califano el al., 1989; Ebersole et al., 1991; Gunsolley 
al_ 1991), suggesting that it is a strong immunogen. This has 
confirmed in both non-human primate (unpublished 
')servations) and rodent models (Shenker et al., 1993). Details 
4en 
the human response consistently showed elevated leukotox- 
antibody in localized early-onset periodontitis (LEOP) 
-7tients (McArthur et al, 
1981; Tsai et al., 1981; Ebersole of a!., 
')831. Relative to the focus of this review, a crucial point is that 
antibody to the leukotoxin was not a dominant antibody 
`sponse in these patients. As mentioned previously, the mag- 
tude of response was clearly to the LPS and serotype determi- 
nants from A. actinomycetemcomitans. The resulting interpretations 
suggested that LPS was an immunodominant antigen, and thus 
the response to this molecule should be the focus of immuno- 
logical efforts to interfere with its pathogenicity. Although the 
biologic relevance of the leukotoxin as a virulence factor has not 
been clearly demonstrated in vivo, recent genotypic studies sup- 
port the concept that A. actinomycetemcornitans isolates which 
have an altered promoter region, resulting in enhanced leuko- 
toxin production, are most frequently associated with disease 
sites in selected populations (DiRenzo et al., 1994; (AO) Haubek 
et at., 1995). Additionally, analysis of recent data suggests that 
leukotoxin antibody levels may be more discriminatory than 
antibody to the whole bacteria (Califano et at., 1997). 
Furthermore, limited evidence from animal models has sug- 
gested that challenge by leukotoxin, of a human immune system 
reconstituted into mice, led to the induction of antibodies 
which correlated with some protection from lesion formation 
(Shenker et al, 1993). Therefore, while the reactivity of humans 
to the leukotoxin cannot be considered a 'dominant' response, 
there appear to be 'dominant epitopes' on this antigen which 
can consistently elicit antibody in infected subjects that 
appears(AO) to ameliorate the effects of this toxin. 
Consequently, the use of antibody to the leukotoxin as a bio- 
marker for this disease, and as an immunological target, seems 
worthy of continued investigation. 
(VI) Concluding Remarks 
As mentioned previously, the examples in this review are to pro- 
vide an overview of the approaches and strategies which have 
been used in medical infections and are currently being used in 
periodontal infections to examine the concept of immunodomi- 
nant antigens. (AO) Where does the future lie for the immu- 
nodominance concept in periodontal disease research? 
'Immunodominance' in periodontal disease may be a relevant 
entity. However, with the complexity of this polymicrobial infec- 
tion and the intertwining of the relationships within the microbial 
ecology, the plethora of host and microbial variables may make 
any successful exploitation of any intervention strategy based on 
the immunodominance concept difficult to implement in this dis- 
ease. This concern is exemplified by the breadth of studies sup- 
plying often-disparate findings regarding the antigenic specificity 
of dominant host responses to the group of putative pathogens 
One important consideration emphasized in this review is 
that future studies and published reports must be more careful in 
their use of the term 'immunodominance'. Authors should be 
clear what they mean by this term and must define it for their read- 
ers. 'Immunodominance' is a term too readily used in an unquali- 
fied manner, leading to much confusion and misinterpretation. 
If the identification of immunodominant antigens is rele- 
vant and additional supportive knowledge is gained, we would 
suggest that utilization of these critical antigens for screening 
and diagnosis of the disease, as well as using them as targets for 
vaccine development, will be not only feasible but also desir- 
able. This is a rich area for future periodontal disease research, 
and we anticipate that additional data will more accurately 
identify whether critical antigens are immunodominant or are 
just the target of a detectable antibody response. Importantly, 
this area of research will require multidisciplinary expertise 
from "chairside to lab bench" in linking clinical, microbial, and 
immunological knowledge and techniques to elucidate this as- 
yet-elusive target. 
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Etiopathogenesis of periodontitis 
in children and adolescents 
DENIS F. KINANE, MICHELLE PODMORE & JEFFREY EBERSOLE 
This chapter provides an account of knowledge on 
the etiopathogenesis of the various periodontal dis- 
eases that affect children and adolescents. This is 
currently an area of active research, and many chal- 
lenging questions remain. In many cases we have in- 
sufficient knowledge to be definitive about the pro- 
cesses involved. This chapter describes the processes 
pertinent to the periodontal diseases, with particular 
emphasis on the inflammatory and immune re- 
sponses occurring in the periodontal region during 
gingivitis and periodontitis. 
This chapter will be structured in the following 
way: firstly the basic elements of the host response 
processes relevant to periodontal disease will be re- 
lated; then follows a description of how the pro- 
cesses interact in the pathogenesis of the diseases; 
and lastly the specifics of the host response which 
may be relevant to the causation and diagnosis of 
the various forms of periodontal disease will be con- 
sidered. 
As described in the first chapter in this volume, 
the periodontal diseases affecting children and ado- 
lescents are numerous. These diseases can be con- 
veniently grouped into the following entities: gingi- 
vitis; early-onset forms of periodontitis; necrotizing 
gingivitis and periodontitis; incipient adult peri- 
odontitis; and periodontitis associated with systemic 
diseases. Further categories exist within these broad 
definitions, in particular, gingivitis has many forms, 
but in children the puberty-related form is common 
and most significant. Similarly, early-onset peri- 
odontitis has several categories namely: prepubertal, 
which can be localised or generalized; early-onset 
periodontitis, which again can be localised or gener- 
alized; and incidental early-onset periodontitis (not 
extensive enough to fit any other category). All of 
the early-onset periodontal diseases are initiated by 
dental plaque and result in destructive disease pro- 
gression in susceptible individuals. The susceptibil- 
ity criteria for these diseases remain elusive; the im- 
mune causation could be due to variations or defects 
in the host response to the plaque, however, the im- 
mune and inflammatory responses during the devel- 
opment and progression of periodontitis are highly 
complex, making inferences more difficult to draw. 
For example, reduced neutrophil chemotaxis has 
been reported in localized early-onset periodontitis 
and generalized early-onset periodontitis (93,94, 
319,320,323-325) but is not a consistent finding 
across all populations (152,153). If the abnormalities 
actually exist, they do not appear to predispose the 
patient to other diseases, suggesting that these are 
either mild abnormalities or only relevant in the 
periodontal environment (152,153). 
In the many cases where periodontal disease is 
predisposed to by systemic disease, identifiable 
components of the immune or inflammatory pro- 
cess may be impaired or absent. In leukocyte ad- 
hesion deficiency or neutropenia, the systemic de- 
fect is obvious. The effect of the absence of this com- 
ponent in the host response can be deduced from 
the description of the normal immune and inflam- 
matory responses in periodontal disease. The patho- 
genesis of the periodontal destruction in the forms 
related to systemic diseases is covered in the chapter 
by Gonzalez & Meyle (203) in this volume. 
A pertinent aspect when considering periodontal 
disease in children is the hormonal influences on the 
tissues and the host response, which are particularly 
relevant in pubertal gingivitis. In addition, the 
known variations in the host response in early-onset 
periodontitis are described, but the genetics of this 
and other periodontal diseases are dealt with fully in 
a further chapter in this volume. Briefly, early-onset 
periodontitis is clearly a familial disease with an 
autosomal dominant mode of inheritance. Genes 
coding for several aspects of the host immune re- 
sponse have been suggested as candidate markers 
to be investigated in early-onset periodontitis. These 
have included allelic variations in the Fc receptor for 
immunoglobulin G-, (264,343). The interleukin-1 
polymorphisms associated with adult periodontitis 
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have not, however, been found in the early-onset 
periodontitis patients studied and further may sug- 
gest intrinsic differences between these disease enti- 
ties. 
The early-onset forms of periodontal disease most 
probably share a common pathogenic pathway, 
which may, in fact, be similar to that of adult peri- 
odontitis, although the causal pathways may differ 
considerably. The predisposing aspects responsible 
for the much earlier onset and more rapid destruc- 
tion in early-onset forms of periodontitis are prob- 
ably genetically related but are still not fully under- 
stood. Thus, the pathogenesis of adult periodontal 
disease is covered in some detail and points relevant 
to children and adolescents are highlighted. The eti- 
opathogenesis of necrotizing forms of periodontitis 
are quite unique and are also discussed. 
The host defenses in periodontal 
diseases 
The host defense system comprises a collection of 
tissues, cells and molecules whose function is to 
protect the host against infectious agents (275). 
The immune response may be subdivided into two 
broad divisions, the innate (nonspecific) and the 
adaptive (specific) responses. Innate reactions in- 
clude the inflammatory response and do not in- 
volve immune mechanisms. Adaptive or immune 
responses tend to be more effective, as the host re- 
sponse is a specific immune response to the of- 
fending pathogens. 
Innate immunity represents an important first line 
of defence against infectious agents. This type of im- 
munity is present from birth, is not enhanced by 
prior exposure and lacks memory. The innate re- 
sponse has the advantage of speed, but lacks speci- 
ficity and may cause host tissue damage. Innate im- 
munity entails a number of elements, both cellular 
and noncellular. Physical barriers such as the skin 
and mucous membranes represent a component 
that infectious agents must breach to gain access to 
the host. The washing action of fluids such as tears, 
saliva, urine and gingival crevicular fluid keeps mu- 
cosal surfaces clear of invading organisms and also 
contain bactericidal agents. 
The intact epithelial barrier of the gingiva, sulcular 
and junctional epithelium normally prevents bac- 
terial invasion of the periodontal tissues. It is nor- 
mally an effective physical barrier against bacterial 
products and components. The epithelial cell wall, 
secreted proteins and fatty acids are toxic to many 
microbes. Salivary secretions provide a continuous 
flushing of the oral cavity as well as providing a con- 
tinuing supply of agglutinins and specific antibodies. 
Furthermore, the gingival crevicular fluid flushes the 
gingival sulcus and delivers all the components of 
serum, including complement and specific anti- 
bodies. 
The microbial biofilm that colonizes the tooth sur- 
face releases large quantities of metabolites that may 
diffuse through the junctional epithelium. These 
metabolites include fatty acids, peptides and lipo- 
polysaccharides of gram-negative bacteria. By re- 
leasing proteolytic and noxious waste products, 
plaque microorganisms may damage cellular and 
structural components of the periodontium. As well 
as releasing these waste products, microorganisms 
could also invade the soft tissues. 
Microorganisms produce a large variety of soluble 
enzymes in order to digest extracellularly host pro- 
teins and other molecules, thereby producing nutri- 
ents for growth. They also release numerous meta- 
bolic products, such as ammonia, indole, hydrogen 
sulfide and butyric acid. Among the enzymes re- 
leased by bacteria are proteases capable of digesting 
collagen, elastin, fibronectin, fibrin, and other com- 
ponents of the intercellular matrix of epithelial and 
connective tissues. The released waste products 
stimulate junctional epithelial cells to release various 
inflammatory mediators including interleukin-1, 
prostaglandin EZ and matrix metalloproteinases, all 
of which can transverse the junctional epithelium 
and enter the crevicular fluid (1). 
The normal flora of the body can also act as an 
effective buffer against infection, by inhibiting the 
growth of pathogenic organisms by competition for 
nutrients or production of inhibitors. Phagocytic 
cells in the blood stream and tissues can destroy in- 
vading agents. These include polymorphonuclear 
leukocytes (or neutrophils), monocyte/macro- 
phages, and natural killer cells. Finally, there are the 
soluble components. These consist of a wide range 
of molecules that are normally protective, but, how- 
ever, can also damage microbial cell walls, aid 
phagocytosis and cell recruitment or prevent cellular 
infection. These soluble components include lyso- 
zymes, antimicrobial peptides, cytokines, acute- 
phase proteins, complement components and Inter- 
ferons. 
The persistence of an infection in spite of the ac- 
tions of the innate immune response leads to the 
induction of an adaptive immune response. Adaptive 
immune responses are characterized by 1) specificity 
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for the offending antigen(s), 2) memory, which 
allows a more rapid and heightened response upon 
reinfection by the same or closely related antigen, 3) 
diversity, the ability to respond to a wide range of 
different antigens, and 4) self versus non-self recog- 
nition. The adaptive immune response can be subdi- 
vided into humoral and cell-mediated immunity. 
Humoral immunity is mediated by antibodies, 
whereas cell-mediated immunity involves the direct 
action of immune cells. 
The lipopolysaccharides of gram-negative micro- 
organisms are capable of invoking both the in- 
flammatory and immune responses as it interacts 
with host cells. The immune response will result in 
further release of cytokines and proinflammatory 
mediators, which in turn will increase the inflam- 
mation and thus be more harmful to the host. The 
quality of the host inflammatory response is critical 
to the disease process. Although its purpose is pro- 
tection and prevention of bacterial invasion into the 
tissues, it is also detrimental, as, it can be an ineffec- 
tive, chronic and frustrated response that actually 
causes much of the tissue damage that occurs in 
periodontal disease. Inflammation, acute and 
chronic, nonspecific and immune-mediated, all play 
a role in periodontal disease. The components of 
these responses are now considered. 
Inflammatory mediators 
Inflammatory mediators play a major role in acute 
and chronic inflammation, and there is a strong evi- 
dence for participation of these mediators in peri- 
odontitis. These comprise a range of interacting 
molecules that include the cytokine system, protein- 
ases, proteinase activators, thrombin, histamine, 
prostaglandins, leukotrienes, tissue and blood fac- 
tors such as Hageman's factor, complement and clot- 
ting factors. The purpose of these and many other 
mediators is to initiate and perpetuate and eventu- 
ally terminate an inflammatory response to insult. 
In the periodontium they are produced by activated 
resident gingival cells and infiltrating leukocytes. In 
the blood plasma they are produced by the comple- 
ment cascade and kinin system. Monocytes from in- 
dividuals susceptible to or suffering from severe 
periodontitis produce elevated amounts of me- 
diators (87). Mediators are present in inflamed gin- 
giva and gingival crevicular fluid from diseased sites 
in high concentrations (221). Concentrations of in- 
flammatory mediators typically decrease following 
successful periodontal therapy. There now follows a 
discussion of the various components capable of 
promoting, sustaining and terminating inflamma- 
tory and immune reactions. 
Cytokines 
The term "cytokine" is derived from the Greek 
words kytos meaning cell, and kinesis, meaning 
movement. Cytokines are low-molecular-weight 
polypeptides of (5-70 kDa) (17). They function as 
soluble mediators produced by cells, to regulate or 
modify the activity of other cells. The cytokines 
can be broadly split into two groups, those in- 
volved in inflammatory and immune reactions and 
those involved in tissue growth and repair (growth- 
and colony-stimulating factors). 
The first group is further subdivided into: 
" the interleukins transmit information between 
leucocytes; 
" the chemokines (chemotactic cytokines) involved 
in cell recruitment; and 
" the interferons that influence lymphocyte activity. 
Various cells secrete cytokines in response to injury 
or stimulation. These proteins are biologically active 
in even femtomolar concentrations. Most cytokines 
are multifunctional molecules that act locally and 
have a variety of target or effector cells (341). Cyto- 
kines act by binding to specific receptors on the sur- 
face of effector cells, which then stimulate intracellu- 
lar activation of the cell. In certain situations recep- 
tors become saturated and cytokines such as tumor 
necrosis factor, interleukin-1 and interleukin-6 may 
spill over into the systemic circulation and stimulate 
distant tissues and organs (216). 
Collectively, the cytokines and other related mol- 
ecules form a complex network that controls the in- 
flammatory and immune responses (356) and sub- 
sequent tissue healing. Many cytokines have over- 
lapping functions, and some may inhibit the action 
of others (156). A cytokine may have different forms 
of receptors that may produce opposing actions, and 
paradoxically, elevated levels of proinflammatory 
cytokines may be evident during periods of healing 
as well as during destructive phases. These are im- 
portant considerations when interpreting peri- 
odontal studies of single or even combinations of 
cytokines. These studies may not reflect the true 
situation in the living organism (356). 
Cytokine regulation is achieved through several 
mechanisms. Control of cytokines can take place at 
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the gene activation level, during secretion and circu- 
lation and at the cell receptor level (17). Cytokine 
production is usually short-lived and self-limiting 
(137). In addition, many cytokine receptors exist in 
soluble forms, which may be cleaved from the target 
cells, allowing them to bind and neutralize cytokines 
extracellularly (17). Thus, the local tissue environ- 
ment influences cytokine and cytokine receptor ac- 
tivity. Proinflammatory cytokines are also regulated 
by high-affinity autoantibodies and anti-inflamma- 
tory cytokines such as interleukin-1 receptor antag- 
onist, interleukin-4 and interleukin-10 (17). 
Interleukin-1 
In humans, two distinct interleukin-1 gene products 
have been cloned interleukin-la and interleukin-1ß. 
Sources of interleukin-1 production includes mono- 
nuclear phagocytes, keratinocytes (186), fibroblasts 
(126), endothelial cells (204) and osteoblasts (120). 
Interleukin-1 is a major mediator in periodontitis 
(235,289). Production is induced by lipopolysac- 
charide and other bacterial components and by in- 
terleukin-1 which is autostimulatory (216). Interleu- 
kin-1 is mainly secreted by monocytes or macro- 
phages but can also be secreted by most nucleated 
cells (144,197). 
All three members of the interleukin-1 group (in- 
terleukin-la, interleukin-lß and interleukitt-1 recep- 
tor antagonist) bind to interleukin-1 receptors I and 
interleukin-1 receptors II. Corticosteroids induce in- 
terleukin-1 receptors II messenger RNA synthesis 
and the release of secreted interleukin- 1 receptors II, 
mostly from neutrophils, which may partly explain 
their anti-inflammatory and immunosuppressive ac- 
tions (17). 
Tumor necrosis factor 
Tumor necrosis factor-a is a multipotential cytokine, 
produced mainly by macrophages, with a wide var- 
iety of biological effects similar to interleukin-1 (43, 
170). Tumor necrosis factor-a and interleukin-1 both 
act on endothelial cells to increase recruitment of 
polymorphonuclear leukocytes and monocytes to 
sites of inflammation (20). Tumor necrosis factor-a 
and interleukin-I are key mediators of chronic in- 
flammatory diseases and have the potential to in- 
itiate tissue destruction and bone loss in periodontal 
disease (22). Tumor necrosis factor also mediates 
connective tissue destruction through its action on 
the matrix metalloproteinase system (51,200). Tu- 
mor necrosis factor receptors exist in membrane- 
bound and soluble forms similar to the interleukin- 
I receptors (17). These receptors (secreted tumor ne- 
crosis factor receptors I and secreted tumor necrosis 
factor receptors II) regulate the activity of both tu- 
mor necrosis factor-a and the less potent form, tu- 
mor necrosis factor-ß. 
In addition to interleukin-1 and tumor necrosis 
factor-a, we must consider additional proinflamma- 
tory cytokines such as interleukin-6 and related mol- 
ecules such as the prostaglandins and leukotrienes 
and the inhibitors of inflammatory cytokines such as 
interleukin- 10. 
Interleukin-6 
Interleukin-6 is produced by macrophages, fibro- 
blasts, lymphocytes and endothelial cells. Produc- 
tion is induced by interleukin-1 and lipopolysac- 
charide and suppressed by estrogen and progester- 
one. It may be through interleukin-6 that these 
hormones exert their effects on gingiva. Interleukin- 
6 causes fusion of monocytes to form multinuclear 
cells that resorb bone. 
Interleukin-8 
Interleukin-8 is produced by a wide variety of cell 
types, including polymorphonuclear leukocytes, 
monocytes, fibroblasts and keratinocytes in re- 
sponse to microorganisms, mitogens and endoge- 
nous mediators such as interleukin-1 and tumor ne- 
crosis factor. One of the major functions of interleu- 
kin-8 is its ability to induce the directional migration 
of cells, including polymorphonuclear leukocytes, 
monocytes and T cells (230), thus playing a key role 
in the accumulation of leukocytes at sites of in- 
flammation. 
Interleukin-10 
Interleukin-10 plays a major role in suppressing im- 
mune and inflammatory responses. It is produced by 
T cells, including human ThO, Thi and Th2 cells, B 
cells and monocytes and macrophages after acti- 
vation (55). Interleukin-10 inhibits the antigen-pre- 
senting capacity of macrophages by downregulating 
class II major histocompatability complex express- 
ion. It has also been reported to inhibit antigen pres- 
entation by Langerhans cells (77). Human interleu- 
kin-10 reduces significantly the proliferation and 
production of cytokines by both Thi and Th2 clones 
exposed to specific antigen and phytohemagglutin 
(55). It also has direct inhibitory effects on inter- 
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feron-y production (54,56). Interleukin-10 has been 
found to act as a specific chemotactic factor towards 
CD8+ T cells while suppressing the ability of CD4+ 
T cells to migrate in response to interleukin-8 (145). 
Interleukin-10 is a potent growth and differentiation 
factor for activated human B cells and thus plays an 
important role in amplifying the humoral immune 
response (253). Interleukin-10 inhibits the synthesis 
of interleukin-la, interleukin-6 and interleukin-8 
but enhances the production of the interleukin-1 re- 
ceptor antagonist, so that this cytokine dampens im- 
mune proliferation and the inflammatory response 
(54,89). Interleukin-10 abrogates antigen presen- 
tation by macrophages and indirectly inhibits T-cell 
activation (17). 
The lymphocyte cytokines 
The lymphocyte-signaling cytokines interleukin-2, 
interleukin-3, interleukin-4 and interleukin-5 are all 
involved in lymphocyte clonal expansion, differen- 
tiation of B cells into antibody-producing plasma 
cells and immunoglobulin isotype switching. In- 
terleukin-2 is produced by both CD4+ (helper) and 
CD8+ (suppresser) (142), activated T lymphocytes 
and induces expression of clones of specific T cells 
and secretion of interleukin-3 and interleukin-4. In- 
terleukin-4 regulates immunoglobulin production 
and suppresses activated macrophages and causes 
their apoptosis. 
Transforming growth factor-ß 
Role of matrix metalloproteinases in 
periodontal disease 
Loss of attachment, as occurs in periodontal disease, 
is associated with extensive breakdown of collagen 
fibers in the periodontal tissues. Since the major 
structural protein of the periodontium is collagen, 
the assessment of matrix metalloproteinase levels 
during inflammation will reflect the association of 
matrix metalloproteinases in collagen destruction in 
periodontitis (Fig. 1). The involvement of matrix 
metalloproteinases in pathological tissue destruc- 
tion is well documented, and the evidence for their 
role in periodontal destruction has increased over 
the years. In earlier studies, collagenases has been 
identified in explanted gingival tissues and their cul- 
ture fluids (22,83,249) and in homogenates of gingi- 
val biopsies (316). Collagenase activity has also been 
demonstrated in gingival crevicular fluid, and this 
activity increased with the severity of inflammation 
(101). Further evidence that matrix metalloprotein- 
ases are involved in tissue destruction in human 
periodontal disease were summarized by Birkedal- 
Hansen (22), which includes: 
" cells isolated from normal and inflamed gingiva 
express matrix metalloproteinases in culture; 
" several metalloproteinases can be detected in hu- 
man gingiva cells in vivo; 
" polymorphonuclear leukocytes collagenase and 
gelatinases can be detected in gingival crevicular 
fluid from gingivitis and periodontitis patients. 
Transforming growth factor-ß is produced by acti- 
vated T cells. It is a chemoattractant for monocytes 
and it suppresses their activation. It also induces 
production of immunoglobulin A and immuno- 
globulin G2b. Transforming growth factor-a is pro- 
duced by macrophages and serves as a mitogen for 
fibroblasts, epithelial and endothelial cells. Inter- 
feron-y is produced by CD8+ T cells and is respon- 
sible for recruiting and activating macrophages 
and also upregulates the major histocompatibility 
complex on virally infected cells and targets them 
for killing. 
In summary the cytokine network has a crucial 
role in immune homeostasis. Complex summative, 
overlapping, synergistic and inhibitory interactions 
exist between the various members of this family of 
molecules. This allows for redundancy within the 
system and a high level of fine control which pre- 
vents devastating effects to the host when dysfunc- 
tion or dysregulation occurs. 
Each of the major cell types of human periodontal 
tissues is capable of expressing a unique comple- 
ment of matrix metalloproteinase when properly 
stimulated. The cells include polymorphonuclear 
Fibroblasts 
Collagenase 
Bone resorption 
Tissue 
breakdown 
°° 
°o 0 
0 
Osteoblast Osteoclast 
Fig. 1. Macrophages produced cytokines (such as interleu- 
kin-1) induce fibroblasts and osteoblasts to produce pro- 
teases which result in bone and tissue breakdown. 
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leukocyte, fibroblast, keratinocyte, macrophage and 
endothelial cells. 
Collagenases in tissues may existed in different 
forms, that is, in active form, in inactive form that 
is an enzyme inhibitor complex, or in latent form 
(proenzyme). Total collagenase activity has been 
shown to be high in gingival crevicular fluid of in- 
flamed dogs gingiva (161), in gingival crevicular fluid 
of localized early-onset periodontitis and chronic 
adult periodontitis patients compared with gingivitis 
and control patients (329,330), in gingival crevicular 
fluid of untreated localized early-onset periodontitis 
patients and also that the activity decreased after 
treatment (169). Gingival crevicular fluid collagenase 
activity has been noted to increase with disease se- 
verity, that is, adult periodontitis and localized early- 
onset periodontitis > gingivitis > healthy gingiva 
(329,330). ingman et al. (139) demonstrated that sal- 
iva samples did not reflect periodontal tissue de- 
struction clearly as they found, only low amount of 
total collagenase activity in saliva of untreated local- 
ized early-onset periodontitis patient and the level 
was comparable to normal patients. Ingman et al. 
(140) also demonstrated that in saliva no difference 
in collagenolytic activity could be seen in adult peri- 
odontitis, localized early-onset periodontitis and 
control patients. 
Latent collagenase levels were found to be higher 
in gingival crevicular fluid of gingivitis sites in 
humans and dogs compared to healthy sites (161, 
162,171), and also in normal sites (161). It was also 
detected in the explant of clinically normal tissue 
(125). Higher latent collagenase levels seems to re- 
flect either the normal healthy state or the gingivitis 
state. Little or no active collagenase activity was 
demonstrated in the gingival crevicular fluid of 
healthy and gingivitis sites in dogs (167), but higher 
levels were found in gingival crevicular fluid of local- 
ized early-onset periodontitis compared with normal 
patients (169). Higher levels were also detected in 
gingival crevicular fluid of progressive periodontitis 
patients compared with stable and gingivitis patients 
(171). In whole saliva, high active collagenase activ- 
ity was demonstrated in untreated adult peri- 
odontitis (85,139) and localized early-onset peri- 
odontitis, but as treatment progressed more col- 
lagenase is present in the latent form (85). Higher 
levels of active collagenase correlates with active de- 
structive phases of periodontal disease (171). 
Although there is no direct evidence for a causal 
relationship between matrix inetalloprotcinases and 
periodontal tissue destruction, the evidence for the 
involvement of collagenase in collagen breakdown 
during chronic inflammatory periodontal disease is 
strong. Matrix metalloproteinase-8 is detected at 
high levels in gingival crevicular fluid and saliva dur- 
ing gingivitis or periodontitis, whereas it is undetect- 
able in healthy individuals (139,285). In extracts or 
homogenates of diseased periodontal tissues, matrix 
metalloproteinase-1 is abundantly present in con- 
trast to healthy specimens and, as with matrix 
metalloproteinase-8, a positive correlation was 
found between its presence and the severity of in- 
flammation (231). In addition, matrix metallopro- 
teinase-1 has been immunolocalized in inflamed but 
not in healthy periodontal tissue (348). These data 
may suggest that, following production during in- 
flammation, most matrix metalloproteinase-1 re- 
mains in the gingival tissue, whereas most released 
matrix metalloproteinase-8 finds its way to the 
pocket. 
Adhesion molecules 
It has been recognized that blood vessels play a 
central role in orchestrating the inflammatory and 
immune processes. Blood vessels are lined by en- 
dothelial cells that are activated by cytokines and 
bacterial lipopolysaccharide to become more ad- 
hesive to circulating polymorphonuclear leuko- 
cytes, monocytes, eosinophils, basophils and T and 
B lymphocytes. Thus, the endothelial lining is 
transformed from being anti-coagulant to becom- 
ing pro-coagulant. The changes in the vessels con- 
tribute to the inflammatory changes in periodontal 
disease, but the most important features is the mi- 
gration of leukocytes from the circulation. When 
the endothelial cells become activated they express 
adhesion molecules, such as the intercellular ad- 
hesion molecule-I, that enable specific subpopula- 
tions of leukocytes to bind and subsequently mi- 
grate into the tissues under the influence of 
chemotactic gradients (Fig. 2). Activators include 
the proinflammatory cytokines, lipopolysaccharide, 
interleukin-4 and interferons. In vivo, interleukin-1, 
tumor necrosis factor and Iipopolysaccharide will 
result in rapid accumulation of large numbers of 
polymorphonuclear leukocytes. In contrast, in- 
terleukin-4 and interferon are likely to be more 
important in the recruitment of a mononuclear 
cell dominated infiltrate. 
Intercellular adhesion molecule- I is expressed on 
endothelial cells and shows an increase in express- 
ion after stimulation with interleukin-I, tumor ne- 
crosis factor and interferon (Fig. 2,3). It plays an im- 
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portant part in the adhesion of all leukocytes to en- 
dothelial cells and migration. Evidence for this is 
leukocyte adhesion deficiency, a congenital disease 
with low levels of adhesion molecules. Patients sub- 
sequently suffer from recurrent infections due to in- 
ability of their leukocytes to extravasate into dam- 
aged or injured tissue. A constant and characteristic 
feature of these individuals is a very rapid severe 
generalized prepubertal periodontitis affecting both 
the primary and permanent dentition (335). 
The endothelial cell leukocyte adhesion molecule- 
1 has been found to play an important role in poly- 
morphonuclear leukocytes binding to activated en- 
dothelial cells. It is rapidly induced by interleukin-1, 
tumor necrosis factor or lipopolysaccharide. 
In clinically healthy gingiva, endothelial cell 
leukocyte adhesion molecule-1 and intercellular ad- 
hesion molecule-I are found in postcapillary venules 
in the vicinity of the gingival crevice, with more dis- 
tant vessels being negative. A further finding in the 
study of Moughal et al. (211) 
was 
the observation 
that junctional epithelium expresses intercellular ad- 
hesion molecule-1. This specialized epithelium may 
be adapted to express intercellular adhesion mol- 
ecule-1 constitutively even in the absence of inter- 
feron-y stimulation. This may reflect the fact that 
junctional epithelium is the site of extensive poly- 
morphonuclear leukocytes migration both in health 
and in disease (12,266,269). 
Polymorphonuclear leukocytes 
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Fig. 2. The leucocyte contacts, rolls, sticks and eventually 
extravasates out of the blood vessel prior to beginning its 
journey to the site of inflanunation. 
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Fig. 3. Molecules, cells and process influencing the in- 
creased adherence of leucocytes to bllod vessels so that 
they can extravasate and begin to chemotact towards the 
microbes. 
The polymorphonuclear leukocyte is a phagocytic 
cell and is the predominant leukocyte in blood and 
in the gingival crevice (12). It forms about 62% of 
peripheral white blood cells and about 91% of gingi- 
val crevicular cells recovered by aspiration (278). 
Polymorphonuclear leukocytes are found at sites of 
both gingival health and disease (12). The polymor- 
phonuclear leukocytes is an important cell because, 
along with the integrity of the physical surface bar- 
rier, it forms the first-line defense against invading 
pathogens. Evidence for its crucial role in the de- 
fense of the periodontal tissues comes from experi- 
ments of nature where neutrophils are depleted or 
malfunctioning, such as in neutropenia or Chediak- 
Higashi syndrome, and there is severe and rapid loss 
of alveolar bone and teeth. 
Polymorphonuclear leukocytes develop from plur- 
ipotential bone marrow stem cells and the cells go 
through several stages prior to maturity. The lifespan 
of a polymorphonuclear leukocyte outside the bone 
marrow is short, on average of 7 to 58 hours. As poly- 
morphonuclear leukocytes mature they become 
more deformable, alter their surface charge and ac- 
quire new cell surface receptors (337). Following 
these changes mature polymorphonuclear leuko- 
cytes can cross endothelial barriers in the bone mar- 
row and enter the bloodstream. 
In the circulation polymorphonuclear leukocytes 
form two pools; circulating and marginated. Mar- 
ginated polymorphonuclear leukocytes are stored 
in the small vessels, particularly of the lung and 
spleen. They can be mobilized at short notice in 
times of acute need. The average range of poly- 
morphonuclear leukocyte numbers in the circula- 
tion is 2.5 to 7.5X 109 cells/liter. This number can 
increase 10 fold within 28 hours in times of acute 
inflammation. This rapid and substantial increase 
in polymorphonuclear leukocyte number occurs as 
a result of several processes; transfer of cells from 
the marginated to the circulating pool, increased 
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release of mature cells from the bone marrow and 
an increase in the rate of maturation of cells 
within the bone marrow. 
Numerous surface receptors are present on poly- 
morphonuclear leukocytes (251) of which there four 
major classes: 
" receptors for inflammatory mediators and bac- 
terial products; 
" receptors for lymphokines and monokines; 
" receptors for opsonization (Fc); and 
" receptors for endothelium and proteins of the 
tissue matrix. 
These receptors are used for all stages of polymor- 
phonuclear leukocyte emigration from blood vessels, 
chemotactic movement, recognition of foreign ma- 
terials, its binding and phagocytosis and for the con- 
trol of these processes via lymphokines and monok- 
ines. 
The polymorphonuclear leukocyte has a charac- 
teristic light microscopic appearance with a multi- 
lobed nucleus and numerous cytoplasmic granules. 
The granular component of the cell consists of many 
cytoplasmic granules with an outer membrane en- 
closing the densely packed protein in a mucopolys- 
accharide matrix. 
Three types of granules exist: 
" primary or azurophil granules; 
" secondary or specific granules; and 
" tertiary or C particles. 
Primary granules are identified by their peroxidase 
content. Positive staining for peroxidase is seen in 
the granules, at all stages, and in the secretory ap- 
paratus of polymorphonuclear leukocytes during 
their formation. The contents of the primary gran- 
ules are largely responsible for the non-oxidative kill- 
ing mechanisms of the neutrophil (205), and these 
granules contain: 
" antimicrobial agents or defensins, which include 
myeloperoxidase, lysozyme and cationic proteins; 
and 
" proteinases, which include elastase and cathepsin 
G. 
Secondary granules are peroxidase negative, of low 
density and are twice as numerous as primary gran- 
ules in the mature polyniorphonuclear leukocyte. 
Their size is variable and they are typically spheres 
or rods containing: 
" antimicrobial agents - lysozyme 
" proteinases - collagenase 
" other molecules 
- lactoferrin 
- B12 binding protein 
- laminin receptor (67 kDa) 
- CD11b/CD18 (C3bi) 
- fibronectin receptor alpha 
- vitronectin receptor alpha. 
The release characteristics and kinetics of primary 
and secondary granules are different. Secondary 
granules are released chiefly extracellularly, with the 
granules being found close to the advancing edge of 
cells responding to a chemotactic stimulus (349). 
Evidence of secondary granule release extracellurly 
is more prominent than that of primary granule re- 
lease and occurs at an earlier stage. These phenom- 
enon have been interpreted in the past as indicating 
a secondary and extracellular function of secondary 
granules and an intracellular function of primary 
granules related to phagocytosis (349). 
The process of degranulation is calcium depend- 
ent and is not related to cell death (301,349) with 
lysozymal enzymes released without a rise in lactate 
dehydrogenase, an indicator of cell death. In vitro, 
granule release can be stimulated by dental plaque 
(301), binding of immune complexes and comple- 
ment, binding to nonphagocytosable surfaces and 
passage through membranes (349). 
Polymorphonuclear leukocytes in 
inflammation 
When functioning efficiently against infectious 
agents, polymorphonuclear leukocytes leave blood 
vessels and move across tissues towards a chemo- 
tactic source where they attempt to kill the organ- 
ism. Adhesion molecules relevant to the movement 
of polymorphonuclear leukocytes from vessels are 
expressed on endothelial cells and polymorpho- 
nuclear leukocytes (251). During inflammation the 
molecules appear before those for other leukocytes, 
thus polymorphonuclear leukocytes are the first cells 
to cross the vessel wall. The immediate adhesion of 
polymorphonuclear leukocytes is mediated via up- 
regulation of P-selectin on endothelial cells by 
thrombin or histamine. Stimulation of post-capillary 
venules by inflammatory mediators triggers the up- 
regulation of expression of the endothelial cell ad- 
hesion molecules (291). This functions over 24 
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hours, increasing the interaction of leukocytes with 
the cells of the vessel walls. Various endothelial 
markers including intercellular adhesion molecule- 
1, intercellular adhesion molecule-2 and vascular 
cell adhesion molecule-1 bind to the LeuCAM family 
of integrins, which are expressed on polymorpho- 
nuclear leukocytes. Leukocyte function-associated 
antigen-1 binds specifically to intercellular adhesion 
molecule-1 and intercellular adhesion molecule-2. 
In response to the expression of surface markers, 
the cells change shape and roll along the blood ves- 
sel wall (Fig. 1). They finally stop moving, flatten and 
their membranes develope a ruffled border. They 
then migrate through the endothelial wall. Endo- 
thelial cell leukocyte adhesion molecule-1, which is 
necessary for this migration, is expressed in response 
to interleukin-1 and tumor necrosis factor. Interleu- 
kin-1 and tumor necrosis factor-a thus have a crucial 
role in the control of inflammatory mechanisms fol- 
lowing the initial stimulus. 
Polymorphonuclear leukocytes are capable of re- 
sponding to many different chemoattractants in- 
cluding N-formyl peptides, complement-derived 
C5a, leukotriene B4, interleukin-8 and platelet-activ- 
ating factor (124). Chemoattractant receptors span 
the cell membrane and are GTPase-coupled recep- 
tors. Once outside the vessel, cells migrate through 
the connective tissue towards the chemotactic 
stimulus (Fig. 4). Directed movement of polymor- 
phonuclear leukocytes comes about by the interac- 
tion of specific chemoattractants with surface recep- 
tors on its plasma membrane. This binding activates 
a cascade of secondary intercellular events that lead 
to either chemotaxis or the respiratory burst, de- 
pendent on the chemotactic agent (199). Neutrophils 
stimulated by chemoattractants undergo morpho- 
logical changes, becoming elongated cells with a 
ruffled border. During movement, the anterior edge 
extends forwards and the posterior edge retracts to- 
wards the body of the cell. Adherence of the cells to 
a substratum occurs via the glycoproteins and 
proteoglycans of the extracellular matrix. The con- 
centration of extracellular matrix glycoproteins and 
proteoglycans changes at sites of gingival inflam- 
mation (243), and these molecules can become 
chemotactic for inflammatory cells. Actual cell 
movement occurs by the polymerization of globular 
actin to fibrillar actin, and current models propose 
that the fibrillar actin is involved in the generation 
of the force required for cell movement (229). 
Chemoattractant receptors exist in two intercon- 
vertible forms: high- and low-affinity states (279). 
Chemotaxis is initiated at receptors by concen- 
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Fig. 4. Interleukin-8 is one of the major host produced 
chemotactic agents to attract neutrophils to the gingival 
crevice. 
trations of chemoattractants that are much lower 
than those required to produce the respiratory burst. 
Snyderman & Pike (284) proposed that binding of 
chemoattractant to high-affinity sites results in 
chemotaxis, whereas binding to low-affinity sites re- 
sults in degranulation. Chemoattractants appear to 
be most effective in producing chemotaxis in the fol- 
lowing order of potency: interleukin-8, leukotriene 
B4, C5a, N-formyl peptides and platelet-activating 
factor (199). 
Once at the site of the chemotactic stimulus and 
prior to attachment of the polymorphonuclear 
leukocyte to the invading organism, opsonization 
takes place either in the presence or absence of com- 
plement and antibody. In the presence of comple- 
ment and antibody, activated C3 and immunoglob- 
ulin G bind their respective polymorphonuclear 
leukocyte receptors, CR1 and CR3 for complement 
and Fcy receptor II and Fcy receptor III for antibody. 
Capsular organisms are able to evade this opsoniz- 
ation and phagocytosis due to the masking of the 
antigenic portion of their cell wall by the capsule and 
by avoiding the deposition of complement on their 
surface (280). 
If antibody or complement are not available, then 
alternative systems exist for the opsonization of bac- 
teria. Generally, cell wall antigens determine the ease 
with which an organism is phagocytosed. Lipopoly- 
saccharide-binding protein is an acute-phase reac- 
tant which binds lipopolysaccharide, the cell wall 
component of gram-negative bacteria. The binding 
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of lipopolysaccharide-binding protein to bacteria 
enables binding to the CD14 receptor on polymor- 
phonuclear leukocytes and macrophages, thus en- 
hancing phagocytosis (350). Since gram-negative 
bacteria are abundant in the gingival crevice and 
complement and antibody can be locally destroyed 
(92), it is likely that this system is in operation. 
Following opsonization, phagocytosis can occur. 
Phagocytosis is the process by which the polymor- 
phonuclear leukocyte takes up a particle. It involves 
attachment of the phagocyte to the particle and its 
subsequent engulfment. It starts with the receptor- 
ligand binding between polymorphonuclear leuko- 
cyte and the microbe. This interaction activates the 
ingestion phases which involve actin, myosin and 
actin-binding proteins. The membrane surrounds 
the particle, pseudopodia are produced and a 
phagocytic vacuole is formed. Simultaneously cyto- 
plasmic granules fuse with the phagosome mem- 
brane to form a phagolysosome,. This final fusion of 
the membranes and release of granule contents gen- 
erally results in destruction of the engulfed particle 
(328). 
Once phagocytosed and engulfed by the polymor- 
phonuclear leukocyte, two mechanisms exist to kill 
the organism; oxygen- dependent and oxygen-inde- 
pendent mechanisms (323). Oxygen-dependent kill- 
ing is activated when the polymorphonuclear leuko- 
cyte undergoes a respiratory burst coincident with 
phagocytosis. NADPH in the phagolysosome mem- 
brane is activated and reduces 0, to superoxide 
(340). Following the generation of hydrogen peroxide 
and OH in this reaction, a second enzyme system 
involving myeloperoxidase, a primary granule com- 
ponent, becomes active. Myeloperoxidase is released 
in large quantities but on its own has little effect. In 
combination with H20,, myeloperoxidase is capable 
of catalyzing the oxidation of plasma halides, the 
most important of which is chloride because of its 
concentration. It is at this stage that the interaction 
between chlorinated oxidants, protease inhibitors 
and proteases can occur such that the proteases can 
act efficiently on their substrate (Fig. 5). 
OH is considered the most toxic of all the free rad- 
icals. If this reaction occurs in vivo then the rate- 
limiting step is the availability of iron. Little free iron 
is available due to its binding to transferrin and lac- 
toferrin extracellularly and apoferritin intracellularly 
(259). In the phagocytic vacuole the p11 is reduced 
and some iron may be lost from transferrin; however, 
lactoferrin retains its ability to hind iron at low pll, 
thus protecting the cell and limiting the production 
of 011 (118). 
Oxygen-independent killing is based on the poly- 
morphonuclear leukocyte granule network. Anti- 
microbial agents that are independent of 0., are re- 
leased into the phagolysosome during phagocytosis 
(311). These granule components, including bacteri- 
cidal and permeability-increasing protein, chymo- 
trypsin-like cationic protein and defensins (328,340) 
and those outlined above, are strongly bacteriocidal 
and in most cases effectively kill bacteria (205). In 
addition to killing bacteria, the proteolytic enzymes, 
including elastase and the metalloprotefnases, have 
the potential to damage extracellular tissue and have 
been suggested to operate in periodontal tissues 
(22). 
It has been demonstrated that sera from localized 
early-onset periodontitis patients with decreased 
neutrophil function can modify the activity of 
healthy neutrophils (2). The serum factors respon- 
sible for these effects have been identified as being 
inflammatory mediators such as prostaglandins and 
cytokines. Small quantities of bacterial lipopolysac- 
charide (in the picogram range) can induce the se- 
cretion of tumor necrosis factor-a, interleukin- I and 
prostaglandin E , from monocytes. The production of 
interleukin- l -tumor necrosis factor-a and tumor ne- 
crosis factor-a-prostaglandin E2 are strongly corre- 
lated (208). Very small increases in serum cytokine 
levels can alter neutrophil function. Prostaglandin E, 
and cytokines also stimulate fibroblasts to release 
matrix metalloproteinases, which break down the 
extracellular matrix. In addition, interleukin-1, tu- 
mor necrosis factor-a and prostaglandin E., are po- 
tent stimulators of bone resorption. Adherent mono- 
nuclear cells from localized early-onset periodontitis 
patients have been found to secrete higher levels of 
prostaglandin E and tumor necrosis factor-a than 
generalized early-onset periodontitis patients or 
healthy controls (274). More recently, insulin-de- 
pendent diabetic patients with periodontitis have 
been reported to manifest excessive levels of in- 
flammatory mediators (256-258). It has been sug- 
gested that these observations indicate an underly- 
ing immune defect of monocytes in certain diagnos- 
tic groups (216). 
The concept of excessive inflammatory mediator 
production by monocytes has been proposed as a 
possible causative pathway for periodontitis, and in- 
deed one of the mechanisms whereby periodontitis 
can influence other systemic conditions such as car- 
diovascular disease (216). Early investigations of 
genetic polytnorphisms of cytokines have attempted 
to identify a possible link between different peri- 
odontal categories and specific alleles related to an 
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Fig. 5. The four main processes whereby antibodies can 
detrimentally affect bacteria: 1) inhibition of adhesion or 
invasion; 2) complement mediated killing; 3) neutralis- 
ability to overproduce cytokines (57,84,102,159). In 
addition, a family linkage study of early-onset peri- 
odontitis suggested that the COX-1 enzyme system, 
which acts as a catalyst for the breakdown of arachi- 
donic acid, one of the products of which is prosta- 
glandin E2, may be associated with susceptibility to 
early-onset periodontitis (89). 
A further host defense defect that may increase 
susceptibility to early-onset periodontitis is neutro- 
phil chemotactic defects. A high percentage of mem- 
bers of families with a background of localized early- 
onset periodontitis have been reported to show ab- 
normal neutrophil chemotaxis (323). Analysis of 22 
families with localized early-onset periodontitis 
demonstrated that, in 19 of these families, the pre- 
senting localized early-onset periodontitis patient 
and their family members all demonstrated neutro- 
phil chemotaxis disorders. In these 22 families the 
chemotactic defect was found in almost 50% of the 
siblings, indicating a dominant mode of inheritance 
IgG 
Phagoso 
0 
0 
ation of microbial toxins (cf leukotoxin); and 4) opsonis- 
ation of microbes prior to phagocytosis and enhancement 
of phagocytosis. 
(323). Whether the trait is due to an intrinsic defect 
of neutrophils or is caused by extrinsic factors in the 
sera and thus is environmentally influenced remains 
controversial (2). The neutrophil chemotactic defect 
is not noted in all populations exhibiting localized 
early-onset periodontitis, and a significant number 
of patients and families with localized early-onset 
periodontitis do not show evidence of the defect 
(152,153,232). 
Decreased neutrophil chemotaxis in localized 
early-onset periodontitis has been linked to a re- 
duced receptors density for chemoattractants such 
as N-formyl-methyl-leucyl-phenylalanine, comple- 
ment fragment C5a, leukotriene B4 and interleukin- 
8 (49,52). A cell surface glycoprotein (gp110), which 
is thought to be involved in neutrophil movement 
and secretion, is reduced in localized early-onset 
periodontitis patients (324). In addition, several 
other post-receptor defects have been identified 
(49). De Nardin (53) found that decreased N-formyl- 
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methyl-leucyl-phenylalanine binding was related to 
variations in N-formyl-methyl-leucyl-phenylalanine 
receptor DNA in localized early-onset periodontitis 
patients and healthy controls. These preliminary re- 
sults indicate a possible role for a N-formyl-methyl- 
leucyl-phenylalanine receptor alteration in neutro- 
phil chemotaxis. However, many molecules related 
to neutrophil dysfunction in localized early-onset 
periodontitis patients belong to the same family of 
surface receptors and have similar morphogenic 
characteristics. Similarities in signal transduction 
mechanism between cell surface components also 
exist. De Nardin (53) hypothesized that a common 
underlying defect, at either the cell surface receptor 
or post-receptor level, may contribute to the alter- 
ation in neutrophil function seen in patients with lo- 
calized early-onset periodontitis. 
Fc receptors 
Fc receptors are the receptors found on leukocytes 
that can bind immunoglobulin and are thus relevant 
to the microbial opsonization properties of phago- 
cytes. Some investigators have shown that patients 
with generalized early-onset periodontitis have high 
antibody titers against Actinobacillus actinomyce- 
temcomitans serotype b outer membrane antigens 
(107,310,342). It has also been suggested that the 
subclass IgG2 is a poor opsonin because it fixes com- 
plement less effectively than IgG3 and IgG1 and 
binds weakly to Fc receptors on the surface of 
phagocytes (250), which tends to complicate theor- 
ies of protective effects afforded by high anti-A. acti- 
nomycetemcomitans titers of IgG2 in black localized 
early-onset periodontitis patients. 
However, a further aspect of the immune response 
may yet explain this phenomenon. Fc receptors are 
the crucial link between the humoral and inflam- 
matory components of the host defense system. Fcy 
receptors on phagocytes recognize the Fc region of 
IgG and facilitate opsonization of microbes. It has 
been shown that neutrophils express low-affinity 
variants of Fcy receptors (Fcy receptors II and Fcy 
receptors III) under normal conditions. Fcy recep- 
tors II binds all subclasses of IgG, but Fcy receptors 
III only binds IgG3 and IgGI. Many more Fcy recep- 
tors III than Fcy receptors II are expressed on the 
surface of neutrophils. However, while Fcy receptors 
III can evoke lysosomal degranulation, they cannot 
promote the necessary respiratory burst activity and 
phagocytosis needed for microbial killing of opsonis- 
ed bacteria. Fcy receptors 11, on the other hand, can 
precipitate all three activities. It is possible that Fcy 
receptors III may prepare polymorphonuclear leuko- 
cytes for phagocytosis mediated by Fcy receptors II 
(343). 
It has been reported that the numbers of Fcy re- 
ceptors II and Fcy receptors III on peripheral blood 
neutrophils of localized early-onset periodontitis pa- 
tients are within the normal range (172). Miyazaki et 
al. (205) found that both Fcy receptors II and Fcy 
receptors III expression and neutrophil phagocytosis 
were significantly depressed in gingival crevicular 
fluid compared with peripheral blood in adult peri- 
odontitis patients. The reduction in Fcy receptors 
was significantly correlated with phagocytic activity. 
In addition, the messenger RNA level of Fey recep- 
tors III was also significantly lower in gingival crevic- 
ular fluid neutrophils than in peripheral blood neu- 
trophils but not the messenger RNA level of Fey re- 
ceptors II. These findings indicate local suppression 
of Fcy receptor expression and/or the production of 
Fcy-binding proteins by periodontal pathogens 
(130). 
Adaptive aspects of the immune 
response in early-onset periodontal 
disease 
In contrast to the innate immune mechanisms dis- 
cussed previously, adaptive immune responses are 
not initiated at the site where a pathogen first estab- 
lishes a focus of infection. 
The humoral immune response 
The main function of the humoral immune response 
is the destruction of extracellular microorganisms 
and prevention of the spread of intracellular infec- 
tions. This is achieved by antibodies secreted by B 
lymphocytes. Antibodies induced have many func- 
tions ranging from neutralization, to leading to op- 
sonization. The activation of B cells and their differ- 
entiation into antibody-secreting cells is triggered by 
antigen and usually requires helper T cells. 
Many studies over the years have demonstrated 
that antibody responses to various periodontal 
pathogens are increased in patients with periodontal 
disease compared with subjects without the disease. 
Therefore, antibody titers, isotypes and the re- 
sponses of the humoral immune system have been 
investigated over the years. 
Mouton et at. (212) established that antibody to 
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Porphyromonas gingivalis is found in a significant 
proportion of healthy adults as well as being detect- 
able in children as young as 6 months. In both adults 
and children there was a positive correlation be- 
tween antibody levels and age. Nevertheless, serum 
IgG antibody increased by 500-800% in adult peri- 
odontitis and generalized early-onset periodontitis 
patients. Multiple subsequent studies confirmed 
these findings and showed a significant increases in 
levels and frequency of antibody to P. gingivalis in 
adult periodontitis and a subset of generalized early- 
onset periodontitis patients (10,11). Chen et al. (39) 
noted that only some generalized early-onset peri- 
odontitis patients displayed an elevated humoral im- 
mune response to P gingivalis, albeit these anti- 
bodies were of low avidity and increased following 
periodontal therapy. celenligil & Ebersole (32) dem- 
onstrated a significantly higher level of antibody to 
the P gingivalis strains (that is, strains generally de- 
rived from United States populations) in United 
States patients compared with similar disease groups 
derived from a Turkish population. However, the 
Turkish early-onset periodontitis patients exhibited 
a significantly higher frequency of elevated antibody 
to the P gingivalis compared with a geographically 
matched normal group. The four concepts originally 
put forth by Mouton et al. (212) regarding this patho- 
gen were: (i) based on the humoral immune re- 
sponse, P. gingivalis is probably an causative agent 
in periodontal disease; (ii) the humoral immune re- 
sponse is probably protective; (iii) diseased and 
healthy individuals can be distinguished in terms of 
their antibody response to this organism; and (iv) 
differences in the antibody response characteristics 
may denote different periodontal disease classifi- 
cations. To these can now be added that the humoral 
immune response to P. gingivalis may contribute a 
better understanding of patient susceptibility, diag- 
nostic categories, treatment effects and immune 
protection and that this pathogen may have the ca- 
pacity to express antigenic diversity between sub- 
jects in a population and across patient populations. 
A wealth of literature supports the existence of lo- 
cal specific antibody production by plasma cells 
present in inflamed tissues of the periodontal pocket 
(68,72,167,283,295). Likewise, a proportion of gin- 
gival crevicular fluid samples within a given subject 
have local antibody levels significantly greater than 
can be accounted for by a serum contribution (68, 
71,146). In addition to these inflammatory me- 
diators, evidence has been provided that indicates 
that both C3 and C4 components of the complement 
system are cleaved in gingival crevicular fluid from 
early-onset periodontitis (237,265), indicating the 
potential of antigen-antibody complexes to contrib- 
ute to local immune modulation. Cross-sectional 
studies have suggested that those gingival crevicular 
fluid samples with elevated antibody frequently 
harbor the homologous bacteria and suggest that a 
combination of the antigen and the host-response is 
frequently associated with progressing disease (72); 
these local antibody levels decreased with pocket 
depth, attachment level stabilized and inflammation 
resolved following therapy (72). 
Lu et al. (185) have shown that, in certain popula- 
tions, serum IgG2 levels are increased in localized 
early-onset periodontitis patients, but not general- 
ized early-onset periodontitis, adult periodontitis or 
periodontally healthy individuals. IgG2 is the pre- 
dominant immunoglobulin subclass that reacts with 
carbohydrate antigens preferentially and is particu- 
larly reactive with A. actinomycetemcomitans sero- 
type b outer membrane antigens. A. actinomycetem- 
comitans is a microbe commonly associated with 
early-onset periodontitis (see Darby & Curtis in this 
volume). Serum IgG2 levels increase with age and a 
rise can be detected at puberty (185). An interesting 
association is that black subjects in general have 
higher levels of IgG2 than whites, and the incidence of 
localized early-onset periodontitis among black indi- 
viduals has been shown to be up to 15 times greater 
than among whites (182,201,263). Furthermore, the 
increase in serum IgG2 levels in localized early-onset 
periodontitis patients was due to high anti-A. actino- 
mycetemcomitans serotype b levels, which actually 
only accounted for around 10% of the IgG excess in 
localized early-onset periodontitis patients. It thus 
appears that localized early-onset periodontitis pa- 
tients, particularly black individuals, have a tendency 
to produce increased levels of IgG2 (310). 
A family study of early-onset periodontitis indi- 
cated the possibility of genetic transmission of IgG., 
levels (193). Tew et al. (310) suggest a protective role 
for high levels of IgG2 in patients with localiazed 
early-onset periodontitis. Smoking has been found 
to suppress the IgG, response in adult periodontitis 
and generalized early-onset periodontitis patients 
and is associated with more severe destruction, but 
this does not appear to occur in localized early-onset 
periodontitis patients (310). Furthermore, the para- 
doxically lower IgG2 titers seen in black generalized 
early-onset periodontitis smokers may be specific to 
A. actinomycetemcomitans, and the IgG2 response 
against antigens of other bacteria may not be lower 
in generalized early-onset periodontitis subjects who 
smoke (306). 
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The cell-mediated immune response 
Through nonspecific interactions of the T lympho- 
cyte with other cells, controlled by a varying array of 
adhesion molecules, the naive T-cell migrates 
through lymph nodes, makes initial interactions with 
antigen-presenting cells and, after specific acti- 
vation, eventually moves to peripheral tissues, where 
it can interact with target cells. This is thought to be 
the case during the maturation of T cells in peri- 
odontal disease, culminating in the homing of speci- 
fic T cells to the gingival tissues where they can effect 
their protective function. 
Effector T cells fall into 3 functional classes that 
detect antigens derived from different types of 
pathogens, presented by the 2 different classes of 
major histocompatibility complex molecule. Anti- 
gens derived from pathogens that multiply in the 
cytosol are carried to the cell surface by major histo- 
compatibility complex class I molecules and pre- 
sented to CD8' cytotoxic T cells, and those derived 
from extracellular bacteria and toxins are carried to 
the cell surface by major histocompatibility complex 
class II molecules and presented to CD4+ T cells. 
These cells, often referred to as helper cells, can dif- 
ferentiate into two types of effector T-cell; Thl and 
Th2 cells. Thl cells secrete both interleukin-2 and 
interferon--i when activated by certain types of T-de- 
pendent antigens so that they can enhance cell-me- 
diated responses. The Th2 subset of T helper cells 
produce interleukin-4, interleukin-5, interleukin-10 
and interleukin-13 and thereby promote the hu- 
moral immune response. 
Although much of the literature discusses the im- 
portance of the humoral aspect of the immune re- 
sponse in periodontal disease, models used in earlier 
years suggested that the initial periodontal lesion is 
composed mainly of T lymphocytes, with B cells and 
plasma cells predominating at a later stage (188,272, 
273). Studies have been carried out reporting differ- 
ences in CD4 : CD8 ratios in lesions and peripheral 
blood of periodontitis patients (226,308) compared 
with healthy controls, further indicating that the 
cell-mediated immune system is potentially as im- 
portant in a discussion of this disease as that of the 
humoral arm. 
It appears that, in terms of periodontal disease, 
the antigen is picked up by an antigen-presenting 
cell, such as a Langerhans cell, at the site of infec- 
tion, whereupon it is carried to a primary lymphoid 
tissue where the presentation to a circulating naive T 
cell takes place. This leads to antigen-specific clonal 
activation, where some activated cells become effec- 
tor cells and others remain in the circulation as 
memory cells, naive T cells expressing CD45RA and 
memory cells CD45RO. 
CD45 is a transmembrane tyrosine phosphatase 
with three variable exons that encode part of its exter- 
nal domain. In naive T cells, high-molecular-weight 
isoforms CD45RA are found. In memory T cells, the 
variable exons are removed by alternative splicing of 
CD45 RNA and this isoform is known as CD45RO. The 
general dogma indicates that memory T cells 
(CD45RO`) greatly outnumber naive (CD45RA`) T 
cells in periodontitis lesions (88,155,168,354). How- 
ever, it has also been shown that a proportion of these 
cells are CD45RA+, which suggests reactivation of the 
memory cell population by specific but as yet iden- 
tified antigens in the tissues. It has been reported that 
memory T cells adhere to vascular endothelial cells 
and augment their permeability to macromolecules 
(48). This functional ability of memory T cells to con- 
trol endothelial permeability and to adhere to endo- 
thelial cells maybe a dominant factor that contributes 
to the preferential migration of memory T cells into 
sites of chronic inflammation (240), such as the dis- 
eased gingival tissues. 
The realization that T lymphocytes are present in 
large numbers in the diseased tissues of early-onset 
periodontitis patients and not in health has led to in- 
vestigations of the numbers, ratios and functionality 
of T cells in both the peripheral blood and diseased 
tissues of patients with periodontal disease. Studies of 
peripheral blood T-lymphocyte subsets in early-onset 
forms of periodontal disease have revealed a wide var- 
iety of contradictory results with either depressed 
CD4' : CD8 ' ratios (154) or mixed (148), or even not 
correlated to the disease (76). A number of studies 
have also looked at the distribution of the T-cell sub- 
sets in the tissues. One study reports that the 
CD4+ : CD8+ ratio in the tissues of early-onset peri- 
odontitis patients and even their families tend to be 
increased (300). A study by Stoufi et al. (295) and one 
by Celenligil et al. (36), however, clearly states that the 
ratio is decreased in patients with this disease. What 
is obvious and further indicated by a study looking at 
juvenile periodontitis (202) is that the ratios are highly 
variable between different patients with the same dis- 
ease, making generalizations and conclusions ex- 
tremely difficult. What the above study did suggest 
however, was that the high CD4 ': CD8- ratios were 
seen in those patients that had a greater degree of in- 
flammatory cell infiltration, while the low 
CD4' : CD8 * ratio tissues were less inflamed. 
When diseased gingival tissue is removed and the 
cells extracted, both CD4 ' and CD8' lymphocytes 
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are present in large numbers (296,308). Many 
studies have indicated raised levels of CD8 ` cells in 
diseased tissues; however, CD4' cells, although 
prominent, were found at lower levels than in the 
peripheral blood. Overall ratios of CD4' : CD8' were 
not found to be altered in early-onset periodontitis 
and chronic periodontitis patients (196); however, 
these ratios were found to be depressed in patients 
with localized early-onset periodontitis and general- 
ized early-onset periodontitis (154). 
T-cell functions 
The role of CD4+ T cells in periodontal 
disease 
T-cell functions in periodontal granulation and gin- 
gival tissues can be elucidated by their cytokine syn- 
thesis profile (353). There are two main subsets of T- 
helper cells, Thl and Th2, which are usually deter- 
mined by the cytokine profile that is characteristic of 
them (see Table 1 for characteristics of cytokines that 
play an important role in the progression of peri- 
odontal disease). ThO cells have also been identified, 
and these cells are thought to secrete interleukin-4 
and interferon-y. Their actual role is yet to be con- 
firmed; however, it is thought that they may play a 
role as a precursor cell to "l'-helper cells yet to have 
differentiated to become either Thl or Th2 cells 
(207). Although the cytokine profile is a good tool for 
T-cell subset investigations, the results reported are 
often conflicting, causing confusion. Often the re- 
suits cannot assess the relative importance of the 
Th 1 and Th2 subsets. 
Fujihashi et al. (81) investigated ThI and Th2 cyto- 
kine messenger RNA expression by CD4' '1' cells 
from diseased gingival tissues. They detected inter- 
feron--y, a Thl cytokine, but failed to detect the Th2 
cytokine interleukin-4, thus indicating a more domi- 
nant role for Thl cells. Other groups, however, indi- 
cate a more dominant role for Th2 cells after detec- 
tion of interleukin-4, interleukin-5, interleukin-6 (10, 
192,355) and interleukin-10 (90). One of the current 
theories on the Thl/Th2 paradigm is that both cells 
have an important but different role. Gemmell et at. 
(89), have suggested that Thl cells remain tightly lo- 
calized at sites undergoing an active disease process, 
whereas Th2 cells are more widely distributed 
throughout the tissue and typify a more quiescent 
stage of the disease; that is, the immune response in 
periodontal disease is predominantly Th2 driven, 
with active phases of the disease leading to a foci of 
Thl activity. 
The role of these cell types is that of help for the 
immune response. Thl cells, characterized often by 
their production of interferon-y, are important in 
microbial killing and are known to augment cyto- 
toxic T-cell functions through their production of in- 
terleukin-2 and interferon-y. Th2 cells, however, in- 
hibit much of the work done by Thl cells. The pro- 
duction of interleukin-4 and interleukin-10 by these 
cells inhibits the actions of interferon-y, hence has 
anti-inflammatory characteristics. The production of 
Table 1. The role of cytokines in the pathogenesis of periodontal disease 
Cytokine Produced by Role 
Interleukin- I Large quantities produced by Proinflammatory properties 
macrophages Mediator of tissue destruction in peridontal disease (6) 
Interleukin-4 Activated T cells Inhibits production of interleukin- 1, tumor necrosis factor and 
interleukin-6 
An absence of interleukin-4 in the periodontal tissues has been 
suggested to trigger disease progression (80,132) 
Interleukin-6 Lymphoid and non-lymphoid Mediates inflammatory tissue destruction 
cell types Thought to be an important cytokine in B-cell differentiation and 
Production is triggered by hence to play a role in the induction of the elevated B-cell response 
interleukin-1, tumor necrosis in patients with periodontal disease (80) 
factor and interferon-y 
Interleukin-8 Mononuclear monocytes and Attracts and activates neutrophils into the tissues of the 
many of the tissue cells periodontimn, particularly as it is produced by gingival fibroblasts 
(: 304) 
Interleukin-12 Monocytes, macrophages, Pleiotrophic effects on natural killer cells and T cells in the tissues 
8-cells and accessory cells Induces interferon-y production and is necessary for ThI induction 
Tumor necrosis Macrophages and lymphocvtes Similar effects to interleukin- I and interleukin-6 
factor a and J1 respectively 
Interferon y Activated T cells Potent inhibitor of interleukin- 1, tumor necrosis factor-u and tumor 
necrosis factor-(3 
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interleukin-4, interleukin-5 and interleukin-6 elicits 
and helps maintain a humoral immune response. 
Natural killer cells 
Natural killer cells are also said to constitute a large 
part of the cell-mediated immune system, although 
they are classed as a component of the innate im- 
mune system. These cells are large granular lympho- 
cytes that are often detected by the marker CD16, 
thus making the actual numbers detected very diffi- 
cult to report, since this marker is also found on 
other peripheral blood lymphocytes and monocytes. 
In contrast to CD8+ cytotoxic T cells and killer cells, 
which kill infected targets cells in an antigen-specific 
manner, natural killer cells kill infected target cells or 
tumor cells in an antigen-nonspecific manner (196). 
The role of natural killer cells in periodontal dis- 
ease are present is unknown. However, there are re- 
ports of an increase in the numbers of natural killer 
cells in the peripheral blood of'patients with early- 
onset periodontitis (35,158,339). 
Other studies have reported no increase in the 
numbers of natural killer cells found in the periph- 
eral blood of diseased patients compared with health 
(358). In the tissues of diseased patients an increase 
of natural killer cells is seen, which is actually not 
difficult or surprising considering the fact that, in 
health, very few natural killer cells are present in the 
gingival tissues. The numbers of natural killer cells 
in the tissues are seen to increase from health to gin- 
givitis to periodontitis (44,82,351), although the 
proportion of these cells relative to total lymphocyte 
numbers actually decreases (44). 
The activity of natural killer cells is highly in- 
creased by soluble mediators such as interleukin-2, 
interferon-a, interferon-0 and interferon-y. Inter- 
ferons a and ß are antiviral proteins synthesized and 
released by leukocytes, fibroblasts and virally in- 
fected cells; interleukin-2 and interferon-y are re- 
leased by activated T cells (18). Surface lipopolysac- 
charide from gram-negative bacteria, however, ap- 
pear to provide the major activation signal for 
natural killer cell-mediated cytotoxicity in peri- 
odontal disease (174), which leads to natural killer 
cell cytotoxic activity against host cells. 
Cytokines in periodontal disease 
Interleukin-1 
In the periodontal tissues, interleukin-10 predomi- 
nates over interleukin-la and is present at higher 
levels in active diseased sites compared with healthy 
or stable diseased sites (144,289). The variation in 
interleukin-1 concentrations between sites in the 
same individual, and the lack of variation in serum 
interleukin-1ß levels between adult periodontitis pa- 
tients and healthy controls, suggests local rather 
than systemic production of interleukin-1 (38). Acti- 
vated keratinocytes and Langerhans cells produce 
interleukin-la and interleukin-1ß (131). Macro- 
phages, polymorphonuclear leukocytes, B cells and 
fibroblasts secrete interleukin-1ß (90,144,302). Not 
surprisingly, interleukin-1 receptor antagonist has 
been detected in periodontal macrophages and 
found in the periodontal crevicular fluid of patients 
with periodontitis (137,147). 
Numerous periodontal bacteria can stimulate host 
cells to produce interleukin-1 (88,90). Levels of in- 
terleukin-iß correlate with the periodontal status 
(242). Interleukin-1 stimulates fibroblasts, endo- 
thelial cells, monocytes and granulocytes resident in 
the gingival connective tissue to express adhesion 
molecules (303). These adhesion molecules aid the 
passage of immune response cells from the capil- 
laries into the inflamed tissues. 
Interleukin-1 can induce the gingival fibroblast 
production of plasminogen activator, interleukin-6 
and prostaglandin E2 as well as the matrix metallo- 
proteinases, which are involved in tissue destruction, 
turnover and remodeling (246). Both interleukin-1 
and tumor necrosis factor-a strongly induce matrix 
metalloproteinase expression in resident and immi- 
grant cells, but interleukin-1 is more potent than tu- 
mor necrosis factor-a (22,318). Interleukin-1 stimu- 
lates osteoclasts to resorb bone (136) while inhibit- 
ing the formation of bone (288). More specifically, 
interleukin-1-mediated resorption of bone can be 
induced by periodontal pathogens (141). 
Tumor necrosis factor 
The proinflammatory cytokines tumor necrosis fac- 
tor-a, interleukin- la and interleukin-1 ß have been 
identified in periodontitis lesions from patients with 
adult periodontitis at higher levels than in healthy 
sites (197,290). However, cells containing interleu- 
kin-1 were found in much greater numbers than 
those producing tumor necrosis factor-a and in- 
terleukin-la (290). In contrast to interleukin-1, only 
very low concentrations of tumor necrosis factor-a 
have been demonstrated in gingival crevicular fluid 
from both adult and early-onset periodontitis pa- 
tients (252,357). However, high levels of tumor ne- 
crosis factor-a in periodontal lesions appear to rep- 
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resent an established inflammatory and immune re- 
sponse. Salvi et al. (256) examined gingival crevicular 
fluid interleukin-1 ß, tumor necrosis factor-a and 
prostaglandin E2 levels in insulin-dependent dia- 
betes mellitus patients with periodontal disease. 
They found that diabetics had significantly increased 
levels of prostaglandin E2 and interleukin-1 ß but not 
tumor necrosis factor-a, compared with non-dia- 
betic controls with similar periodontal status. In ad- 
dition, diabetics with moderate to severe disease had 
almost two-fold higher levels of prostaglandin E2 
and interleukin-1 p compared with diabetics with 
gingivitis or mild periodontitis. 
Prostaglandin E2 causes increased vascular di- 
lation and permeability. It also stimulates macro- 
phages to secrete matrix metalloproteinases and has 
been shown to trigger bone resorption in vitro (22), 
thus acting synergistically with interleukin- 1 and tu- 
mor necrosis factor-a. Furthermore, it upregulates 
receptors for complement and immunoglobulin on 
monocytes and neutrophils (216). The major source 
of prostaglandins and leukotrienes in inflamed peri- 
odontal tissue is the activated macrophages, al- 
though they can also be produced by fibroblasts. 
Prostaglandins, especially prostaglandin Ems, com- 
prise the primary pathway of alveolar bone destruc- 
tion in periodontitis. Leukotrienes, especially leuko- 
triene B4, are potent chemoattractants for polymor- 
phonuclear leukocytes. 
odontitis) than from healthy or gingivitis sections. 
They suggested that in gingivitis interleukin-10 
might suppress inflammation by decreasing macro- 
phage activity, thereby preventing progression to 
periodontitis. No differences were found in the per- 
centages of interleukin-10* CD4+ cells between the 
two disease categories. However, some individuals 
were found to have higher numbers of interleukin- 
10+ T cells regardless of disease category. It appears 
that the overall variation between the two diseases 
entities in interleukin-10+ CD8+ cells may have been 
due to individual variation in interleukin-10 secre- 
tion patterns rather than differences in pathogenesis 
between the two disease categories. Further studies 
are needed to elucidate the role of interleukin-10 in 
periodontal disease. 
In summary, interleukin-1, interleukin-6 and tu- 
mor necrosis factor are proinflammatory cytokines 
which are detected and may be modulated within 
the periodontium. They are important and ubiqui- 
tous aspects of the host defense system, operating in 
the periodontal tissues during health, destruction 
and healing phases. Similar claims may in future be 
made for other members of the cytokine network, 
in particular interleukin-10 and various soluble and 
cellbound receptors and inhibitors of cytokine func- 
tion. These molecules are inter-related and are part 
of the immune, inflammatory, breakdown and repair 
homeostasis ongoing within the periodontium. 
Interleukin-10 
Interleukin-10 may have a role in the progression of 
adult periodontitis. This was suggested by Gemmell 
et al. (90), who found that T-cell lines from both the 
peripheral blood of these patients and their gingival 
tissue secreted interleukin-10, but clones derived 
from the peripheral blood of an individual with gin- 
givitis did not. It has also been suggested by Stein et 
al. (292,293) that interleukin-10 may contribute to 
autoimmune reactions against gingival tissues. In- 
terleukin-10 is able to favor the development of a 
particular clone of B cells (CD5), which can secrete 
high levels of autoantibody and is found in increased 
numbers in inflamed gingival sections (297). It was 
found that a subset of type I diabetics may be more 
susceptible to developing periodontitis through an 
autoimmune type of reaction directed against gingi- 
val connective tissue when exposed to periodontal 
pathogens (292,293). 
Gemmell & Seymour (90) have demonstrated a 
significantly reduced number of interleukin-10' 
CD8' cells from periodontitis lesions (adult peri- 
The pathology of the 
periodontal diseases affecting 
children and adolescents 
Gingivitis 
Various hypotheses have been made over the years 
linking the severity of gingivitis in childhood with 
various factors including puberty. 
An increase in the sex steroid hormones during 
the period of puberty is believed to have a transient 
effect on the inflammatory status of the gingiva 
(194). Enlargement of the gingivae occurs in both 
males and females in areas of local irritation. The 
inflammation has been described as marginal in dis- 
tribution, characterized by prominent bulbous 
proximal papillae. Enlargement is often only found 
on the facial gingiva, whereas the lingual surfaces 
remain unaltered (98). Although this view is widely 
accepted, the evidence obtained from cross-sec- 
tional and longitudinal studies for this hypothesis is 
mainly circumstantial and often fragmented, al- 
though still of importance. 
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Sutcliffe (299) reported a 6-year longitudinal study 
that had been carried out to observe the changes in 
gingivitis in 127 children 11-17 years old, and the 
relationship of these changes with oral hygiene. He 
reported an increase in gingivitis associated with pu- 
berty. It was noted that girls tended to experience 
their maximum gingivitis before boys, girls at a mean 
age of 12 years and 10 months and boys at 13 years 
and 7 months. Hence, he noted that the distributions 
of age were consistent with the hypothesis that there 
is an increase in gingivitis associated with puberty. 
The problems with this and further studies is that 
they only provide circumstantial evidence linking 
puberty and gingivitis. Thus, the association be- 
tween the increase in sex hormone levels and gingi- 
vitis needs confirmation. Chronological age is a poor 
indicator of puberty, the measurement of the maxi- 
mum gingivitis experience is extremely subjective 
and, further, none of the studies reported have 
measured the hormone levels of the subjects. An 
alternative explanation for increased gingivitis dur- 
ing puberty is that this is a period of mixed dentition 
where erupting and exfoliating teeth present many 
sites for plaque retention. The fact that gingivitis de- 
creases after puberty may reflect the general im- 
provement seen in children as they improve their 
dexterity and become more aware of oral hygiene. 
Other clinical indications of a hormonal effect in- 
clude fluctuations in gingivitis with phases of the 
menstrual cycle (133,176), increased incidence and 
severity of gingivitis during pregnancy (27,138), gingi- 
val enlargement induced by oral contraceptives (149, 
187,287) and circumstantial evidence suggesting that 
there is an increased number of desquamative gingi- 
val lesions in menopausal females (216). The mech- 
anisms by which the hormones may influence the 
gingiva have so far not been fully elucidated. 
Steroid hormone receptors are located in hor- 
mone-sensitive tissues, where the hormones tend to 
be retained and allowed to accumulate. In a number 
of species accumulation of androgens, estrogens and 
progestins have been observed in the periodontium 
(194), and particularly pertinent are auto radiographic 
studies that have demonstrated nuclear localization 
of estradiol in human gingival epithelium and gingival 
fibroblast cells (332-334). The actual accumulation 
and effect of sex steroid hormone on the gingiva is un- 
known; however, a number of theories have arisen. 
Microbial effects of hormones 
Microbial plaque and its presence is a very import- 
ant factor on the onset, progression and severity of 
gingivitis. It has been reported in other studies of a 
hormonal nature that microorganisms are effected. 
Kornman & Loesche (138,149) reported higher levels 
of P intermedia in pregnant females with elevated 
levels of sex hormones and also in women taking 
oral contraceptives. Therefore, it seems logical that 
if levels of sex hormones can effect the microflora at 
one time they must be affected during other periods 
of hormonal fluctuation. Many studies have been 
carried out often leading to reports of speculative re- 
sults. Several reports of a transient increase of black 
pigmented gram-negative anaerobic rods in children 
during puberty have arisen (46,47,347). However, 
none of these studies have used hormone levels as a 
measure of puberty, and therefore it is difficult to 
draw inference in this situation. 
Vasculature effects of hormones 
Investigations in animals suggest that the sex hor- 
mones, particularly progesterone, may produce in- 
creased inflammation by generating changes in the 
gingival vasculature (138,149). Local or systemic ad- 
ministration of progesterone produces an increase in 
vascularity in ear chamber wounds in rabbits (178). 
Following systemic administration of progesterone, 
certain observations suggested that the hormone 
might induce alterations in the plasma-endothelial 
lining of the post-capillary venules (178), resulting in 
an increased leakage of plasma proteins and leuco- 
cytes. Gingival exudate also increased following ad- 
ministration of sex hormones to dogs (177), and pro- 
gesterone enhanced acute inflammation during 
wound healing in rabbits (220). 
Immune effects of hormones 
The importance of sex hormones is emphasized by 
the findings related to gender-related disease sus- 
ceptibility. For example, a number of diseases can be 
modulated by hormones, mainly estrogens, such as 
rheumatoid arthritis (128) and Graves disease (8), 
which are both affected during pregnancy. Therefore, 
some immune responses and reactions are affected 
in the gingiva leading to a possible role for sex hor- 
mones in this disease. The degree of influence of this 
is unknown, however. 
Cellular effects of hormones 
Sex hormones are known to effect the cells of the 
body. Histological studies have shown that estrogens 
increase epithelial keratinization, stimulate prolifer- 
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ation (247,248,362) and increase the downgrowth 
of epithelial attachment (219). Androgens have also 
been shown to have effects. 
Human gingiva is capable of metabolising sex hor- 
mones (334), and receptors for estrogen have been 
found in gingival tissues (16). Furthermore, inflamed 
gingiva has been found to metabolize progesterone 
more rapidly, and these metabolites differ from 
those produced by healthy gingiva (121). Vittek et al. 
(334) have shown a positive correlation between pro- 
gesterone and gingival inflammation. It is known 
that the gingival levels of progesterone and its meta- 
bolites increase during pregnancy and that these 
metabolites increase the inflammation in pre- 
existing gingivitis (225). These effects, produced by 
progesterone alone or in combination with estrogen, 
could account for many of the changes seen in pu- 
berty and other conditions in which there are in- 
creased circulating sex hormones. In the treatment 
of children undergoing puberty with gingivitis, the 
increased susceptibility to plaque-induced inflam- 
matory changes should be reduced by the use of op- 
timal levels of plaque control. 
The pathogenesis and host responses of 
gingivitis and periodontitis 
The normal healthy gingiva is characterized by its 
pink color and its firm consistency. Interdentally, the 
healthy gingival tissues are firm and do not bleed on 
gentle probing and fill the space below the contact 
areas between the teeth. Healthy gingiva often ex- 
hibits a stippled appearance and there is a knife- 
edge margin between the soft tissue and the tooth. 
In theory, normal gingiva are free from histological 
evidence of inflammation, but this ideal condition is 
very rarely seen due to the ever present microbial 
plaque. Even in the very healthy state, the gingiva 
has a leukocyte infiltrate that is predominantly com- 
prised of neutrophils or polymorphonuclear leuko- 
cytes. The primary purpose of these phagocytes is to 
kill bacteria, which they do by emigrating through 
and out of the tissues into the gingival crevicular 
area. 
Clinical changes in the early stages of inflam- 
mation of the gingival tissues following plaque ac- 
cumulation are subtle, but quite rapidly the gingiva 
appears red, swollen and the soft tissue has an in- 
creased tendency to bleed on gentle probing. Histo- 
logically, this stage is described by increased vascular 
dilation and permeability, which leads to an influx 
of exudative fluid, proteins and inflammatory cells 
into the tissues giving them their swollen appear- 
ante. At this stage there is intense recruitment of 
polymorphonuclear leukocytes, macrophages and 
their progenitor cells monocytes into the tissues. 
These leukocytes migrate up a chemoattractant 
gradient to the crevice and are aided by adhesion 
molecules such as intercellular adhesion molecule-1 
and endothelial cell leukocyte adhesion moelcule-1, 
which assist leukocyte binding to the post-capillary 
venules and help cells to leave the vessels (151). In 
addition, as the microbes damage the epithelial cells, 
the epithelial cells release cytokines, which further 
encourage recruitment of leukocytes (predominantly 
neutrophils) into the crevice. The neutrophils within 
the crevice can phagocytose and digest bacteria and 
so remove these bacteria from the pocket. In ad- 
dition to this, if the neutrophil is overloaded with 
bacteria, it degranulates or explodes and, by doing 
so, causes tissue damage due to the toxic enzymes it 
releases. The neutrophil can thus be viewed as being 
both helpful and potentially harmful. This neutro- 
phil defense may in some instances operate well and 
reduce the bacterial load and can be considered im- 
portant in preventing the gingivitis lesion from being 
established. If, however, there is an overload of mi- 
crobial plaque, then the neutrophils and the barrier 
that is comprised of epithelial cells will not be suf- 
ficient. 
After approximately 7 days of plaque accumu- 
lation, the initial lesion is said to progress to the 
early lesion (26,238,267,268). Lymphocytes and 
macrophages predominate, and the infiltrate occu- 
pies 10-15% of the gingival connective tissue. Both 
clinically and histologically the changes are very vis- 
ible. The established lesion as defined by Page & 
Schroeder (233) is one dominated by plasma cells. 
Plasma cells have been shown to be predominantly 
IgG-producing cells, with a lower proportion being 
IgA (188,189,223,336). In early-onset periodontitis, 
local IgG4-producing cells in particular seem to be 
elevated. Clinically in the established lesion, colla- 
gen loss continues both laterally and apically and the 
dentogingival epithelium continues to proliferate. 
Two types of established lesion, however, appear to 
exist. One remains stable not progressing for months 
or years (175,234), and the second becomes more 
active and converts to progressive destructive 
lesions. The very nature of early-onset periodontitis 
and the knowledge that it is a rapidly progressing 
destructive disease make it clear that the established 
lesion here will progress speedily to the destructive 
advanced lesion. The advanced lesion is character- 
ized by hone loss, periodontal ligament loss, apical 
migration of the junctional epithelium to form a true 
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pocket and histopathologically by an increase to over 
50% of plasma cells in the infiltrated connective 
tissues (151). 
Gingivitis is primarily a response to the bacteria 
in plaque. It includes a vascular response with in- 
creased fluid accumulation and inflammatory cell 
infiltration. Serum IgG antibody levels to Actinomyc- 
es spp. were found to be higher in gingivitis (73), and 
a similar study showed that antibodies to at least 
three bacteria (Actinomyces spp., Bacterionema ma- 
truchotti and Leptotrichia buccalis) were detected in 
gingivitis patients with a wide variation in levels (73). 
Multiple reports have suggested that gingivitis pa- 
tients can present with antibody to suspected oral 
pathogens (50,228), including P. gingivalis and A. 
actinomycetemcomitans. Bimstein & Ebersole (21) 
noted that IgM antibody levels were significantly dif- 
ferent to many bacteria when comparing children 
versus adults with gingivitis. In contrast, the IgG 
levels were unrelated to disease in the adult groups 
but did help to distinguish between the children 
with and without gingivitis. Thus, generally, the gin- 
givitis patients exhibit antibody to a wide array of 
these bacteria; however, the levels to suspected peri- 
odontal pathogens are uniformly significantly lower 
than those seen in periodontitis patients (62,63). Fi- 
nally, we observed lower IgA levels in gingivitis sites 
compared to healthy sites of normal subjects (65), 
and Grbic et al. (103) demonstrated that IgA levels 
were significantly increased in gingival crevicular 
fluid from gingivitis sites compared with peri- 
odontitis sites, suggesting the potential for IgA to 
function as a protective factor in this local environ- 
ment. Generally low levels of antibody to bacteria 
associated with periodontitis are found in gingival 
crevicular fluid from gingivitis sites. 
The progression from gingivitis to 
periodontitis 
Brecx et al. (25) suggests that more than 6 months 
may be needed in the normal situation for gingivitis 
to change to a periodontitis lesion. Furthermore, this 
move from gingivitis to periodontitis probably only 
occurs in 10% to 150 of the population. The reason 
why some patients develop periodontitis more read- 
ily than others is highly elusive and thought to be 
multifactorial. It should be borne in mind that the 
changes during gingivitis, even in prolonged estab- 
lished gingivitis lesion, are to a large extent revers- 
ible, whereas the changes during periodontitis, that 
is, the bone loss and apical migration of the epi- 
thelial attachment, are irreversible. Periodontitis is a 
cumulative condition whereby once there is bone 
loss, it is almost impossible to have it re-established 
and therefore, patients lose bone incrementally over 
the years. The worst effects of periodontitis are 
therefore, commonly seen in older patients rather 
than younger patients, who have still to develop 
these deep pockets or this extensive bone loss or the 
associated gingival recession that occurs in peri- 
odontitis. The early-onset forms of periodontitis are, 
however, situations where the normal slow destruc- 
tive process is greatly accelerated. 
Differences between chronic gingivitis 
and periodontitis 
The similarities in the inflammatory infiltrate be- 
tween the stable established chronic gingivitis lesion 
and advanced periodontitis lesions have encouraged 
many investigators to look for qualitative and quan- 
titative differences that may be involved in deter- 
mining the progression of gingivitis to destructive 
periodontitis. 
Seymour et al. (271) hypothesized that a change 
from T-cell to B-cell dominance causes periodontitis. 
However, Page (236) has disagreed with this view, as 
have Gillett et al. (97), who showed a predominantly 
B-cell infiltrate to be associated with stable, non- 
progressive lesions in childhood gingivitis. Liljenberg 
et al. (173) compared plasma cell densities in sites 
with active progressive periodontitis and in sites 
with deep pockets and gingivitis but no significant 
attachment loss over a 2-year period. The density of 
plasma cells (51.3%) was very much increased in ac- 
tive sites as compared with inactive sites (31.0%). It 
is now generally accepted that plasma cells are the 
dominant cell type in the advanced lesion (86). 
Necrotizing ulcerative gingivitis and 
periodontitis 
Necrotizing ulcerative gingivitis is an acute inflam- 
matory condition associated with a fusospirochaetal 
microbial complex. Necrotizing ulcerative gingivitis 
begins as linear erythema of the marginal gingiva 
and extends to form ulcerated, punched-out, painful 
and necrotic papillae and later may extend to ulcer- 
ation of the gingival margins (134). The ulcers are 
covered by a grayish slough, which if removed causes 
bleeding from the exposed ulcers. The condition is 
painful and is associated with marked halitosis often 
termed foetor oris. As the necrosis progresses, deep 
bone cratering appears in the interproximal regions 
in the areas where the papillae have been lost. If left 
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untreated, necrotizing ulcerative gingivitis will pro- 
gress to necrotising ulcerative periodontitis, which 
involves destruction of the interproximal alveolar 
bone and the periodontal ligament (134,198). 
Marked gingival recession and sequestra formation 
is a sequel of the rapid necrosis. In industrialized 
countries, adolescents and young adults are most 
predisposed to this condition, and a prevalence of 
approximately 0.5% has been reported (135). 
In a classic electron microscopic study by Listgart- 
en in 1965 (179) four zones were identified. These 
zones are the: 1) bacteria-rich zone or plaque zone, 
2) neutrophil-rich zone in which neutrophils pre- 
dominate; 3) necrotic zone, which has dead cell, 
spirochetes and other bacteria; and 4) the spirochet- 
al infiltration zone, in which tissue structures is pre- 
served but many invading spirochetes are noted. 
Necrotizing ulcerative gingivitis has been char- 
acterized by the emergence of selected members of 
the oral microbiota: Treponema spp. and P. interme- 
dia, which develop as a response to altered resis- 
tance to infection of the host tissue (immunosup- 
pression). These oral spirochetes have been shown 
to be capable of invading the infected host tissue 
(79,181,255). IgG antibody to oral spirochetes (Tre- 
ponema denticola and Treponema vincentii) has 
been reported; the data have shown below normal 
to selected elevations in disease subjects (14,41,143, 
166,213,270,346). Therefore, while treponemal spe- 
cies are frequent in subgingival plaque and comprise 
a major proportion of some plaques in periodontitis 
and necrotizing ulcerative gingivitis (281,282), there 
does not appear to be an elevation in systemic anti- 
body responses, indicative of an active host re- 
sponse, to the cultured treponemal species. Serum 
antibody to Actinomyces viscosus, Actinomyces israe- 
lii, Prevotella melaninogenica and P. gingivalis were 
within normal limits in necrotizing ulcerative gingi- 
vitis during acute and convalescence; however, anti- 
body to Prevotella intermedia was significantly elev- 
ated in convalescent sera (73), suggesting that acute 
disease may exhibit a specific pathogenic microbiota 
to which the host responds. The contribution of this 
response to resolution of the disease remains un- 
known. 
Cancrum oris or noma is a devastating orofacial 
gangrenous disease that is considered a very severe 
form of necrotizing ulcerative periodontitis and is 
commonly reported in underprivileged African 
children (78). The children often suffer from chronic 
malnutrition, numerous endemic communicable 
diseases, including viral diseases, and severe adverse 
physical conditions. These severe debilitating factors 
may deplete the subject's immune and inflammatory 
system. Measles is the most common infection pre- 
ceding the development of noma in Nigerian 
children (78). Acquired immunodeficiency in combi- 
nation with the impaired endocrine balance in 
malnourished children results in widespread infec- 
tion with the measles virus. Anergy resulting from 
the combination of malnutrition and measles virus 
infection may promote overgrowth and invasion of 
anaerobic organisms, including gram-negative bac- 
cilli and spirochetes. Due to the severe debilitation 
of the malnourished child, the infection is not con- 
fined locally as necrotizing ulcerative gingivitis but 
spreads rapidly across normal anatomical barriers. 
Severe necrosis and possible sequestration as exem- 
plified by noma are then seen. Minimal data are 
available on host responses in this disease. 
Murray et al. (214) also demonstrated that the 
microbiota of periodontitis in human immunodefic- 
iency virus (HIV) patients was similar to that seen in 
systemically healthy periodontitis individuals; how- 
ever, there were significant increases in the numbers 
of Campylobacter spp. and Treponema spp. Serum 
IgG antibody to P. intermedia, P. gingivalis and Fuso- 
bacterium nucleatum have been found to be elev- 
ated in HIV-positive homosexuals compared with 
control normals and seronegative homosexuals 
(105). Both necrotizing ulcerative gingivitis and nec- 
rotizing ulcerative periodontitis (74) occur in a pro- 
portion of HIV-infected patients. Rams et al. (244) 
compared the distribution of several bacterial mor- 
photypes in necrotizing ulcerative periodontitis and 
clinically normal periodontitis subjects and found 
that the morphotypes were very similar from areas of 
necrotizing ulcerative gingivitis-like tissue necrotic 
lesions and necrotizing ulcerative periodontitis sites. 
Importantly, all the patients with the necrotizing ul- 
cerative gingivitis-like lesions had significantly high 
levels of spirochetes in their pockets. However, the 
levels of serum antibody to oral microorganisms in 
HIV subjects has had minimal investigation. Grieve 
et al. (104) suggested that HIV periodontitis (necrot- 
izing ulcerative periodontitis) patients exhibited el- 
evations in serum antibody to P. gingivalis, P. inter- 
media, F. nucleatum, A. actinomycetemcomitans and 
Eikenella corrodens. We recently examined serum 
IgG antibody to a battery of oral pathogens, includ- 
ing T denticola, in HIV patients. We found that, 
while some of the patients with necrotizing ulcer- 
ative periodontitis exhibited elevated antibody to 
suspected periodontal pathogens, the antibody level 
to T. denticola isolates was low, and selected HIV pa- 
tients had minimal antibody to all of the oral micro- 
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organisms. Additional studies will be required to de- 
lineate the capability of the host response in manag- 
ing periodontal infections in these patients. 
Pathogenic features of adult and 
early-onset periodontitis 
Experimental short-term clinical studies have shown 
that microorganisms quickly colonize clean tooth 
surfaces when an individual stops toothbrushing. 
Within a few days, microscopical and clinical signs 
of gingivitis are then apparent. These inflammatory 
changes can be resolved when adequate tooth- 
cleaning methods are resumed (183,317). Thus, 
microorganisms that form dental plaque and cause 
gingivitis probably do so by the release of compo- 
nents from the bacterium that induce inflammation 
in the tissues. Short- and long-term clinical trials 
have underlined the importance of supragingival 
plaque and subgingival microbial plaque in both the 
treatment of gingivitis and petiodontitis. Further- 
more, animal experiments have indicated that gingi- 
vitis only develops in animals that accumulate bac- 
terial plaque deposits. Gingivitis is necessary prior to 
the tissue developing periodontitis, and this implies 
that prevention of gingivitis is also a primary preven- 
tive measure for periodontitis. 
The pathogenic processes are largely the response 
to microbe-induced destructive processes. These 
processes are initiated by the microbes but are 
undertaken by the host cells, and thus it is the host 
tissue itself that results in the destruction seen. The 
host produces enzymes that break down host tissue. 
This is a necessary process that the host initiates and 
controls in order to allow the tissues to retreat from 
the microbial destructive lesions. 
Microbial plaque accumulation occurs on the sur- 
face of the teeth adjacent to gingival tissues, bringing 
the oral sulcular and junctional epithelium into con- 
tact with colonizing bacteria and their waste prod- 
ucts such as proteases, enzymes, lipopolysaccharide 
and toxins. As these products build up, the irritation 
to the tissues increases, until production of chemical 
mediators of inflammation commences and a host 
inflammatory response is induced. 
Elements of the host response that could 
differentiate adult and early-onset forms of 
periodontitis 
The various aspects of the host response that may 
contribute to peridontal disease have been covered 
generally, but several aspects supported within the 
literature may be specifically relevant to early-onset 
periodontitis. These include aspects of the innate, 
inflammatory and immune defense systems. 
The innate defense system includes epithelial, 
connective tissue elements and soluble products 
that are antimicrobial and in the normal healthy 
state may protect against periodontal disease. There 
are, however, defects reported in epithelial, connec- 
tive tissue (fibroblasts and cementum), body fluids 
(saliva) and enzymes (alkaline phosphatase) that 
may be relevant to early-onset periodontitis (5,9,15, 
45). Structural defects such as the absence of endo- 
thelial adressins for leukocyte adherence and sub- 
sequent migration from the bloodstream into lesions 
(seen in leukocyte adhesion deficiency with marked 
periodontal destruction) and defects of epithelium 
and connective tissue (as seen in Papillon-Lefevre 
syndrome) as well as more obvious periodontal de- 
fects such as that of hypophosphatasia (where defec- 
tive cementum results in early tooth loss) can all 
have major effects on the periodontal tissues and 
lead to early loss of teeth. 
Pathogens 
The microbes involved in adult periodontitis are 
largely gram-negative anaerobic bacilli with some 
anaerobic cocci and a large quantity of anaerobic 
spirochaetes. The main organisms linked with deep 
destructive periodontal lesions are P. gingivalis, P. in- 
termedia, Bacteroides forsythus, A. actinomycetem- 
comitans and T. denticola (360). 
P. gingivalis is more frequently detected in severe 
adult periodontitis, in destructive forms of disease 
and in active lesions than in health or gingivitis or 
edentulous subjects. P gingivalis is reduced in num- 
bers in successfully treated sites but is seen in sites 
with recurrence of disease after therapy (16,112, 
326). It has been shown that P. gingivalis induces el- 
evated systemic and local antibody responses in 
subjects with various forms of periodontitis (61). P. 
intermedia levels have been shown to be elevated 
in certain forms of periodontitis (9). Elevated serum 
antibodies to this species have been observed in 
some but not all subjects with refractory peri- 
odontitis (31). B. forsythus has been found in higher 
numbers in sites exhibiting destructive periodontal 
disease than in gingivitis or healthy sites (47). In ad- 
dition, B. forsythus was detected more frequently in 
active periodontal lesions (13). Although spirochetes 
such as T. denticola are notoriously difficult to cul- 
ture in the laboratory, these strict anaerobes may 
comprise more than 30% of the periodontal subgin- 
22 
Etiopathogenesis of periodontitis in children and adolescents 
gival microfiora. The above mentioned putative 
pathogens are always part of a large and varied mi- 
croflora found in the subgingival plaque. Some are 
not detected in certain sites with periodontitis and 
can even be completely absent in cultures from 
multiple sites within an untreated periodontitis pa- 
tient. 
The dominant microorganisms involved in early- 
onset periodontitis include A. actinomycetemcomit- 
ans, Capnocytophaga spp., Eikenella spp., P interme- 
dia and anaerobic rods such as Campylobacter rectus 
(312). Much of the literature regarding the bacterial 
effects in early-onset periodontitis have centred 
around studies on A. actinomycetemcomitans. A. 
actinomycetemcomitans is a short, facultatively an- 
aerobic gram-negative rod that is nonmotile and re- 
garded as a key microorganism in early-onset peri- 
odontitis. Studies of association have shown in- 
creased levels of A. actinomycetemcomitans and 
increased frequency of antibody to A. actinomyce- 
temcomitans in localized early onset periodontitis 
(24). A later study by these researchers (25) showed 
a significantly increased level of IgG antibody to A. 
actinomycetemcomitans serotype b in 90% of local- 
ized early-onset periodontitis patients, 40% of gener- 
alized early-onset periodontitis and only 25% of 
adult periodontitis patients. Furthermore, clinical 
studies carried out to observe the effect of treatment 
on A. actinomycetemcomitans load have related poor 
therapeutic outcome with an inability to reduce the 
subgingival load of A. actinomycetemcomitans (113, 
114,214). 
In localized early-onset periodontitis when pres- 
ent, A. actinomycetemcomitans, is predominant. 
Genco et al. (91) indicated that organisms of the nor- 
mal flora play a key role in gingivitis, while exoge- 
nous organisms or more unusual anaerobic organ- 
isms seem to be implicated in periodontitis. Im- 
munological studies involving patients with localised 
early-onset periodontitis indicate significantly elev- 
ated titers of serum antibodies to A. actinomycetem- 
comitans in localized early-onset periodontitis pa- 
tients (67,69,73,95,180,191,260,315,331). These 
patients have also been seen to produce antibodies 
locally to A. actinomycetemcomitans (260). 
Accompanying the documentation of specific in- 
fections in periodontitis patients has been the defi- 
nition of active host systemic immune responses to 
these bacteria (73). In particular, it appears clear 
that, in most populations, patients with localized 
juvenile periodontitis exhibit elevated serum IgG 
antibody to A. actinomycetemcomitans (30,73). 
These results have been derived from cross-sectional 
studies and demonstrated some correlation with the 
ability to identify the homologous microorganism in 
the subgingival plaque (66,309). Accumulating evi- 
dence has supported the concept that the predomi- 
nant serotype of A. actinomycetemcomitans appears 
to differ throughout the world (11,40,60,75,99,100, 
109,210,224,262,314,352,359) and may represent 
some more general genotypic, phenotypic, and 
pathogenetic heterogeneity in this species. Ebersole 
et al. (30) reported a study that examined the fre- 
quency of oral disease in an adolescent population 
and assessed the relationship to A. actinomycetem- 
comitans. Heavy accumulations of plaque and calcu- 
lus were frequently observed and were associated 
with gingival inflammation and, significantly, 25.7% 
of the students exhibited early-onset periodontitis 
with 1.7% diagnosed as localized early-onset peri- 
odontitis. The findings supported the hypothesis 
that A. actinomycetemcomitans may represent a 
pathogen in periodontitis and, while oral health care 
may be poor, contact with the microorganism ap- 
pears to be required to initiate disease in this popu- 
lation (30). Ebersole et al. have reported humoral re- 
sponses in periodontitis patients in various Turkish 
populations (32). All localized early-onset peri- 
odontitis patients from Turkey exhibited elevated 
antibody levels to A. actinomycetemcomitans, par- 
ticularly serotypes c and a, while antibody levels to 
A. actinomycetemcomitans serotype b were highest 
in United States localized early-onset periodontitis 
patients. Fifty percent of the Turkish generalized 
early-onset periodontitis patients also showed elev- 
ated anti-A. actinomycetemcomitans antibody. These 
data suggested that considerable variation exists in 
the systemic antibody levels to periodontal patho- 
gens and support potential differences in subgingi- 
val colonization or antigenic composition of these 
pathogens between patient populations from differ- 
ent geographical regions. Additional studies by this 
group have also noted elevated serum antibody re- 
sponses to A. actinomycetemcomitans and selected 
other oral periodontopathogens in Sjögren's syn- 
drome patients with periodontitis (34) and in pa- 
tients with Behcet's disease and periodontitis (33). 
Thus, numerous investigations of many ethnic and 
geographically disparate groups tend to confirm that 
A. actinomycetemcomitans is frequently associated 
with localized early-onset periodontitis, and prob- 
ably an causative agent in the vast majority of cases 
and in a substantial proportion of other early-onset 
periodontitis patients. 
Our findings and those of others (23,28,235,277, 
338,344,345) suggest that human serum antibody 
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reactivities to A. actinomycetemcomitans are ob- 
served to a wide variety of antigens derived from the 
outer membrane of this pathogen. The results indi- 
cated a response to certain antigens that were dis- 
tinctive in active disease patients and may: (i) indi- 
cate changes in antigen expression by A. actinomyce- 
temcomitans (115); (ii) reflect the overall increase in 
serum antibody levels noted in active disease pa- 
tients; or (iii) relate to the increase in the A. actino- 
mycetemcomitans burden, resulting in greater anti- 
genic load, (iv) reflect the extent of existing disease 
(59) or (v) be associated with more severe disease. 
The previously mentioned studies concentrated 
their efforts on analysis of serum IgG antibody to A. 
actinomycetemcomitans or antigens isolated from 
the bacteria. The IgG isotype of immunoglobulin 
consists of four subclasses, IgGl-4, which have been 
shown to be elicited selectively by certain types of 
antigens and to have diverse functions. Thus, the 
isotype and subclass of antibodies in the patient 
serum specific to A. actinomycettmcomitans may re- 
flect restrictions on the capacity of host antibody to 
bind to particular antigens (61,63,64,96,157). The 
repertoire of immunoglobulin isotypes and IgG sub- 
class responses to particular antigens may account 
for variations in host resistance to infection and dis- 
ease. 
A wealth of literature supports the existence of lo- 
cal specific antibody production by plasma cells 
present in inflamed tissues of the periodontal pocket 
(68,72,167,283,294). Likewise, a proportion of gin- 
gival crevicular fluid samples within a given subject 
have local antibody levels significantly greater than 
can be accounted for by a serum contribution (68, 
71,72,146). In addition to these inflammatory me- 
diators, evidence has been provided that indicates 
that both C3 and C4 components of the complement 
system are cleaved in gingival crevicular fluid from 
early-onset periodontitis (237,265), indicating the 
potential of antigen-antibody complexes to contrib- 
ute to local immune modulation. Cross-sectional 
studies have suggested that the gingival crevicular 
fluid samples with elevated antibody frequently 
harbor the homologous bacteria and suggest that a 
combination of the antigen and the host-response is 
frequently associated with progressing disease (72). 
These local antibody levels decreased with pocket 
depth, attachment level stabilized and inflammation 
resolved following therapy (72). 
Studies on early-onset periodontitis patients dem- 
onstrating infection with A. actinomycetemcomitans 
have demonstrated elevated gingival crevicular fluid 
antibodies to A. actinomycetemcornitans in the ma- 
jority of the patients (116,117,260). The presence of 
all subclasses of IgG have been identified in gingival 
crevicular fluid, with IgGi, and/or IgG4 levels in gin- 
gival crevicular fluid were elevated relative to serum 
concentrations (241,245). The results support a 
unique local response in individual sites within cer- 
tain patients and are consistent with a progression 
of subclass responses at sites of infection and dis- 
ease. An intriguing facet of host responses in peri- 
odontitis has been the relationship between local 
and systemic antibodies. The general paradigm 
exists that gingival crevicular fluid is comprised pri- 
marily of a serum transudate at the site of inflam- 
mation (37,42). However, other findings are consist- 
ent with systemic antibody being a manifestation of 
the local antibody responses in the gingival tissues 
and that a portion of serum antibody may be derived 
from local gingival responses to this infection. The 
studies described above document some character- 
istics of the local immune response and their re- 
lationship to infection and clinical presentation in 
early-onset periodontitis patients, particularly within 
A. actinomycetemcomitans infected periodontitis pa- 
tients. The findings are consistent with the potential 
to utilize antibodies or local mediators in gingival 
crevicular fluid as adjuncts in the diagnosis of peri- 
odontitis and in defining the mechanisms of disease. 
A. actinomycetemcomitans is not always found in 
localized early-onset periodontitis patients (108,119, 
150,184,227,327). Furthermore, A. actinomycetem- 
comitans has been found in patients with no clinical 
attachment loss (47,75,209). Leukotoxin produc- 
tion, a factor considered crucial in the virulence 
attributes of A. actinomycetemcomitans, varies 
among strains and has been found in A. actinomyce- 
temcomitans isolated from localized early-onset 
periodontitis rather than adult periodontitis or 
healthy patients (361). A study in Denmark, however, 
found no occurrence of the high leukotoxin-produc- 
ing strains of A. actinomycetemcomitans in their 
population of localized early-onset periodontitis pa- 
tients (123). In summary A. actinomycetemcomitans 
does not seem to be found in all cases of localized 
early-onset periodontitis. Nevertheless, clinical 
studies carried out observing effect of treatment with 
A. actinomycetemcomitans load have linked failure of 
treatment with inability to reduce the subgingival 
load of A. actinomycetemcomitans (114,214). 
Inflammatory mediators 
It has been demonstrated that sera from localized 
early-onset periodontitis patients with decreased 
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neutrophil function can modify the activity of 
healthy neutrophils (2). The serum factors respon- 
sible for these effects have been identified as being 
inflammatory mediators such as prostaglandins and 
cytokines, which have correlated with periodontal 
disease (208). Adherent mononuclear cells from lo- 
calized early-onset periodontitis patients have been 
found to secrete higher levels of prostaglandin E2 
and tumor necrosis factor-a than generalized early- 
onset periodontitis patients or healthy controls 
(274). More recently, insulin-dependent diabetic pa- 
tients with periodontitis have been reported to 
manifest excessive levels of inflammatory mediators 
(256-258). It has been suggested that these obser- 
vations indicate an underlying immune defect of 
monocytes in certain diagnostic groups (222). 
Early investigations of genetic polymorphisms of 
cytokines have attempted to identify a possible link 
between different periodontal categories and speci- 
fic alleles related to an ability to overproduce cyto- 
kines (57,159). In addition, a fartily linkage study of 
early-onset periodontitis suggested that the COX-1 
enzyme system, which acts as a catalyst for the 
breakdown of arachidonic acid, one of the products 
of which is prostaglandin E2, may be associated with 
susceptibility to early-onset periodontitis (89). 
Neutrophil chemotactic defects 
A further host defense defect that may increase sus- 
ceptibility to early-onset periodontitis is neutrophil 
chemotactic defects. A high percentage of members 
of families with a background of localized early-on- 
set periodontitis have been reported to show abnor- 
mal neutrophil chemotaxis (323). Whether the trait 
is due to an intrinsic defect of neutrophils or is 
caused by extrinsic factors in the sera and thus is 
environmentally influenced remains controversial 
(2). The neutrophil chemotactic defect is not noted 
in all populations exhibiting localized early-onset 
periodontitis, and many families with localized 
early-onset periodontitis do not show evidence of 
the defect (152,153). Decreased neutrophil chemo- 
taxis in localized early-onset periodontitis has been 
linked to a reduced receptors density for chemo- 
attractants such as N-formyl-methyl-leucyl-phenyl- 
alanine, complement fragment C5a, leukotriene B, 
and interleukin-8 (49,52). De Nardin (53) found that 
decreased N-formyl-methyl-leucyl-phenylalanine 
binding which was related to variations in N-formyl- 
methyl-leucyl-phenylalanine receptor DNA in local- 
ized early-onset periodontitis patients and healthy 
controls. These preliminary results indicate a poss- 
ible role for a N-formyl-methyl-leucyl-phenylalanine 
receptor alteration in neutrophil chemotaxis. How- 
ever, many molecules related to neutrophil dysfunc- 
tion in localized early-onset periodontitis patients 
belong to the same family of surface receptors and 
have similar morphogenic characteristics. De Nardin 
(53) hypothesized that a common underlying defect, 
at either the cell surface receptor or post-receptor 
level may contribute to the alteration in neutrophil 
function seen in patients with localized early-onset 
periodontitis. 
Humoral immune aspects 
Lu et al. (185) have shown that in certain popula- 
tions serum IgG2 levels are increased in localized 
early-onset periodontitis patients, but not general- 
ized early-onset periodontitis, adult periodontitis or 
periodontally healthy individuals. An interesting as- 
sociation is that black subjects in general have 
higher levels of IgG2 than whites and the incidence 
of localized early-onset periodontitis among black 
individuals has been shown to be up to 15 times 
greater than among whites (182). It thus appears that 
localized early-onset periodontitis patients, particu- 
larly black individuals, have a tendency to produce 
increased levels of IgG2 (310). 
A family study of early-onset periodontitis indi- 
cated the possibility of genetic transmission of IgG2 
levels (193). Smoking has been found to suppress the 
IgG2 response in adult periodontitis and generalized 
early-onset periodontitis patients and is associated 
with more severe destruction but this does not ap- 
pear to occur in localized early-onset periodontitis 
patients (310). Furthermore, the paradoxically lower 
IgG2 titers seen in black generalized early-onset 
periodontitis smokers may be specific to A. actino- 
mycetemcomitans and the IgG2 response against 
antigens of other bacteria may not be lower in gener- 
alized early-onset periodontitis subjects who smoke 
(306). 
Fc receptors 
It has been suggested that the subclass IgG2 is a poor 
opsonin because it fixes complement less effectively 
than IgG3 and IgGI and binds weakly to Fc receptors 
on the surface of phagocytes, which tends to compli- 
cate theories of protective effects afforded by high 
anti-A. actinomycetemcomtians titers of IgG2 in 
black localized early-onset periodontitis patients 
(108,310). However, a further aspect of the immune 
response may yet explain this phenomenon. Fc re- 
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ceptors are the crucial link between the humoral and 
inflammatory components of the host defense sys- 
tem. It is possible that Fcy receptors III may prepare 
polymorphonuclear leukocytes for phagocytosis me- 
diated by Fcy receptors II (343). 
It has been reported that the numbers of Fcy re- 
ceptors II and Fcy receptors III on peripheral blood 
neutrophils of localized early-onset periodontitis pa- 
tients are within the normal range (172). There may 
be local suppression of Fcy receptor expression and/ 
or the increased production of Fcy-binding proteins 
by periodontal pathogens (130). 
Conclusion 
The various aspects of the host response that may 
contribute to peridontal disease have been covered 
in this chapter as have several aspects that may be 
specifically relevant to early-onset periodontitis, in- 
cluding aspects of the innate, inflammatory and im- 
mune defense systems. In summary, the differences 
in the causation and pathogenesis of adult and early- 
onset forms of periodontitis are not yet sufficiently 
elucidated (322). However, multiple specific host de- 
fense features are emerging in the early-onset forms 
of periodontitis that may have a genetic basis and 
that may serve to differentiate the different forms of 
periodontitis and may have utility in terms of 
screening, diagnosis and therapy. 
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